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Abstract 
 
Campylobacteriosis is the leading cause of bacterial gastroenteritis in Australia, with poultry 
considered the major source. Australia’s Food Regulation Secretariat released for comment a 
foodborne illness reduction strategy in 2018, which includes a focus on addressing Campylobacter 
and Salmonella at all points along the food supply chain from farm to consumer. This thesis, 
through the following five aims, will provide evidence and knowledge for both industry and 
regulators. Aim 1 determined the effect of current poultry processing parameters in Australian 
abattoirs on both the level and prevalence of Campylobacter on whole chickens through the 
processing line and provided evidence for the effectiveness of current practice. In order to 
determine if some genotypes have improved survival through processing, a large number were 
genotyped for aim 2. Comparison to circulating human isolates provided evidence for overlap as 
well as unique genotypes. Selection of potentially more pathogenic strains was addressed through 
the third aim of characterizing strains/isolates using a range of phenomic and genomic assays. For 
aim 4, their responses to exposure to the stresses of poultry processing were then measured through 
the modelling of death curves of isolates/strains subjected to heating and separately to chlorine. For 
the final aim, this thesis provided information on the transcriptional changes in Campylobacter to 
understand the stress response upon exposure to sub-lethal chlorine.  
 
The effectiveness of Australian poultry processing in reducing Campylobacter is comparable to 
published international data. Critical control points that effect a reduction in Campylobacter 
numbers were highlighted as the scalding tanks and the immersion chillers. The numbers of E. coli 
could be monitored as an aid to understanding the effect of processing parameters on the numbers 
of Campylobacter. Carriage of specific genotypes varied in a flock and genotype dependent 
manner. Some genotypes were not recorded after specific interventions, indicating variation in 
survival across genotypes. While not a definitive study, there was overlap between chicken and 
human genotypes. With a greater diversity of genotypes noted in human isolates, sources of human 
infection other than poultry should be investigated.  
 
A subset of Campylobacter strains, selected on a basis of survival through poultry processing and 
frequency of isolation from humans, was further characterised using a range of assays. Whole 
genome sequencing was used to determine lipooligosaccharide and capsular polysaccharide classes. 
Isolates/strains could only be differentiated in bile salt agar assays. The host/source groupings upon 
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which the subset were chosen could not be differentiated in any assay, although a level of variation 
was noted, suggesting that poultry processing does not select for a more pathogenic genotype.  
 
GInaFiT software was used to model survival when exposed to high and low scald temperatures and 
when exposed to chlorine. Australian Campylobacter, as represented by the sub-set of 
isolates/strains, do not have any unusual heat resistance characteristics. The potential for 
Campylobacter to develop a heat resistant sub-population at the higher scald temperatures should be 
of concern to the poultry industry. Controlled chlorine/pH levels in the immersion chiller are 
sufficient to control unattached Campylobacter although variation in survival exists. When exposed 
to sub-lethal levels of sodium hypochlorite, Campylobacter NCTC11168 produces a global 
response, with an overlap with the heat stress response and to a lesser extent with the oxidative 
stress response. The lipooligosaccharide may play a greater role in the response to reactive chlorine 
species (RCS) compared to the capsular polysaccharide. It is unlikely that the response to RCS 
increases virulence as the expression of a selection of virulence genes were downregulated or 
unchanged. 
 
Publically available information on the changing numbers and genotypes of Campylobacter through 
poultry processing in Australia is now available for industry, risk assessors and regulators. With a 
correlation noted between E. coli and Campylobacter numbers, industry could utilise E. coli as a 
more rapid measure of the effectiveness of interventions on Campylobacter numbers. Poultry 
processing can select for certain genotypes as a level of variation in survival across genotypes was 
noted. However, poultry should not be considered the sole source of contamination, with evidence 
of the potential of other, unexplored, sources of Campylobacter within human isolates. Scalding 
affects Campylobacter survival, however knowledge of the probable shape of decline can now be 
used to determine the potential risk of Campylobacter survival. Importantly, the development of 
heat resistant sub-populations should also be considered when determining the risk involved in 
scalding operations. Current immersion chilling practices incorporating sodium hypochlorite and 
citric acid are effective controls of unattached Campylobacter, although a high level of variation 
exists in survival. A global transcriptomic response upon exposure to chlorine is exhibited by 
Campylobacter with considerable overlap with the known heat stress response. The possibility of 
broad upregulation of virulence genes during the global response to sodium hypochlorite was not 
demonstrated within this study. Australian poultry processing parameters considered in this thesis 
are not selective for more pathogenic Campylobacter and can achieve effective control of 
Campylobacter numbers.  
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1.1 Campylobacter spp. 
1.1.1 Characteristics 
 
The family Campylobacteraceae consists of the genera Campylobacter, Arcobacter and 
Sulfurospirillum. Members of this family are curved or S shaped spiral rods that are 0.2 to 0.8 µm 
wide and 0.5 to 5 µm long (Debruyne et al., 2008). Cells may form coccoid bodies and most are 
motile with a characteristic screw-like motion with a single polar flagellum. The genus 
Campylobacter is currently made up of 30 species (http://www.bacterio.net/campylobacter, 
accessed February 2018) with five of these having two subspecies. With an optimal growth 
temperature of 41.5 °C and a range between 30 and 45 °C, C. jejuni, C. coli, C. lari, C. helveticus 
and C. upsaliensis are often referred to as the thermophilic Campylobacter (Debruyne et al., 2008). 
While clinical isolates of Campylobacter are frequently not speciated, up to 90 % of isolates are 
considered to be C. jejuni and 5 to 10 % C. coli (Fitzgerald et al., 2008). The remainder of this 
review will focus only on C. jejuni and C. coli. 
 
1.1.2 Epidemiology 
 
Since the first isolation of “related Vibrios” from human stools in 1972 (Dekeyser et al., 1972), 
Campylobacter is now recognized as the leading cause of bacterial gastroenteritis in most western 
countries. Notification rates (per 100, 000 population) vary across the globe. The number of cases 
per 100,000 in 2016 is reported as: 18.6 in the United States (CDC, 2017); 110.2, Australia 
(NNDSS, 2017); 90.2, United Kingdom (EFSA, 2017); and 158.9, New Zealand (ESR, 2017). 
Within the EU there are large geographical variations in confirmed cases of campylobacteriosis, 
from 2.0 in Poland to a high of 228.2 in the Czech Republic, with an overall average across 27 
member states of 66.3 per 100,000 population (EFSA, 2017). The number of cases of 
campylobacteriosis in Australia compared to other causes of gastrointestinal illness is highlighted 
by the selected notification rates from the National Notifiable Diseases Surveillance System 
(NNDSS, 2017) displayed in Table 1-1.  
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Table 1-1: Gastrointestinal disease notification rates in Australia per 100,000 population. Data is extracted from National Notifiable Diseases Surveillance 
System of selected disease by State and Territory and year (NNDSS, 2017). 
 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2010 2011 2012 2013 2014 2015 2016 2017 
Campylobacteriosis 76.2 70.9 92.9 98.0 99.0 125.5 116.2 121.0 120.0 110.0 117.2 117.2 101.8 93.4 124.8 94.6 99.8 110.2 
Salmonellosis 31.8 26.1 31.8 37.5 36.9 36.0 34.9 40.9 44.6 43.5 53.6 54.6 49.1 55.0 69.2 71.1 74.7 67.9 
Shigellosis 8.0 5.8 6.0 6.6 4.3 2.9 2.2 3.6 2.8 2.8 2.5 2.2 2.4 2.3 4.4 4.4 5.8 7.3 
Listeriosis 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.2 0.4 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 
STEC, VTEC NN1 NN NN NN 0.3 0.2 0.3 0.4 0.4 0.6 0.4 0.4 0.5 0.8 0.5 0.6 1.4 2.0 
Typhoid Fever 0.4 0.3 0.3 0.4 0.3 0.4 0.3 0.3 0.4 0.5 0.4 0.6 0.5 0.6 0.5 0.5 0.4 0.6 
Cryptosporidiosis NN NN NN NN NN 8.4 6.1 15.7 13.3 21.3 6.7 8.1 13.8 16.6 10.2 17.0 22.4 19.3 
Hepatitis A 13.3 11.0 8.8 16.4 8.2 2.8 2.2 1.6 0.8 2.6 1.2 0.6 0.7 0.8 1.0 0.8 0.6 0.9 
Hepatitis E NN NN NN NN 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.2 0.2 
1NN: not notifiable 
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Campylobacter is more frequently associated with sporadic cases of disease than outbreaks. In 
Australia between 2001 and 2006, there were 33 Campylobacter outbreaks, with 147 laboratory-
confirmed cases which represented only 0.1% of all notified cases (Unicomb et al., 2009). 
Outbreaks were more likely to occur at commercial premises (restaurants or take-away premises) 
and aged care facilities, and were also more frequently associated with poultry, unpasteurized milk 
and contaminated water (Unicomb et al., 2009). This is supported by US data where 23.8 % of 
water borne non-legionellosis bacterial outbreaks between 1971 and 2006 in the US were caused by 
Campylobacter (Craun et al., 2010). Over 50 % of milk-borne disease outbreaks in the US between 
1990 and 2006 were attributed to Campylobacter (Newkirk et al., 2011). Significantly (P<0.01) 
more of these outbreaks were linked to unpasteurized milk (67.4 %) compared to pasteurized milk 
(29.7 %) (Newkirk et al., 2011). 
 
It has been demonstrated that 500 cells is sufficient to cause disease (Robinson, 1981). 
Campylobacteriosis presents as a self-limiting acute diarrhoeal disease with onset from 18 h up to 
8 days after infection (Blaser and Engberg, 2008). Other symptoms may include a prodromal period 
of fever or abdominal pain, and the diarrhoeal stage may be accompanied by fever, vomiting and 
cramping abdominal pain (Blaser and Engberg, 2008). There may be sequelae following recovery 
from these symptoms including irritable bowel syndrome, inflammatory bowel disease, reactive 
arthritis and Guillain-Barré syndrome (GBS) (Jacobs et al., 2008). Campylobacter are considered 
the dominant preceding infection in GBS (20 – 50 %) and the incidence per 100,000 population lies 
between 0.6 and 1.9 (Jacobs et al., 2008). The reasons for the range of severity of disease as well as 
the infection rates have not been fully elucidated, but may depend upon such factors as previous 
exposure, strain variation and host susceptibility (Young et al., 2007). 
 
Protective immunity to Campylobacter can be found after exposure to high-risk foods such as raw 
milk (Blaser et al., 1987; Jones et al., 1981). In human exposure trials, Black et al. (1988) found that 
when re-challenged with the same strain after infection, volunteers did not become ill a second 
time. Less common serovars tend to be isolated from older people which may suggest that there 
may be an acquired immunity to the more common serovars (Miller et al., 2005). In developing 
countries, campylobacteriosis is considered hyperendemic among young children (Acheson and 
Allos, 2001). This leads to immunity to infection but does not stop asymptomatic carriage (Platts-
Mills and Kosek, 2014; Taylor et al., 1988). 
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1.2 Ecology 
 
The main sources of Campylobacter infection have been identified as the gastrointestinal tracts of 
poultry and mammals, and contaminated waterways. Campylobacter species have been isolated 
from various animals including cattle, pigs, wild birds, companion dogs as well as from drinking 
water (Craun et al., 2010; Horrocks et al., 2009).  
1.2.1 Sources other than poultry 
 
Risk assessments have identified the presence of household pets such as dogs as a risk factor for 
Campylobacter infection, particularly in young children (Kapperud et al., 1992; Tenkate and 
Stafford, 2001). Direct transmission from dogs to humans has been demonstrated by Damborg et al. 
(2004) and Wolfs et al. (2001) although C. upsaliensis and C. helveticus are the prevalent species in 
dogs and cats, respectively (Baker et al., 1999; Moser et al., 2001).  
 
The incidence in beef cattle has been reported to vary between less than 10 % to greater than 60 % 
(Beach et al., 2002). C. jejuni is the dominant species carried by cattle (Bae et al., 2005; Harvey et 
al., 2005). The carriage of Campylobacter appears to be higher in cattle at feedlots compared to 
pasture fed cattle (Bailey et al., 2003; Grau, 1988). Similar to the rapid spread of Campylobacter 
through contaminated poultry flocks (Berndtson et al., 1996; Shreeve et al., 2000), Campylobacter 
also spreads rapidly in cattle held within the confines of a feedlot (Besser et al., 2005). The carriage 
of Campylobacter by dairy cattle varies across studies, with 51.2 % in the US and 27.6 in Canada 
(Englen et al., 2007; Guevremont et al., 2014). Exposure to raw milk and the dairy farm 
environment have been linked to cases of campylobacteriosis (Lahti et al., 2017) with an increase in 
the number of outbreaks due to the consumption of raw milk in the US (Mungai et al., 2015). 
C. coli is the dominant species of Campylobacter found in pigs and a carriage rate of greater than 
99 % has been reported (Alter et al., 2005b). C. jejuni has also been reported from swine faeces, but 
rarely at a greater prevalence than C. coli. Different recovery methods on samples taken throughout 
the swine slaughtering process also indicates C. jejuni contaminating at 1 % compared to a 
contamination rate of 75 % for C. coli (Pearce et al., 2003). A comparison of C. coli from organic 
and conventional pig farms found no difference in carriage rate, MLST diversity, or the ability of 
the isolates to invade host cells (Denis et al., 2017).  
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Ovine carriage of Campylobacter has not been as extensively studied as for other meat producing 
animals. Thermophilic Campylobacters have been isolated from less than 1 % of sheep carcases 
after chilling in Australia (Phillips et al., 2006) but have been found to contaminate sheep carcases 
in Scotland at 90 % (Garcia et al., 2010). C. jejuni was the dominant species contaminating the 
carcases at 78 % compared to 13 % for C. coli. The faecal carriage rate in sheep, as sampled at 
slaughter in Scotland, was reported as 64 %, with species distributed amongst C. jejuni, C. coli, and 
C. upsaliensis at 72 %, 14 % and 6 %, respectively (Garcia et al., 2010). Faecal samples of sheep at 
slaughter in Switzerland, however were contaminated at an overall rate of 63 %, with 13 %, 53 % 
and 33 % identified as C. jejuni , C. coli, and not speciated, respectively (Acik and Cetinkaya, 
2006).  
 
Campylobacter has also been isolated from a number of different types of wildlife including wild 
birds, rabbits, badgers, as well as from waterways and soils (French et al., 2007; Garrett et al., 2007; 
Kwan et al., 2008). Clinical Campylobacter isolates have been found to be more closely related to 
environmental isolates than to those from livestock by use of a phylogenetic approach (Champion et 
al., 2005). However use of a population genetics approach attributed only 3 % of clinical isolates to 
wild animal and environmental sources (Wilson et al., 2008).  
 
1.2.2 Poultry 
 
Poultry are considered the major source of Campylobacter infection in humans in many countries 
(Mullner et al., 2009; Sheppard et al., 2009; Wilson et al., 2008). Poultry meat has been estimated to 
be responsible for approximately 30 % of Campylobacter infections in Australia (Stafford et al., 
2008). Chicken meat consumption accounts for up to 30 % of clinical cases and up to 80 % are 
attributed to chicken meat production as a whole (EFSA, 2010c). The increase in chicken meat 
production from 58.5 million tonnes in 2000 to 95.5 in 2014 has also been suggested as a 
contributing factor for the increase in the global burden of campylobacteriosis (Skarp et al., 2016). 
Hence, retail poultry meat and poultry by-products have been examined for both the prevalence and 
level of contamination by Campylobacter species in many countries. Chicken liver was associated 
with eight outbrekas between 2008 and 2013 in Australia (Merritt et al., 2011; Moffatt et al., 2016; 
Parry et al., 2012). Care must be exercised in comparing studies utilizing different sampling and 
analysis methods, in particular between studies that used enrichment technologies and those that did 
not. However, an overall understanding of the contamination rate of poultry can be gained. The 
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majority of countries have a prevalence on poultry at retail of greater than 50 %, although the 
contamination rate varies greatly between countries (Suzuki and Yamamoto, 2009). Australian 
whole birds have been reported to be contaminated at a prevalence of 88.1% (Pointon et al., 2008) 
at retail, and at 84.3 and 95.8 % immediately following chilling (FSANZ, 2010b; King and Adams, 
2008). 
 
As human Campylobacter isolates are predominantly C. jejuni, the relative contamination rates of 
C. jejuni versus C. coli on poultry and poultry products is of some importance. Differences in risk 
factors have been identified for different Campylobacter species (EFSA, 2010b; Gillespie et al., 
2002). In most surveys, C. jejuni represents greater than 50 % of poultry isolates. Within South 
Africa and Thailand this is reversed, with C. jejuni being only 28 and 32 % of isolates, respectively 
(Suzuki and Yamamoto, 2009). The contamination rate of C. jejuni on Malaysian chicken at retail 
was 92.5 (fresh) and 53.8 % (chilled) samples while C. coli was found on 80 and 56.3 % of fresh 
and chilled samples, respectively (Usha et al., 2010). Research aimed at determining the source of 
Campylobacter causing disease has focused on the genetic relatedness of strains from poultry, 
livestock, humans and the environment.  
 
1.3 Typing methods 
 
Numerous studies have examined poultry as a major route of Campylobacter transmission to 
humans by assessing the overlap in genotypes between hosts. There has been an evolution in 
available typing methods, with a move from phenotypic to molecular based methods. These include 
but are not limited to the historically used heat sensitive (HS) Penner serotyping scheme and 
progressing to the molecular based methods such as flaA restriction fragment polymorphism (flaA-
RFLP), flaA short variable region (flaA-SVR), repetitive extragenic polymorphism PCR (REP-
PCR), pulsed field gel electrophoresis (PFGE), amplified fragment length polymorphism (AFLP), 
multi locus sequence typing (MLST) and, most recently, to whole genome sequencing (WGS). The 
development and application of these methods has been driven by the need to find the cause of 
common source outbreaks or sporadic infections and the need to understand the routes of 
transmission of Campylobacter as it is the cause of the largest number of bacterial foodborne 
gastroenteritis cases in the western world.  
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Serotyping is performed using either the HL method of Lior or the HS (O) method of Penner (Lior 
et al., 1982; Penner et al., 1983). The Penner HS serotyping scheme is based on the capsular 
polysaccharide component of the outer membrane and can differentiate 47 C. jejuni serotypes 
(Penner et al., 1983). Such methods require appropriate serotyping reagents that are expensive and 
time consuming to produce, and as a result the Penner typing scheme is no longer available within 
Australia. Penner serotypes can be determined by multiplex PCR or sequencing (Penner et al., 
1983) of the capsular polysaccharide locus (Poly et al., 2015; Poly et al., 2011).  
 
PFGE has been considered to be more discriminatory than other molecular methods used for the 
typing of Campylobacter and therefore considered more suitable for short term epidemiological 
studies and for the determination of the source in outbreak investigations (Adzitey et al., 2013). 
PFGE depends on the differences in the genomic locations of restriction enzyme sites, and as such, 
mutations, or minor insertions and deletions that do not effect these sites will not be detected. The 
use of two or even three restriction enzymes can better capture any genetic variability (Foley et al., 
2009). The banding profiles produced are based on the entire genome and as such can be seen as an 
improvement over PCR based typing methods which target only small sections of the genome. 
 
MLST is a high resolution bacterial genotyping technique which has been adapted for a wide range 
of organisms including Staphylococcus aureus, Candida albicans, Neisseria meningitidis and 
C. jejuni and C. coli (Dingle et al., 2001; Maiden et al., 1998). MLST utilises PCR amplification of 
seven housekeeping genes followed by sequencing of the amplicons. For Campylobacter, the seven 
housekeeping genes are aspA (aspartase A), glnA (glutamine synthetase), gltA (citrate synthase), 
glyA (serine hydroxylmethyl-transferase), pgm (phosphoglucomutase), tkt (transketolase) and uncA 
(ATP synthase α subunit). These genes are located a minimum of 70 kb from each other on the 
chromosome and hence are unlikely to be co-inherited in the same recombination event (Dingle et 
al., 2001). The different sequences are assigned different alleles and the alleles at the different loci 
give an allelic profile or sequence type (ST). These STs can then be assigned to a clonal complex 
(CC). CCs are defined as groups of two or more independent isolates with a ST that shares identical 
alleles at four or more loci. Each CC is then named after the putative founder of the group, e.g. 
CC- 21 (Dingle et al., 2001). MLST also allows effective inter-lab comparisons through the use of 
the central PubMLST database (https://pubmlst.org/). The accumulation of nucleotide changes in 
housekeeping genes is a relatively slow process which means that MLST profiles are stable enough 
to be used for epidemiological purposes (Foxman et al., 2005).  
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The flaA-RFLP typing scheme was first developed by Nachamkin et al. (1993). Both C. jejuni and 
C. coli possess flaA and flaB genes that are involved in expression of the flagellin filament (Fischer 
and Nachamkin, 1991; Guerry et al., 1990). The flaA gene contains three regions, the conserved N 
and C-terminal and a variable internal V1 region. PCR is performed using a designated set of 
primers against the conserved terminal ends and the product is digested with the restriction enzyme 
DdeI. Resulting banding patterns are visualized on an agarose gel. Harrington et al. (2003) 
compared three flaA-RFLP typing methods, with the method of Nachamkin et al. (1993) having the 
highest diversity index. As the flagellin gene is subject to re-assortment, transfer and recombination 
events, this would suggest that flaA-RFLP typing is not the method of choice for long term 
epidemiological studies. As flaA-RFLP typing is based on the sequence variation of a single gene, 
there may be greater strain variation detected by this method. However, an Australian study 
(O'Reilly et al., 2006) indicated that flaA-RFLP typing was suitable for large numbers of isolates 
based on ease of operation, equipment availability and cost. While the final gel images and analysis 
can be shared via software such as Bionumerics (Applied Maths NV, Belgium), it is not as readily 
comparable across laboratories as the digital outputs created by methods such as MLST.  
 
The flaA gene is also the target site for flaA-SVR typing. A region of the flaA gene within that 
targeted by flaA-RFLP is first amplified by PCR primers that hybridize to conserved sequences with 
the resulting amplicon being sequenced (Meinersmann et al., 1997). Sequences are compiled on a 
central international database which gives this method greater portability than flaA-RFLP. As in 
flaA-RFLP, a single gene is analysed, meaning that this method is also not suitable for long term 
epidemiological studies. However it can be very useful for discriminating more closely related 
strains (Hiett et al., 2007).  
 
Repetitive extragenic palindromic polymerase chain reaction (REP-PCR) typing targets the variable 
regions of the genome. These highly variable regions evolve faster than conserved regions hence 
REP-PCR can give a higher level of resolution than methods that target the more conserved regions 
and are considered useful for mapping short term epidemiology (Maiden et al., 1998). However the 
reproducibility of results with this method when used for Campylobacter typing, can be affected by 
the DNA extraction method used (Behringer et al., 2011).  
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As the costs of WGS have decreased, analysis pipelines have improved and proliferated, resulting in 
an increase in publicly available data, and thus public health laboratories and food regulatory bodies 
have moved to incorporate WGS into their ongoing response to foodborne disease (Taboada et al., 
2017). The US Food and Drug Administration have undertaken WGS since 2003, and their 
GenomeTrakr program has over 165,000 sequences incorporated including more than 10,000 
Campylobacter sequences (FDA, 2018). By the end of 2017, the FDA was adding almost 6,000 
sequences a month. GenomeTrakr utilises whole genome-based MLST (wgMLST) to differentiate 
isolates, allowing a greater number of genes to be assessed compared to PCR-based MLST. In 
conjunction with temporal relationship data, wgMLST has been used to traceback the origin of 
campylobacteriosis in Finland (Kovanen et al., 2016). This study supports the use of wgMLSTas an 
accurate method for comparison of temporarily associated isolates (Kovanen et al., 2016). Other 
publicly available systems such as the Center for Genomic Epidemiology (CGE, 2018) allows the 
user to enter their WGS and determine the presence of antimicrobial resistance genes, potential 
virulence genes and MLST amongst a number of other capabilities depending on the genus of the 
organism. Core genome MLST (cgMLST) is also possible and can produce a rapid and high-
resolution analysis of diverse isolates for both C. coli and C. jejuni (Cody et al., 2017).  
 
The selection of typing method must be carefully considered in the context of the aims of the 
proposed study, the available resources (both physical and financial) and the possible future use of 
the data such as sharing of results. O’Reilly et al. (2006) applied nine different typing techniques to 
84 Campylobacter isolates from a single health area in Australia. The aim of this study was to 
compare the logistics of the various methods and examine their ability to assist in finding outbreaks 
or common sources of sporadic infection. RFLP of the flaA gene was found to be suitable as a 
preliminary typing method based on ease of operation, equipment availability, cost and consistent 
subtypes within the genotypic groupings, as had previously been reported by Harrington et al. 
(1997) and Wassenaar et al. (1995). 
 
Simpsons index of diversity (D) is a mathematical measure of species diversity which accounts for 
both species richness and relative abundance (Hunter and Gaston, 1988). It is frequently used as a 
means to evaluate different typing tools. The D of various typing methods using strain sets of 
Campylobacter are listed in Table 1-2. Methods that utilize the whole genome or examine a larger 
number of targets usually provide a higher index of diversity. While flaA-RFLP has been found to 
be a good first pass typing technique, it has a D value of 0.92 compared to 0.96 and 0.97 for MLST 
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and PFGE, respectively, when used on the same isolate set (O'Reilly et al., 2006). Use of a 
combination of methods has been found to provide the highest index of diversity (Behringer et al., 
2011; Price et al., 2006).  
 
Table 1-2: Simpsoms Index of Diversity for typing methods conducted with sets of Campylobacter 
isolates 
Reference Penner 
flaA- 
RFLP 
flaA- 
SVR 
REP-PCR PFGE MLST WGSa 
O’Reilly et 
al., (2006) 
0.90 0.92 0.87 - 0.97 0.96 - 
Behringer et 
al., (2011) 
- 0.90 - 0.93 0.95 0.92 - 
Price et al., 
(2006) 
- - 0.86 - - 0.94 - 
a No published data that compares the diversity from WGS to the diversity achieved with other 
methods on Campylobacter. 
 
1.4 Pathogenicity 
 
Despite much research into the factors that determine the pathogenicity of Campylobacter, the 
molecular basis for pathogenicity in humans is still not well understood and is complicated by such 
factors as innate and acquired immunity (Havelaar et al., 2009). C. jejuni lacks classical virulence 
factors that are more commonly found in other entero-pathogens (Havelaar et al., 2009). A genome 
wide association study designed to identify markers associated with disease-causing lineages of 
C. jejuni, found 25 genetic markers that were associated with clinically related isolates, not all of 
which have a known function (Buchanan et al., 2017). Numerous areas of plasticity in the relatively 
small genome of Campylobacter assist this organism to colonise poultry and mammals, evade the 
immune response, and confound our understanding of the pathogenicity of this enigmatic organism. 
There has been a growing number of suggested virulence factors in Campylobacter aided by 
publication of the first sequence of C. jejuni NCTC11168 in 2000 (Parkhill et al., 2000). Re-
annotation of this primary genome led to over 18 % of coding sequence product functions being 
revised and major updates to key surface structures such as lipooligosaccharide (LOS) and capsular 
polysaccharide (CPS) (Gundogdu et al., 2007). The use of WGS for broad and in-depth 
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characterization of Campylobacter, particularly in epidemiological studies, has increased our 
understanding of some important pathogenicity determinants (Llarena et al., 2017; Skarp et al., 
2015). The lack of an animal model has led to in vitro assays being widely used to assess potential 
pathogenicity. While virulence is multifactorial, virulence factors can be loosely grouped into 
motility, colonisation, adherence/invasion, stress response, toxin production and surface structures 
such as the lipooligosaccharide and the capsular polysaccharide .  
 
Motility has been correlated with the ability to invade host cells and is highly related to the structure 
of the bi-polar flagella (Golden and Acheson, 2002). Motility has been shown to increase in 
response to increasing viscosity which may influence the level of motility in the human 
gastrointestinal tract (Szymanski et al., 1995). Within the strain NCTC11168 there are eight 
homopolymeric tracts linked to flagella glycosylation (Guerry et al., 2002; Gundogdu et al., 2007; 
Parkhill et al., 2000). These areas of potential slip-strand mispairing are one potential reason for the 
natural population of NCTC11168 producing colonies that contain motile through to hyper-motile 
variants (Karlyshev et al., 2002). Adherence to host cells is also affected by the glycosylation of the 
flagella (Guerry et al., 2006). The flagellum secretes the Campylobacter invasion antigen (ciaB) 
(Konkel et al., 2004) and the invasion associated marker (iamA). CiaB has been shown to affect the 
invasion of host cells, but not adherence (Biswas et al., 2007; Konkel et al., 1999b), while the iamA 
gene has an unknown role in invasion, although it was found more frequently in invasive isolates 
compared to non-invasive isolates of Campylobacter (Carvalho et al., 2001). 
 
Adherence followed by invasion to host epithelial cells are key elements in the infection process. A 
number of outer membrane proteins are involved in adherence, including but not limited to cadF, 
jlpA and PEB1 (Jin et al., 2001; Konkel et al., 2009; Krause-Gruszczynska et al., 2007; Pei et al., 
1998; Pei et al., 1991). CadF and FlpA bind to fibronectin, an extracellular matrix protein (Flanagan 
et al., 2009; Konkel et al., 1997; Konkel et al., 2010) and are required for chicken colonization 
(Ziprin et al., 1999). FlpA protein also plays a role in cell adherence (Flanagan et al., 2009; Konkel 
et al., 2010). These two genes, cadF and flpA, may also produce a cooperative effect in binding 
fibronectin and invading host cells (Eucker and Konkel, 2012). The outer membrane protein, porA, 
has also been found to effect binding to fibronectin and adhesion to INT-407 cells (Moser et al., 
1997). Another adhesin is the surface exposed glycosylated antigenic glycoprotein, jlpA (Scott et 
al., 2009). The available data for the role of jlpA is conflicting. A jlpA mutant had reduced ability to 
bind to HEp-2 cells (Jin et al., 2001) and jlpA was upregulated when the strain was exposed to 
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human mucin (Tu et al., 2008). In comparison, very little reduction in invasion of T84 cells was 
noted (Novik et al., 2010) and there was no reduction in colonisation of chickens by a jlpA mutant 
(Flanagan et al., 2009). Also shown to be immunogenic and to have a role in adherence to HeLa 
cells and invasion of INT-407 cells is the ABC transporter PEB1 (Leon-Kempis et al., 2006; Pei et 
al., 1998; Riddle and Guerry, 2016). A Campylobacter adhesion protein (capA) insertion mutant 
demonstrated reduced ability to invade Caco-2 cells and also did not colonise chickens (Ashgar et 
al., 2007). Flanagan et al. (2009) also found capA insertional mutants did not affect colonization of 
chickens although it did effect in vitro adherence to chicken epithelial cells. More recently a role for 
htrA in adhesion to host cells has been elucidated (Baek et al., 2011). HtrA functions as a protease 
and a chaperone and it is the chaperone activity that affects the adhesion to host cells (Baek et al., 
2011). There is the potential that not all genes that affect, to a greater or lesser extent, the adhesion 
and invasion of host cells or colonization of chickens, have yet been identified. A greater 
understanding of the role of individual genes may occur with improved understanding of the gene 
networks of pathogenicity (Wassenaar et al., 2007). 
 
The cytolethal distending toxin in Campylobacter is made up of three subunits, cdtA, cdtB and cdtC 
(Eyigor et al., 1999) with cdtB the active subunit (Whitehouse et al., 1998). C. jejuni has been 
shown to have higher cytotoxic activity than C. coli (Pickett et al., 1996). Clinical isolates of 
Campylobacter have been found that are negative for the presence of the CDT genes suggesting that 
the CDT is not required for pathogenicity (AbuOun et al., 2005; Gilbert et al., 2009).  
 
Surface structures such as the LOS and CPS also play a role in adhesion and invasion. Isolates with 
a sialylated LOS have been found to be more invasive than non-sialylated isolates (Habib et al., 
2009; Louwen et al., 2008). Mutation of the cstII gene, a sialytransferase for transferring sialic acid 
onto the LOS core, leads to reduced levels of adhesion in only a limited number of strains indicating 
that LOS sialylation plays a lesser role in adhesion than in invasiveness (Louwen et al., 2008). The 
sialylated LOS produces a structurally similar product to human gangliosides, described as 
ganglioside mimicry, which can produce autoantibodies against gangliosides leading to 
neurological issues such as Guillain-Barré syndrome (Nachamkin et al., 1998). The invasiveness of 
some C. jejuni isolates has been linked to the presence of the cgtB or wlaN gene (within the LOS), 
both of which code for putative β-1,3-galactosyltransferase (Muller et al., 2007). The 
homopolymeric tract found in the wlaN gene, when in the ‘on’ position and producing an intact 
product, was only found in strongly invasive isolates (Muller et al., 2007). Isolates with strong 
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colonising and invasion abilities were found to contain the cgtB gene although it was not detected in 
some isolates with colonisation ability (Muller et al., 2006). Survival upon exposure to bile salts is 
required for colonization of the chicken or human gastrointestinal tract. LOS has been demonstrated 
to play a role in the bile resistance of Campylobacter (Iwata et al., 2013). Mutants constructed with 
serial LOS OS truncations demonstrated differences in the resistance to bile salts - the shorter the 
LOS the lower the bile resistance (Iwata et al., 2013). Isolates with the truncated LOS also 
colonized chickens at lower levels than the wild type (Iwata et al., 2013). 
 
The CPS locus is also an area of the Campylobacter genome subject to phase variation through the 
presence of homopolymeric tracts (Bacon et al., 2001) leading to large variation between strains 
(Parker et al., 2006; Poly et al., 2004, 2005). An insertional mutant of kpsM, producing an isolate 
with no capsule, could not colonise a chicken gut (Jones et al., 2004). Contrary to this, colonisation 
of chickens was largely unaffected by the lack of CPS in a 81116 kpsE mutant (Bachtiar et al., 
2007). This mutant also produced 20-fold lower adherence to INT-407 cells and a 2-fold lower 
invasion capability (Bachtiar et al., 2007). Strain 81-176 with no CPS production, also had reduced 
adherence and invasion of INT407 cells (Bacon et al., 2001). In a ferret model this CPS negative 
81-176 mutant, produced a lower incidence of disease compared to the capsulated wild type (Bacon 
et al., 2001).  
 
1.5 The poultry chain 
 
The poultry chain from farm to fork can be separated into distinct stages; farm, transport, slaughter, 
evisceration, washing and chilling, and further processing including retail. The majority of chickens 
in Australia that are destined for the table are reared within intense commercial broiler production 
facilities. When the required live weight is reached, the flock, or part of the flock, is transported to a 
poultry processing facility for slaughter and dressing. A generic description of the slaughtering 
process is outlined in Figure 1-1.  
Further processing of dressed birds may involve a number of different processes depending on the 
customer requirements. It may be as little as bagging the whole bird to portioning, marinating or 
production of specific further processed products such as nuggets. All products then move through 
public retail or food service outlets for consumption by the end consumer. 
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Figure 1-1: Schematic of a generic chicken processing operation 
1.5.1 Ecology on-farm 
 
Numerous studies have examined the ecology of Campylobacter within chicken farms. Once a flock 
becomes infected there is a rapid transmission of Campylobacter throughout the flock and the 
environment (Berndtson et al., 1996; Shreeve et al., 2000). Risk factors for flock contamination by 
Campylobacter have been found to include, but are not limited to, seasonality, free-range and 
organic birds, size of flock, and the use of nipple drinkers with trays (Barrios et al., 2006; Nather et 
al., 2009; Wallace et al., 1997). The role of flies in the contamination of broiler flocks has also been 
suggested (Bahrndorff et al., 2013; Ekdahl et al., 2005). Seasonality of Campylobacter infection of 
broilers has been recognized, with a number of studies describing a significant increase in the 
summer months (Barrios et al., 2006; Nather et al., 2009; Wedderkopp et al., 2000). However, 
studies by Evans and Sayers (2000) and Humphrey et al. (1993) found no significant difference in 
prevalence on farm between summer and winter. On-farm contamination with Campylobacter is 
complex and multi-factorial and may include further factors such as country and management 
practices. Within the European Union the prevention of broiler flock contamination is recognized as 
a food safety priority (EFSA, 2011).  
 
The prevalence of Campylobacter has been found to be higher in organic chickens than that found 
in conventional flocks (Heuer et al., 2001). Significant differences between production systems 
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were noted in Denmark with 100 % (22/22) organic flocks, 36.7 % (29/79) conventional flocks and 
49.2 % (29/59) extensive indoor flocks positive for Campylobacter (Heuer et al., 2001). The 
estimated within flock prevalence of these three rearing systems did not differ significantly. A 
systematic review of the prevalence of Campylobacter in organic and conventionally raised poultry 
(other enteropathogens and production animals were also analysed) found the prevalence to be 
higher in organic chickens at slaughter but no difference between systems at retail (Young et al., 
2009). 
 
The carriage on Danish chickens at slaughter was 54 % for organic and 19.7 % for conventionally 
raised poultry, although the level of Campylobacter was not different (Rosenquist et al., 2013). 
Organically raised poultry meat therefore was calculated to carry a risk of causing clinical disease 
linked to Campylobacter 1.7 times that of conventionally raised meat (Rosenquist et al., 2013). 
Suggestions for the difference in flock prevalence between production systems may be attributed in 
part to the age at which the flocks are sent for slaughter, with organic flocks generally slaughtered 
at a greater age. Increasing age at slaughter has been demonstrated to be linked to the risk of flock 
infection (Barrios et al., 2006; Evans and Sayers, 2000). The lack of strict biosecurity measures may 
also play a role in the infection of organic flocks. The control of movement of personnel and other 
biosecurity measures such as control of rodents and other pests has also been reported as important 
in reducing Campylobacter infection on-farm (Rosenquist et al., 2009).  
 
1.5.2 Ecology through chain 
 
There is large variation in both prevalence and level of contamination of poultry throughout the 
processing chain. The amount of variability in the prevalence of Campylobacter as seen across 
studies as well as the general trend for reduction in prevalence during the recognized control points, 
scalding and chilling, is highlighted in a systematic review by Guerin et al. (2010) and is shown in 
Figure 1-2. While there are no published data on the effect of poultry processing on the level of 
Campylobacter on poultry in Australia, other studies generally indicate reductions after scald and 
again after washing/chilling (Rosenquist et al., 2006). Currently available data suggests that 
immersion chilling has a highly variable effect on the prevalence of Campylobacter. Reduction in 
the prevalence of Campylobacter through chilling has been observed across 62 % of studies used in 
the systematic review by Guerin et al. (2010). While only two studies were included, scalding was 
also noted to result in a reduction in the prevalence of Campylobacter. 
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The World Health Organization published a risk assessment of Campylobacter in broiler chickens 
in 2009 (FAO/WHO, 2009). This risk assessment utilized data from various countries to provide 
relative risk comparisons that can be used to characterize a specific system. Although data was 
obtained from various geographic areas, significant data gaps were highlighted, which included the 
prevalence and enumeration at various processing steps.  
 
 
Figure 1-2: The range of reported change in prevalence on chicken carcases before and after 
specific stages of processing as reported by 13 studies. n=indicates the number of studies. Modified 
from Guerin et al. (2010). 
 
1.5.3 Australian processed poultry data 
 
The risk assessment conducted by FSANZ (2005) on the public health and safety of poultry meat in 
Australia has indicated data gaps through the processing chain. The accuracy of these types of 
assessment is partially based on the initial assumptions of the model and the available data. The 
FSANZ assessment was only conducted qualitatively for the through chain process due to a lack of 
quantitative data. Earlier published work is restricted in its usefulness by both sampling only at 
retail and by the limited sample sizes. Publication of the FSANZ survey, which targeted whole birds 
immediately post spin chill, has gone some way to alleviate this problem. This study demonstrated a 
prevalence of 84 % in whole bird rinse (WBR) samples (n=1104) collected from processing plants 
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post immersion chilling, in WA, SA, NSW and Qld (FSANZ, 2010b). This prevalence data includes 
samples that were positive by enrichment alone, indicating some samples were below the limit of 
direct enumeration. The mean count of Campylobacter in this survey was 0.70 log10 CFU/cm2. Data 
on in-line sampling for Campylobacter throughout the poultry processing chain in Australia has not 
been published.  
 
1.5.4 Diversity through processing 
 
The level of diversity of Campylobacter that survives through the poultry process varies across the 
published studies. Very little diversity, as measured by flaA and flaB-RFLP, was found in UK 
broiler flocks both from caecal contents and after processing, with the limited number of subtypes 
that colonized broiler flocks being the same subtypes observed after washing (Newell et al., 2001). 
A limited number of Campylobacter isolates were typed from each positive sample. In four of the 
five flocks examined, at least one of the types isolated from the caeca were also isolated from the 
carcase rinse (Newell et al., 2001). However the strain diversity decreased slightly from caeca to 
post chill carcases (Newell et al., 2001).  
 
While there is inherent difficulty in comparing studies conducted with different methods, the 
limited study by Rivoal et al. (1999) found a change in flaA-RFLP types on neck skin samples 
taken after evisceration (11 types) compared to fecal samples taken on farm (8 types) of organic 
birds. Of the types found during processing, four had not been detected on farm, cross 
contamination through processing being the most likely source. There was also a change in the 
percentage of isolates that belonged to each genotype from farm to processing. This may indicate 
better survival of some genotypes through the processing chain or the level and frequency of cross 
contamination events. A major limitation of many of these types of studies is the number of isolates 
examined by the chosen typing methods. Many studies select only 1 or 2 isolates from each sample 
and thus may not reflect the true level of diversity. Use of different typing methods across different 
studies, with varying levels of discriminatory power, also limits the ability to make conclusions 
around the impact of processing on the diversity of Campylobacter. Some studies are also limited 
by the number of samples or number of flocks. All of these issues are difficult to address in a single 
study due mainly to the limitation of resources.  
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However, the study conducted by Hunter et al. (2009) in the US included 20 broiler processing 
plants, sampled four times each at both rehang (after slaughter and defeathering but before 
evisceration) and after chill, with 10 birds sampled at each point, and up to four Campylobacter 
isolates stored from each positive sample, leading to 1,478 Campylobacter isolates. The flaA-SVR 
typing method was used to discriminate between isolates. Diversity from this study varied, with one 
plant having a single genotype while up to 16 genotypes were recognized from another plant. There 
was a significant difference in the amount of diversity, with six plants having significantly less 
diversity in Campylobacter flaA-SVR types than the other 11 positive plants. Within each season, 
there was a significant difference in the Simpson’s index of diversity between rehang and post chill 
samples, with decreasing diversity through the poultry process. These changes in diversity may 
indicate that a number of genotypes can survive processing better than others. This concept is also 
supported by Lienau et al. (2007) who reported that specific genotypes detected at primary 
production were found through processing and on final product. A smaller number of genotypes 
were detected sporadically throughout processing and these may indicate genotypes that are less 
resistant to poultry stresses or those that are not present in large enough numbers (Lienau et al., 
2007).  
 
Alternatively, Colles et al. (2010), noted a significant increase in the diversity of Campylobacter 
types from farm (19 STs) to immediately after slaughter (25 STs) as well as an increase in the 
proportion of C. coli. Colles et al. (2010) emphasised the need to take a sufficiently large number of 
samples to determine the full extent of diversity within a flock. There were some indications of 
differential survival of STs through the process within this study. This suggestion of some subtypes 
surviving the stresses of poultry processing is also indicated by Newell et al. (2001).  
 
It is apparent from the number of studies that have examined the carriage of Campylobacter through 
processing that there are many factors impacting on the prevalence, concentration and variation of 
genotypes of Campylobacter detected on poultry at the end of processing. Specific genotypes may 
survive processing stresses either due to the sheer weight of numbers, the level of effectiveness of 
the intervention strategies used, or due to the as yet largely unknown survival mechanisms.  
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1.6 Stress - Survival 
 
Despite the fastidious growth requirements and lack of resistance to environmental stresses 
compared to other foodborne pathogens (Park, 2002), Campylobacter is responsible for the largest 
number of bacterial foodborne gastroenteritis cases in most of the western world (CDC, 2017; 
EFSA, 2017; ESR, 2017; NNDSS, 2017). As poultry, and therefore poultry processing, is 
considered a major source of contamination (EFSA, 2010c; Suzuki and Yamamoto, 2009) it is 
important to understand how this organism responds to the environmental stresses presented during 
poultry processing. Strain to strain variation is commonly reported in Campylobacter studies and 
extensive variation in the genetic makeup of this organism compared to other enteric bacteria was 
noted by Park (2002). The genotypic variation within the Campylobacter genus may allow specific 
genotypes to occur or be selected for when encountering environmental stresses (Wassenaar et al., 
1998). It has been suggested that Campylobacter strains also vary in their capacity to survive during 
poultry processing (Allen et al., 2007; Alter et al., 2005a; Habib et al., 2010; Newell et al., 2001).  
 
1.6.1 Heat (scald) survival 
 
Examination of the heat resistance of Campylobacter under laboratory conditions suggests that 
Campylobacter are sensitive to heat treatment. The D values (time to a one log reduction) in 
chicken meat of a five strain cocktail of C. jejuni at 49, 53 and 57 °C were 20.5, 4.85 and 0.79 min, 
respectively (Blankenship and Craven, 1982). D values at 55 °C in heart infusion broth (HIB) have 
been recorded as 5.3 and 4.6 for C. jejuni, which is significantly (p<0.05) lower from that recorded 
for two strains of C. coli in the same experiments (Table 1-3). C. coli may be regarded as being 
more heat resistant than C. jejuni, when D values are compared (Table 1-3). The importance of 
examining specific genotypes of Campylobacter through processing has been highlighted by Habib 
et al. (2010). Both CC45-ST45 and CC21-ST50 are commonly isolated from Belgian chicken meat 
and may represent a subpopulation that is more resistant to poultry processing stresses than other 
strains. After heating in broth at 55 °C for 5 mins, strains of CC-21 were significantly more resistant 
than strains of CC-45 (Habib et al., 2010). Variation in heat resistance has also been reported for 
cells grown to stationary phase compared to those in exponential growth phase (Klancnik et al., 
2014; Sagarzazu et al., 2010). C. jejuni that had been shown to decrease by either 1 log or 5 log 
after exposure to 48 or 55 °C was used to measure the potential difference in virulence after 
exposure to thermal stress (Klancnik et al., 2014). Using a mouse model as a measure of virulence, 
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Campylobacter treated at 48 °C (3 or 20 min) or 55 °C (3 min), did not affect infectivity although 
there were lower numbers of organisms in the spleen and liver (Klancnik et al., 2014). Heating at 
55 °C for 20 min prior to inoculation prevented the development of a systemic infection (Klancnik 
et al., 2014).  
 
The attachment of Campylobacter to surfaces increases the resistance to heat compared to cells 
grown in 1 % peptone (Table 1-3) (Blankenship and Craven, 1982). C. jejuni attached to chicken 
skin had higher D55 and D60 values than those unattached (Yang et al., 2001). The development of a 
more heat resistant subpopulation when exposed to the higher scald temperatures was also noted by 
Yang et al. (2001). This subpopulation was found when Campylobacter was heated at 55 °C in 
scald water and at 55 °C and 60 °C when attached to chicken skin (Table 1-3). However the initial 
numbers attached to the skin did not affect the survival curves of Campylobacter. At a common 
scald temperature used in Australia (56 °C), a tailing effect was noted, with a divergence from 
linearity in the log survivor curves of C. coli (Moore and Madden, 2000). Other factors may also 
play a role in the survival of Campylobacter through scald temperatures such as the effect of 
temperature on the skin microtopography. Whole chickens scalded at 56 °C were contaminated with 
Campylobacter at significantly lower levels than chickens scalded at 60 °C (Slavik et al., 1995). 
The skin microtopography of chickens scalded at 56 °C allows less bacterial attachment of 
Salmonella (Kim et al., 1993), and it is suggested that the attachment of Campylobacter may be 
similar. The pH may also affect survival as demonstrated by the varying D values found in scald 
water at 52 °C with pH ranging from 4 to 10 (Humphrey and Lanning, 1987). 
 
The exposure to stresses along any foodborne contamination route is many and varied. Within the 
poultry supply chain, organisms may be subjected to rapid chilling during production, and at a later 
stage subjected to heating by the consumer. The effect of chilling on the response of C. jejuni to 
subsequent heating was examined by Hughes et al. (2010; 2009). Prior exposure at 6 °C for 24 h 
leads to the appearance of a heat resistant sub-population, although there is no overall increase in 
heat resistance for the majority of strains examined (Hughes et al., 2010). However, for a few 
strains a small but significant difference in either the death rate (β) or curve shape (α) using Weibull 
equations was noted. This may be related to the subpopulations demonstrated by Yang et al. (2001). 
The Weibull model has been extensively utilized to enable modeling of bacterial survival curves 
that incorporate phenomena such as shoulders and tailing (Albert and Mafart, 2005).  
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Table 1-3: Examples of published D values of Campylobacter  
Species and strain Material D50 D52 D55 D60 Reference 
C. jejuni (AR6) HIB1 36  5.3 0.7 Nguyen et al. (2006) 
C. jejuni (L51) HIB 39  4.6 0.8 Nguyen et al. (2006) 
C. coli (DR4 HIB 60  6.6 0.9 Nguyen et al. (2006) 
C. coli (L6) HIB 51  6.6 1.4 Nguyen et al. (2006) 
C. jejuni (H-840) 1 % Peptone   0.64  Blankenship and Craven (1982) 
C. jejuni (H-840) Cooked Chicken   2.12  Blankenship and Craven (1982) 
C. jejuni (NR)2 Scald water (pH 4)  0.4   Humphrey and Lanning (1987) 
C. jejuni (NR) Scald water (pH 6)  8.72   Humphrey and Lanning (1987) 
C. jejuni (NR) Scald water (pH 7)  11.5   Humphrey and Lanning (1987) 
C. jejuni (NR) Scald water (pH 8)  6.4   Humphrey and Lanning (1987) 
C. jejuni (NR) Scald water (pH 9)  2.0   Humphrey and Lanning (1987) 
C. jejuni (NR) Scald water (pH10)  1.0   Humphrey and Lanning (1987) 
C. jejuni 
ATCC33291 
Scald water 4.0  0.2 <0.2 Yang et al. (2001) 
C. jejuni 
ATCC33291 
Chicken skin 2.1  2.2 0.5 Yang et al. (2001) 
C. jejuni 
ATCC33291 
Scald water   13.93  Yang et al. (2001) 
C. jejuni 
ATCC33291 
Chicken skin   19.43 18.33 Yang et al. (2001) 
1 Heart infusion broth 
2NR; Not Recorded 
3 Subpopulation 
 
1.6.2 Chlorine 
 
Chlorine, in combination with cold temperatures, could be considered a critical control point in 
poultry processing. The primary production and processing standard for poultry (FSANZ, 2010a), 
in conjunction with the Australia New Zealand food standards code regarding processing aids 
(FSANZ, 2011), states that free available chlorine may be added up to a maximum of 5 mg/kg. 
When human isolates (n=3) of C. jejuni were subjected to various chlorine levels for 10 min at 4 °C 
(pH 6.5-7.0), up to 90 % of Campylobacter cells were found to be injured (Terzieva and Mcfeters, 
1992) as measured by the different numbers recovered on selective as compared to nonselective 
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agar. Between 43 and 90 % of cells were killed. The level of chlorine required to kill C. jejuni cells 
was dependent upon the initial number of C. jejuni.  
 
Commonly used levels of chlorine for water treatment (0.1 mg/L) have been demonstrated to have a 
greater effect on C. jejuni (n=3) than on E. coli ATCC11229 (Blaser et al., 1986). Furthermore, a 
high percentage of surviving cells were found to be injured as measured by the number of recovered 
cells on agar containing antibiotics compared to agar containing no antibiotics (Blaser et al., 1986). 
Chlorine concentration at 10, 30 and 50 ppm in water led to decreasing D values of 17.2, 1.3 and 
0.5 min, respectively (Yang et al., 2001). When attached to chicken skin and exposed to 50 ppm 
chlorine, a D value of 73 was obtained, significantly higher than that of unattached cells indicating 
that attachment, the presence of chicken skin, or a combination, enhances Campylobacter survival 
in the presence of chlorine.  
 
However, these studies have largely been conducted using organisms grown in a planktonic state 
using liquid growth media and may not be reflective of what occurs in the natural setting of large 
immersion chill tanks. The presence of organic material, the state of the organism (planktonic or 
sessile), and the abrasive nature of tumbling chickens may all influence the effectiveness of chlorine 
or other disinfectants in an industrial setting. Chlorine dissolves in water to form hypochlorous acid 
(HOCl) and hypochlorite ion (FAO/WHO, 2008). Hypochlorous acid is the most biocidal form, 
although the formation of these two compounds is pH dependent. The acid form is very reactive, 
being both an oxidizing and halogenating species, and therefore the level of free available chlorine 
in conjunction with pH and contact time will determine the effectiveness of chlorine as a 
disinfectant on poultry (FAO/WHO, 2008). At pH above 4.0 the equilibrium favours HOCl and at 
pH above 9.0 HOCl dissociates almost completely to hypochlorite ions (IARC, 1991). A level of 
50 ppm chlorine delivered via a spray wash at 81 psi for 5 s, at temperatures of 21, 43 and 54 °C 
was not effective in reducing Campylobacter numbers on broilers (Northcutt et al., 2005). However 
Campylobacter grown in biofilms were completely inactivated after exposure to chlorine at 55 °C 
for 45 s (Trachoo and Frank, 2002). The use of 8 h old chiller water which contains a higher organic 
load compared to fresh chiller water resulted in a lessening of the effect of added chlorine (Yang et 
al., 2001).  
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1.6.3 Cold 
 
The use of refrigeration temperatures and freezing has long been a key control measure for spoilage 
organisms and pathogens alike. Within the poultry processing chain, whole chickens are chilled, 
using either immersion chilling or air chilling. In Australia, chickens are required to reach a 
temperature of < 7 °C within 6 h of stunning (FSANZ, 2018). Final product is required to reach 
≤ 5 °C within 12 h and be held at this temperature (FSANZ, 2018). The effect of refrigeration 
temperatures on the survival of Campylobacter on red meat and on chicken has been documented 
(Eideh and Al-Qadiri, 2011; Yang et al., 2001). The role of sub-lethal injury due to temperature has 
also been assessed in some studies. The effect of cold temperatures on Campylobacter varies 
somewhat between the studies, which in part can be attributed to the use of different strains or 
recovery methodology (Eideh and Al-Qadiri, 2011). 
 
A study on the survival and injury of C. jejuni (strains ATCC 29428 and ATCC 33291) on cooked 
chicken held at 4 °C for up to 7 d was limited as 45 % of samples had surviving Campylobacter 
when inoculated at a level of 1.7 log10 CFU/g (Eideh and Al-Qadiri, 2011). Under the same 
conditions, a 2.7 log10 CFU/g inoculum resulted in 77.5 % of samples with surviving 
Campylobacter (Eideh and Al-Qadiri, 2011). The effect of a higher initial load of Campylobacter 
leading to a higher number of survivors after being subjected to a chilling stress is supported by 
Sampers et al. (2008).  
 
Freezing has been suggested as a control measure for reducing the numbers of Campylobacter on 
broiler carcases. Moorhead and Dykes (2002) examined the survival of two strains of C. jejuni 
originally isolated from cattle and sheep faeces on beef meat trim held at -18 °C. Most decrease was 
observed in the first seven days of storage with no further significant change in counts up to 112 
days. This is consistent with the study by Habib et al. (2010) where the greatest decline in numbers 
of Campylobacter occurred after only 1 day at -21 °C. Strain variation has been reported, with the 
survival of the common CC21 strains significantly lower than that of strains from CC45 at -21 °C 
(Habib et al., 2010). 
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1.6.4 Oxygen 
 
The oxidative defense mechanism of Campylobacter is important for both the survival outside the 
host and for survival and colonization within the intestinal tract. In general, C. jejuni survive 
oxidative stress in the form of exposure to air or exposure to chemical oxidizing agents better at 
4 °C than at higher temperatures of 42 °C and 25 °C (Garenaux et al., 2009). The response to 
oxidative stress in the form of H2O2 is strain dependent (Koolman et al., 2016). Strain 11168 did not 
invade or adhere to Caco-2 cells after exposure to H2O2 while other strains had reduced adhesion or 
reduced invasion. A single poultry isolate demonstrated increased invasion after exposure 
(Koolman et al., 2016). Sopwith et al. (2008) have suggested the strains of CC45 may be more 
environmentally adapted than strains from other clonal complexes. By selecting strains from the 
most common clonal complexes, Habib et al. (2010) demonstrated that C. jejuni strains belonging 
to CC45 were significantly more resistant to oxidative stress created by the addition of H2O2 than 
strains belonging to CC21. Strains of CC45 declined by less than 30 % following 1 h exposure to 
H2O2, in comparison to strains of CC21 that declined by 30 %. However under aerobic storage at 
4 °C there was significantly better survival of strains of CC21 over CC45 strains (Habib et al., 
2010). Exposure to oxygen may increase pathogenicity, as measured by the ability to invade Caco-2 
cells (Mihaljevic et al., 2007).  
 
Through poultry processing, Campylobacter may be exposed to all of the above environmental 
stresses either singularly, in multiples, or sequentially. The concept of multiple hurdles for control 
of microorganisms in food processing has been developed since the 1990’s (Fellows, 2009). 
Hurdles may affect the survival, or disrupt microbial cells, or cellular metabolism (Fellows, 2009). 
Within poultry processing, the major hurdles for the survival of Campylobacter are ongoing 
exposure to oxygen throughout the process, high temperatures during scalding, antimicrobial 
chemicals in in-line sprays i.e. chlorine, cold, and further antimicrobial chemicals in the immersion 
chiller, or cold and decreasing water activity in air chillers. These stress factors may influence the 
survival of Campylobacter individually or by lowering the resistance to downstream stresses.  
 
1.7 Stress - Response 
 
Campylobacter lacks common stress response mechanisms such as global stationary phase stress 
response factor RpoS and the oxidative stress response factor, SoxRS, amongst others (Park, 2002). 
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However, adaptive tolerance responses (ATR) to acidic and aerobic stress have been demonstrated 
(Alter and Scherer, 2006; Murphy et al., 2003). The ATR can lead to a higher survival potential for 
some strains after survival through a milder stress (Alter and Scherer, 2006). Other regulators such 
as PerR (peroxide sensing regulator), Fur (ferric uptake regulator) and Cj1000, which is a LysR-
type transcription regulator, have all been found within C. jejuni (Dufour et al., 2013; Palyada et al., 
2009).  
 
1.71 Heat 
 
Heat-shock proteins are commonly up-regulated upon exposure to heat in many bacterial species 
(Andersen et al., 2005). A number of heat-shock protein (HSP) homologues, including chaperones 
and ATP-dependent proteases, have been described in C. jejuni NCTC11168 (Parkhill et al., 2000). 
DnaJ was identified as one of 24 heat shock proteins and a DnaJ null mutant showed reduced 
growth at 46 °C and could not colonise chickens (Konkel et al., 1998). A number of other HSPs 
have also been identified following heat shock experiments including GroEL and GroES (Wu et al., 
1994). A temperature shift from 37 to 42 °C results in 12 chaperones, HSPs or regulators producing 
a > 1.5 times change in expression (Stintzi, 2003). Campylobacter lack the common heat shock 
response regulatory factors such as σ32. Such factors have been replaced by the two component 
regulatory system RacRS, and orthologues of HrcA and HspR (Bras et al., 1999; Parkhill et al., 
2000; Stintzi, 2003). A homologue of the negative transcriptional regulatory protein, HspR, is 
involved in control of the heat shock response (Andersen et al., 2005). A hspR mutant was found to 
be unable to form colonies at 44 °C. Additionally, the hspR mutant demonstrated reduced motility, 
autoagglutination, and reduced ability to adhere to and invade human epithelial INT-407 cells 
(Andersen et al., 2005). This response is most likely due to the down regulation of eight genes 
predicted to be involved in the formation of the flagellar apparatus (Andersen et al., 2005). Mutants 
defective in racR and racS could not colonise chickens and had reduced motility (Apel et al., 2012). 
RacRS directly regulates dnaJ and is also required for the regulation of other chaperones groEL and 
dnaK (Apel et al., 2012).  
 
1.7.2 Chlorine 
 
Little is known about the cellular response of Campylobacter to chlorine. It has been suggested that 
chlorine induced injury may affect the cell’s ability to adhere to and invade HeLa cells although the 
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extent of adhesion/invasion of HeLa cells was found to be strain dependent (Terzieva and Mcfeters, 
1992). A number of microbial processes have been correlated with death by exposure to RCS 
including loss of ATP, inhibition of F1 ATPase, loss of DNA replication, and failure of transport 
across the inner membrane, with the inner membrane being the main site of lethal damage (Gray et 
al., 2013). Some of the responses to exposure to sub-lethal RCS parallel those that occur after 
exposure to oxidative stress, as RCS are strong oxidants. Catalases and peroxidases are H2O2 
scavenging enzymes that are upregulated when Escherichia coli, Pseudomonas aeruginosa, 
Mycobacterium bovis are exposed to RCS (Dukan et al., 1998; Jang et al., 2009; Small et al., 2007b; 
Wang et al., 2009). Helicobacter pylori lacking methionine sulfoxide reductase are more sensitive 
to the effects of HOCl, although this is dependent on the presence of the GroEL chaperone 
(Mahawar et al., 2011). Genes involved in the repair of iron-sulfur clusters (redox cofactors) are 
upregulated upon exposure to RCS in E. coli and P. aeruginosa (Small et al., 2007b; Wang et al., 
2009). A number of bacterial species modify the properties of their cell envelope upon exposure to 
RCS (Gray et al., 2013). E. coli upregulates ycfR to reduce permeability and increase 
hydrophobicity of the outer membrane (Deng et al., 2011; Wang et al., 2009). Exposure to RCS can 
initiate protein unfolding and aggregation, unlike exposure to reactive oxygen species, which have 
little effect on protein folding (Gray et al., 2013). Pathways involved in this process degrade 
damaged or unfolded protein and upregulate chaperones and proteases that prevent the formation of 
protein aggregates (Jang et al., 2009; Small et al., 2007b; Wang et al., 2009). There are a number of 
other bacterial responses to sub-lethal doses of RCS, with most studied in organisms such as E. coli 
and P. aeruginosa. These responses may include, but are not limited to, increased levels of 
glutathione, which assists in maintaining the reducing potential of the cytoplasm, changes in 
cysteine and methionine metabolism, defense against DNA damage, changes in carbon metabolism 
and defense against reactive metals (Gray et al., 2013). 
 
1.7.3 Cold 
 
Metabolic activity, de novo protein synthesis, chemotaxis and aerotaxis have been demonstrated to 
occur at temperatures as low as 4 °C (Hazeleger et al., 1998). Chilled C. coli cells have been shown 
to express different proteins at 4 and 20 °C, as well as changes in the ratio of shorter to longer chain 
fatty acids at 37 and 20 °C compared to 4 and 10 °C (Höller et al., 1998). C. jejuni was found not to 
alter its fatty acid composition in response to cold stress (6 °C) as do other organisms such as 
E. coli. This suggests that C. jejuni membranes do not become more fluid as the temperature 
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decreases and therefore do not allow membrane leakage upon a temperature upshift (Hughes et al., 
2009). The nucleic acid and carbohydrate regions of the fourier transformed infrared spectroscopy 
(FTIR) spectra of C. jejuni increased significantly compared to controls when the organism was 
subjected to -18 °C (Lu et al., 2011). However when the same strains were subjected to 4 °C for 12 
days there was a reduction within these spectral regions. An increase in polysaccharides by C. jejuni 
when subjected to cold stress was also noted by Oust et al. (2006). Campylobacter may therefore 
down regulate many functions and increase the production of polysaccharides and oligosaccharides 
for protection against some forms of environmental stress (Lu et al., 2011). Genes involved in 
motility, flaA and flaB, are down regulated upon exposure to 5 °C (Moen et al., 2005). Freeze/thaw 
treatment can kill cells by ice nucleation and dehydration and also by the production of superoxide 
anions (Park, 2002). Oxidative stress therefore can play a role in the freeze/thaw killing of 
Campylobacter. It has been suggested that the cj1371 gene (encoding a periplasmic protein) does 
not play a role in the detoxification of reactive oxygen species produced during freeze/thaw while 
sodB (superoxide dismutase) mutants were more sensitive to freeze-thaw treatments (Garenaux et 
al., 2009). Sensitization of cells to oxidative stress by a freeze/thaw treatment followed by further 
storage at 4 °C enhances the cell death of the oxidative stress-sensitive population (Garenaux et al., 
2009).  
 
1.7.4 Oxygen 
 
Campylobacter lack the common oxidative response factor SoxRS (Park, 2002). While not the sole 
defense against oxidative stress, there have been three key genes identified: sodB removes 
superoxide anions by their dismutation into hydrogen peroxide and oxygen; katA, a peroxide stress 
defense protein catalase, degrades hydrogen peroxide to hydrogen and water; ahpC is an iron 
regulated alkyl hydrogen reductase important in the resistance to alkyl hydroperoxides (Atack and 
Kelly, 2009; Murphy et al., 2006). The cmeG (cj1375) gene contributes to the survival of C. jejuni 
NCTC11168 under oxidative stress as measured by inhibition of growth by H2O2 (Jeon et al., 
2010). Mutation of the downstream gene cmeH (cj1376) alone did not affect the susceptibility to 
H2O2. No differences were noted in the expression of oxidative stress genes sodB and aphC of 
starved and non-starved C. jejuni by exposure to H2O2 for 10 min and exposure to 5 h of 
atmospheric oxygen (Klancnik et al., 2006). The superoxide dismutase protein SodB protects 
against the superoxide anion (Palyada et al., 2009) and is required for survival in oxygen or in the 
chicken gut (Purdy et al., 1999). Cross protection from a global response to cold temperatures may 
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overlap the oxidative stress response (Stintzi, 2003). Exposure to oxidative stress can influence the 
transcription levels of some virulence associated genes (Koolman et al., 2016). Motility and/or 
invasion associated genes flaA, flaB, ciaB, iamA, cdtA and the regulator rpoN did not have an 
altered level of expression (Koolman et al., 2016). In comparison, flaA and flaB genes have also 
been found to undergo upregulation upon exposure to oxidative stress (Garenaux et al., 2008b). The 
regulation of a number of genes, upon exposure of the organism to a measured stress, have been 
demonstrated to be strain dependent (Koolman et al., 2016). The regulator luxS has been shown to 
effect survival under oxidative stress for strain 81-176 (He et al., 2008) but not for strain 11168 
(Elvers and Park, 2002).  
 
In seeking to further understand the stress response of Campylobacter, use of next generation 
sequencing tools can be beneficial, such as the use of RNAseq for transcriptome profiling. 
Improvements in pipelines from sample preparation, sequencing platforms and data analysis has 
provided the opportunity to generate a large amount of data that can encompass ribosomal RNA, 
messenger RNA, non-coding RNA and small nuclear RNA. RNA-seq experiments start with 
isolating good quality RNA, converting it to complementary DNA, preparing the sequencing 
library, undertaking the sequencing, and data analysis. There are numerous considerations that 
should be assessed before undertaking RNA-seq transcriptome analysis. The design of RNA-seq 
experiments should encompass biological and technical replicates, depth of sequencing, coverage of 
the transcriptome and unfortunately a balance between quality results and cost (Kukurba and 
Montgomery, 2015).  
 
The expression levels for each gene can be analysed with an ever increasing number of software 
tools. There is currently no consensus on the best analysis for ensuring robustness, accuracy and 
reproducibility of results (Costa-Silva et al., 2017). Poisson distribution of read counts was 
originally utilized (Marioni et al., 2008) in early RNA-seq studies although biological variability is 
not captured leading to high false positive results (Langmead et al., 2010; Robinson and Oshlack, 
2010). Negative binomial distributions are now utilized by tools such as edgeR (Robinson et al., 
2010) and bayseq (Hardcastle and Kelly, 2010). An understanding of the effects of all stages of 
RNAseq experiments is important in the final biological interpretation. The constraints and model 
parameters of various software is key to producinh meaningful and accurate biological conclusions 
(Bullard et al., 2010).  
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The responses of Campylobacter to the stresses encountered within a poultry processing plant are 
not fully understood. Genetic variability inherent within this genus may contribute to the variable 
survival rates. A number of other antimicrobial agents have been demonstrated to have an effect on 
the inactivation, reversing attachment, and inhibiting attachment of C. jejuni to chicken skin. These 
may be authorized for use within the poultry industry of other countries and include but are not 
limited to such agents as cetylpyridium chloride, trisodium phosphate, acidified sodium chlorite, 
monochloramine and peracetic acid (Arritt et al., 2002; Bauermeister et al., 2008; Blaser et al., 
1986). 
 
1.8 Conclusions and aims of this study 
 
Campylobacter is the leading cause of bacterial foodborne gastroenteritis in the western world. The 
European Union, New Zealand and Australia have all linked from 30 to 80 % of human cases to 
poultry or the poultry chain (EFSA, 2010c; Mullner et al., 2009; Stafford et al., 2008). It is clear 
from the published literature that poultry processing, using good manufacturing controls, can reduce 
both the prevalence and level of Campylobacter on final whole chickens. The key control points for 
reduction in prevalence have been identified through most studies as the scalding and chilling 
stages, although not all studies demonstrate the same level of reduced prevalence. The 
manufacturing stages which may effect a reduction in the level of Campylobacter have proven more 
difficult to confirm due to the large variation that can be found across samples. This knowledge gap 
has been highlighted by previous FAO/WHO and Australian risk assessments of Campylobacter in 
poultry processing (FAO/WHO, 2009; FSANZ, 2005). Most studies assess only a minimum number 
of isolates from various sampling sites and these may not be representative of the true genotypic 
diversity present. Most studies that assess the changing genotypes through poultry processing 
suggest that some genotypes may be better able to survive processing than others. As in-line 
sampling of chickens has not been previously published from Australian poultry processing, it is 
unknown if current standard production processes affect the diversity of Campylobacter on the 
whole chicken after packaging. It has been observed that molecular epidemiological differences 
between countries may be greater than those found between poultry and human isolates within a 
country (Wassenaar et al., 2009). However, in New Zealand, where poultry production is dominated 
by a small number of vertically integrated companies, differences exist in the genotypes of 
Campylobacter between companies and an internationally rare genotype was the dominant human 
genotype (Mullner et al., 2010). As such, studies conducted in other countries may not be applicable 
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to the understanding of the dynamics of Campylobacter under Australian poultry processing 
conditions. 
 
To understand how this organism survives along the food chain, a number of laboratory based 
studies have reported the effect of some environmental stresses on the survival of Campylobacter 
and on the survival of selected genotypes that are commonly found in poultry and humans (Al-
Sakkaf and Jones, 2012; Melero et al., 2012; Newell et al., 2001; Scanlon et al., 2015). Computer 
models such as Weibull equations can be used to further compare and contrast the survival capacity 
of different genotypes. This approach has been used to determine that New Zealand poultry-
associated Campylobacter did not have an unusually high level of heat resistance (Al-Sakkaf and 
Jones, 2012). The heat resistance of Australian Campylobacter is currently unknown.  
 
Published knowledge of specific cellular responses of Campylobacter to the environmental stresses 
encountered along the food processing chain is continually increasing. The mechanisms by which 
some genotypes survive through poultry processing may include factors that also play a role in the 
virulence of this organism. The related organism, H. pylori, has been shown to have an altered 
virulence potential in response to environmental stress (Hatakeyama and Brzozowski, 2006). 
In-vitro adhesion and invasion assays are currently gold standard for measurement of virulence 
potential for Campylobacter due to the lack of an animal model. Some cellular stress responses 
have been found to be strain dependent (Koolman et al., 2016). Both phenotypic and genotypic 
assessment of potential pathogenicity may be of importance as it has been shown that for some 
strains a cellular response to stress did not match the expected phenotypic response (Koolman et al., 
2016). The process of pathogenicity is multifactorial and strain dependent.  
 
There are a limited number of studies that examine the effect of chlorine on the survival of 
Campylobacter. Chlorine is not allowed as a processing aid in the production of poultry in the EU 
but is in Australia, NZ and the USA. Available data suggests that survival of specific genotypes can 
occur through poultry processing. The major critical control point in poultry processing in Australia 
is in the final chilling stage - either immersion chilling with chlorine, or other processing aids, or air 
chilling. The cellular response of Campylobacter to exposure to sub-lethal levels of chlorine has not 
been published. Due to the lack of more well-characterized stress response factors in 
Campylobacter, it is important to understand how this organism survives through immersion 
chilling and if the process itself may upregulate potential virulence factors.  
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The specific aims of this study were to: 
 
1 – Determine the effect of current poultry processing parameters in two Australian abattoirs on 
both the level and prevalence of Campylobacter on whole chickens through the processing line. 
2 – Map the genotypic diversity of Campylobacter through poultry processing in order to identify 
persistent strains and compare to those genotypes circulating in the human population. 
3 – Characterise Campylobacter from poultry and humans for virulence potential as measured by 
attachment and invasion to Caco-2 cell lines and investigate associations between other phenotypic 
and genetic factors. 
4 – Explore the survival of a representative subset of C. jejuni and C. coli from poultry and humans, 
when subjected to stresses that commonly occur in the poultry processing plant. 
5 – Explore the genetic response to immersion chilling stress using RNAseq. 
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2.1 Manuscript Information 
 
The leading cause of bacterial gastroenteritis in Australia is Campylobacter (NNDSS, 2017). Source 
attribution studies highlighted poultry as a major source in Australia, Europe and the USA (EFSA, 
2010c; Friedman et al., 2004; Stafford et al., 2008). There was very limited data available on 
Campylobacter prevalence and numbers on dressed whole chickens. No data was available on 
Campylobacter prevalence and numbers through the multiple stages of poultry processing. The data 
collected in this chapter provides information to industry and regulators on the effectiveness of the 
processing parameters in use at the time, in reducing Campylobacter prevalence and numbers 
through poultry processing. The processing parameter in use at the time of sampling produced 
between a 2.70 and 5.46 log10 CFU/mL decrease in Campylobacter numbers from before scald to 
after chilling.  
 
The Campylobacter isolates collected from all sampling sites along the poultry processing line were 
genotyped in chapter 3, and used to determine if specific genotypes survived processing better than 
others. A subset of these isolates, in conjunction with cinical isolates, were used to phenotypically 
and genetically assess the potential pathogenicity of Campylobacter that survive poultry processing, 
those that do not survive processing, those commonly found in humans and those that were not 
commonly isolated from humans (chapter 4). 
 
2.2 Introduction 
 
Campylobacter is the leading cause of bacterial gastroenteritis in many industrialised countries 
including Australia (Allos, 2001; EFSA, 2012; Stafford et al., 2008). Notification rates vary across 
the globe. The number of cases per 100,000 is reported as 14.3 in the United States (CDC, 2013) , 
101.6, Australia (NNDSS, 2013), 162.5, New Zealand (NZPHSR, 2013) in 2012 and 113.4, United 
Kingdom (EFSA, 2012) in 2010. Although campylobacteriosis is typically moderate in severity and 
self-limiting, it is a cause of significant morbidity and sequelae including irritable bowel syndrome, 
inflammatory bowel disease, reactive arthritis and Guillain-Barré syndrome (GBS) (Jacobs et al., 
2008). Although only a small proportion of Campylobacter infections go on to develop these severe 
symptoms, the large number of campylobacteriosis cases means that a notable number of people 
need substantial on-going care following infection (Jacobs et al., 2008).  
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Poultry meat is considered the leading source of Campylobacter exposure in Europe, the USA and 
Australia (EFSA, 2010c; Friedman et al., 2004; Stafford et al., 2008). The prevalence of 
Campylobacter carriage in poultry at slaughter can vary from 5 to 100 %, with a mean across 
European Member states in 2008 of 75.8% (EFSA, 2010a). The prevalence of Campylobacter on 
poultry at retail or at the end of processing in Australia has been reported from 84.3 to 95.8 % 
(FSANZ, 2010b; King and Adams, 2008). It has been recognized in a risk assessment of broilers 
conducted by the World Health Organization (FAO/WHO, 2009), that there are a lack of 
quantitative data both on-farm and through primary processing of poultry meat. This lack of data 
was also highlighted in an Australian risk assessment of broilers conducted by Food Standards 
Australia and New Zealand (FSANZ) (FSANZ, 2005), such that primary processing stages were 
only assessed qualitatively. The lack of such data makes it difficult to conclusively identify which 
stages within poultry processing which may have a significant impact on the prevalence or level of 
Campylobacter within Australian poultry processing. 
 
While FSANZ have released a primary production and processing standard for the poultry industry 
in Australia (FSANZ, 2010a), there are currently no regulatory measures regarding an acceptable 
prevalence or concentration of Campylobacter or Salmonella in poultry. However, poultry growers 
work towards minimising the introduction and spread of these food borne pathogens by compliance 
with an industry biosecurity manual (DAFF, 2009). While much work continues on pre-processing 
controls of Campylobacter such as farm biosecurity, the use of Hazard Analysis and Critical 
Control Point programs within the processing plant should also be highlighted. A reduction of 
2 log10 on carcass has been suggested to be able to reduce the campylobacteriosis rate in humans by 
30 times (Rosenquist et al., 2003). There is a higher difficulty and cost associated with monitoring 
Campylobacter in poultry processing in comparison to E. coli (Altekruse et al., 2009; Berrang and 
Bailey, 2008) which creates a challenge with respect to implementing regulations based on 
Campylobacter.  
 
The Australian chicken meat industry slaughtered 512 million chickens in 2010 to produce 934,000 
tonnes of chicken meat (ACMF, 2011). The average dressed weight of chickens at slaughter in 
Australia in 2010 was 1.82 kg (ACMF, 2011). As a general guide Australian poultry processing 
plants operate in the following stages; Stunning either electrical or gas, bleeding, scalding between 
50 and 58 °C for 2 to 3 min with counter flow multistage tanks, evisceration, pre-wash followed by 
immersion chilling and/or air chilling. Immersion chill tanks are commonly multistage counter flow 
with the use of chlorine at a level up to 5 ppm of free available chlorine. This study was designed as 
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a pilot to begin to fill the gap in data availability on Campylobacter prevalence through the poultry 
processing chain and provide quantitative data on processes that effectively reduce Campylobacter 
concentration, to enable future risk assessments. The study also aims to assess the potential use of 
E. coli as a surrogate measure of the control of Campylobacter concentration through broiler 
processing.  
 
2.3 Materials and Methods 
 
2.3.1 Sampling  
 
Whole chickens were collected from poultry processing at Plant A (flocks 1 and 3) and Plant B 
(flocks 2 and 4). The plants, located in different Australian states, were sampled in order of flock 
number; November 2009, January 2010, April 2010 and July 2010. Both plants operated with a line 
speed of approximately 160 chickens per minute. Flocks were not pre-tested for the presence of 
Campylobacter before being sent for slaughter, but were selected on the day of sampling after 
arrival at the abattoir, as the next flock scheduled for slaughter with a live weight >2.5 kg and were 
≥40 days of age. No flocks that were slaughtered at the beginning of a processing shift were 
selected. It is usual within Australian poultry production that flocks are thinned and as each selected 
flock was at the upper end of age/live weight it was expected that the flocks had previously 
undergone thinning. 
 
Carcasses (n=10) were collected in-line (approximately every fifth chicken) from five sites 
sequentially such that the same flock was tested throughout the process at the following sites: 
immediately before scald but after bleed-out (BS); immediately after scald but before defeathering 
(AS); after evisceration immediately before immersion chilling (BC); after immersion chilling 
(AC); and after packaging (AP). After packaging samples were collected immediately before whole 
chickens were bagged so as to capture the final product before leaving the processing plant. 
Individual caeca (n=10) were also collected from each flock at the point of evisceration and placed 
into small stomacher bags (17 x 30 cm; Amyl Media, Victoria, Australia), for a total of 240 samples 
across all flocks. Caecal samples were held on ice, to ensure they were chilled but not frozen before 
processing at the Brisbane laboratory within 24 h of collection. Whole birds were placed into 
individual large stomacher bags (38 x 50 cm; Sarstedt, Australia) held at ambient temperature and 
sampled within 2 h of collection. At sampling sites where chickens with intact feathers, feet, heads, 
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intestinal contents or combinations of these materials were sampled, the chickens were rinsed as is 
without removal of these parts.  
 
Whole chickens were sampled using the whole bird rinse technique following Australian Standard 
AS5013.30 (AS5013.30, 2004). Briefly, 500 mL of Buffered Peptone Water (BPW; ThermoFischer, 
UK) was poured into the bag and each chicken was vigorously shaken and hand massaged for 2 
mins. A volume of 250 mL (to ensure minimal headspace) of the rinsate was stored in sterile plastic 
bottles before shipment, on ice to ensure samples were chilled but not frozen, to the Brisbane 
laboratory. Rinsates were tested within 24 h. Processing conditions including scald and immersion 
chiller temperatures, immersion chiller pH and the level of free available chlorine, as recorded by 
Quality Assurance staff, are presented in Table 2-1. The method of measuring FAC in each plant 
was not recorded. 
 
2.3.2 Qualitative Campylobacter analysis 
 
Rinsates and caecal contents were tested for Campylobacter following a modified Australian 
Standard (AS5013.6, 2004). A modification was made in the selection of agar plates by replacing 
Preston Agar with modified Charcoal Cefoperazone Deoxycholate Agar (mCCDA; 
ThermoFischer). A 50 mL portion of each rinsate was added to 50 mL of double strength Preston 
Broth without antibiotics and incubated at 37 °C for 2 h. Preston antibiotic supplement 
(ThermoFisher) was added and the sample incubated at 42 °C for 46 h under 5 % CO2 (Duffy and 
Dykes, 2009) atmosphere generated within a CB150 incubator (Binder, Germany). Generation of 5 
% CO2 for the growth of Campylobacter has been extensively utilised in our laboratory. All caeca 
were sampled by aseptically cutting the end of the caecal loop and squeezing the contents into a 
small stomacher bag. Caecal material and Preston Broths were streaked onto mCCDA with 
antibiotic supplement (SR0155E, ThermoFischer) and Skirrow agar (BioMérieux, France). All 
plates were incubated with 5 % CO2 at 42 °C for 48 h. Presumptive positive colonies were sub-
cultured on CCDA (without antibiotics) before storing at -80 °C in Protect Bacterial Preserver 
Beads (Technical Service Consultants, UK). 
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2.3.3 Quantitative Campylobacter analysis 
 
Preston Broth was added to the caecal contents to create a 9:1 wt:wt ratio before being stomached 
for 2 min. Rinsates and caecal samples were decimal diluted in BPW and 100 µL spread plated on 
both mCCDA and Skirrow agar. Samples from after chilling and after packaging were additionally 
analysed by spreading each of six plates of mCCDA and Skirrow agar with 500 µL of rinsate each. 
The agar, either mCCDA or Skirrow, with the highest confirmed count was used to calculate the 
CFU/mL. The detection limit was -0.48 log10 CFU/mL. All plates were incubated at 42 °C for 48 h 
under 5 % CO2. Up to 12 presumptive positive colonies from each sample were selected and sub-
cultured on CCDA (without antibiotics) before storing at -80 °C, in Protect Bacterial Preserver 
Beads (Technical Service Consultants), for confirmation and speciation. Confirmed colonies were 
used to correct the count/mL of rinsate before transforming to log10 CFU per mL. Samples that were 
positive by enrichment but below the level of quantifiable detection were assigned a value equal to 
the limit of detection. Negative samples were assigned a value of -0.77 log10 CFU/mL for 
calculation of medians. As chickens at different sample sites vary with regard to surface area due to 
presence of feathers, head and legs all counts are expressed as per mL. 
  
2.3.4 Quantitative E. coli analysis 
 
Rinsates and caecal material diluted in Preston broth as described in 2.3 were 10 fold serially 
diluted in BPW and 1 mL plated onto E. coli/Coliform Petrifilm™ (3M, Australia) following 
manufacturer’s instructions. Petrifilm were incubated at 37 °C for 48 h and all blue colonies with or 
without gas were counted. Concentrations were calculated per mL of rinsate then transformed to 
log10 CFU per mL. 
2.3.5 Campylobacter speciation 
 
All isolates (up to 12 from each sample) were recovered from -80 °C storage by incubation on 
CCDA (without antibiotics) under 5 % CO2 at 42 °C for 48 h. A loopful of culture was then added 
to 10 ml of Nutrient Broth No. 2 (ThermoFischer) in a 10 ml tube with limited headspace. The tubes 
were incubated under 5 % CO2 at 42°C for 48 h. A 1 mL portion was centrifuged at 13,000 g for 3 
min, supernatant removed, and the pellet resuspended in 200 µL of sterile distilled water. The 
sample was boiled for 10 min before centrifuging at 13, 000 g for 5 min and the supernatant used as 
the DNA template. All isolates were speciated by PCR using the method of Klena et al. (2004) 
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and/or the method of Khan and Edge (2007) for isolates that did not produce a result with the Klena 
PCR. All products were separated on a 2 % (wt:vol) agarose gel, stained with ethidium bromide 
before visualising under UV light (Gene Genius, Syngene, UK).  
 
Table 2-1 Processing conditions at time of slaughter for each flock, as recorded by Quality 
Assurance staff. 
 
 
Scald 
temperature/ time 
Immersion chiller 
temperature/ time 
Immersion 
chiller pH 
Immersion 
chiller FACa 
Flock 1 55°C/2 min 20 s 4.2°C/30 min 8.00 3.5 ppm 
Flock 2 55°C/2 min 30 s 6.9°C/45 min 7.03 1.0 ppm 
Flock 3 55°C/2 min 20 s 4.4°C/30 min 7.50 2.7 ppm 
Flock 4 55°C/2 min 30 s 7.0°C/45 min 7.05 1.0 ppm 
 
a FAC; free available chlorine 
 
2.3.6 Statistics 
 
Log transformed Campylobacter and E. coli concentrations across all sampling sites for each flock 
were assessed for normality (Anderson Darling) and for equality of variance (Levene). Mann-
Whitney was used to compare the median at each sampling point within and between each flock. 
Correlation between Campylobacter and E. coli concentration was assessed using Spearmans rank 
order coefficient. Changes in the percentage carriage of each species were tested for significance 
using Chi-squared. A retrospective power analysis was conducted. All analyses were conducted 
using Minitab 16 software (Minitab Inc., USA).  
 
 
2.4 Results and Discussion 
 
The prevalence of Campylobacter on whole chickens at the end of processing, in this study (82.5 %, 
n=40) is comparable to that of other Australian studies (84.3, n=1104 to 95.8 %, n=264) (FSANZ, 
2010b; King and Adams, 2008). This could be considered high in comparison to some baseline 
surveys conducted in Canada, UK, USA and Sweden, 75.0, 65.2, 46.6 and 15 % respectively 
(Bohaychuk et al., 2009; Lindblad et al., 2006; UKFSA, 2009; USDA, 2009). Differences in 
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methodology both in isolation such as limit of detection and in process methodology such as the use 
of chlorine make direct comparisons difficult.  
 
The primary aim of this study was to provide data on the effect of current processing practices 
(previously suggested to reduce Campylobacter levels) on the prevalence and concentration of 
Campylobacter on whole chickens, therefore flocks were selected as described to increase the 
probability of high levels of Campylobacter in the caeca. The increasing age of a flock has 
previously been linked to an increase in the prevalence of Campylobacter. The two companies that 
took part in this study do not require pre-slaughter analysis of Campylobacter prevalence or 
quantification in flocks scheduled for slaughter. Australian poultry flocks are commonly subjected 
to thinning and this also may have increased the chance of selecting a positive flock. Prevalence in 
caeca has previously been found to influence the prevalence on carcasses (Allen et al., 2007; Hue et 
al., 2010; Reich et al., 2008). This is supported by the current study for three of the four flocks, with 
100 % prevalence in the caeca and on the whole chickens after packaging (Figure 2-1).The mean 
concentration of Campylobacter in the caeca from Australian chickens has been reported as 6.87 
log10 CFU/g (FSANZ, 2010b) compared to the current study with median concentration of 7.81, 
8.52, 7.00 and 6.31 log10 CFU/g for flocks 1 to 4 respectively (Table 2-2). Each flock had a 
significantly (P<0.05) different concentration in the caeca compared to the other flocks (Table 2-2). 
While the prevalence of Campylobacter in caeca is related to the age of the chickens, the 
concentration is not (Hue et al., 2010), which suggests that chickens sampled in the previous 
FSANZ study had not been colonized for the same length of time as those in the current study. 
 
The application and control of specific processing technology along the poultry processing chain 
within each plant may account for some level of variation although there was no significant 
(P<0.05) effect of plant in this study with each plant having consistent measured processing 
parameters (Table 2-1). When comparing a number of studies (Guerin et al., 2010; Rosenquist et al., 
2006), defeathering and evisceration have been shown to maintain or increase the concentration of 
Campylobacter in a number of studies. The use of sprays that may contain biocides such as chlorine 
or best practice use of equipment to minimise rupture of viscera may offer some control through 
these stages but these may not always be universally well implemented. In the current study there 
was no significant (P<0.05) change in concentration for samples taken after scalding compared to 
samples taken before chilling which encompasses the stages of defeathering and evisceration (Table 
2-2). Reductions were noted in most studies through scalding and again through washing and 
cooling (Guerin et al., 2010; Rosenquist et al., 2006). This is in agreement with the current study 
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where all flocks had a significant (P<0.05) decline in concentration following scalding and again 
following chilling with overall mean decreases of 1.69 and 2.99 log10 CFU/mL (Figure 2-2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1: Prevalence of Campylobacter spp. at each sampling site and percentage of isolates that 
are C. jejuni and C. coli. The black line indicates overall prevalence of Campylobacter spp. Dark 
columns indicate prevalence of C. coli and light columns indicate prevalence of C. jejuni at each 
sampling site. A. Flock 1; B. Flock 2; C. Flock 3; D. Flock 4. 
 
Control of processing parameters such as scald temperature and chlorine 
concentration/temperature/pH of immersion chiller water may play a more important role in 
reducing the concentration of Campylobacter on whole chickens within these processing plants than 
the initial concentration of Campylobacter in the caeca. Larger more targeted studies will need to be 
undertaken to examine these specific production conditions. Within the immersion chiller, 
variability may be affected by the volume of water used in respect to the number of chickens in the 
tank, the effectiveness of the auger screw and any congestion points that may prevent the effective 
washing of all chickens. Cross contamination has also been suggested as a source of contamination 
in immersion chillers (Reich et al., 2008) although it was not assessed in this study. Attention to 
detail with hygienic practices throughout production and primary processing and alterations to the 
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immersion-chiller conditions were suggested as key areas that lead to reductions in the prevalence 
and concentration of Campylobacter of whole chicken carcasses in New Zealand (Sears et al., 
2011). The mandatory testing of poultry carcass rinsates and setting of performance targets were 
also key to this improvement (Sears et al., 2011).  
 
Variation in Campylobacter concentration occurred within flocks and across sampling sites 
suggests that the contamination of carcasses does not occur homogenously. The median 
Campylobacter concentration of all samples after packaging was 0.80 (Q1-Q3; 0.20-2.41) 
log10 CFU/mL with individual counts ranging from -0.48 to 4.60 log10 CFU/mL. Variability in 
Campylobacter concentration has been suggested to be related to the variable concentration of 
caecal carriage in individual chickens, variable contamination due to visceral breakage or leakage 
and to potentially different sensitivities of Campylobacter strains to processing stresses (Allen et al., 
2007; Stern and Robach, 2003). This variability is of most concern when only one or a few samples 
are collected (Hansson et al., 2010). A retrospective power analysis indicated that a sample size of 
10 had a >60 % chance of detecting a difference of at least 1 log10 CFU/mL. A smaller change in 
the median values would require larger sample sizes to have adequate power, however changes of 
< 1 log10 CFU/mL may not be biologically significant in the poultry processing system. The use of 
different methods for sampling and calculation of the concentration of Campylobacter makes 
comparison between studies difficult, although a general guide to the effect of individual processing 
steps can be gained. The systematic review of prevalence of Campylobacter through poultry 
processing by Guerin et al. (2010) highlights the need for standardised testing methods and 
reporting.  
 
The significant decrease in the concentration of Campylobacter at scald and again at immersion 
chilling for all flocks is in agreement with other published reports (Guerin et al., 2010; Rosenquist 
et al., 2006). While some studies report increases during to defeathering and / or evisceration 
(Guerin et al., 2010) the overall effect of these stages on the concentration of Campylobacter was 
not significant (P>0.05) in this study which supports the initial study design. A decrease in medians 
of greater than 3 log10 CFU/mL was recorded after chilling for three of four flocks in this study 
(Table 2-2). Cross contamination within immersion chillers has previously been noted (Reich et al., 
2008) which may play a role in the different results noted for flock 2. No explanation for this 
difference in flocks 2 and 4 slaughtered at abattoir B can be suggested as processing controls such 
as chlorine concentration, pH and temperature of the immersion chillers, as measured by Quality 
Assurance staff, were identical at both visits (Table 2-1). Variations in such data are common, with 
Chapter 2 Quantitative in-line analysis 
 
 
43 
 
a recent study of UK flocks demonstrating a decline of approximately 1 log10 CFU/g in neck and 
breast skin after chilling in only two of five flocks and an increase of approximately 0.2 to 0.4 log10 
CFU/g in the remaining three flocks after chilling (Elvers et al., 2011).  
 
The concentration of E. coli on post-chill chicken carcasses has been found to fit a logistic 
distribution and therefore may have value in process control plans (Altekruse et al., 2009). E. coli 
concentration has been found to decrease concurrently with Campylobacter concentration from re-
hang to post-chill (Altekruse et al., 2009; Berrang et al., 2007) which is supported by the results of 
this study. All flocks had a significant (P<0.05) decrease in concentration after scald and again after 
immersion chilling (Table 2-3) with a mean decline of 1.34 and 2.47 log10 CFU/mL respectively. At 
all sampling sites for all four flocks good correlation (r>0.6) was noted between E. coli and 
Campylobacter concentration with similar declines of the two organisms at each processing stage 
for samples over the detection limit (Figure 2-3). This suggests that when Campylobacter is present, 
processes currently operating in these abattoirs that decrease E. coli concentration will also affect a 
similar decrease in Campylobacter concentration. A correlation between the concentration of 
Campylobacter and E. coli has been recorded (Ghafir et al., 2008; Habib et al., 2012) and this may 
suggest the use of E. coli as an indicator of high concentrations of Campylobacter (Habib et al., 
2012). Conversely the weak but positive correlation between E. coli and Campylobacter was 
suggested to not be a reliable indicator of concentrations of Campylobacter (Wiliams and Ebel, 
2014).  
 
Differences in risk factors for human exposure have been identified for different Campylobacter 
species and as such, data should be collected for both C. jejuni and C. coli to improve risk 
calculations (EFSA, 2010b; Gillespie et al., 2002). The relative prevalence of different species of 
Campylobacter has been reported in some studies (Allen et al., 2007; Huat et al., 2010; Klein et al., 
2007b; Reich et al., 2008; Wedderkopp et al., 2000) either in caecal contents or after packaging. All 
isolates in this study (n=1890) were either C. jejuni or C. coli with 39 and 12 % of after packaging 
samples were contaminated with a single species respectively. A total of 48 % were contaminated 
with both species. Differences were noted in the proportional carriage of C. jejuni and C. coli across 
sampling sites in a flock dependant manner (Figure 2-1). The examination of the change in carriage 
of each species, chickens contaminated with both species were counted for both C. jejuni and 
C. coli. The proportional carriage of C. coli increased through processing in flock 1 from before 
scald (56 %) to after chill (81 %) or after packaging (75 %), suggesting that these strains may be 
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better able to survive processing compared to the C. jejuni strains contaminating this flock. The 
increased survival of C. coli compared to C. jejuni is also suggested in flock 3 with a significant 
(P<0.05) increase in proportional carriage from 40 % before chilling to 67 % after chilling. The 
change in carriage of species may be related to the high level of C. coli in the caeca of both flock 1 
and 3 (98 and 83 % respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2. The effect of each processing stage on the median concentration of Campylobacter and 
E. coli and the cumulative effect of the slaughter process for each flock. Solid bars are the 
concentration of Campylobacter and grey bars are the concentration of E. coli A. Flock 1; B. Flock 
2; C. Flock 3; D. Flock 4. Error bars represent the 95 % confidence interval for the point estimate of 
the difference in the two population medians at the beginning and end of each process, as calculated 
in the Mann-Whitney test. 
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Figure 2-3: Correlation of Campylobacter and E. coli levels at all sampling sites within each flock. 
Only samples with a recorded count of Campylobacter are included. Number of samples (n=), 
pearsons rho (ρ), and r2 value are displayed for each graph. Sampling sites are indicated by ◊ 
Before scald, □ After scald, ∆ Before chill, x After chill and ○ After packaging. 
 
This study provides the first published report of through-chain qualitative and quantitative data on 
Campylobacter and E. coli in Australian poultry processing plants. As a pilot study, it is not possible 
to thoroughly examine all aspects of the poultry slaughter process and their effects on 
Campylobacter concentrations. The through-chain quantitative data can be incorporated into future 
risk assessments enabling a quantitative evaluation of poultry processing stages. The processing 
steps, scalding and immersion chilling, are highlighted as key control points in the production 
process. However the decrease was not uniform and further more targeted studies may enhance our 
understanding of the effect of specific processing factors on the resulting prevalence and 
concentration of Campylobacter. Use of E. coli concentration, as an indicator of the effect of 
processing practices on Campylobacter concentration, but not presence/absence, may represent a 
more applicable and practical solution to monitoring and validating process effects, based on the 
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relative ease and standardisation of E. coli enumeration. Further characterization of isolates 
obtained from this study will enable increased understanding of the survival of specific genotypes 
of Campylobacter through the poultry processing chain. This in turn may aid future improved 
control strategies. 
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Table 2-2. Median and mean Campylobacter level, for each sampling site from the four tested flocks.  
  Caeca 
 (Log10 CFU/g)  
BSa  
(Log10 CFU/mL) 
AS  
(Log10 CFU/mL) 
BC 
 (Log10 CFU/mL) 
AC  
(Log10 CFU/mL) 
AP 
(Log10 CFU/mL)  
Flock 1b Mediand 7.81 (7.74–7.98)A 6.40 (6.14 – 6.62)fA 4.48 (3.56 - 4.86)gA 4.31 (3.99 – 4.67)gA 0.58 (0.00 – 1.65)hA 1.74 (0.78 – 3.18)iA  
Mean ± SEe 7.84 ± 0.04 6.18 ± 0.28 4.31 ± 0.23 4.26 ± 0.14 0.98 ± 0.45 2.05 ± 0.42 
Flock 2c Median 8.52 (8.13 - 8.72)B 5.51 (5.35 – 5.70)fB 4.02 (3.01 – 4.74)gA 3.64 (3.31 – 4.76)gA 2.84 (2.75 – 3.04)hB 2.54 (2.29 – 3.46)hA  
Mean ± SE 8.36 ± 0.17 5.47 ± 0.09 3.93 ± 0.27 3.89 ± 0.29 2.87 ± 0.06 2.77 ± 0.20 
Flock 3b Median 7.00 (6.94 – 7.14)C 6.12 (6.06 – 6.48)fA 4.21 (3.93 – 4.78)gA 4.15 (3.80 – 4.65)gA 0.30 (-0.30 – 0.43)hA 0.71 (0.55 – 0.88)iB  
Mean ± SE 7.07 ± 0.06 6.21 ± 0.08 4.30 ± 0.16 4.13 ± 0.17 0.15 ± 0.11 0.75 ± 0.08 
Flock 4c Median 6.31 (5.65 – 6.88)D 4.53 (4.34 – 4.70)fC 2.63 (1.48 – 3.78)gB 2.82 (2.25 – 3.41)gB -0.77 (-0.77 - -0.48)hC -0.77 (-0.77 - -0.36)hC   
Mean ± SE 6.31 ± 0.23 4.55 ± 0.09 2.56 ± 0.36 2.94 ± 0.29 -0.65 ± 0.06 -0.58 ± 0.11  
a BS, before scald; AS after scald; BC, before chill; AC, after chill; AP, after packaging  
b Flocks slaughtered at Plant A 
c Flocks slaughtered at Plant B 
d Median (25th percentile – 75th percentile) 
e Mean ± standard error of the mean (SE) 
All analysis was conducted using median values only. Levels of Campylobacter that have the same superscript lower case letter following are not 
significantly different from each other across rows (excluding caeca). Levels of Campylobacter that have the same superscript upper case following are 
not significantly different from each other in columns. 
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Table 2-3. Median and mean E. coli concentration, for each sampling site from the four tested flocks.  
  Caeca  
(Log10 CFU/g)  
BSa 
 (Log10 CFU/mL) 
AS  
(Log10 CFU/mL)  
BC 
(Log10 CFU/mL)  
AC 
 (Log10 CFU/mL) 
AP 
(Log10 CFU/mL)  
Flock 1b Mediand NT 6.34 (5.87 – 6.71)fA 5.08 (4.82 – 5.34)gA 4.08 (3.21 – 4.41)h 1.53 (0.74 – 2.45)iA 1.62 (1.06 – 2.54)jAB 
 Mean ± SEe NT 6.31 ± 0.14 5.10 ± 0.13 3.96 ± 0.19 1.65 ± 0.36 1.88 ± 0.38 
Flock 2c Median 4.83 (4.57 – 5.35)A 5.15 (5.06 – 5.36)fB 4.08 (3.13 – 4.21)gB 3.21 (3.08 – 4.24)g 2.33 (2.27 – 2.42)hB 2.27 (2.16 – 3.04)hA 
 Mean ± SE 4.95 ± 0.19 5.19 ± 0.05 3.90 ± 0.15 3.65 ± 0.26 2.33 ± 0.04 2.50 ± 0.14 
Flock 3b Median 4.80 (4.60 – 5.39)A 5.88 (5.74 – 6.40)fA 4.08 (3.83 – 4.47)gB 4.88 (4.00 – 5.22)h 1.28 (0.96 – 2.26)iA 1.40 (1.04 – 2.01)iB 
 Mean ± SE 4.95 ± 0.19 6.00 ± 0.12 4.10 ± 0.14 4.74 ± 0.18 1.67 ± 0.29 1.53 ± 0.18 
Flock 4c Median 5.78 (5.47 – 5.85)A 5.06 (4.65 – 5.46)fB 3.84 (3.52 – 4.10)gB 3.74 (3.11 – 4.28)g 0.88 (0.57 – 1.82)hA 1.17 (0.85 – 2.03)hB 
 Mean ± SE 5.59 ± 0.19 5.04 ± 0.15 3.79 ± 0.11 3.87 ± 0.25 1.05 ± 0.20 1.45 ± 0.22 
a BS, before scald; AS after scald; BC, before chill; AC, after chill; AP, after packaging  
b Flocks slaughtered at Plant A 
c Flocks slaughtered at Plant B 
d Median (25th percentile – 75th percentile) 
e Mean ± standard error of the mean (SE) 
All analysis was conducted using median values only. Levels of E. coli that have the same superscript lower case letter following are not significantly 
different from each other across rows (excluding caeca). Levels of E. coli that have the same superscript upper case letter following are not 
significantly different from each other in columns. 
NT – Not tested 
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3.1 Manuscript Information 
 
The changing numbers of Campylobacter through poultry processing in an Australian setting was 
explored in chapter 2. Previous studies have suggested that some Campylobacter survive processing 
better than others (Allen et al., 2007; Colles et al., 2010; Newell et al., 2001). Using 1866 isolates 
from chapter 2, this chapter demonstrates that some genotypes do not survive processing as 
frequently as other genotypes. As poultry is considered a major source of Campylobacter (EFSA, 
2010c; Friedman et al., 2004; Stafford et al., 2008) human clinical isolates were collected weekly 
during the six months that the poultry flocks were tested in this chapter. The genotyping of the 
clinical isolates demonstrated an overlap with the poultry genotypes. Analysis of the genotypes also 
demonstrated that some are frequent survivers of processing and some are found only before the 
chilling stage. The separation of isolates, using flaA-RFLP, formed the basis for selection of a 
subset of Campylobacter isolates/strains. This subset was used to further examine and compare 
genotypic and phenotypic differences across isolates in chapter 4 and survival under laboratory 
conditions that mimic the poultry processing control points of scalding and immersion chilling in 
chapter 5. 
 
3.2 Introduction 
 
Campylobacter are reported as the most common cause of bacterial gastroenteritis in most western 
countries (EFSA, 2013). Poultry are considered to be a major source of this organism (EFSA, 
2010c; Friedman et al., 2004; Stafford et al., 2008). In Australian chickens caecal samples had a 
prevalence of 84 % (FSANZ, 2010b) and whole chickens from processing plants have been found 
to have a prevalence of 84 to 95 % (FSANZ, 2010b; King and Adams, 2008; Pointon et al., 2008).  
 
The contribution of each processing stage to overall Campylobacter contamination is not well 
defined due to flock to flock variations and across processing plant variations. The concentration of 
Campylobacter on carcases changes through processing, with increases reported through feather 
picking and evisceration and decreases generally reported during chilling (Guerin et al., 2010). 
Contamination of carcases can occur at a number of stages of processing including scalding, 
defeathering, evisceration and during chilling (Allen et al., 2007; Berrang et al., 2001; Newell et al., 
2001; Rosenquist et al., 2006). Genotypes of Campylobacter from caeca are commonly found on 
carcases at the end of processing (Elvers et al., 2011; Melero et al., 2012; Newell et al., 2001; 
Rivoal et al., 1999). The presence of genotypes at the end of processing that were not related to the 
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caecal isolates of the flock indicates possible cross-contamination or the differential survival of 
genotypes during processing (Allen et al., 2007; Colles et al., 2010; Newell et al., 2001).  
 
Typing of large strain sets can be costly and time consuming. A number of techniques are available 
for typing of Campylobacter. MLST is considered the gold standard but can be considered 
expensive with seven genes to be sequenced with a current cost for external sequencing of 
amplicons of approximately AUD18 (total AUD126). An Australian study of genotyping methods 
found that restriction fragment length polymorphism (RFLP) of the flaA gene is a suitable 
preliminary typing method based on the ease of operation, equipment availability and cost (O'Reilly 
et al., 2006). Within our laboratory RFLP can be conducted on-site at no additional external cost. 
Whole genome sequencing can be currently sourced for AUD120 but can be examined for further 
information such as antimicrobial resistance genes. It has been previously suggested that the 
recombination within and between flagellin loci make flaA-RFLP unsuitable for long-term 
monitoring of Campylobacter population changes (Harrington et al., 1997). The aim of the current 
study is to assess the change in genotypes during the slaughter of four flocks using flaA-RFLP and 
to compare these to temporally related genotypes found in the human population. 
 
3.3 Materials and Methods 
 
3.3.1 Origin of isolates 
 
Campylobacter isolates used in this study were collected and stored as described previously in 
chapter 2. Whole chickens were collected from poultry processing at plant A (flocks 1 and 3) and 
plant B (flocks 2 and 4). The plants were located in different Australian states. Flocks were sampled 
by testing ten carcasses obtained from ten chickens collected at each of the following sites - before 
scald, after scald, before chill, after chill and after packaging. Individual caeca from ten chickens 
were also collected. Up to 12 isolates from each sample were stored at -80 °C in Protect Bacterial 
Preserver Beads (Technical Service Consultants, UK). A total of 1866 chicken isolates were 
included in the current study. Clinical Campylobacter isolates (n=497) were collected weekly 
(during the same time period as poultry isolate collection) from one of the two major pathology 
companies in the state of Queensland. Clinical isolates were stored as above until required. All 
isolates were either Campylobacter jejuni or Campylobacter coli. 
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3.3.2 Typing by flaA-RFLP 
 
All isolates (up to 12 from each sample) were recovered from -80 °C storage by incubation on 
CCDA (without antibiotics) under 5 % CO2 at 42 °C for 48 h. A loopful of culture was then added 
to 10 mL of Nutrient Broth No. 2 (Oxoid) in a 10 ml tube with limited headspace. The tubes were 
incubated under 5 % CO2 at 42 °C for 48 h. A 1 ml portion was centrifuged at 13, 000 g for 3 min, 
supernatant removed, and the pellet resuspended in 200 µl of sterile distilled water. The sample was 
then boiled for 10 min before centrifuging at 13, 000 g for 5 min and the supernatant used as a DNA 
template. 
 
Typing by FlaA-RFLP was conducted following a modified method of Nachamkin et al. (1993). 
Each PCR consisted of reaction buffer (Fermentas, Thermo Scientific, Canada), 2.0 mM dNTP’s, 
0.2 µM primers FlaF and FlaR (Nachamkin et al., 1993), 0.2 U Taq polymerase (Fermentas) and 
2 µL of DNA template. PCR was performed in a Perkin Elmer 9300 machine using an initial 
denaturation step of 94 °C for 1 min, followed by 35 cycles of 94 °C for 30 s, 50 °C for 1 min, 
72 °C for 2 min, with a final extension of 72 °C for 5 min. The generated product of approximately 
1700 bp was then digested by incubation at 37°C for 18 h in a reaction mix containing 7.3 µL 
sdH2O, 0.5 µL DdeI (New England Biolabs, USA), 2.0 µL Buffer 3 (New England Biolabs), 0.2 µL 
bovine serum albumin and 10 µl of DNA. RFLP products were separated on a 2 % agarose gel at 
100 V for 100 min. Gels were visualised under UV light after post-staining with GelRed (Biotium, 
USA) for 5 min and the image captured using Gene Genius (Syngene, UK). Images in TIFF format 
were imported into Bionumerics 6.5 (Applied Maths NV, Belgium). The similarity matrix was 
calculated using Dice similarity coefficient and clustering by the Unweighted Paired Group Method 
with Arithmetic Mean values (UPGMA). Band position tolerance and the optimization coefficient 
were both set to 1.5 %, within the recommended range set by Bionumerics. The Lambda 100bp 
ladder (Invitrogen, USA) was used as the molecular size marker after every six samples. Isolates 
were assigned to a genotype (with 100% similarity) and given a genotype number (gt) where more 
than three isolates occurred. Clusters were defined at the 75 % similarity level using Bionumerics. 
Genotypes represented by three or fewer isolates were assigned to a miscellaneous grouping. 
 
3.3.4 Statistics  
 
Simpsons index of diversity (D) and the corresponding 95% confidence interval (CI) was calculated 
using the web based tool http://www.comparingpartitions.info. A t-test using the calculated variance 
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of D was used to determine if Simpson's diversity values are significantly different between and 
across flocks, and between sampling sites. 
 
3.4 Results 
 
3.4.1 Typing by FlaA-RFLP 
 
A total of 32 genotypes, with four or more isolates, were recorded across all isolates (Figure 3-1). 
Clusters (n=18) were defined at 75 % similarity. Simpsons Index of Diversity (D) varied with 
flocks one to four having an overall D of 0.529, 0.124, 0.593 and 0.767 respectively (Table 3-1). 
Significant (P<0.05) differences in D were noted both across flocks and between sampling sites 
within flocks (Table 3-1). Flock 2 was significantly (P<0.05) less diverse than all other flocks at 
most sampling sites and across the entire flock. Diversity in the caeca in flock 1 was significantly 
(P<0.01) lower than from before scald chickens. In comparison the diversity of Campylobacter in 
caeca from flock 4 was significantly (P<0.05) higher than from before scald samples. Scalding did 
not significantly (P>0.05) alter the diversity of Campylobacter in any flock. In three of four flocks 
D significantly (P<0.05) decreased after chilling in comparison to immediately before chilling.  
 
Unique genotypes were found within each flock (Table 3-2). Flock 1 isolates were dominated by 
gt 6 which made up at least 50 % of isolates from any sampling site (Table 3-2). Genotype 3 
represented 25 % of after packaging isolates in flock 1 but represented only 2 % of isolates from the 
caeca. Flock 2 was dominated by isolates of gt 1 (Table 3-2) which were found within all sampling 
sites. Genotype 16 was isolated only from after chilling and after packaging samples within flock 1 
in comparison to gt 22 which constituted 21 % of caecal isolates but was not found at other 
sampling sites.  
 
The majority of isolates from the Flock 3 caeca were gt 4 (68 %) and this gt continued to dominate 
throughout the processing chain (Table 3-2). Genotype 2 strains increased from only 15 % of caecal 
isolates to 40 % of isolates after packaging. Flock 4 was dominated by gt 3 in the caecal contents 
(31 %) and in samples from after packaging (47 %). Genotype 3 was not the dominant strain at all 
sampling sites across the processing chain as gt 8 dominated before scald (49 %), before chilling 
(53 %) and after chilling (100 %) sites, although only 11 isolates were obtained after chilling.  
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The genotypes isolated from individual chickens are displayed in Figure 3-2. Across all flocks 
caecal samples carried a mean of two genotypes with up to six different genotypes in an individual 
chicken, flock 1, sample three and nine (Figure 3-2). After packaging samples carried a mean of 2.3 
genotypes with a maximum of four in chicken sample 3 flock 3 and samples 1,8 and 9 in flock 4. 
Non-caecal related genotypes were isolated from after packaging samples within all flocks.  
 
At least one dominant caecal genotype in each flock was well represented in after packaging 
samples (Table 3-2). Some genotypes isolated from caecal samples across flocks 2, 3 and 4 were 
not isolated from any downstream samples. In flock 2, 21% of the 80 caecal isolates (gt 22) were 
not detected in after chill or after packaging samples. Within the most diverse flock in this study 
(flock 4) up to six genotypes were isolated from some individual caeca and from whole chickens 
sampled before scald (Figure 3-2). 
 
Clinical isolates were significantly (P<0.01) more diverse (D=0.932; CI 0.925-0.940) than the 
Campylobacter from all chickens in this study (D=0.829; CI 0.821-0.837). The most common 
genotypes from clinical isolates were 2, 3, 4, 6, 7 and 8 with 55 % of all clinical isolates belonging 
to this group (Figure 3-3). Genotypes 2, 3, 4, 6 and 8 were also, in conjunction with gt 1, the most 
prevalent genotypes amongst all chicken isolates (Figure 3-3). A total of 7 genotypes representing 
11 % of clinical isolates, (excluding miscellaneous isolates) did not occur in the chicken isolates. 
Isolates from a further 8 genotypes included 21 % of clinical isolates that were only isolated 
upstream from after chilling samples. Genotypes 9 and 20 were not isolated from clinical samples 
and were only recovered from before scald samples in flock 1 (gt 9) and from caecal samples in 
flock 3 (gt 20). 
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Figure 3-1: Dendrogram of representatives from each genotype including clinical and poultry 
isolates. The number of isolates of each genotype is displayed from ahuman samples and bpoultry 
samples. The similarity matrix was calculated using dice similarity coefficient and clustering by 
unweighted paired group method with arithmetic mean values. Band position tolerance and 
optimization coefficient were set to 1.5%. Clusters (n=18) were calculated at the 75% similarity 
level. The percentage similarity at each node is displayed. There were 59 miscellaneous isolates not 
represented in the dendrogram. 
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Table 3-1: Simpsons index of Diversity (D) for each Flock at each sampling site and across the 
entire processing chain 
Sampling Sites Flock 1 Flock 2 Flock 3 Flock 4 
Caeca 0.285±0.0030a 
(0.174 – 0.395)b 
 
0.339±0.0028 
(0.234-0.444) 
 
0.508±0.0033 
(0.394-0.622 
 
0.853±0.0010 
(0.805-0.809) 
 
Before Scald 0.592±0.0006 
(0.544-0.640) 
 
0.000 0.556±0.0041 
(0.429-0.683) 
 
0.709±0.0016 
(0.629-0.789) 
 
After Scald 0.566±0.0008 
(0.511-0.621) 
 
0.000 0.663±0.0031 
(0.552-0.774) 
 
0.778±0.0011 
(0.712-0.844) 
 
Before Chill 0.614±0.0013 
(0.543-0.686) 
 
0.000 0.683±0.0080 
(0.626-0.740) 
 
0.683±0.0030 
(0.573-0.792) 
 
After Chill 0.373±0.0040 
(0.240-0.506) 
 
0.200±0.0023 
(0.103-0.296) 
 
0.418±0.0036 
(0.298-0.538) 
 
0.000 
After Packaging 0.497±0.0023 
(0.401-0.593) 
 
0.151±0.0026 
(0.049-0.253) 
 
0.549±0.0007 
(0.495-0.604) 
 
0.717±0.0033 
(0.602-0.831) 
 
All Isolates 0.529±0.0003 
(0.493-0.566) 
 
0.124±0.0004 
(0.085-0.163) 
 
0.593±0.0004 
(0.551-0.634) 
 
0.767±0.0003 
(0.732-0.802) 
 
avariance of Simpsons Index of Diversity 
b95% CI of Simpsons Index of Diversity 
D values that have the same superscript lower casse letter following are not significantly (P>0.05) 
different from each other across rows. D values that have the same superscript upper case letter 
following are not significantly different (P>0.05) from each other in columns 
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Table 3-2: The percentage of each genotype calculated from the total number of isolates from each sampling 
site within each flock analysed with flaA-restriction fragment length polymorphism. Genotypes unique to 
each flock are in bold. 
 
  Sampling Sites1 
 Genotype Caeca BS AS BC AC AP 
Flock 1  n=992 n=125 n=96 n=85 n=62 n=93 
 2  0.9 2.0 1.2   
 3 2.0  39.2  39.6 31.8 17.7 24.7  
 6 83.8 50.4 53.1 52.9 77.4 66.7 
 7   1.0    
 9  3.2     
 17 12.1 6.4 1.0 10.6  1.1 
 22    1.2   
 25   2.0    
 27      2.2 
 28 1.0    4.8  
 29    1.2  1.1 
 30   1.0    
 M 1.0   1.2  4.3 
        
Flock 2  n=80 n=103 n=95 n=64 n=110 n=89 
 1 78.8 100 100 100 89.1 92.1 
 3     0.9 1.1 
 10     0.9 2.3 
 16     9.1 3.4 
 22 21.3      
 27      1.1 
        
Flock 3  n=80 n=48 n=72 n=98 n=93 n=88 
 1   1.4    
 2 15.0 20.8 6.9 40.8 9.7 39.8 
 3  2.1 11.1 6.1 9.7 2.3 
 4 67.5 62.5 55.6 41.8 75.3 54.6 
 5  14.6 12.5 2.0   
 6   2.8  1.1  
 8   1.4 1.0   
 12     1.1  
 15   5.6 4.1   
 16   1.4    
 20 13.8      
 21    4.1 3.2 2.3 
 M 3.8  1.4   1.1 
        
Flock 4  n=39 n=94 n=44 n=64 n=11 n=34 
 1 2.6  2.3    
 2  1.1    2.9 
 3 30.8 12.8 15.9 12.5  47.1 
 4 12.8 6.4 4.6 14.1  5.9 
 5 2.6 3.2    2.9 
 6 10.3 18.1 31.8 4.7  23.5 
 7    1.6   
 8 12.8 48.9 31.8 53.1 100 14.7 
 11  6.4 9.1 7.8   
 12 5.1  2.3    
 14    3.1   
 16    3.1   
 26  1.1     
 27  2.1     
 28 2.6      
 30 15.4      
 M 5.1  2.3   2.9 
1BS-Before Scald; AS-After Scald; BC-Before Chill; AC-After Chill; AP-After Packaging 
2Number of isolates from the sampling site for each flock 
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Figure 3-2: Map of genotypes found on individual chickens from each of four flocks; + represents a 
positive sample with no isolates recovered from storage; - represents a negative chicken sample. 
Only genotypes isolated from each flock are displayed for that flock, a 12 point greyscale represents 
from 1 to 12 isolates. M represents the miscellaneous isolates which are those where less than four 
isolates occurred within a genotype. 
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Figure 3-3: Percent of each genotype from different sources, black columns - human, light grey – prior to chilling and dark grey - after chilling. Prior to 
chilling samples include isolates from all poultry samples from caeca, before scald, after scald and before chilling sampling sites. After chilling 
samples include isolates from all poultry samples from after chilling and after packaging. The percentage is calculated from the number of isolates of 
that genotype and the total number of isolates from a particular source (human, prior to chilling or after chilling). 
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3.5 Discussion 
 
The primary aim of the present study was to track the carriage of specific Campylobacter 
genotypes through the slaughter of four poultry flocks. It has been suggested that 
Campylobacter strains can vary in their capacity to survive during processing (Allen et al., 
2007; Alter et al., 2005a; Habib et al., 2010; Newell et al., 2001). While only four flocks were 
examined in this study, the carriage of specific genotypes varied in a flock and genotype 
dependent manner. It is well recognized that Campylobacter contaminating final chilled 
carcases are frequently the same genotype as those isolated from the caeca of the same flock 
(Allen et al., 2007; Elvers et al., 2011; Kudirkiene et al., 2011). Caecal genotypes were 
commonly isolated from after packaging samples in the current study however there were 
some genotypes from caecal samples that were not isolated from any downstream samples. A 
possible reason for this observation is the greater survival of the more dominant genotypes 
(such as gt 1, 78 % of caecal isolates, in this study) in the processing environment when 
subjected to high temperatures in scalding and the low temperature combined with chlorine in 
immersion chilling (Alter and Scherer, 2006; Humphrey et al., 2007; Murphy et al., 2006). 
The method of isolation may also affect the number of genotypes isolated with differences 
noted in other studies between genotypes from direct plating and enrichment samples 
(Kudirkiene et al., 2011; Newell et al., 2001). 
 
It is unknown if the stress imposed on Campylobacter during poultry processing is able to 
produce spontaneous recombination of the two similar flagellin genes, flaA and flaB, that has 
been demonstrated under laboratory conditions (Wassenaar et al., 1995). Recombination 
events would add to the complexity of tracking genotypes through processing using flaA-
RFLP. A group of related Campylobacter poultry isolates have been shown to have 
undergone recombination events before isolation, but attempts to recreate this in the 
laboratory were unsuccessful (Wassenaar et al., 1998).  This study was not designed as a 
longitudinal study over an extensive period of time for collection of poultry isolates but rather 
a set of four, point in time, collections through the poultry process. The potential instability of 
flaA-RFLP genotyping prevents its use in global or long-term time-related epidemiological 
studies (Wassenaar and Newell, 2000). It has been shown in some studies that the number of 
genotypes decrease from the beginning to the end of slaughtering (Hiett et al., 2002; Klein et 
al., 2007a) suggesting that some genotypes may be more tolerant to the environmental 
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stresses in poultry processing (Allen et al., 2007; Alter et al., 2005a; Newell et al., 2001). 
Using probes specific to the short variable region of flaA two specific genotypes were noted 
to decrease in one flock studied by Elvers et al. (2011) suggesting a decreased ability to 
survive through processing. In the current study three of four flocks had an increase in the 
number of genotypes from caecal samples compared to after packaging samples. However 
when taking both caecal and before scald samples together and comparing to after packaging 
samples two flocks decreased, one remained unchanged and one flock increased in the 
number of genotypes. Isolates from before scald samples may contaminate the outside of the 
chicken from sources on-farm, during transport from contaminated crates (Melero et al., 
2012), faecal material from other transported chickens, or from aerosols generated from the 
hanging area prior to stunning (Allen et al., 2007; Kudirkiene et al., 2011). Genotype 3 was 
present at a higher percentage in before scald samples (39 %) compared to caecal samples 
(2 %) in flock 1 suggesting sources of contamination before slaughter for this genotype other 
than the caecal carriage within the flock. 
 
Simpson’s index of diversity (D) measures both the number of genotypes present and the 
abundance of each genotype. A D value of 1 indicates that each member of a population can 
be distinguished from every other and a D value of zero indicates that all members of a 
population are identical. The number of genotypes carried by chickens has been suggested to 
be limited (Elvers et al., 2011; Lindmark et al., 2006; Newell et al., 2001). Analysing up to 12 
isolates from each chicken in the current study found a greater diversity in some samples (six 
genotypes) compared to that found by Elvers et al., (2011) where three genotypes from a 
caecal sample were isolated from 20 colonies. The current study demonstrates the value of 
characterising a greater number of isolates from each sample, where strain diversity is of 
interest. 
 
Cross contamination from previously processed flocks or the abattoir environment has been 
noted as a source of non-flock related genotypes (Allen et al., 2007; Kudirkiene et al., 2011). 
Flocks dominated by a single genotype at the start of processing have previously been noted 
to have less potential cross contamination than flocks contaminated by more genotypes 
(Elvers et al., 2011). This may vary on a flock to flock basis as flock 2 was dominated by a 
single genotype at greater than 78 % throughout processing however a further four genotypes 
(10 % of isolates) occurred at either after chill or after packaging. Variation in the level and 
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prevalence of Campylobacter occurs across individual chickens within a flock (Elvers et al., 
2011; Hansson et al., 2010; Newell et al., 2001). This variation should be considered within 
project design and interpretation, within the limits of laboratory resources. In the current 
study selection of a single chicken at many of the sample sites may not have revealed the true 
diversity of genotypes across the entire flock. Within flock 1, chickens from the processing 
stages of before scald (1/10), after scald (4/10), before chill (3/10), and after packaging 
(5/10), were carrying other non-caecal related genotypes giving rise to greater variation and 
possibly suggesting cross contamination (Figure 3-2). 
 
While not designed to define the relationship between clinical and poultry isolates across 
Australia, the collection of clinical isolates within the same time period of chicken sampling 
enables some general conclusions to be drawn. The finding of common overlapping 
genotypes between human and poultry isolates in this study lends weight to the commonly 
accepted paradigm that poultry are a major source of campylobacteriosis. The use of flaA-
RFLP has been found to be a reliable predictor of MLST clonal complexes (Djordjevic et al., 
2007) and hence an evolutionary connection between human and poultry isolates could be 
presumed. Consideration of the possibility of genomic changes affecting the flaA-RFLP type 
occurring during passage from chicken to human to clinical isolate should be considered 
within Campylobacter studies. To cause human disease, Campylobacter must survive and 
grow within the gastrointestinal tract where environmental stress may lead to naturally 
occurring recombination events and hence changes in flagellin genotypes (Harrington et al., 
1997). Despite the recognised possibility of genomic changes affecting flaA-RFLP genotypes 
particularly during human infection, the observation in this study of a number of overlapping 
genotypes between poultry and human isolates confirms the link that poultry are a major 
contributor to the abundance of human campylobacteriosis. 
 
The majority of isolates from both clinical (55 %) and chicken (63 %) belong to the same top 
six genotypes. Between 50 and 80 % of campylobacteriosis cases have been attributed to 
poultry across the European Union (EFSA, 2010c). An Australian source attribution study 
states only 30 % of clinical cases are related to poultry (Stafford et al., 2008). In this study 
the 8 genotypes found in clinical isolates but not found in chicken isolates make up 11 % of 
all clinical isolates. Another 8 genotypes found in chicken samples taken before the final 
control point of immersion chilling (or further upstream) represent 21 % of clinical isolates. 
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Taken together this represents 32 % of clinical isolates that were not isolated from the final 
stages of poultry processing. This suggests the possibility of sources of Campylobacter other 
than poultry. Clinical isolates have been found to have a greater variety of flaA-short variable 
region genotypes compared to chicken isolates (Fitch et al., 2005). Some caution should be 
used in interpreting this data from the current study as only four flocks from two processing 
plants were analysed and this may not be a true representation of the Campylobacter carried 
by the Australian poultry flock as a whole.  
 
In comparison to the major overlapping genotypes, a single chicken genotype (gt 1) 
represented 27 % of all chicken isolates but only represented 2 % of clinical isolates. There 
are a number of potential reasons for this. The genotype made up the majority of isolates 
from flock 2 (Table 3-2) and was only found in small numbers in flock 3 and 4 from samples 
taken upstream of chilling. This could suggest that chickens carrying gt 1 may not have been 
as widely distributed in the retail chain as chickens from other flocks. However the 
Australian industry is dominated by a few large companies and the plant that processed 
flock 2 is operated by one of these major companies. The chickens from flock 2 may 
therefore be transported across a large geographical area to meet supply. The potential 
virulence of this genotype may be lower than that of other genotypes more frequently isolated 
from clinical samples. It has been suggested that some Campylobacter are more pathogenic 
than others (Melero et al., 2012).  
 
 3.6 Conclusion 
 
In conclusion the genotypes entering the processing plant on the external surface of the 
chicken may be as important to the final representation of genotypes as those carried in the 
caeca. Non-caecal related genotypes may contaminate final product although commonly at a 
low percentage of the total isolates. The diversity of Campylobacter is flock dependant and 
may alter through processing. This study confirms previous reports that some genotypes may 
be more susceptible to the stresses of poultry processing than others. Australian 
campylobacteriosis cases are likely to have a poultry source with numerous overlapping 
genotypes and the dominance of some genotypes in both poultry and clinical isolates. 
However sources other than poultry should be further investigated in the Australian context. 
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4.1 Introduction 
 
Numerous factors are suggested to influence the pathogenicity of Campylobacter. Multi Locus 
Sequence Typing (MLST) has provided the scientific community with a way of describing the 
population genetics of a microbial species without the need to exchange the organisms themselves, 
between laboratories (Maiden, 2006). C. jejuni has a weakly clonal population structure with some 
clonal complexes (CCs) found to be associated with the original clinically associated Penner 
serotypes (Dingle et al., 2001). Autoagglutination (AAG) has been shown to be related to virulence 
potential in organisms such as Yersinia (Laird and Cavanaigh, 1980) and Vibrio cholera (Chiang et 
al., 1995). In Campylobacter, AAG has been shown to be variable across isolates, highly associated 
with flagellar expression, and is correlated with bacterial hydrophobicity and adherence to INT407 
cells (Guerry et al., 2006; Misawa and Blaser, 2000).  
 
Campylobacter motility is suggested to be related to adherence, invasion and epithelial 
translocation (Grant et al., 1993; Yao et al., 1994). Motile isolates have been shown to have an 
increased efficiency for attachment and invasion of Caco2 cells (Szymanski et al., 1995). Numerous 
studies have been published that examine the carriage of potential pathogenicity related genes 
(Abu-Madi et al., 2016; Datta et al., 2003; Wieczorek and Osek, 2008). This was taken further by 
the development of a PCR based binary typing scheme (P-BIT) to provide a measure of isolate risk 
ranking that examines the presence/absence of 18 putative virulence genes (Cornelius et al., 2010). 
To survive the gastrointestinal tract, Campylobacter must be able to survive the presence of bile 
salts. The normal bile salt concentration in the small intestine of humans ranges from approximately 
0.2 – 2 % (w/v), depending upon the individual and the type and amount of food ingested (Malik-
Kale et al., 2008). Growth has been demonstrated in up to 5 % (w/v) ox-bile although with a 20-fold 
decrease in growth rate compared to controls with no bile (Fox et al., 2007). Recently C. jejuni 
exposed to deoxycholate (a component of bile salts) has been shown to alter global gene 
transcription in a similar manner to exposure to reactive oxygen stress (Negretti et al., 2017).  
 
Cell surface glycoconjugates such as the lipo-oligosaccharide (LOS) and capsular polysaccharide 
(CPS) have been suggested to have a role in bile resistance (Iwata et al., 2013), biofilm formation 
and stress survival (Naito et al., 2010), chick colonization (Iwata et al., 2013; Javed et al., 2012), 
serum sensitivity (Bacon et al., 2001; Guerry et al., 2000; Keo et al., 2011) as well as 
hydrophobicity and attachment to surfaces (Bacon et al., 2001; Nguyen et al., 2013). C. jejuni 
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isolates capable of sialylating their LOS have demonstrated higher levels of adhesion and invasion 
of human cell lines (Habib et al., 2009; Louwen et al., 2008).  
 
The process of attachment to and invasion of epithelial cells is required for Campylobacter to cause 
disease. As a convincing animal model does not exist, in vitro assays have been widely used to 
assess bacterial adherence, invasion, protein secretion, intracellular survival and toxin production. 
The lipoprotein JlpA, the peb1A locus, the virulence protein CiaC and fibronectin binding through 
FlpA have all been identified as virulence attributes through incorporation of adhesion and invasion 
assays into the experimental design (Jin et al., 2001; Konkel et al., 2010; Neal-McKinney and 
Konkel, 2012; Pei et al., 1998). Not all clinical isolates, however, have been found to invade cell 
lines or produce toxins (Ketley, 1997).  
 
Studies have examined the survival of Campylobacter under conditions that simulate the stresses 
found in poultry processing, namely scalding and immersion chilling (Al-Sakkaf and Jones, 2012; 
Yang et al., 2001). In Australia, eating chicken meat may account for 30 % of Campylobacter cases 
(Stafford et al., 2007). Previous studies have indicated that not all genotypes of Campylobacter may 
survive the stresses of poultry processing (Allen et al., 2007; Alter et al., 2005a; Newell et al., 2001) 
and as demonstrated in chapter 3. The current chapter describes a study that incorporates isolates 
commonly found in both human and processed poultry, isolates that were infrequently isolated from 
humans, and isolates that were only present at the beginning of poultry processing, allowing a 
preliminary examination of poultry processing survival relative to human disease risk. The aim of 
this study was to assess and compare the potential pathogenicity of isolates/strains, and between 
groups of isolates, using phenotypic and genotypic characteristics that have been previously linked 
to pathogenicity.  
  
4.2 Materials and Methods 
 
4.2.1 Bacterial isolates/strains  
 
The 32 isolates used in this study were selected from 2,363 isolates obtained from both clinical and 
poultry samples and are listed in Table 4-1. Selection was based on flaA-RFLP genotypes 
determined in chapter 3, which was used to separate isolates into four groups: H-P, those genotypes 
commonly found in humans and that commonly survive poultry processing; NH-P, those genotypes 
that are not commonly found in humans but commonly survive poultry processing; NH-NP, those 
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genotypes that are not commonly found inhumans (less than five isolates) and do not commonly 
survive poultry processing (ceacal or before scald samples only); and H-NP, those genotypes that 
are commonly found in humans and do not commonly survive poultry processing. A total of 20 
C. jejuni, made up of 10 human and 10 poultry isolates, and 10 C. coli consisting of three human 
and seven poultry isolates, were included along with C. jejuni NCTC11168 and C. coli RM2228 as 
control strains. 
 
Campylobacter were recovered from -80 °C by plating Protect Bacterial Preserver beads (Technical 
Service Consultants, UK) onto Charcoal Cefoperazone Deoxycholate Agar (mCCDA; 
ThermoFisher, Australia) without antibiotics and incubating at 42 °C for 48 h under 5 % CO2 
atmosphere (Duffy and Dykes, 2009) generated within a CB150 incubator (Binder, Germany). 
Generation of 5 % CO2 for the growth of Campylobacter has been extensively utilised in our 
laboratory. A loopful of culture was then added to 10 mL of Nutrient Broth No. 2 (NB2; 
ThermoFisher) in a 10 mL tube with limited headspace. The tubes were incubated under 5 % CO2 at 
42 °C for 48 h to generate stationary phase cultures. A DNA template was made for each 
isolate/strain. A 1 mL portion of the broth culture was centrifuged at 13,000 g for 3 mins, 
resuspended in high quality water, heated at 100 °C for 10 min, centrifuged at 13,000 g for 3 min 
and the supernatant used as DNA template where required.  
 
4.2.2 MLST  
 
MLST was performed according to the method of Dingle et al. (2001). Sequences were assigned to 
allele numbers using the Campylobacter Multi Locus Sequence Typing website 
(http://pubmlst.org/campylobacter) (Jolley and Maiden, 2010). The allelic profile becomes the 
sequence type (ST) for that isolate. A CC is defined as a group of two or more isolates with a 
sequence type (ST) that shares the same alleles for at least four loci out of seven (Dingle and 
Maiden, 2005). 
 
4.2.3 Autoagglutination Assay  
 
Isolates/strains in NB2 were centrifuged for 20 min at 4500 g at 4 °C and resuspended in phosphate 
buffered saline at pH 7.4 (PBS; Sigma, Australia) to an OD600 of 1.0. AAG activity was determined 
using the assay described by Misawa and Blaser (2000). Polypropylene tubes containing 2 mL of 
suspension were incubated at 25 °C for 24 and 48 h. After each incubation period, 1 mL of the 
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upper phase was removed and the OD600 measured. AAG activity was calculated from the 
difference in A600 at time zero and the time of measurement. 
 
4.2.4 Motility Assays  
 
Isolates/strains in NB2 were centrifuged for 20 min at 4,500 g at 4 °C and resuspended in PBS to an 
OD600 of 1.0. Motility assays were conducted according to the method of Louwen et al. (2012). A 
2 µL portion of the bacterial suspension was stabbed onto semisolid NB2 agar (NB2 0.4 % agar) 
supplemented with 0.05 g/L 2,3,5-triphenyltetrazolium chloride (Sigma). The diameter of the red 
cloudy pattern was measured at both 24 and 48 h after incubation at 37 and 42 °C. A recorded 
diameter of 6 mm or less represents an isolate/strain with no motility. 
 
4.2.5 P-BIT 
 
PCR binary typing was performed and coded as described by Cornelius et al. (2010). Each PCR 
consisted of 1 x Dream Taq™ buffer (ThermoFisher), 250 mM of dNTPs (ThermoFisher), 12.5 pM 
of each primer, 1.25 U Dream Taq polymerase (ThermoFisher) and 2 µL of DNA template 
(prepared in 4.1.1) in a 25 µL reaction mix. PCR was performed in a Perkin Elmer 9300 machine 
using an initial denaturation step of 94 °C for 1 min, followed by 40 cycles of 94 °C for 1 min, 
59 °C for 1 min, 74 °C for 1 min, with a final extension of 74 °C for 8 min. The amplicons were 
analysed by electrophoresis on 1.5 % agarose gel stained with ethidium bromide and visualized 
with a UV transilluminator. The presence or absence of each gene was entered into Bionumerics 
(Applied Maths NV, Belgium) as binary data. A dendrogram was produced using simple matching 
coefficient and unweighted paired-group method with arithmetic means (UPGMA). The six figure 
P-BIT code was generated as described by Cornelius et al. (2010). 
 
4.2.6 Putative virulence markers  
 
All primers for testing the presence of the 18 putative virulence markers were selected from the 
literature and are listed in Appendix A, Table A-2. The genes include those for stress response 
(cbrR, sodB, htrA, clpA), motility (flaA, flaC), toxin production (cdtA, cdtB, cdtC, cdt cluster), 
adhesion/invasion (pldA, virB11, dnaJ, cadF, ciaB, ceuA, racR) and LOS biosynthesis (wlaN). PCR 
was performed with standardized cycling parameters; 95 °C for 1 min followed by 35 cycles of 
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95 °C for 1 min, 53 °C for 1 min and 72 °C for 1 min followed by an extension step of 72 °C for 3 
min. All PCR assays were performed in a total volume of 25 µL containing 1 x Dream Taq™ buffer 
(ThermoFisher), 250 mM of dNTPs, 1 µM of each primer, 1 U Dream Taq polymerase 
(ThermoFisher) and 2 µL of DNA template (prepared in 4.1.1). The amplicons were analysed by 
electrophoresis on a 1.5 % agarose gel stained with ethidium bromide and visualized with a UV 
transilluminator. The presence or absence of each gene was entered into Bionumerics as binary 
data. A dendrogram was produced using simple matching coefficient and UPGMA.  
 
4.2.7 Bile Salts 
 
4.1.7.1 Broth Dilution. Isolates/strains grown on CCDA without antibiotics were suspended in NB2 
to an OD595 of 0.20 ± 0.02. The cultures were further diluted in NB2 to obtain 105 CFU/mL. A 96-
well microplate assay system based on the work of Bishop-Hurley et al. (2010) and Navarro et al. 
(2015) was used to correlate the concentration of sodium deoxycholate (DOC; Sigma) with the 
degree of inhibition of growth. The upper and bottom rows of wells in each plate contained 200 µL 
sterile NB2 (negative control) and the Campylobacter isolates/strains without bile salts (150 µL 
NB2) and 50 µL of inoculum; (positive control), respectively. The test wells in the six intermediate 
rows contained 50 µL of bile salt solution, 100 µL of NB2 and 50 µL of inoculum with the 
inoculum added last. The DOC was prepared in NB2 at a concentration of 80 g/L or 8 %. This was 
two-fold serially diluted in NB2 to generate 12 concentrations ranging from 4 to 0.00195 % in the 
microtitre plate. The growth inhibitory capacities of the bile salt concentrations was calculated 
using the following; percentage inhibition = [1-(T48 OD595 – T0 OD595)/(C48 OD595 – C0 OD595)] x 
100, where T0 and T48 are the treatment wells at 0 and 48 h and C0 and C48 are the positive 
control wells at 0 and 48 h, respectively. All assays were run in triplicate and repeated in two 
independent experiments. 
 
4.2.7.2 Agar Dilution. DOC was added to NB2 with 1.5 % Technical Agar No. 3 (ThermoFisher) to 
produce Bile Salt Nutrient Broth Agar (BSNB). BSNB agar plates had DOC concentrations of 0, 
0.1, 0.5, 0.75 and 1 % (final concentration in the agar) added after autoclaving. Dilutions of NB2 
were spread plated (100 µL) onto BSNB agar (with different concentrations of DOC) in duplicate. 
Plates were incubated at 42 °C for 48 – 72 h under 5 % CO2. Colonies were counted and recorded. 
The percentage of average inhibition was calculated by comparing counts on BSNB agar against 
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counts on 0 % bile salts. All assays were run in triplicate and repeated in two independent 
experiments. 
 
4.2.8 LOS and CPS 
 
All isolates/strains were subcultured in NB2 as described in 4.1.1. Genomic DNA was extracted 
using DNeasy blood and tissue kit (Qiagen, Australia) according to the manufacturer’s instructions. 
Genomic DNA was stored at 4 °C until required. Whole genome sequencing (including library 
preparation) was performed by staff at the Ramaciotti Center, University of New South Wales. 
DNA libraries were prepared using the Nextera XT DNA library preparation kit (Illumina) and 
paired-end (2x300 bp) reads were generated using MiSeq V3 (Illumina). Sequences were aligned to 
the reference strains RM2228 and NCTC11168 using SPAdes 3.5.0. Annotation was performed 
with Prokka 1.11 using protein sequences from strains RM2228 and NCTC11168. Where LOS and 
CPS gene clusters were contained in multiple contigs, further assembly was undertaken in Geneious 
(Biomatters, New Zealand). PCR and Sanger sequencing was used to confirm the Geneious 
assembly of the LOS and CPS clusters.  
 
Definition of the LOS cluster followed that of Gilbert et al. (2002) and Richards et al. (2013) and 
was designated as those genes between, and inclusive of, waaC and waaF. Previously described 
classes A – W were compared to the LOS locus of isolates/strains used in this study (Gilbert et al., 
2002; Godschalk et al., 2004; Parker et al., 2008; Richards et al., 2013). The CPS cluster was 
compared to class A – E and F – L for C. jejuni and class I to VIII for C. coli (Karlyshev et al., 
2005; Richards et al., 2013). The CPS cluster was designated as those genes between, and inclusive 
of, kpsC to kpsF. Where all genes were present and in the same order compared to a previously 
published class, any single nucleotide polymorphisms (SNPs) were not considered a different class. 
Homopolymeric tracts that forced differences in open reading frames but still retained the same 
gene structure were also not considered a different class. All isolates/strains and their LOS and CPS 
class are listed in Table 4-4 and Table 4-5. The annotations for all isolates/strains and their 
associated LOS and CPS clusters are in Appendix A, Table A-3 and Table A-4. Where no match 
was made with a previously published class, a BLAST search was used to find a matching 
LOS/CPS cluster in other sequenced Campylobacter. If a match of ≥ 99 % was found for the 
complete cluster, the accession number was noted in Table 4-4 or Table 4-5.  
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 4.2.9 Adhesion to Caco-2 cells 
 
Caco-2 cell lines (ECACC 86010202) were maintained at 37 °C in 5 % CO2 in T-75 flasks 
(Sarstedt, Australia) containing 10 mL of complete growth medium. This medium consisted of low 
glucose Dulbecco’s minimal essential medium (DMEM) 10% feotal bovine serum (FBS), 1 % non-
essential amino acids, and 100 U/mL penicillin and 100 µg/mL streptomycin (final concentrations) 
(ThermoFisher). The medium was changed every second day and cells were subcultured using a 1:6 
split ratio every 2 to 3 days. At 80 % confluence, cells were split by adding trypsin-EDTA solution 
(0.25 % trypsin – 1 mM EDTA; ThermoFisher) and counted using a TC10 auto counter (Biorad, 
Australia) before seeding at a concentration of 1 x 105 cells/well in 24-well tissue culture plates 
(Sarstedt) containing 2 mL of complete growth medium/well. Plates were incubated at 37 °C in 5 % 
CO2. The culture medium was changed on alternate days until the cells reached confluence. At this 
stage complete growth medium minus antibiotics was added and the assay performed the following 
day. 
 
The 48 h broths of each isolate/strain were centrifuged at 10,000 g for 20 min at 4 °C, washed in 
5 mL PBS, centrifuged again before being resuspended in 5 mL of PBS to an OD600 of 0.200. 
Isolates/strains were then diluted (0.5 mL into 4.5 mL of DMEM plus FBS) before addition to both 
adhesion and gentamicin protection assay (GPA) plates. Prior to the attachment assay, Caco-2 cell 
monolayers in each well were washed three times with 1 mL PBS. Aliquots of 1 mL of bacterial 
suspensions (approximately 2 x 107) were added to each well (MOI 100) and incubated for 2 h at 
37 °C in 5 % CO2. Following incubation, the unattached bacteria were removed by washing the 
monolayer with 1 mL of sterile PBS three times. Cell lines and attached bacteria were then detached 
from the wells by incubating the monolayer in 200 µL PBS-Triton X-100 per well for 30 min. 
Following lysis, serial 10 fold dilutions were prepared using PBS and 100 µL aliquots were plated 
onto mCCDA without antibiotics and incubated at 42 °C for 48 h in 5 % CO2. Spread plates of 
bacteria from before and after attachment were counted. The adhesion results were calculated for 
cell association where the total number of bacteria adhered and invaded was divided by the total 
bacterial count added to the well.  
 
4.2.10 Gentamicin Protection Assay  
 
Caco-2 cell lines were maintained as described for the adhesion assay. After incubation without 
antibiotics the day before the assay, Caco-2 monolayers were incubated with individual 
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Campylobacter isolates/strains at an MOI of 100 for 4 h at 37 °C and 5 % CO2. Following the 
invasion period, the Caco-2 cells were washed with pre-warmed complete growth medium minus 
antibiotics and incubated for a further 2 h in DMEM containing 480 µg/mL gentamicin (Sigma-
Aldrich, Australia) to kill extracellular bacteria. Following gentamicin treatment, the Caco-2 cells 
were washed three times with DMEM and detached from the wells by incubating the monolayer in 
200 µL trypsin-EDTA per well for 10 min at 37 °C followed by vigorous pipetting. Following 
detachment, serial 10 fold dilutions were prepared using 0.85 % saline and 100 µL aliquots were 
plated onto Mueller Hinton agar (ThermoFisher) and incubated at 42 °C for 48 h in 5 % CO2. The 
invasion efficiency was calculated as the total number of bacteria invaded divided by the total 
number of bacteria that adhered and invaded.  
 
4.2.11 Statistics 
 
One-way analysis of means, regression plots, correlations and comparison of means (Tukey’s 
method) were performed on data sets using Minitab software (Minitab 18, Mintab Inc., USA). The 
χ2 test was used to compare the level of carriage of each gene between chicken and human 
isolates/strains and between species. 
 
4.3 Results 
 
4.3.1 MLST 
 
The ST and CC of the 32 isolates in this study are listed in Table 4-1. As of January 2018, there 
were a total of 230 records (including isolates from this study) of Australian Campylobacter isolates 
in the international online MLST database (https://pubmlst.org/campylobacter/; (Jolley and Maiden, 
2010). Of these, 121 were listed as being from chickens or humans. These represent 18 CCs with 20 
STs not assigned to a CC. Isolates in the current study represent the top five CCs from Australian 
chickens or humans listed in the international database (CCs 21, 828, 48, 52 and 354). A further 
three CCs that make up from 2 to 5 % of Australian chicken and human isolates are represented by 
four isolates and another two isolates in this study are unassigned to a CC. The breakdown of 
Australian chicken and human isolates in the MLST database is shown in Appendix A, Figure A-1.  
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4.3.2 Autoagglutination (AAG) 
 
The AAG activity at 6 and 24 h for all individual isolates is displayed in Appendix A, Figure A-2. 
When all isolates are assessed together there was significantly (P<0.05) more AAG activity (lower 
OD values) at 24 h compared to 6 h (Figure 4-1). C. coli had significantly (P<0.05) more AAG 
activity than C. jejuni at 6 and 24 h (Figure 4-1). No significant (P>0.05) difference was noted in 
the isolate groups at either 6 or 24 h. The AAG activity assessed across CCs is displayed in Figure 
4-2. CC-828, all C. coli isolates, and CC-257 had significantly (P<0.01) more AAG activity than 
CC-48 and CC-354.  
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Table 4-1: Description of isolates used in this study 
 
Isolate Source Sitea Species flaA-RFLP Group
b MLST Date ST CC 
117 Chicken BS C. jejuni 9 NH - NP 5820 354 Nov 2009 
436 Human  C. coli 2 H - P 3985 828 Apr 2010 
448 Chicken AP C. jejuni 3 H - P 354 354 Nov 2009 
462 Chicken AP C. coli 17 NH - P 3985 828 Nov 2009 
470 Chicken AP C. coli 6 H - P 3985 828 Nov 2009 
697 Human  C. jejuni 30 H - NP 5821 48 Mar 2010 
722 Human  C. coli 17 NH - P 3985 828 Mar 2010 
741 Human  C. jejuni 17 NH - P 2947 257 Mar 2010 
743 Human  C. jejuni 2 H - P 4263 52 Mar 2010 
744 Human  C. jejuni 1 H - P 52 52 Mar 2010 
1180 Chicken AC C. jejuni 1 H - P 5822 52 Mar 2010 
1377 Human  C. jejuni 21 NH - P 859 443 Mar 2010 
1431 Human  C. jejuni 3 H - P 5824 354 Apr 2010 
1765 Chicken AC C. coli 15 H - NP 3985 828 Apr 2010 
1786 Chicken AC C. coli 3 H - P 5833 828 Apr 2010 
1790 Chicken AC C. coli 21 NH - P 3985 828 Apr 2010 
1898 Chicken AP C. jejuni 2 H - P 5827 52 Apr 2010 
1973 Chicken Caeca C. coli 20 NH - NP 3985 828 Apr 2010 
1998 Chicken Caeca C. coli 22 NH - NP 3985 828 Apr 2010 
2043 Human  C. jejuni 6 H - P 5828 21 May 2010 
2046 Human  C. jejuni 11 H - NP 2783 48 May 2010 
2189 Human  C. jejuni 3 H - P 51 443 July 2010 
2323 Human  C. jejuni 2 H - P 1518 48 Aug 2010 
2350 Human  C. coli 15 H - NP 5834 828 Aug 2010 
2554 Chicken AS C. jejuni 11 H - NP 48 48 Jul 2010 
2670 Chicken AS C. jejuni 2 H - P 5830 48 Jul 2010 
2672 Chicken AP C. jejuni 3 H - P 5831 -c Jul 2010 
2674 Chicken AP C. jejuni 6 H - P 525 607 Jul 2010 
2689 Chicken Caeca C. jejuni 3 H - P 5832 - Jul 2010 
2704 Chicken Caeca C. jejuni 30 H - NP 48 48 Jul 2010 
NCTC11168 Human  C. jejuni - Control 43 21  
RM2228 Chicken  C. coli - Control 1063 828  
aSite is the processing stage from which the chicken isolates were isolated; BS before scald, AS 
after scald, AC after chill and AP after packaging 
b Isolate groups using flaA-RFLP genotypes were generated as follows; H-P, found in humans and 
survive poultry processing; H-NP, found in humans but not found at end of poultry processing 
(found in caecal or before scald samples only); NH-NP, not commonly found in humans (less than 
five isolates) and not found at end of poultry processing; and NH-P, not commonly found in 
humans and survive poultry processing. 
cIsolate could not be placed in a CC 
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Figure 4-1: Autoagglutination (AAG) activity of human and chicken Campylobacter isolates; 6 and 
24 h within species, 6 h compared to 24 h of all isolates, the four isolate groups at 6, and 24 h. 
Columns with the same letter above within each of these groupings are not significantly (P<0.05) 
different. The lower the OD600 values the stronger the AAG activity. Error bars represent the 
standard deviation. Isolates were separated into isolate groups using flaA-RFLP genotypes as 
follows; H-P, found in humans and survive poultry processing; H-NP, found in humans but not 
found at end of poultry processing (found in caecal or before scald samples only); NH-NP, not 
commonly found in humans (less than five isolates) and not found at end of poultry processing; and 
NH-P, not commonly found in humans and survive poultry processing.  
 
 
 
 
 
 
 
 
Figure 4-2: Autoagglutination (AAG) activity of human and chicken Campylobacter isolates 
grouped into Clonal Complex (CC) at 6 h and 24 h. The lower the OD600 values the stronger the 
AAG activity. N/A are those isolates not assigned to a CC. Error bars represent the standard 
deviation. Values with the same capital letter above are not significantly different (P<0.05).  
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4.3.3 Motility 
 
The motility of all isolates/strains ranged from non-motile with a diameter of ≤ 6 mm to 69.7 mm 
(isolate 2189; 48 h/42 °C) and are listed in Appendix A, Table A-1. A total of 26 isolates/strains 
(81 %) were significantly (P<0.05) more motile at 42 °C/48 h than any other temperature/time 
combination. The H – P isolate group was significantly (P<0.05) less motile than the NH – P isolate 
group at three of the four temperature/time clusters (Table 4-2). A single isolate, 2674, was not 
motile under any of the tested conditions. A further six isolates/strains (743, 470, 1180, 2689 and 
2898) were not motile at 37 °C after 24 h and one of these, 743, was only motile at 42 °C. No 
significant (P>0.05) difference was found between human and poultry isolates within each species. 
 
Table 4-2: Mean motility values (± S.D.) for each temperature/time combination for each group of 
human and chicken Campylobacter isolates, excluding the two control strains. 
Groupc 37 °C/24 h 37 °C/48 h 42 °C/24 h 42°C/48 h 37 & 42 °C/24 h 37 & 42 °C/48 h 
H – P 8.56±4.19b 19.33±11.13b 11.38±5.64a 35.62±18.65b 9.97±5.14b 27.69±17.31b 
H – NP 12.27±4.13a 28.87±14.21ab 13.13±5.72a 47.07±12.28ab 12.70±4.92ab 37.97±16.00a 
NH – NP 13.89±3.89a 37.56±11.76a 11.33±4.95a 45.11±21.27ab 12.61±4.51ab 41.33±17.12a 
NH – P 12.73±4.04a 31.60±14.62a 15.00±7.35a 53.93±9.61a 13.87±5.94a 42.77±16.64a 
aMean motility within each temperature/time cluster that have the same superscript lower case letter 
following are not significantly different from each other in columns 
c Isolate groups using flaA-RFLP genotypes were generated as follows; H-P, found in humans and 
survive poultry processing; H-NP, found in humans but not found at end of poultry processing 
(found in caecal or before scald samples only); NH-NP, not commonly found in humans (less than 
five isolates) and not found at end of poultry processing; and NH-P, not commonly found in 
humans and survive poultry processing.  
 
4.3.4 P-BIT and virulence markers 
 
The dendrogram of the P-BIT and virulence markers is displayed in Figure 4-3. There are 10 clusters 
identified at the 80 % level. The strain NCTC11168 differs markedly from most of the Australian 
human isolates and is in a single cluster. CC48 and CC52 isolates are all in cluster 1. The majority 
of the C. coli isolates are in cluster 5 with only three others in three different clusters. The isolate 
groups H-P, H-NP, NH-NP and NH-P did not associate in any particular cluster. Only three genes 
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were carried by 100 % of isolates/strains, cj0122 that codes for a hypothetical protein, flaC 
(flagellin protein), and cadF (Campylobacter adhesion to fibronectin). A total of 31 (97 %) 
isolates/strains carried the genes cfrA (putative iron uptake protein), sodB (superoxide dismutase), 
cj1321 (putative transferase, part of the O-linked glycosylation island), and CJE1733 (putative 
arsenic resistance). No isolates/strains carried panB (a hydroxymethyltransferase) or maf5 (flagella 
formation). The carriage of the target genes was compared between isolates/strains of chicken and 
human origin, between C. coli and C. jejuni and between the isolate groups (Table 4-3). There was 
a significantly greater carriage in isolates from humans compared to those from chickens of two 
genes, tet(O) (P=0.043) and cj0423 (P=0.016). A total of eight genes were found to be carried at 
significantly (P<.05) different levels between C. jejuni and C. coli (Table 4-3). The gene cj0008 
was carried in the H-P group at significantly (P=0.025) lower levels than in the H-NP isolate group.  
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Figure 4-3: Dendrogram generated using Bionumerics v 6.7 using simple matching coefficient and 
unweighted paired-group method with arithmetic mean values on the basis of P-BIT data and other putative 
pathogenicity markers for human and chicken derived Campylobacter isolates. Numbers on the branches of 
the dendrogram indicate similarity level between isolates. Clusters were identified at the 80 % level and are 
identified in brackets with the isolate group. A cluster of 1 isolate is identified by a dot. 
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Table 4-3: Prevalence of gene targets for chicken and human sourced isolates of C. jejuni and C. coli, compared using the χ2 test for association. P 
values indicate level of association, where significant. 
 
Gene 
Prevalence  Prevalence  Prevalencea  
Chicken 
(n=18) 
Human 
(n=14) P 
C. jejuni 
(n=21) 
C. coli 
(n=11) P 
H-P 
(n=16) 
NH-P 
(n=5) 
NH-NP 
(n=3) 
H-NP 
(n=4) P 
Cj008 3 4 n.sb 7 0 n.s 2 0 0 4 0.0254 H-P< H-NP 
Cj0122 18 14 n.s 21 11 n.s 16 5 3 6 n.s 
Cj0265 0 2 n.s 2 0 n.s 1 0 0 0 n.s 
panB (Cj0298c) 0 0 n.s 0 0 n.s 0 0 0 0 n.s 
Cj0423 6 11 0.0155 16 1 0.0005 9 2 0 5 n.s 
cfrA (Cj0755) 17 14 n.s 20 11 n.s 15 5 3 6 n.s 
Cj1135 8 5 n.s 5 8 0.0205 6 4 1 1 n.s 
Cj1136 0 2 n.s 2 0 n.s 1 0 0 0 n.s 
wlaN (Cj1139) 9 9 n.s 17 1 0.0001 10 1 1 4 n.s 
CJE1500 4 1 n.s 5 0 n.s 4 0 1 0 n.s 
Cj1321 13 11 n.s 14 10 n.s 11 4 2 6 n.s 
maf5/pseE (Cj1337) 0 0 n.s 0 0 n.s 0 0 0 0 n.s 
gmhA2 (Cj1424) 9 7 n.s 16 0 0.0001 10 1 1 3 n.s 
flgE2 (Cj1729c) 1 2 n.s 3 0 n.s 1 1 0 0 n.s 
CJE1733 16 10 n.s 15 11 n.s 13 3 3 6 n.s 
cgtA 1 0 n.s 1 0 n.s 1 0 0 0 n.s 
virB8/comB1 (Cjp1) 11 6 n.s 9 8 n.s 7 2 3 3 n.s 
tetO 10 13 0.043 16 7 n.s 11 4 1 6 n.s 
cbrR 8 11 n.s 19 0 0.0001 11 2 1 4 n.s 
sodB 17 14 n.s 20 11 n.s 16 5 3 5 n.s 
htrA 15 12 n.s 21 6 0.0023 14 3 3 5 n.s 
flaC 18 14 n.s 21 11 n.s 16 5 3 6 n.s 
ClpA 7 8 n.s 15 0 0.0001 8 2 1 3 n.s 
CadF 18 14 n.s 21 11 n.s 16 5 3 6 n.s 
RacR 7 9 n.s 16 0 0.0001 8 2 1 4 n.s 
FlaA 16 14 n.s 20 10 n.s 15 5 3 5 n.s 
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Gene 
Prevalence  Prevalence  Prevalencea  
Chicken 
(n=18) 
Human 
(n=14) P 
C. jejuni 
(n=21) 
C. coli 
(n=11) P 
H-P 
(n=16) 
NH-P 
(n=5) 
NH-NP 
(n=3) 
H-NP 
(n=4) P 
CiaB 10 11 n.s 21 0 0.0001 13 2 1 4 n.s 
CeuA 9 10 n.s 19 0 0.0001 11 2 1 4 n.s 
cdtA 9 12 n.s 18 3 0.0018 11 3 1 5 n.s 
cdtB 12 12 n.s 20 4 0.0007 13 3 1 5 n.s 
cdtC 10 11 n.s 21 0 0.0001 13 2 1 4 n.s 
cdt cluster 7 9 n.s 16 0 0.0001 8 2 1 4 n.s 
wlaN (Cj1139) 0 2 n.s 2 0 n.s 1 0 0 0 n.s 
pldA 8 8 n.s 16 0 0.0001 9 1 1 4 n.s 
virB11 9 7 n.s 10 6 n.s 9 1 2 3 n.s 
dnaJ 7 6 n.s 13 0 0.0006 8 1 1 2 n.s 
 
aControl strains NCTC11168 and RM2228 are not included in the four groupings 
bn.s Not statistically significant 
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4.3.5 Bile Salts 
 
In broth assays, C. coli had no significant (P>0.05) change in growth compared to the no bile salts 
control up to 0.0635 % DOC. From 0.25 to 4 % DOC there was a significant (P<0.05) difference in 
the mean level of inhibition compared to the lower DOC levels (Figure 4-4). For C. jejuni 
isolates/strains the change in percent inhibition is not as distinct as for C. coli (Figure 4-4). A 
number of outliers were recorded amongst the C. jejuni isolates/strains. A limited number of 
isolates demonstrated an increase in growth above that of the no DOC control. The concentration at 
which this occurs was isolate dependent. There were six isolates that, at an isolate dependent 
concentration of DOC, exhibited growth greater than that of the no DOC control (117, 436, 448, 
462, 697, 2046).  
 
Using the agar dilution method, human isolates were significantly (P<0.05) less inhibited than 
poultry isolates at 0.5 (P=0.047), 0.75 (P=0.015) and 1 % DOC (P=0.007) but not at 0.25 % DOC. 
In the agar dilution method there was no significant (P>0.05) overall mean inhibition of growth at 
the lowest concentrations of DOC, 0.1 and 0.5 %. A total of five isolates had significantly (P<0.05) 
lower levels of inhibition at 1 % DOC compared to some or all other concentrations tested. All 
isolates/strains at all concentrations displayed some level of inhibition on agar, with none growing 
more than the control without DOC. The large variation across all the isolates/strains can be seen by 
the spread of the boxplots in Figure 4-5. At the clinically relevant levels of DOC (0.75 and 1 %), 
isolate 1377 was significantly (P>0.05) different from 22 of the remaining isolates due to the 
enhanced growth in the presence of DOC. 
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Figure 4-4: Boxplot of median inhibition of growth of A. 11 C. coli isolates and B. 21 C. jejuni 
isolates using the Broth Dilution method. Sodium deoxycholate concentrations vary from 0.00195 
to 4 %. Outliers are marked with an asterix, the boxes represent the middle 50 % of the data and the 
median is marked with a line. The whiskers extend to the last datapoint that is ≤ or ≥ 1.5 x the 
interquartile range. The positive control with no deoxycholate is designated as a mean inhibition of 
0 (black line). Values below zero indicate an increase in growth compared to the control. Values 
above zero indicate an inhibition of growth compared to the control. 
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Figure 4-5: Boxplot of median inhibition of growth for the agar dilution method of A. 11 C. coli 
isolates and B. 21 C. jejuni isolates. Sodium deoxycholate concentrations vary from 0.1 to 1 %. 
Outliers are marked with an asterix, the boxes are 25 and 75 % of the level with the median marked 
with a line. The whiskers extend to the last datapoint that is ≤ or ≥ 1.5 x the interquartile range. The 
positive control with no doexycholate is designated as a mean inhibition of 0 (black line). Values 
below zero indicate an increase in growth compared to the control. Values above zero indicate an 
inhibition of growth compared to the control. 
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4.3.6 LOS and CPS 
 
The 11 C. coli isolates/strains represented three known LOS classes (Table 4-4). RM2228 was class 
III, isolate 2350 was class VII and the remaining isolates were either class II (n=5) or of unknown 
class (n=4). Interestingly those with an unknown LOS class had a CPS match to accession 
#CP006702 and those designated class II LOS were also a match to #CP006702, with a missing 
1,001 bp fragment. RM2228 had a CPS locus of class I and isolate 2350 class III CPS. With the 
exception of isolate 2350, all C. coli contained an alpha 2,3-sialytransferase gene that annotated as 
cstI. For isolates 470, 722, 1786 and RM2228 the cstI gene was carried outside of the LOS locus, 
the remaining six isolates contained the gene within the locus. No C. coli isolate/strain carried 
neuBCA associated with sialic acid biosynthesis. The 21 C. jejuni isolates/strains represented eight 
known LOS classes (Table 4-5). There were 11 C. jejuni isolates/strains that contained the 
sialylation cluster within the LOS, made up of contiguous neuBCA and cst, placing them in LOS 
class A, B or C. Class B was found in eight isolates and there was no significant (P<0.05) difference 
in carriage between chickens or humans. 
 
Table 4-4: Lipooligosaccharide and capsular polysaccharide class for C. coli isolates 
Isolate/strain LOS Accession number CPS Accession numberb 
436 2 NAc NDa #CP006702 minus 1001 bp 
462 2 NA ND #CP006702 minus 1001 bp 
470 2 NA ND #CP006702 minus 1001 bp 
722 ND #CP017873 ND #CP006702 
1765 2 NA ND #CP006702 minus 1001 bp 
1786 ND None ND #CP006702 
1790 2 NA ND #CP006702 minus 1001 bp 
1973 ND #CP017873 ND #CP006702 
1998 ND #CP017873 ND #CP006702 
2350 7 NA III NA 
RM2228 III NA I NA 
a ND – no match with published LOS or CPS class 
b Accession number of match from blast search > 99% 
c NA – not applicable as a class match was obtained 
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Table 4-5: Lipooligosaccharide and capsular polysaccharide class for C. jejuni isolates 
Isolate/strain LOS Accession number CPS Accession number 
117 NDa ND ND #CP001960b 
448 S NAc I NA 
697 B NA ND #CP022079 
741 B NA A NA 
743 ND ND ND #CP017033 
744 F NA ND #KT868843 
1180 F NA ND #KT868843 
1377 P NA ND ND 
1431 J NA I NA 
1898 F NA ND #CP017033 
2043 C NA K NA 
2046 B NA ND ND 
2189 ND #CP005388 ND #KT893431 
2323 B NA ND ND 
2554 B NA ND ND 
2670 B NA ND ND 
2672 T NA J NA 
2674 B NA A NA 
2689 A NA ND ND 
2704 B NA ND ND 
NCTC11168 C NA A NA 
a ND – no match with published LOS or CPS class 
b Accession number of match from blast search > 99% 
c NA – not applicable as a class match was obtained 
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4.3.7 Adhesion and Invasion of Caco-2 cells 
 
The mean cell association for all isolates/strains ranged from 0.115 to 1.455 % (Appendix A, Figure 
A-3). Only 19 % (6/32) of all isolates/strains had a cell association greater than 1.0 %. C. coli strain 
RM2228 had a mean cell association of 0.510 and C. jejuni strain NCTC11168 had a mean cell 
association of 1.060. There was no significant (P>0.05) difference in cell association based on CC, 
group or source. C. jejuni (0.6238) had a significantly (P<0.05) higher cell association than C. coli 
(0.4215).  
 
The mean invasion efficiency (IE) ranged from 0.00577 to 2.287 % (Figure A-4, Appendix A). 
There was no significant (P>0.05) difference of IE by CC or source. There was a significant 
(P<0.05) difference between C. jejuni and C. coli, with an IE of 0.444 and 0.950, respectively. The 
isolate groups also had significant (P<0.05) differences, with the NH-NP (1.366) and H-NP (1.207) 
groups having a significantly (P<0.05) higher IE then the H-P group (0.3212) (Figure 4-6). A total 
of 8 isolates (25 %) had an invasion efficiency of 1 % or higher. Only two of the C. jejuni isolates 
from chickens had an invasion efficiency ≥ 1 % although these isolates had a cell association of < 
0.4 % with only one other C. jejuni having such a low association. 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 4-6: Invasion efficiency of each Campylobacter isolate group. Error bars represent standard 
deviation and columns with the same capital letter above are not significantly different (P<0.05). 
Isolate groups using flaA-RFLP genotypes were generated as follows; H-P, found in humans and 
survive poultry processing; H-NP, found in humans but not found at end of poultry processing 
(found in caecal or before scald samples only); NH-NP, not commonly found in humans (less than 
five isolates) and not found at end of poultry processing; and NH-P, not commonly found in 
humans and survive poultry processing. 
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4.4 Discussion 
 
Campylobacter remains a major source of zoonotic disease in Australia and much of the developed 
world. The handling, preparation and consumption of poultry as well as the poultry reservoir itself 
may account for up to 80 % of cases (EFSA, 2010c). During poultry processing Campylobacter 
must survive a number of environmental stress factors, including heat and chlorine. The survival of 
some genotypes over others during processing has been investigated in chapter 3 and other studies 
(Allen et al., 2007; Alter et al., 2005a; Newell et al., 2001). When under stress, pathogens may alter 
gene expression to aid survival. C. jejuni responds in an isolate-dependent way, with some strains 
increasing invasion of host cells after exposure to oxidative stress and some losing invasiveness 
(Koolman et al., 2016). A number of putative pathogenicity factors have been identified as playing 
a role in clinical cases of campylobacteriosis. This study examines a number of these factors: 
MLST; AAG, motility, gene content, resistance to bile salts, the class of LOS and/or CPS and the 
adhesion and invasion to host cell lines which serves as an in vitro model of human disease 
potential. The aim of this study was to assess and compare the potential pathogenicity of 
isolates/strains, and between groups of isolates, using the stated phenotypic and genotypic 
characteristics.  
 
4.4.1 MLST. Isolates/strains in this study were analysed for MLST through sequencing of the seven 
housekeeping genes aspA, glnA, gltA, glyA, pgm, tkt, and uncA. Australian C. jejuni have been 
previously shown to belong to CCs that have both a global and domestic distribution (Mickan et al., 
2007). A number of STs were first identified in this study. STs5821, 5822, 5824, 5827, 5828, 5830, 
5833 and 5834 and were assigned to CCs. ST-5831 and ST-5832 were also first identified in this 
study and could not be assigned to a CC. These STs appear to be unique to the Australian continent, 
at least at the current time (https://pubmlst.org/campylobacter/ searched January 2018). C. jejuni 
isolates from gastrointestinal infections of humans in Australia were distributed into 15 CCs and 
approximately 19 % were unassigned to a CC (Mickan et al., 2007). All of the CCs represented in 
the current study are included in these previously described Australian, clinically related, CCs. 
Some caution should be applied to interpreting the MLST database as not all isolates are submitted 
for online curation, particularly if the isolate has the same allelic profile as a previously submitted 
isolate, and the human CC assignation by Mickan et al. (2007) is now 10 years old. The isolates 
used in this study include the top five CCs isolated from Australian chickens or humans represented 
in the online MLST database. Other STs in this study had a very limited representation in the 
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MLST online database, such as ST-2783 which is assigned to CC-48, and that has four isolates in 
the database from either Australia or the United Kingdom. ST-263 from CC-52 has only one other 
entry in the database, from China. These may represent clones that have a limited spread both here 
and overseas or may represent a return of international travelers. . The cross over of flaA-RFLP 
genotpes between C. coli and C. jejuni has been previously noted (Behringer et al., 2011). In this 
study five flaA-RFLP genotypes were found to cross over between the two species. However flaA-
RFLP has also been demonstrated to be a good predictor of MLST (Djordjevic et al., 2007) 
although this was not well supported in the current study with the same flaA-RFLP genotypes that 
crossed species having multiple CC. 
 
4.4.2 Autoagglutination. AAG has been linked to virulence, interactions with host cells and to the 
ability to attach to biotic surfaces such as fibronectin (Guerry et al., 2006; Misawa and Blaser, 
2000; Nguyen et al., 2013). Autoagglutination is associated with flagella and affects cell 
hydrophobicity (Misawa and Blaser, 2000) and hence has the potential to affect attachment 
(Nguyen et al., 2013). In the current study, when all isolates/strains are taken together, there was no 
correlation between AAG at 24 h and motility, LOS/CPS class, cell association or invasion 
efficiency. No single group related to the survival through poultry processing (described in 4.1.1) 
was over represented in isolates/strains with high or low AAG activity. This may indicate that 
survival through poultry processing does not select for Campylobacter that display greater AAG 
characteristics. In this study, C. coli isolates/strains had a significantly (P<0.05) higher AAG 
activity then C. jejuni isolates/strains. Contrary to this, the AAG activity of C. coli VC167 wild type 
was lower than that of the C. jejuni 81-176 wild type (Guerry et al., 2006) although method 
differences have been shown to affect the AAG results (Misawa and Blaser, 2000). Disease caused 
by C. coli can not be differentiated from that caused by C. jejuni (Kaakoush et al., 2015). 
Association of AAG activity with CC has not been published before. However, C. coli isolates (CC-
828) and the C. jejuni CC-257 had significantly (P<0.05) higher AAG activity than CC-48 or CC-
354. Both CC-48 and CC-354 represented > 20 % (Mickan et al., 2007) of human isolates 
suggesting the level of AAG activity is not a good measure, at least by itself, of the ability to cause 
disease in humans. Further work is needed to confirm the suggested linkages between AAG and 
attachment to surfaces and the role of CPS/LOS which may affect the survival of Campylobacter 
through processing. 
 
4.4.3 Motility. A component and indicator of the pathogenesis of Campylobacter, both in vitro and 
in vivo, is the level of motility (Golden and Acheson, 2002; Yao et al., 1994). Motility has been 
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correlated with the ability to invade host cells and is highly related to the structure of the flagella, 
and hence, autoagglutination (Golden and Acheson, 2002). Overall, the motility was greatest at 
42 °C compared to 37 °C and this may be at least partially explained by the fact that the swimming 
speed of C. jejuni is faster at 42 °C compared to 37 °C (Yamamoto et al., 2013). The variation seen 
across the isolate/strain set may in part be influenced by the hypervariable plasticity regions 
recorded in Campylobacter (Pearson et al., 2003). The existence of phase variable genes allows 
these genes to be in an on or off state. There are 29 variable poly-G tracts in NCTC11168, eight of 
which have been linked to flagellar glycosylation (Guerry et al., 2002; Gundogdu et al., 2007; 
Parkhill et al., 2000). A natural population of NCTC11168 has been shown to produce colonies that 
contain non-motile through to hyper-motile variants that may offer an adaptation to the exposure to 
various conditions (Karlyshev et al., 2002). A NCTC11168 strain has been found to have lower 
motility than human isolates (Karlyshev et al., 2002). The NCTC11168 strain in this study was in 
the lowest two or three human isolates/strains ranked in terms of motility and was non-motile after 
24 h at 37°C. Genetic and phenotypic changes associated with NCTC11168 have occurred in 
comparison to the original strain (Gaynor et al., 2004) which may explain differences reported 
across studies utilizing NCTC11168.  
 
While recognized as an important component of pathogenicity, the level of motility is highly 
variable across isolates obtained from both chickens and humans with no significant (P>0.05) 
difference between these sources. Isolate 2674 was the only non-motile isolate under any conditions 
and that did not carry the flaA gene, as tested by PCR. The only other isolate in which the flaA gene 
was not detected, isolate 1765, was highly motile at 37 and 42 °C after 48 h. Both of these isolates 
have genes annotated as flaA and a virtual PCR using Geneious found a match to the forward 
primer but not the reverse suggesting a significant mismatch. Differences in the expression of the 
flagellar genes that contribute to motility, as well as changes in other gene families, have been 
recorded when NCTC 11168 was exposed to different oxygen tensions (Gaynor et al., 2004). 
Expression differences may therefore occur between in vitro and in vivo studies. Isolate 743 was 
motile only at 42 °C which may suggest a lower level of clinical risk for this isolate although 
expression may alter in vivo. Comparison of the whole genome sequence of the isolates/strains used 
in this study may highlight genetic differences indicative of the phenotypic profile. Variation in 
motility was seen across the four isolate groups (H-P, NH-P, NH-NP, H-NP) based on their original 
flaA-RFLP, and as fully described in section 4.1.1. The H-P group differs from the NH-P group that 
is not commonly isolated from humans, by having lower levels of motility. All five isolates 
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demonstrating no motility after 24 h/37 °C are from the H-P group, commonly found in humans and 
found at the end of poultry processing. This suggests that while motility is recognized as an 
important part of pathogenicity, it is only in conjunction with other factors that an isolate shifts 
from having a poultry association to a human association.  
 
4.4.4 P-BIT and virulence genes. The 18 gene targets in the P-BIT approach are based on their 
distribution in multiple genomes and known or putative status as virulence factors (Cornelius et al., 
2010). The typing scheme also provides information on the relative risk of individual isolates 
(Cornelius et al., 2010). Strain NCTC11168 was incorporated in this study and has previously been 
described as a high risk strain with a P-BIT code of 677600 (Cornelius et al., 2010; Gaynor et al., 
2004). No isolate in this study was clustered with NCTC11168 and/or produced a similar code. 
Human isolates in this study were spread across six of the remaining nine clusters, suggesting a 
diverse spread of putative virulence gene markers in these isolates. The human isolates in this study 
were isolated from patients who had diarrhea with or without blood and/or abdominal pain and/or 
fever, but no information was obtained on the severity of the symptoms or sequelae that may have 
occurred. It is not possible to determine if the P-BIT codes generated relate to more severe cases of 
disease. The addition of a further 18 virulence markers to the P-BIT assay allowed the separation of 
most C. coli into a single cluster, cluster 5. In comparison, although only using a small sample size, 
the addition of eight extra markers to the P-BIT system has been shown to allow differentiation of 
C. coli isolates from across countries (Duffy et al., 2011). A total of 16 genes was found to be 
carried by significantly (P<0.05) more C. jejuni isolates than by C. coli isolates. The original P-BIT 
typing scheme was developed largely on C. jejuni isolates (Cornelius et al., 2010) as this species 
represent up to 90 % of clinical isolates with only 5 to 10 % of isolates being C. coli (Fitzgerald et 
al., 2008). Further studies that better define C. coli virulence marker carriage are therefore 
warranted. All CC-48 and CC-52 isolates were in cluster 1 (Figure 4-3). Some CCs, including CC-
52, have been previously shown to form well defined clusters within the P-BIT scheme (Cornelius 
et al., 2010). 
 
The lack of detection of panB and maf5 (cj1337) was unexpected, as two previous small Australian 
studies indicated the carriage of panB in 15/16 and 25/26 chicken, and 20/22 human isolates (Lajhar 
et al., 2015; Wieczorek et al., 2013). Similarly, carriage of the maf5 gene was detected by the same 
PCR primers used in this study in 12/16 and 24/26 chicken, and 20/22 human isolates (Lajhar et al., 
2015; Wieczorek et al., 2013). The maf5 (pseE) gene has previously been reported in the 
NCTC11168 genome (Karlyshev et al., 2002) and is required for flagella assembly as part of the 
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flagellar glycosylation locus (Guerry et al., 2006). Further examination of the annotations found maf 
genes in all isolates/strains and panB in all but isolate 2689.  
 
The carriage of the target genes was compared between isolates/strains of chicken and human 
origin. Only two genes had a significantly greater carriage in humans, tet(O) (P=0.043) and cj0423 
(P=0.016). The carriage of these two genes in chicken and human isolates was not significantly 
(P>0.05) different in another Australian study (Lajhar et al., 2015). However the carriage of tet(O), 
which encodes for tetracycline resistance, was significantly (P=0.035) higher in isolates from one 
region studied which had an ongoing higher incidence of campylobacteriosis and was supplied by a 
single poultry supplier (Lajhar et al., 2015). The carriage of tet(O) in Australian Campylobacter has 
also been previously confirmed in phenotypically resistant human and chicken isolates (Pratt and 
Korolik, 2005) and from 10/16 chicken isolates of which only one displayed phenotypic clinical 
resistance (Wieczorek et al., 2013). The gene cj0423 encodes for putative integral 
membrane/periplasmic proteins with function unknown and is upregulated in the presence of an 
inhibitory dose of erythromycin (Xia et al., 2013). Erythromycin is used in the treatment of 
campylobacteriosis (Eiland and Jenkins, 2008) and a higher presence of cj0423 in the human 
isolates may suggest the possibility of previous use in the community although person to person 
transmission of Campylobacter is infrequent in developed countries. The significantly higher 
carriage of this gene in C. jejuni isolates compared to C. coli isolates may also influence this 
finding. Comparison between the isolate groupings (described in 4.1.1) found that H-NP isolates 
had a significantly (P=0.0245) higher carriage of cj0008 than H-P isolates. Cj0008 is a conserved 
hypothetical protein that is upregulated in the presence of 0.1% DOC (Malik-Kale et al., 2008). 
There was no explanation as to why human isolates not usually found in poultry carry this gene 
more frequently than those more commonly found in poultry.  
 
4.4.5 Bile Salts. Overall, there was an expected increase in inhibition as the DOC concentration 
increased. The growth response in comparison to DOC is not linear across all concentrations. For 
some isolates/strains there were distinct DOC concentrations that produced less inhibition than the 
next tested concentration. This variability in growth is in agreement with a study using a C. jejuni 
isolate in which variable inhibition of 0, 40 and 20 % was recorded at DOC concentrations of 0.025, 
0.05 and 0.1 %, respectively (Malik-Kale et al., 2008). However, in the current study, for five 
isolates at DOC concentrations of 0.0625, 0.125 or 0.25 %, a higher level of growth was recorded 
than the no DOC control. As the normal bile salt concentration in the small intestine of humans 
ranges from 0.2 to 2 % (w/v) depending on the individual and the type and amount of food digested 
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(Malik-Kale et al., 2008), the increased growth within the clinically relevant range is of concern, 
particularly for the potential of increased pathogenicity. Increased pathogenicity after exposure to 
0.1 % DOC has been demonstrated by increased invasion to INT 407 cells (but not adhesion) and 
up regulation of virulence related genes (Clark et al., 2014; Lin et al., 2005; Malik-Kale et al., 2008; 
Raphael et al., 2005). The effect of prior exposure to DOC before inoculation onto Caco-2 cells was 
not assessed in the current study. However, those isolates/strains with the least amount of inhibition 
when exposed to DOC did not produce the highest adherence or invasion of Caco-2 cells. This 
suggests that having the innate ability to resist exposure to DOC is not sufficient to increase 
adhesion or invasion of Caco-2 cells, but that exposure must occur first. Confirmation of the 
validity of this suggestion requires further testing. The presence of the CmeABC efflux pump was 
not investigated in the strains used in this study. CmeABC is required for mediating resistance to 
bile salts in the intestinal tract of chickens, and hence for colonization (Lin et al., 2003). Further 
analysis of the strains for the presence of known functioning resistance determinants should be 
undertaken. The changing patterns of resistance to DOC (in broth) observed in the current study 
was strain dependent and unrelated to the source of the isolate/strain. The six isolates that grew 
better in the presence of DOC than the no DOC control were a mixture of chicken and human 
isolates and of C. coli and C. jejuni.  
 
Resistance to DOC, as measured on agar plates, was highly variable across the isolates/strains and 
the concentrations tested. At the clinically relevant DOC concentrations (0.75 and 1 %), isolate 
1377 (human, C. jejuni) had significantly (P<0.05) less inhibition than the majority of other 
isolates/strains. There were noted difference between broth and agar based methods when compared 
at the same concentration, with the broth dilution producing a higher level of inhibition. Interactions 
may occur between solid agar and the substance being tested, particularly if the substance is 
amphiphatic or hydrophobic in nature, such as DOC (Bonev et al., 2008). In this study, the addition 
of DOC to the NB2 agar plates at concentrations higher than the 0.5 % resulted in the formation of 
micelles, observed as small zones of clearing, indicating a possible reaction between the agar 
components and the DOC. It should also be considered that the use of agar diffusion methods does 
not expose the bacteria to the full volume of the antibacterial substance, compared to the broth 
dilution assays which are dependent on the concentration of the antibacterial substance at the 
bacterial surface (Bonev et al., 2008). It has been reported that isolates of human origin are more 
likely to survive higher concentrations of DOC on agar than poultry isolates (Van Deun et al., 2007) 
which is in agreement with the current study, using the agar dilution method, where human isolates 
were significantly (P<0.05) less inhibited than poultry isolates at 0.5 (P=0.047), 0.75 (P=0.015) and 
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1 % DOC (P=0.007) but not at 0.25 % DOC. This study highlights the importance of utilizing 
multiple strains of C. jejuni and C. coli to ensure that the diversity of response to treatments is 
included. The range of survival when exposed to DOC in this study, in conjunction with other 
studies that report increased expression of virulence markers, highlights that isolates that are better 
able to survive ingestion and passage through the gastrointestinal tract may have a greater 
propensity to cause disease beyond simple access to adhesion sites.  
 
4.4.6 LOS/CPS. The cell surface structure, LOS, is known to be variable in gene content and gene 
arrangement, with LOS classes A – W previously described (Godschalk et al., 2004; Parker et al., 
2008; Poly et al., 2011; Richards et al., 2013). A further seven LOS classes have been noted but not 
yet fully described (Richards et al., 2013). An important pathogenicity factor is the ganglioside 
mimicry displayed by C. jejuni isolates that possess genes capable of synthesizing and transferring 
sialic acid (Godschalk et al., 2004). The sialic acid biosynthesis genes neuBCA and the sialic acid 
transferase gene cst are usually found clustered together within the LOS locus of C. jejuni classes 
A, B, C, M and R (Godschalk et al., 2004; Parker et al., 2008). More recently, class V has also been 
found to carry this cluster of genes involved in sialylation of the LOS (Richards et al., 2013). In the 
current study, the percentage of C. jejuni isolates from humans carrying sialylated classes of LOS 
(50 %) was lower than other studies, where carriage rates of 64 and 73 % have been reported 
(Godschalk et al., 2004; Lajhar et al., 2015). The three C. jejuni isolates not placed in a LOS class 
did not carry any of the sialic acid related genes. In the only other Australian study, C. jejuni 
carrying class B LOS were found in 13.6 % of human isolates (Lajhar et al., 2015) compared to 
40 % in both chickens and humans in the present study. In agreement with Lajhar et al. (2015), 
there was no significant (P<0.05) difference in the carriage of sialylated classes of LOS in chicken 
or human isolates, suggesting chicken processing is not selecting for these potentially more 
pathogenic isolates. This is further supported by the finding of no relationship between LOS class 
and the groupings based on survival through processing and frequency of isolation from human 
samples (described in 4.2.1). 
 
Previous studies have assigned C. coli isolates to LOS classes I to XII (Culebro et al., 2016; 
Richards et al., 2013; Skarp-de Haan et al., 2014). In the current study, there was less diversity in 
the LOS classes of C. coli compared to C. jejuni, with five isolates carrying class II, one class VII, 
and the remaining four not allocated to a known class. Of the four isolates that could not be 
assigned in a known class, three carried an LOS locus of the same gene content and arrangement as 
that of C. coli strain WA333, originally isolated from chicken liver in Oklahoma, USA (Marasini 
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and Fakhr, 2017; Noormohamed and Fakhr, 2012). This suggests that, in conjunction with those 
carrying known classes, the genetic arrangement of the LOS cluster of Australian C. coli strains is 
not unique. Consideration should be given to the small sample size of C. coli isolates in this study 
and that the chicken isolates were taken from two geographically separated processing plants. The 
cluster of sialylation genes cst and neuBCA have been reported in the LOS locus from a single 
C. coli LOS class IX (Skarp-de Haan et al., 2014) and have also been found in two strains within 
the CPS (Richards et al., 2013). A total of 10 of the isolates/strains of C. coli used in this study 
carried the cstI gene, with six inside the LOS locus and four strains with the cstI gene located 
outside of either the LOS or CPS locus. It is unknown what role this cst gene may undertake 
without contiguous sialic acid synthase genes although carriage of genes involved in sialylation of 
the LOS and hence linked to Guillain-Barré syndrome, is of concern. Disruption of the sialic acid 
transferase gene (cst) within the C. jejuni LOS leads to reduced invasion potential (Louwen et al., 
2008). The only C. coli in this study with no cst gene had the highest invasion of all isolates 
suggesting that for C. coli, other pathways to invasive phenotype exist. The C. coli sialytransferases 
(cstI) have been suggested to have a different substrate specificity to the distantly related cstII and 
cstIII genes more commonly found in C. jejuni isolates (Skarp-de Haan et al., 2014).  
 
Comparison of the CPS clusters to previously published classes carried by C. jejuni and C. coli 
(Karlyshev et al., 2005; Richards et al., 2013) recorded only seven isolates/strains of C. jejuni and 
two isolates/strains of C. coli that could be placed into a published class. Of the remaining 14 
C. jejuni isolates, seven could be matched to sequence data deposited at NCBI. There were two sets 
of pairs of isolates with matches to the same accession number (Table 4-5). The seven additional 
classes with no designation letter noted by Richards et al. (2013) were also used to match the 
sequences in this study. With no contiguous matches for the entire length of any sequence in the 
published classes, there is therefore a further potential 12 classes of C. jejuni CPS generated in this 
study. The CPS clusters of C. coli isolates placed the isolates in the same groupings as the LOS. 
Those C. coli with LOS class II had a CPS that matched accession number #CP006702, minus a 
1,001 bp fragment that is annotated as a hypothetical protein in the original sequence of C. coli 15-
537360 from a clinical sample (Pearson et al., 2013). The remaining C. coli isolates with no 
designated LOS or CPS class had CPS sequences that matched the strain 15-537369 for gene 
content and arrangement.  
 
A mechanism by which Campylobacter can alter gene expression is via the presence of 
homopolymeric tracts (Parkhill et al., 2000). These tracts cause a frame shift, turning gene 
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expression on or off and can lead to fragmented ORFs (Parkhill et al., 2000). The missing 1,001 bp 
fragment in some C. coli CPS contains a tract of 11 cytosines which may cause the hypothetical 
protein to be switched on or off. The effect of this on the survival or pathogenicity of C. coli is 
unknown, as the role of this protein is unknown. Homopolymeric tracts were considered to be 
transient when comparing to designated classes and only gene content, gene alignment and >85 % 
overall sequence homology as found in Geneious were considered. No relationship was found 
between LOS or CPS class and the groupings based on survival through processing and frequency 
of isolation from human samples (described in 4.1.1). This suggests that there is no selection by the 
stress encountered in poultry processing based on the LOS or CPS class.  
 
The LOS class has been shown to be related to the clonal complex, with 86 % of C. jejuni CC-21 
found to carry LOS class C (Habib et al., 2009). This is supported by the current study, with all 
C. jejuni CC-48 carrying class B LOS and all C. jejuni CC-52 carrying class F LOS. The two LOS 
class C isolates were also CC-21, in agreeance with the study of Habib et al. (2009). This does not 
hold for C. coli isolates/strains in this study as all belong to CC-828 but carry four different LOS 
classes.  
 
The LOS locus is important for both adhesion and invasion of host cells (Guerry et al., 2006; 
Kanipes et al., 2006). C. jejuni carrying LOS class B or C have been shown to have a higher 
invasion activity for Caco-2 and INT-407 cells than isolates from other LOS classes (Habib et al., 
2009; Louwen et al., 2008). Some individual isolates of LOS B however were found to have much 
lower invasion levels (Habib et al., 2009), suggesting that while there may be some broad trends 
linking LOS class and invasion potential, the individual isolate needs to be considered. In 
comparison, C. jejuni carrying the sialylated classes of LOS were found to have varying levels of 
invasion in the current study, which supports the stance of invasion potential being strain 
dependent. Adhesion to Caco-2 cells was also found to be strain dependent. C. jejuni LOS class B 
isolates were found in the bottom and top four of isolates ranked by adhesion. The genetic tools are 
now available to allow a deeper understanding of the role of individual genetic components, often 
by the use of knockout mutants. To be able to effectively characterise the risk that these potentially 
more pathogenic strains pose, it is important to gather knowledge on the variability between strains 
(Wassenaar et al., 2007). 
 
4.4.7 Caco-2 adhesion and invasion. Adhesion and invasion of host cells is widely used in 
assessing the potential virulence of Campylobacter due to the lack of an efficient animal model 
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(Friis et al., 2005). In this study, there was no effect of source on either cell association (CA) or 
invasion efficiency (IE), which is in agreement with a study of 52 C. jejuni isolates where there was 
also no significant difference in invasiveness of Caco-2 cells between chicken and human isolates 
(Habib et al., 2009). Cell association was significantly (P<0.05) higher in C. jejuni than C. coli in 
comparison to IE which was significantly (P<0.05) higher in C. coli. It is difficult to compare to 
other published studies as any changes in experimental conditions can have large impacts on CA or 
IE (Friis et al., 2005). IE was found to be higher in the two isolate groups NH-P (n=5) and NH-NP 
(n=3), with both of these groups containing isolates that were not commonly found in humans 
during the study period described in chapter 2 and 3. Isolation from clinical human cases would 
presume that the isolates have a proven level of pathogenicity. As these groups included isolates 
that either did or did not survive poultry processing, survival through poultry processing may not 
necessarily select for more pathogenic strains as measured by IE, although numbers in these groups 
are small. These genotypes not commonly isolated from humans as shown in chapter 3, may be due 
to a less pathogenic genetic makeup or simply less common in the overall Campylobacter 
population. 
 
4.4.8 Cross-assay relationships. The expression of pathogenicity is complex and a number of 
studies have demonstrated correlations between some of these assays and adhesion or invasion of 
host cells as documented in this discussion. An aim of these characterization studies was to 
determine if there was any relationship with the level of pathogenicity as measured by Caco-2 
adhesion and/or invasion and between the groups described and the assays undertaken. STs were 
found to be both unique and globally represented. Correlation of ST with LOS class for C. jejuni 
isolates/strains was noted for LOS class B C. jejuni isolates, however more isolates would be 
required to confirm this. No correlation was found with other assays except where C. coli was 
different from C. jejuni as all C. coli were all CC-828. All strains that were non-motile after 24 h at 
37 °C belonged to the H-P group but this is unlikely to be a causal relationship as the remaining H-P 
isolates were spread across the range of motility recorded. The cj008 gene that is upregulated upon 
exposure to DOC is carried more frequently by the H-NP isolates than isolated from the other 
groups. The inhibition of growth when exposed to DOC did not correlate with any other assay or 
with the groups of isolates. It was found that when inhibition by DOC is measured on agar, that 
human isolates are less inhibited than chicken isolates suggesting a measure of resistance that may 
have enabled survival through the human gut. The strain dependent manner of Caco-2 adhesion and 
invasion has been previously noted (Habib et al., 2009; Koolman et al., 2016) and is supported in 
this study. There was no relationship with LOS/CPS class and chicken or human isolates or with the 
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isolate groups. Source of isolate/strain was also not linked to the adhesion/invasion of Caco-2 cells. 
C. jejuni produced higher levels of adhesion then C. coli but this was reversed for invasion of 
Caco-2 cells. The isolate groups NH-P and NH-NP produced higher levels of invasion than the 
other groups.  
 
4.5 Conclusion 
 
The only assay that differentiated chicken and human isolates was growth on bile salts agar. The 
grouping of isolates according to their survival through poultry processing and their frequency of 
isolation from clinical human samples (H-P, NH-P, NH-NP, H-NP) did not result in any 
relationship that suggests survival through poultry processing selects for potentially more 
pathogenic strains. It is the accepted paradigm that between 30 and 80 % of human isolates are 
originally sourced from chicken. There were only 32 isolates/strains in this study and perhaps the 
inclusion of the numerous other flaA types found in humans, which were not detected in chickens 
over the same time period as shown in chapter 3, Figure 3-4, should be examined to determine if 
non-chicken related human isolates differ from those from chicken. Further sampling of the national 
poultry flock within a source attribution study would enable a more comprehensive collection of 
potential non-chicken related human isolates. Further work may then assess these putative 
pathogenicity factors against survival traits such as the stresses encountered in poultry processing 
(scalding and chlorine immersion chilling).  
 
While the study incorporated a small subset of strains, there was strain to strain variation across 
most of the assays undertaken. As highlighted by other studies, strain to strain variation exists and it 
is important to account for the genotypic diversity in the wild population of Campylobacter (Habib 
et al., 2010; Koolman et al., 2016) in studies looking at phenotypic and genotypic characterisation. 
Furthermore, risk assessors have expressed a need for improved data on the variability between 
strains (Wassenaar et al., 2007). As MLST types have both a domestic and a global spread (Mickan 
et al., 2007) it is important that the variability captured in future work incorporates any unique 
Australian domestic clones. A more comprehensive examination of the genome of these 
isolates/strains may provide further knowledge on their potential pathogenicity and perhaps allow 
an understanding of the phenotypic variation. Further examination of high and low risk 
isolates/strains through multiple processing hurdles may provide future indication of the 
survivability of these potentially more pathogenic isolates. 
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5.1 Introduction 
 
Poultry products are frequently identified as a source of campylobacteriosis in Australia and across 
the European Union (EFSA and ECDC, 2015; Stafford et al., 2008). During the slaughter and 
processing of chickens there are a number of steps that may lower the numbers and/or prevalence of 
Campylobacter on chicken carcasses (Guerin et al., 2010; Rosenquist et al., 2006) including the key 
steps of scalding and immersion chilling (Chapter 2). The differential survival of some genotypes 
during slaughter has been noted in chapter 3 and in a number of other studies (Allen et al., 2007; 
Colles et al., 2010; Newell et al., 2001; Wirz et al., 2010). Campylobacter genotypes isolated from 
whole chickens before scald may not always be isolated from the same flock after scald, potentially 
indicating that some genotypes may not survive scalding (Chapter 3). 
 
Inactivation curves can take a number of forms, including linear decline, sigmoidal, shoulder, 
tailing, biphasic, convex or concave shapes (Geeraerd et al., 2005). A useful tool for comparison of 
these inactivation curves is GInaFit Inactivation Model Fitting Tool 7 (Geeraerd et al., 2005). This 
tool allows the user to independently examine nine microbial survival models to identify which 
model best fits their data with a stated aim of bridging the gap between people developing 
predictive modelling approaches and end-users in the food industry (Geeraerd et al., 2005). The 
Weibull model has been identified as the most suitable model to describe the thermal inactivation 
kinetics of Campylobacter (Al-Sakkaf and Jones, 2012; Scanlon et al., 2015). These studies 
compared linear and non-linear models to determine the inactivation model that has the best fit with 
empirical data. The Weibull model includes scaling (death rate, δ), and shape, β, parameters to 
describe the thermal inactivation curve, and the model can also be used to calculate the reduction 
after a specified period of time (Geeraerd et al., 2005). When the shape parameter, β, equals 1, the 
curve can be described as linear and the scaling parameter, δ, can be compared to the classical 
decimal reduction time D (Geeraerd et al., 2005). Temperatures in scald tanks can vary from low 
52/53 °C to a high of 57/58 °C’s and time in scald can vary from 2 to 3 min depending on such 
factors as bird size and temperature. The use of inactivation models enables the effect of differing 
processing parameters to be compared. 
  
While air chilling is conducted in some poultry processing plants in Australia, immersion chilling 
using chlorine as a processing aid is currently more common. Chlorine (up to 50 ppm) is approved 
by the US Department of Agriculture (USDA, 2008) and by Food Standards Australia and New 
Zealand (5 ppm free available chlorine) for use in commercial poultry processing (FSANZ, 2011). 
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Chlorine is not approved for use in poultry processing in Europe due to concerns regarding the 
replacement of good hygienic practices during processing of poultry carcases with no toxicological 
risks identified (EFSA, 2006). Concerns have also been raised regarding the formation of 
potentially carcinogenic and teratogenic trihalomethanes and haloacetic acids (FAO/WHO, 2008). It 
has been demonstrated that control of scalding temperatures and control of chlorine and pH in 
immersion chillers can affect the numbers of Campylobacter on carcasses (Rosenquist et al., 2006). 
While immersion chilling is influenced by numerous factors, differences in the effective reduction 
of Campylobacter numbers suggest that some Campylobacter are more resistant to chlorine than 
others. Some genotypes of Campylobacter have also been shown to make up a greater proportion of 
the isolated Campylobacter after chilling compared to sampling points from upstream processes 
during poultry slaughter (Chapter 3). 
 
Most published studies on the thermal inactivation of Campylobacter utilize a limited number of 
strains. Campylobacter can be considered to be genetically diverse, and understanding the diversity 
of resultant behaviour when subjected to processing stress is important in the food safety chain. The 
objective of this work was to examine the differences in survival of a range of both C. jejuni and C. 
coli when subjected to the major poultry processing stresses of heat and chlorine. It is important for 
the poultry industry to understand the variation that may exist in Campylobacter strains within their 
flocks when subjected to the normal range of processing practices of scalding and immersion 
chilling in order to refine processes such that they effectively reduce viable Campylobacter. 
 
5.2 Materials and Methods 
 
5.2.1 Bacterial isolates and strains 
 
Campylobacter isolates (Table 5-1) are fully described in Chapter 4. Briefly, they were obtained 
during the quantitative analysis of Campylobacter and E. coli through two Australian processing 
plants undertaken in Chapter 2 and selected using the flaA-RFLP results obtained in Chapter 3. The 
isolate set (n=32; fully described in chapter 4) contained 20 C. jejuni (10 poultry, 10 human), 10 C. 
coli (7 poultry, 3 human) and a control strain for each species, ATCC 700819, strain designation 
NCTC11168 and ATCC BAA-1061, strain designation RM2228 . The isolate set incorporated those 
flaA-RFLP genotypes that were commonly found in both humans and processed poultry, genotypes 
that were infrequently isolated from humans, and genotypes that were only present at the beginning 
of poultry processing.  
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All isolates and strains were recovered from Protect by plating on Nutrient Broth No 2 agar (NB2A; 
Nutrient Broth No 2 25 g/L, Technical Agar No 3 15 g/L, ThermoFisher, Australia). Plates were 
incubated at 42 °C for 48 h under 5 % CO2. A loopful of culture was added to 10 mL of Nutrient 
Broth No 2 (NB2) containing Campylobacter Growth Supplement (CGS; ThermoFisher) and 
incubated at 42 °C for 48 h under 5 % CO2. The culture incubated in NB2 was centrifuged at 4500 g 
for 15 min and the pelleted cells resuspended in an equal volume of NB2 plus CGS. 
 
5.2.2 Heating Assay 
 
A 20 mL portion of NB2 plus CGS was preheated to either 53.1 or 57.3 °C in 50 mL centrifuge 
tubes. A 1 mL portion of Campylobacter cultures, prepared as described in 5.2.1, was added to the 
preheated NB2 and quickly mixed by swirling. Portions were removed immediately, and then every 
30 s, for 5 min. Isolates/strains were serially diluted in Phosphate Buffered Saline (PBS; Sigma, 
Australia) as required and 0.1 mL spread plated onto CCDA without antibiotics. Plates were 
incubated under 5 % CO2 for 48 h at 42 °C before colonies were counted and recorded. 
Thermocouples were placed in identically treated tubes and used to record temperature every 10 s. 
A total time of 5 min ensured that all isolates and strains had sufficient data recorded to enable 
modelling to be used.  
 
5.2.3 Chlorine Assay 
 
Preliminary experiments that subjected control strains NCTC11168 and RM2228 to 4.5 ppm free 
available chlorine (FAC) resulted in levels of inactivation that could not be measured before the 
first sampling time, 0.2 min (results not shown). Chlorine levels were adjusted to allow a decline in 
Campylobacter numbers across 20 min to be measured. NaOCl (Sigma, Australia) was added to 
NB2 plus CGS and pH adjusted with 1 M citric acid. Chlorine concentration was determined (after 
10 min) by an iodometric method. The NB2/NaClO solution was mixed with acidified KI and 
titrated against standardised Na2S2O3 until the colourless endpoint, using soluble starch as an 
indicator. NB2 was precooled to 4 °C before addition of chlorine. A 1 mL portion of 
Campylobacter culture, prepared as described in section 5.2.1, was added to the precooled 20 mL 
chlorinated NB2 and quickly mixed by swirling. NB2 was mixed gently by swirling every 5 min. 
Samples were taken at zero time and every 5 min up to 20 min. A 500 uL portion was taken at each 
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time point and immediately added to 500 uL of sodium thiosulphate. Samples were serially diluted 
in PBS as required and 0.1 mL spread plated onto CCDA without antibiotics. Plates were incubated 
under 5 % CO2 for 48 h at 42 °C before colonies were counted and recorded. 
 
5.2.4 Weibull Models 
 
For each experiment, non-linear death curves were modelled using the GInaFiT Inactivation Model 
Fitting Tool freeware add-on tool Version 1.7 (Geeraerd et al., 2005). Previous studies (Al-Sakkaf 
and Jones, 2012; Scanlon et al., 2015) examining the thermal inactivation of Campylobacter spp. 
have stated that the Weibull model variants were the most suitable to describe inactivation kinetics 
of Campylobacter. Therefore, only the Weibull, Weibull Tail (WT) and Double Weibull (DW) 
models were utilised. The Weibull model was used to calculate the level of Campylobacter after 
180 s exposure to 53.1 and 57.4 °C heat treatments to simulate a typical scalding period using 
equation 1 (Written as reformulated for identification purposes as stated in GInaFiT software). The 
reduction after 180 s was calculated by subtracting the calculated log10 (N180) from log10 (N0). The 
reduction after 10 min exposure to chlorine was similarly calculated. The factors in the Weibull 
equation are: δ, time to the first decimal reduction, also described as the rate of decline; β, shape of 
curve; and t time. For curve shape, a β value of > 1 indicates the curve is concave from below, a 
value < 1 indicates the curve is convex, a value of 1 is a linear relationship. Weibull with tail (WT) 
and double Weibull (DW) equations are provided as reformulated for indentification purposes in the 
GInaFiT software, in equations 2 and 3 respectively. 
 
𝐿𝐿𝐿𝐿𝐿𝐿10(𝑁𝑁) = 𝐿𝐿𝐿𝐿𝐿𝐿10(𝑁𝑁0) − (�𝑡𝑡
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−  𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺𝐺 𝐺𝐺𝑡𝑡 𝐺𝐺𝑎𝑎. , 2005) 𝐸𝐸𝐸𝐸𝐸𝐸. 2 
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To compare and rank the three models, the corrected Akaike’s Information Criterion (AICc) was 
calculated for each strain and model using equation 4, where RSS is the residual sum of squares, k 
is the number of parameters in the model, which is increased by 1 when using the RSS values, and n 
is the sample size. As the sample size is small (n/k < 40) AICc was chosen over AIC. Akaike 
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weights were calculated following Symonds and Moussalli (2011) and used to determine the 
probability that a given model is the best approximating model (Symonds and Moussalli, 2011) . 
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 = n �ln �RSS
n
�� + 2k + 2k(k+1)
n−k−1
 – (Symonds and Moussalli, 2011) - Eqn. 4 
 
5.2.5 Statistical analysis 
 
Significant differences in the level of decline at the stated times (180 s for heat, 10 min for 
chlorine), and differences in the model parameters δ and β were determined by one way analysis of 
variance using Minitab 17 software (Minitab Inc., Minneapolis, USA). 
 
5.3 Results 
 
5.3.1 Heat Stress 
 
The isolate/strain MLST and Weibull model parameters (δ and β) are listed in Table 5-1 for all 
isolates. The mean δ at 53 °C was 109.3 s (95 % CI: 88.9 – 129.7) compared to a mean of 6.78 at 
57 °C (95 % CI: 4.31 – 9.26 s). The δ was significantly (P<0.001) longer at 53 compared to 57 °C. 
Only six isolates/strains at 53 °C had a δ value less than 50 s which is a significantly (P<0.001) 
lower number of isolates/strains than at 57 °C, where all isolates/strains had δ < 50 s. The shape of 
the curve β was concave at 53 °C with a mean of 1.12 (95 % CI: 0.99 – 1.25) compared to a convex 
shape at 57 °C with a mean of 0.43 (95 % CI: 0.38 – 0.48). There were significantly (P<0.001) 
more isolates/strains that had β values ≥ 0.95 at 53 °C compared to 57 °C. The calculated decline 
using the Weibull model after 180 s exposure to heat are displayed graphically for all 
isolates/strains in Figure 5-1. 
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Table 5-1: Weibull equation variables δ (rate of change) and β (shape of curve) for isolate/strains 
identified by species, MLST, and flaA-RFLP genotype when subjected to various temperature and 
chlorine conditions. 
Isolatea Speciesb 
flaA-
RFLP 
MLST 53 °C 57 °C Chlorine 
ST CC δ β δ β δ β 
117 (P) C.j 9 5820 354 117.5 1.38 1.7 0.39 0.83 0.48 
436 (H) C.c 2 3985 828 188.7 1.08 2.7 0.33 1.53 0.34 
448 (P) C.j 3 354 354 87.6 1.12 0.8 0.32 2.89 0.70 
462 (P) C.c 17 3985 828 202.9 1.63 0.3 0.28 3.20 0.40 
470 (P) C.c 6 3985 828 154.4 1.10 1.6 0.32 1.56 0.73 
697 (H) C.j 30 5821 48 19.9 0.51 0.9 0.22 0.47 0.55 
722 (H) C.c 17 3985 828 131.1 1.45 6.5 0.51 0.86 0.56 
741 (H) C.j 17 2947 257 110.6 1.40 2.8 0.41 0.54 0.65 
743 (H) C.j 2 4263 52 77.1 1.16 0.6 0.29 3.14 1.10 
744 (H) C.j 1 52 52 144.3 1.13 5.5 0.43 3.91 1.10 
1180 (P) C.j 1 5822 52 80.8 0.97 29.9 0.71 6.15 1.20 
1377 (H) C.j 21 859 443 95.1 1.09 11.7 0.57 2.52 1.10 
1431 (H) C.j 3 5824 354 105.6 1.14 4.8 0.46 2.32 0.72 
1765 (P) C.c 15 3985 828 103.1 0.97 0.5 0.28 1.13 0.81 
1786 (P) C.c 4 5833 828 185.8 1.47 16.2 0.61 7.70 0.80 
1790 (P) C.c 21 3985 828 149.2 1.36 11.6 0.45 2.77 0.67 
1898 (P) C.j 2 5827 52 98.5 1.20 18.2 0.65 7.72 1.31 
1973 (P) C.c 20 3985 828 157.6 2.02 13.4 0.66 1.77 0.66 
1998 (P) C.c 22 3985 828 131.9 1.32 2.7 0.38 0.65 0.52 
2043 (H) C.j 6 1864 21 75.7 0.79 5.7 0.48 3.84 0.97 
2046 (H) C.j 11 2783 48 19.43 0.51 7.4 0.49 2.05 0.74 
2189 (H) C.j 4 51 443 82.2 0.98 0.6 0.32 2.33 0.77 
2323 (H) C.j 8 1518 48 28.9 0.75 5.7 0.46 2.33 0.61 
2350 (H) C.c 15 5834 828 262.8 1.20 10.7 0.48 1.41 0.73 
2554 (P) C.j 11 48 48 42.0 0.78 0.02 0.18 0.04 0.34 
2670 (P) C.j 8 5830 48 26.1 0.56 8.7 0.44 2.33 0.61 
2672 (P) C.j 3 5831 - 92.4 1.02 0.2 0.24 6.32 1.10 
2674 (P) C.j 6 525 607 108.3 0.98 0.5 0.28 7.73 0.84 
2689 (P) C.j 4 5832 - 104.9 1.01 11.3 0.49 1.15 0.63 
2704 (P) C.j 30 48 48 38.5 0.76 17.0 0.58 0.49 0.33 
NCTC11168 (H) C.j - 43 21 115.2 1.14 8.7 0.54 2.15 0.83 
RM2228 (P) C.c - 1063 828 161.5 2.01 1.28 0.32 7.96 1.29 
a sample numbers followed by a P are from poultry and those followed by a H are from clinical 
cases 
b C. coli is represented by C. c and C. jejuni is represented by C. j 
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The log10 CFU/mL decline ranges from 0.64 to 1.72 for C. coli at 53 °C and from 4.00 to 6.55 at 
57 °C. For C. jejuni, the log10 CFU/mL decline ranges from 1.32 to 3.97 at 53 °C and from 3.57 to 
6.76 at 57 °C. C. coli isolates had significantly (P<0.001) higher δ and β values than the C. jejuni 
isolates at 53 °C but not at 57 °C (Table 5-2). This increase in heat resistance of C. coli compared to 
C. jejuni at 53 °C but not at 57 °C is supported by significantly (P<0.001) different calculated 
decreases after 180 s (Table 5-2). There was no significant difference (P>0.05) in any model 
parameters when comparing isolate source (human or poultry). Weibull model parameters 
demonstrated significant (P<0.05) differences between CC’s at 53 °C (Table 5-3), with no 
differences in δ or β at 57 °C. 
 
 
 
 
 
 
 
 
 
 
Figure 5-1: Log10 CFU/mL decline for C. coli and C. jejuni isolates (represented by number 
designations on the x axis) at 53 °C ● and 57 °C ○ after 180 s, as calculated from equation 1 
(Weibull model, using GInaFit Inactivation Model Fitting Tool). 
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Table 5-2: Weibull model parameters and calculated log10 CFU/mL decrease after 180 s for each 
Campylobacter species. Significant (P<0.05) differences between species for each parameter are in 
bold. 
Parameter C. coli C. jejuni P value 
δ 53 °C 166.3 79.4 <0.001 
β 53 °C 1.42 0.97 <0.001 
δ 57 °C 6.78 6.78 0.999 
β 57 °C 0.43 0.43 0.891 
Dec180 s#/53 °C 1.20 2.32 <0.001 
Dec180 s#/57 °C 5.42 5.21 0.539 
# Modelled Log10 CFU/mL decrease after 180 s 
 
Table 5-3: Weibull model parameters following heat treatment for each Campylobacter clonal 
complex of sequence types as determined by MLST. 
CC δ 53 °C β 53 °C 
Dec 180 s# 53 °C 
Log10 CFU/mL 
Dec 180 s# 57 °C 
Log10 CFU/mL 
828 166.3a 1.42a 1.20c 5.41ab 
257 110.6ab 1.40ab 1.98bc 6.22ab 
607 108.3ab 0.98abc 1.65bc 6.13ab 
354 103.6b 1.22ab 1.96b 5.88a 
52 99.4b 1.12ab 2.06b 4.67bc 
21 95.5b 0.96bc 1.82b 5.50abc 
443 88.6b 1.04abc 2.08b 6.13a 
48 29.2c 0.64c 3.24a 4.40c 
aValues with the same superscript letter are not significantly (P<0.05) different in columns 
# Modelled Log10 CFU/mL decrease after 180 s 
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5.3.2 Chlorine Stress 
 
The Weibull model parameters δ and β for each isolate/strain are listed in Table 5-1. The model 
parameters were also assessed by species, source and clonal complex (CC) (Table 5-4). The 
calculated log10 CFU/mL decline using the Weibull model after 10 min exposure to chlorine (1.1 
ppm, pH 6.50) for all isolates/strains is displayed in Figure 5-2 and grouped by source, species and 
CC in Table 5-4. The minimum reduction after 10 min exposure to chlorine was 1.23 log10 CFU/mL 
(strain 1786, CC828, poultry, C. coli) and the maximum decrease was 6.58 log10 CFU/mL (strain 
741, CC, 257, human, C. jejuni). There was no significant (P>0.05) difference in the δ value (rate of 
decline) or the calculated log10 CFU/mL decrease after 10 min exposure, for species or source 
parameters. When assessing the shape of the curve, CC52 was significantly (P=0.003) different 
from CC48, 354 and 828. CC52 demonstrated an overall concave curve compared to convex curves 
produced by isolates/strains belonging to other CCs. 
 
 
 
Figure 5-2: Log10 CFU/mL decline for C. coli and C. jejuni isolates (represented by number 
designations on the x axis) at 1.10 ppm free available chlorine (FAC) at pH 6.50 after 10 min, as 
calculated from equation 1 (Weibull model, using GInaFit Inactivation Model Fitting Tool). 
 
5.3.3 Weibull Models 
 
Model outputs for each model and all isolates/strains are displayed in Appendix B, Table B-1 for 
53 °C, Table B-2 for 57 °C, and Table B-3 for chlorine data. Aikake’s criterion and Akaike weights 
were used to assess the best approximating model in describing the data given the three models 
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chosen. The GInaFit program outputs evaluation measures for each analysis, including the mean 
root mean square error (RMSE), mean squared error (MSE), regression coefficient (R2) and the 
adjusted coefficient of determination (R2adj). These were then used to assess the goodness of fit for 
that model for each isolate. There were significantly (P=0.002) more isolates/strains that were best 
approximated by the Weibull model compared to the WT and DW models at 53 °C compared to 
57 °C. At 53 °C, where the Weibull model was calculated as the best model, there was a mean 
82 % (95 % CI: 79.8 – 84.7) chance of Weibull being the best approximating model for that 
isolate/strain. All isolates/strains were successfully fitted by the Weibull model using the GInaFit 
program. 
 
The Weibull with tailing (WT) model provides an estimate of the residual population (Nres). The 
GInaFiT software also has built in logical constraints that produces a warning when the model is not 
substantiated by the input data. There were 14 isolates/strains that were listed as unlikely to fit the 
WT model at 57 °C. Of the remaining 18 isolates/strains, the mean residual population was 1.28 
log10 CFU/mL (95 % CI: 0.97 – 1.59) with a range from 0.41 to 2.90 log10 CFU/mL (strain 436) 
(Table B-2). The Double Weibull (DW) model describes the rate of decline (or D value) of the two 
populations with different heat resistance, δ1 and δ2. Isolate 436, which had a high residual 
population in the WT model, demonstrated a δ1, δ2 of 0.78 s and 24.6 s, respectively (Table B-2). 
The greatest difference in δ between the initial population and the residual population is produced 
by isolate 1431 with a δ1 and δ2 of 28.2 and 163 s, respectively. 
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Table 5-4: Weibull model parameters for chlorine (1.10 ppm, pH 6.50) exposure. Data is grouped 
according to species, source or clonal complex (CC).  
 
 δ β 
Decrease@10 min   
Log10 CFU/mL 
All isolates 
and Strains 
   
 2.87 ± 2.37 0.753 ± 0.274 3.16 ± 1.46 
Species    
C. jejuni (11)# 2.92 ± 2.31a 0.790 ± 0.283a 3.04 ± 1.48a 
C. coli (21) 2.78 ± 2.61a 0.682 ± 0.254a 3.22 ± 1.48a 
Source    
Human (14) 2.49 ± 1.84a 0.804 ± 0.261a 3.46 ± 1.34a 
Poultry (18) 3.20 ± 2.78a 0.709 ± 0.285a 2.89 ± 1.55a 
CC    
52 (4) 5.23 ± 2.10a 1.179 ± 0.103a 2.40 ± 0.98a 
443 (2) 2.42 ± 0.14a 0.932 ± 0.235ab 3.80 ± 1.05a 
21 (2) 2.99 ± 1.19a 0.903 ± 0.101ab 3.07 ± 0.74a 
607 (1) 7.73 ± 0a 0.841 ± 0ab 1.24 ± 0a 
828 (11) 2.78 ± 2.61a 0.682 ± 0.254b 3.04 ± 1.48a 
257 (1) 0.543 ± 0a 0.646 ± 0ab 6.58 ± 0a 
354 (3) 2.01 ± 1.06a 0.635 ± 0.132b 2.87 ± 0.48a 
48 (6) 1.28 ± 1.06a 0.516 ± 0.159b 3.72 ± 1.76a 
a Values with the same superscript letter are not significantly (P<0.05) different in columns within 
each of the groups, All isolates/strains, Species, Source and CC (Clonal Complex). 
#The number in brackets is the number of isolates/strains represented in that group. Two isolates 
were not assigned a CC and are not included. 
Chapter 5 Thermal and chlorine inactivation 
 
 
110 
 
 
 5.4 Discussion  
 
Rates of campylobacteriosis vary around the world, however one of the highest recorded was an 
average annual rate (2002-2006) of 353.8/100,000 population in New Zealand (Sears et al., 2011). 
While there are numerous potential sources of infection, consumption of chicken is commonly 
reported as the highest risk factor for Campylobacter infection. In Australia, eating chicken meat 
may account for 30 % of Campylobacter cases (Stafford et al., 2007). In New Zealand, before 
interventions were undertaken, 58 – 76 % of Campylobacter cases were attributed to poultry 
sources (Mullner et al., 2009). Following efforts across primary production, processing, retail and 
consumer sectors, the annual rate for New Zealand in 2008 had declined by 54 % to 161.5/100,000 
population (Sears et al., 2011). While there are numerous factors that supported this decline, 
attention to detail with hygienic practices in production and processing as well as improvements to 
immersion chillers were key areas leading to the decline in human campylobacteriosis (Sears et al., 
2011). The two main areas in poultry processing that can effectively reduce the numbers of 
Campylobacter are scalding and chilling (Guerin et al., 2010; Rosenquist et al., 2006). Other 
operations within the processing chain such as defeathering and evisceration either have a limited 
effect on numbers or may increase the numbers of Campylobacter (Guerin et al., 2010; Rosenquist 
et al., 2006). This study examined Campylobacter inactivation kinetics in broth to represent the key 
processing stresses encountered during scalding and immersion chilling. The Weibull equation was 
used to model the death curves of 32 Campylobacter isolates/strains when subjected to the 
temperature of scalding (53.1 and 57.4 °C) and to laboratory scale levels of chlorine and pH 
representative of that found in water immersion chillers (1.10 ppm, pH 6.50). At free available 
chlorine levels above 1.5 ppm in NB2, death was very rapid and no plate counts could be obtained. 
 
Studies have investigated the effect of temperature between 50 and 60 °C on reduction in the 
numbers of Campylobacter, most with a limited number of isolates or a limited number of CC’s 
(Habib et al., 2010; Moore and Madden, 2000; Scanlon et al., 2015; Slavik et al., 1995; Yang et al., 
2001). Thermal inactivation of Australian isolates derived from humans or from poultry has not 
been previously examined. Comparisons across isolates were undertaken using the Weibull model. 
The RMSE was used as a measure of the goodness-of-fit for the inactivation curves and has been 
described as the “most simple and most informative measure of goodness-of-fit, both for linear and 
non-linear models” (Ratkowsky, 2003). The Weibull model was the only model that fitted all 
strains, with a range of values of 0.12 to 0.75 at 53 °C and 0.45 to 1.32 at 57 °C. The DW (Double 
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Weibull) and the WT (Weibull with tail) were unable to be fitted to at least some isolates, as 
identified automatically within the GInaFit program. Corrected Akaike’s Information Criterion 
(AICc) was also calculated (Appendix B, Table B-1, Table B-2) for the three models assessed. 
AICc includes sample size and the number of parameters in the model when determining the quality 
of goodness-of-fit (Symonds and Moussalli, 2011) with the lowest value representing the best fit. 
At 53 °C, 25 isolates were best fitted by the Weibull model compared to six by the WT and one 
with the DW. At 57 °C, both Weibull and DW were found to be the best fit for 12 isolates with 7 
isolates best fitted by the WT model. Both Al-Sakkaf and Jones (2012) and Scanlon et al., (2015) 
identified that the Weibull model was the best fit across multiple data sets compared to both linear 
and non-linear models for thermal inactivation curves of Campylobacter. 
 
There are a number of uncertainties in the use of models to compare thermal inactivation of 
bacteria. Uncertainties lie within thermal properties, initial bacterial load, processing conditions and 
plate count (Halder et al., 2007), which might all be labelled as experimental uncertainty. The 
variability in parameters of models that describe death curves can be computed by using Monte 
Carlo simulation (Halder et al., 2007). A coefficient of variance (CV) of at least 10 % has been 
shown for δ and β (van Boekel, 2002) although this can vary across organisms and across studies 
(Halder et al., 2007). Halder et al., (2007) found that if uncertainty in parameters is similar between 
linear and Weibull models then the Weibull model will have a smaller confidence interval for the 
final log reduction compared to the linear model.  
 
As the β value (shape of curve) approaches 1, δ (rate of inactivation) can be used to approximate 
the classical D value. The mean β value at 53.1 °C was 1.12, allowing comparisons to other 
published D or δ values. Overall in this study, δ (53.1 °C) for C. jejuni ranged from 88.9 to 129.7 s. 
This is in agreement with a study at 53.5 °C, where D values for C. jejuni isolates of ST-474, ST-
190 and ST-45 in brain heart infusion broth ranged from 43.3 to 128.2 (Al-Sakkaf and Jones, 2012). 
C. coli δ values in this study are also in agreement with a single C. coli isolate at 53.8 °C with a D 
value of 205.2 obtained in phosphate buffered saline (Moore and Madden, 2000). In the current 
study, C. coli had significantly (P<0.001) greater heat resistance at 53.1 °C compared to C. jejuni 
strains as measured by δ, β and decrease after 180 s exposure (Table 5-2). Comparisons between 
studies should be undertaken with caution as the use of different heating media has been shown to 
affect the survival of Campylobacter. The heat sensitivity of C. coli was similar when conducted in 
PBS and brain heart infusion yeast extract broth but a significantly greater reduction in numbers 
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occurred when heated in scald tank water (Moore and Madden, 2000). Difference in D values have 
also been noted when a C. jejuni isolate was heated in laboratory water (D 4 min) compared to scald 
tank water (D 13.3 min), with the greatest difference in D values found at 50 °C (Yang et al., 2001).  
 
The potential selection of certain genotypes along the poultry processing chain as suggested in 
chapter 3 is not a new suggestion (Allen et al., 2007; Alter et al., 2005a; Newell et al., 2001). Habib 
et al., (2010) concluded that C. jejuni survival under stress may be influenced by the stress-specific 
selection of specific CC’s. Using isolates from the two most common CC’s, CC-21 and CC-45, it 
was noted that CC-21 isolates survived significantly (P=0.022) better compared to isolates of 
CC-45 at 55 °C in Mueller-Hinton broth (Habib et al., 2010). Data from the current study supports 
the difference in resistance of isolates from different CCs at 53.1 °C but not at 57.3 °C. In the 
current study, eight CC’s are represented, with two isolates having a ST not assigned to a CC. 
Isolates of CC-48 had a significantly (P<0.05) different shape of decline (β=0.64) compared to the 
isolates of the four other CC’s. Not surprisingly, given the noted difference between species after 
heating at 53 °C, isolates of CC-828, which were all C. coli, had significantly longer δ values (1.42) 
than isolates of four other CC’s (CC-48 29.2; CC-443 88.6; CC-21 95.5; CC-52 99.4; CC-354 
103.6). The decline after 180 s exposure at 53.1 °C as calculated by the model (1.20 log10 CFU/mL) 
was also significantly (P<0.05) less for isolates of CC-828 compared to isolates of CC-48 (3.24 
log10 CFU/mL).  
 
At 57.3 °C, many differences in model parameters disappear and the shape of the curve tends to < 1, 
indicating a convex shape of decline (thermally sensitive) compared to a concave shape at 53 °C 
(thermally resistant) for most strains. Differences between species also disappear at 57.3 °C with no 
significant (P>0.05) difference in δ, β or decrease after 180 s between C. jejuni and C. coli. There 
was no significant (P>0.05) difference between isolates sourced from human or poultry at either 
temperature, which is in agreement with the study of (Al-Sakkaf and Jones, 2012). As most studies 
included the temperatures of 55 and 60 °C it is not possible to directly compare the 57 °C results to 
a number of other published studies for C. jejuni. A higher D value (14.4 s) was recorded at 58 °C 
in physiological saline, indicating a higher level of heat resistance compared to the current study 
(Sörqvist, 1989). A C. coli isolate heated at 57.2 °C produced a D value of 31.8 s (Moore and 
Madden, 2000) which although not directly comparable due to β<1, is higher than the mean C. coli 
δ value of 6.78 s in the current study, again indicating a higher level of heat resistance compared to 
the current study.  
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At temperatures above 55 °C a tailing effect became obvious for some isolates. A more heat 
resistant sub-population of Campylobacter has been reported in a number of studies (Moore and 
Madden, 2000; Scanlon et al., 2015; Yang et al., 2001). The development of a sub-population at 
higher scalding temperatures is supported by the results of this study, with the thermal inactivation 
data from more isolates at 57.3 °C found to have an increased goodness-of-fit for either a DW or 
WT model rather than the Weibull model. The 24 heat shock proteins described for Campylobacter 
include DnaJ which also has a role in colonizing chickens (Konkel et al., 1998). If time of scalding 
at the higher temperature is sufficient to induce the heat shock proteins then there may be potential 
for increased pathogenicity of the sub-population with increased survival and therefore colonization 
potential. The DW model produces a δ1 and a δ2 value that represents the decimal reduction time for 
two populations, more and less resistant sub-populations. The DW was found to be the best fit for 
strain 1431 as it produced the smallest RMSE and the lowest AICc. The greatest difference in δ 
between the initial population and the more heat resistant residual population is produced by strain 
1431, with a δ1 and δ2 of 28.2 and 163 s, respectively. While the heat resistant sub-population of 
isolate 1431 would be affected after 180 s at high scalding temperatures (57.3 °C in this study) the 
makeup of the scald tank water and the possibility of the Campylobacter being attached to the 
chicken skin is likely to increase the effective δ value. Aged scald tank water and attachment to 
chicken skin have both been shown to increase D values (Yang et al., 2001).  
 
Multiple studies have demonstrated a decline in the numbers of Campylobacter after chilling with 
chlorinated immersion chilling, reducing the numbers by 1.74 log10 compared to a decrease of 0.74 
log10 under air chilling conditions (Bucher, Waddell, Greig, & Smith, 2015). Chlorine is not 
allowed as a processing aid in the production of poultry in the EU but is allowed up to 5 ppm FAC 
in processing waters in Australia (FSANZ, 2011) and up to 50 ppm in the US (USDA, 2008). Due 
to its oxidizing capacity, chlorine is considered an effective antimicrobial in the food industry. 
Chlorine has been used as an antimicrobial on the surface of fruits and vegetables and on surfaces in 
processing environments (Parish et al., 2003). Chlorine resistance varies between organisms and 
between the media used (Virto et al., 2005). Chlorine dissociates into hypochlorus acid (HOCl) and 
hydrochloric acid (HCl) when dissolved in water, dependent on pH (Parish et al., 2003). The HOCl 
form is the more effective antimicrobial. At the time of conducting these experiments, both 
processing plants from which the chicken isolates were recovered were using citric acid to control 
pH levels in immersion chillers, and therefore this acid was used to adjust the pH to 6.5. It has been 
demonstrated that the level of free chlorine decreases rapidly in the first minute when added to 
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water or other medium with an organic load (Tsai et al., 1992; Virto et al., 2005; Yang et al., 2001). 
As noted in the methods, the level of FAC was measured 10 min after the pH was adjusted to 
minimize the rapid decrease in FAC during the exposure period. The exposure time of 10 min used 
for comparison of log10 CFU/mL declines predicted by the Weibull model was selected as a 
minimum time that chickens may spend in an immersion chiller. Processing plants that rely solely 
on immersion chilling may have exposure times of 45 min up to 3 h. Where an immersion chiller is 
followed by air chilling the exposure time may be as short as 10 min up to 1 h (S. Watters, pers 
comm).  
 
The measured δ or D value is strongly affected by the chlorine demand from the medium. Yang et 
al (2001) examined the survival of Campylobacter ATCC33291 in chlorine with D values ranging 
from 17.2 min at 10 ppm to 0.5 min at 50 ppm in water. When 8 h aged scald tank water was used 
with increased levels of organic material, the D values ranged from 113.6 min to 6.0 min at 10 and 
50 ppm, respectively (Yang et al., 2001). The D values were increased further when Campylobacter 
was attached to chicken skin, indicating a further increase in chlorine demand due to the associated 
biological load. The maximum δ value in the current study at 1.10 ppm was 7.73 min in NB2 broth. 
The NB2 broth carries a level of chlorine demand similar to tryptone soya broth (TSB). The 
resistance of Escherichia coli increased markedly when exposed to chlorine (30 ppm) in TSB 
compared to distilled water with chlorine (0.7 ppm) (Virto et al., 2005). On the basis of the limited 
published data, the decline of Australian Campylobacter when subjected to chlorine concentrations 
and pH used in this study does not display any unusual characteristics. Direct comparisons are 
difficult, with varying methods of measuring free chlorine and different medium, isolates/strains, 
chlorine concentration, pH and exposure times across studies.  
 
There were large differences in chlorine resistance as measured by the decline calculated after 10 
min exposure. For C. coli isolates, the decline ranged from 1.23 to 5.80 and for C. jejuni isolates 
from 1.24 to 6.58 log10 CFU/mL. This suggests that the Campylobacter isolate used in testing is an 
important variable to be considered when assessing the effect of intervention steps in poultry 
processing. This is in agreement with other reports using Salmonella Kentucky and S. Typhimurium 
which concluded that the strain of Salmonella is an important independent variable for inclusion in 
models (Mohamed et al., 2015; Oscar et al., 2013). Differences in inactivation curve shape were 
noted for some CCs. Isolates within CC-52 had an overall concave shape and had a β value (1.18) 
significantly (P<0.035) different from CC48, CC-354 and CC-828. Concave inactivation curves 
suggest the potential presence of a shoulder, which has been attributed to accumulation of damage 
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that eventually becomes irreparable, suggesting the presence of sub-lethally injured cells (Virto et 
al., 2005). The highly convex curves of most isolates, with low β values, suggests that most kill is 
affected in the first minutes of exposure to chlorine. Ensuring the maximum removal of these 
organisms from the carcase in the immersion chiller water, with good control of chlorine and pH, 
will ensure that cross contamination at this stage of processing is minimized. The use of chlorine 
within in-line sprays may also improve Campylobacter numbers on carcases as the spray pressure 
may dislodge microorganisms, and without the higher chlorine demand from the chicken skin, 
allow the inactivation of cells due to the chlorine presence. Attached cells have higher D values 
(344.8 min) when exposed to 50 ppm chlorine in a chlorine demand environment such as scald tank 
water compared to unattached cells (6 min) (Yang et al., 2001).  
 
The presence of a more chlorine resistant sub-population has been noted for C. jejuni ATCC33291 
when exposed to 30 or 50 ppm chlorine in 8-h-aged immersion chiller water (Yang et al., 2001). 
The D values for the two populations were 15.2 and 82.0 min for 30 ppm, and 6.0 and 103.0 min for 
50 ppm. The presence of sub-populations was not noted when C. jejuni was attached to chicken skin 
(Yang et al., 2001). The GInaFit software was used to assess the different Weibull models (Weibull, 
WT, DW) as well as the Biphasic model as Yang et al., (2001) suggest the sub-population in their 
study fitted this model type. The model was rejected if the output lists the model as unlikely to fit 
the data or if there is a user non-acceptance of the model due to any parameter with a standard error 
larger than the outputted value. Of the 32 isolates used, 26 fitted the general Weibull model. 
Therefore, in agreement with the later modelling work of Yang et al, (2002) and building on the 
inactivation curves of a single isolate, use of the general Weibull model for assessing the survival of 
Campylobacter in broth mixed with chlorine would allow an understanding of the time to kill and 
the shape of the curve.  
 
As demonstrated in chapter 3 and in other studies (Allen et al., 2007; Alter et al., 2005a; Habib et 
al., 2010; Newell et al., 2001) some genotypes of Campylobacter survive through the poultry 
processing chain more than others. The points within a processing plant that have the greatest 
impact on reducing Campylobacter numbers are firstly scalding and at the end of processing, 
immersion chilling. The four C. coli isolates with the most resistance to chlorine (lowest log10 N 
after 10 min) were also found to be 3 of the top 4 most resistant to 53.1 °C, as measured by the 
lowest log10 N after 180 s, and 2 of the top four most resistant to 57.3 °C. This suggests that for 
C. coli there may be a relationship between heat and chlorine survival. This potential relationship is 
not as clear for C. jejuni isolates. Of the top four most resistant C. jejuni isolates after exposure to 
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chlorine only one is in the top four most resistant after exposure to 53.1 °C and a separate isolate is 
in the top four most resistant after exposure to 57.3 °C. This potential relationship between survival 
when exposed to scalding temperatures near the beginning of processing and survival when exposed 
to chlorine through immersion chilling at the end of processing should be further explored. Survival 
through scalding may, for some Campylobacter, improve the survival through chlorine exposure. 
 
Further studies need to be evaluated for understanding the diversity of inactivation of 
Campylobacter on poultry within the processing plant. Studies should also incorporate an 
experimental design that is closer to ‘real life’ than the broth experiments conducted in this study. 
These future experiments may incorporate similar levels of individual stresses with Campylobacter 
attached to chicken skin to understand survival in this more likely sessile mode. Expanding these 
studies to then incorporate multiple stresses as occurs within a processing plant should provide 
close to ‘real life’ data on Campylobacter survival through poultry processing. 
 
5.5 Conclusion 
 
Overall, the thermal inactivation of Campylobacter in this study confirmed that Australian isolates 
conform to available susceptibility parameters from other published studies. Variation exists across 
isolates/strains at 53.1 °C but not at 57.3 °C. Heat resistant sub-populations were detected for some 
isolates at the higher scalding temperature indicating that caution should be used when increasing 
scald temperatures. Higher temperatures may lead to a higher initial kill of Campylobacter as 
indicated by the generally convex curves at 57.3 °C, but may leave a more heat-resistant sub-
population to continue through the poultry processing line with potential for increased colonisation 
ability. Well controlled chlorine and pH levels will provide sufficient kill of Campylobacter that are 
not attached to the chicken skin. The mechanical removal of Campylobacter from the chicken 
carcase in the immersion chiller should be optimized to ensure the maximum inactivation through 
the immersion chilling process. While the overall reduction in numbers of Campylobacter is 
important throughout chicken processing the ability to model the shape of the curve provides 
information to the industry on where the inactivation may be highest for the intervention step 
applied. For example, convex curves (low β values) have the greatest kill early within the exposure 
to the intervention (heat or chlorine). The use of multiple isolates is recommended to ensure that the 
genetic diversity across Campylobacter strains is captured in the analysis of the inactivation due to 
poultry stresses such as scalding temperatures and immersion chiller chlorine/pH levels. 
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6.1 Introduction 
 
An estimate of the burden of acute gastroenteritis in Australia in 2010 indicated that there were 
774,003 cases of campylobacteriosis, leading to 102 cases of GBS and 52 deaths (Gibney et al., 
2014). Poultry products are frequently identified as a source of campylobacteriosis in Australia and 
across the European Union (EFSA and ECDC, 2015; Stafford et al., 2008). While control measures 
on-farm are important in lowering the burden of Campylobacter entering the slaughter process, 
there are two critical control points within poultry processing. These processing steps, scalding and 
immersion chilling, are critical for controlling numbers (chapter 2) and genotypes (chapter 3) of 
Campylobacter. Data presented in chapter 2 indicated a reduction in numbers of Campylobacter 
through immersion chilling and is supported by the reductions observed for individual 
isolates/strains when exposed to chlorine, as demonstrated in chapter 5. A high level of variation 
was noted across isolates/strains and across replicate studies in some instances (chapter 5) which is 
in agreement with variation noted in previous publications (Virto et al., 2005).  
 
Chlorine (up to 50 ppm) is approved by the US Department of Agriculture (USDA, 2008) and by 
Food Standards Australia and New Zealand (5 ppm free available chlorine) for use in commercial 
poultry processing (FSANZ, 2011). Chlorine is not approved for use in poultry processing in 
Europe due to the formation of potentially carcinogenic and teratogenic trihalomethanes and 
haloacetic acids (FAO/WHO, 2008). Chlorine dissolves in water to form hypochlorous acid (HOCl) 
and hypochlorite ion (FAO/WHO, 2008). Hypochlorous acid is the most biocidal form, although 
the formation of these two compounds is pH dependent. The acid form is very reactive, being both 
an oxidizing and halogenating species, and therefore the level of free available chlorine in 
conjunction with pH and contact time will determine the effectiveness of chlorine as a disinfectant 
on poultry (FAO/WHO, 2008). A number of microbial processes have been correlated with death 
by exposure to reactive chlorine species (RCS), including loss of ATP, inhibition of F1 ATPase, 
loss of DNA replication, and failure of transport across the inner membrane, with the inner 
membrane being the main site of lethal damage (Gray et al., 2013). Some of the responses to 
exposure to sub-lethal RCS parallel those that occur after exposure to oxidative stress, as RCS are 
strong oxidants (Gray et al., 2013). The mechanism of action of sodium hypochlorite on 
Campylobacter has not been elucidated. This study aimed to provide information on the 
transcriptional changes in Campylobacter to understand the stress response mechanisms that may 
facilitate survival of this important poultry borne pathogen during poultry processing. C. jejuni 
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NCTC11168 was exposed to a sub-lethal level of sodium hypochlorite and transcriptomic analysis 
performed on extracted and purified RNA. 
 
6.2 Materials and Methods 
 
6.2.1 Isolates.  
 
Campylobacter NCTC11168 was recovered from -80 °C by plating Protect Bacterial Preserver 
beads (Technical Service Consultants, UK) onto Charcoal Cefoperazone Deoxycholate Agar 
(mCCDA; ThermoFisher, Australia) and incubated at 42 °C for 48 h under a 5 % CO2 (Duffy and 
Dykes, 2009) atmosphere generated within a CB150 incubator (Binder, Germany). Generation of 
5 % CO2 for the growth of Campylobacter has been extensively utilised in our laboratory. A loopful 
of culture was then added to 100 mL of Nutrient Broth No. 2 (NB2, ThermoFisher) and incubated 
under 5 % CO2 at 42 °C for 48 h to generate stationary phase cultures. 
 
6.2.2 Determination of sublethal sodium hypochlorite concentration 
 
The effects of sodium hypochlorite (NaOCl, Sigma, Australia) on the growth of Campylobacter 
strain NCTC11168 were assessed via optical density in 96 well plates. Sodium hypochlorite was 
added to nutrient broth No. 2 to a concentration of approximately 1.10 ppm and the pH adjusted 
with 1 M citric acid to 6.5. Chlorine concentration was determined by an iodometric method after 
10 min, to allow for the initial decline in chlorine levels as noted by Yang et al. (2001) and in 
chapter 5. The NB2/NaOCl solution was mixed with acidified KI and titrated against standardised 
Na2S2O3 until the colourless endpoint, using soluble starch as an indicator. The NaOCl prepared in 
NB2 was further diluted in NB2 with 12 doubling dilutions from 0.54 to 0.00026 ppm. These 
dilutions were used to inoculate the test wells in rows B to G. The stationary phase culture grown in 
6.1.1 was diluted to 105 CFU/mL in NB2. The 96 well plates were inoculated by adding 200 µL 
NB2 to row A (negative control), 150 µL NB2 and 50 µL of 105 bacteria to row H (positive 
control), 150 µL of each dilution of NaOCl in NB2 to each column from 1 to 12 in rows B to G and 
50 µL of 105 bacteria added to each of these wells. The OD600 was read up to 32 h. Growth 
experiments were completed in duplicate. The chlorine concentration chosen for the transcriptome 
experiments effected a reduction in growth rate compared to the no NaOCl control, while 
maintaining a similar final number of Campylobacter NCTC11168. 
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6.2.3 Differential transcriptional analysis.  
 
Stationary phase cultures (6.1.1) were centrifuged at 5,000 g for 10 min, supernatant removed, and 
resuspended in 4 mL of NB2. A total of four control and four treated replicate samples were 
prepared. A 1 mL portion was added to 20 mL of NB2 with 0.0624 ppm chlorine, pH 6.56. The 
chlorine concentration was that obtained from 6.1.2. This was incubated at 24 °C, with gentle 
shaking, for 1 h. A 4 mL volume of 5 % phenol:ethanol solution was added, briefly vortexed, held 
at 4 °C for 30 min and then centrifuged at 5000 g for 10 min. RNA was then extracted from the 
pellet using the Promega SV Total RNA isolation system (Promega, Australia) following the 
manufacturer’s instructions. Samples were then treated with turbo DNAse (Ambion, Australia) 
using the rigorous method stated in the manufacturer’s instructions. Samples were then purified 
using RNA Clean and Concentrate (Zymo Research, Australia) before RNA depletion using the 
Ribo-Zero rRNA Removal Kit (Bacteria) according to the manufacturer’s instructions (Illumina, 
Australia). The rRNA depleted RNA was again passed through the RNA Clean and Concentrate kit, 
eluted in 35 µL of RNase-free water, before being stored at -80 °C until transported frozen to the 
Ramaciotti Centre at the University of New South Wales. Staff at the Ramaciotti Centre completed 
the library preparation using the Illumina TruSeq Stranded kit and 100 bp length, paired-end 
Illumina sequencing on an Illumina HiSeq2500 sequencer. 
 
Transcriptome reads were quality clipped and trimmed of Illumina adaptors with Trimmomatic 
v0.36 using the wrapper script, trimmo.py. All mapping was performed with BBmap v37 using the 
wrapper script, bbmap_general.py. Command lines and scripts used are detailed in the GitHub 
repository, https://github.com/theo-allnutt-bioinformatics/031_lduffy_csiro/. Prior to reference 
genome mapping, reads were checked for ribosomal RNA content by mapping to the entire 
ribosomal RNA region of genome NCTC11168 
(https://www.ncbi.nlm.nih.gov/nuccore/AL111168.1). Considerable variation was found in the 
proportion of reads mapping to rRNA: from 2.8% for sample 1C to 41% for sample 4C. It was 
therefore necessary to use the rRNA unmapped reads, i.e. those filtered of rRNA reads, for mapping 
to the reference genome. rRNA filtered reads were subsampled to 1 million bp forward and 1 
million bp reverse – giving a theoretical mean depth of coverage of the C. jejuni genome of over 
200 X. The subsampled reads were then mapped to the reference genome NCTC11168 and counts 
obtained for all coding sequence (CDS) features. Genes were tested for differential expression (DE) 
between control and treated groups using the R package, EdgeR. A functional annotation of all 839 
genes with DE and a false discovery rate (FDR) <0.01 was attempted using EggNOG v4.5.1 
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(http://eggnogdb.embl.de) and genes were placed into functional categories using the clusters of 
orthologous groups database (COG). The results of the transcriptional data analysis to this point 
were completed by the company, Theo Allnutt Bioinformatics, following the requested services 
from the candidate, and the results supplied in an excel spreadsheet. For some genes, no 
orthologous match was found. The sequence of strain NCTC11168 (chapter 4) was used to 
determine the total number of genes within each COG. The spread of significance and fold change 
noted for all 1570 mapped genes was identified by plotting –log10 p-value against the log2 Fold 
Change (FC) of all 1570 mapped genes. The STRING database (https://string-
db.org/cgi/network.pl) (Szklarczyk et al., 2015) was used to determine if any prior connections had 
been made between selected groups of genes. 
 
6.3 Results 
 
6.3.1 Sublethal experiments  
 
The growth of NCTC11168 was affected in a concentration dependent manner (Figure 6-1). A 
concentration of 0.07 ppm was selected for the transcription analysis experiments as this was the 
highest concentration that produced a reduction in growth rate but still allowed NCTC11168 to 
grow to a similar level as the no NaOCl control.  
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Figure 6-1: Mean growth of C. jejuni NCTC11168 in nutrient broth No.2 with various 
concentrations of NaOCl (ppm), as measured at OD600. Error bars represent the standard deviation 
of duplicate samples. 
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2.3.2 Transcriptional analysis  
 
The number of reads per sample ranged from 4,063,723 to 8,129,794, which was acceptable for the 
genome to be mapped. A description of the number of reads, clipped reads, reads mapped to 
ribosome, reads filtered, and the number of reads subsampled is displayed in Table 6-1. The 
efficiency of rRNA removal was variable, with the percentage of ribosomal reads ranging from 
2.8 % to 41.6 % (Table 6-1). The rRNA depletion did not meet the manufacturer’s expectations 
across all samples, with four samples overall having greater than 25 % ribosomal reads. On average 
> 80 % of reads were mapped to the reference NCTC11168, with one treated sample having only 
53 % of reads mapped (Table 6-1). A total of 1570 genes were mapped (Figure 6-2). Using a false 
discovery rate (FDR) of <0.01, a fold change of >1.5 and a statistical significance of < 0.01, there 
were 787 genes that demonstrated DE after 1 h of exposure to 0.07 ppm NaOCl. A total of 376 
genes had decreased expression after exposure to NaOCl, and 411 genes demonstrated increased 
expression. A complete list of all 787 genes, fold change and COG is displayed in Appendix C, 
Table C-1. 
 
Table 6-1: Description of the number of reads at each stage of the analysis of the transcriptional 
data; total reads, clipped reads, the percentage found to be ribosomal, number of reads after filtering 
out ribosomal reads and the final percentage mapped to the reference genome 
(https://www.ncbi.nlm.nih.gov/nuccore/AL111168.1). 
 
Sample Description 
Total 
Reads 
Clipped 
Reads 
Percentage 
Ribosomal 
Filtered 
Percentage 
Mapped 
1C - NaOCl 25830956 8129794 2.825 15800180 95.253 
2C - NaOCl 23690162 7032057 7.879 12955992 92.050 
3C - NaOCl 21311146 4676555 4.805 8903727 93.917 
4C - NaOCl 23601685 4877338 41.625 5694279 63.696 
1F + NaOCl 19222104 4063723 36.487 9888450 53.058 
2/3F + NaOCl 21583123 5605430 11.796 9888450 83.193 
4F + NaOCl 21745249 5250589 25.874 7784111 75.373 
5F + NaOCl 26957948 6768901 28.443 9687276 85.454 
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Figure 6-2: The log2 fold change (FC) of all 1570 mapped coding sequences from NCTC11168 
after exposure to 0.07 ppm NaOCl.  
 
 
Differentially expressed genes were categorized into 19 functional categories (Table 6-2). A total of 
19 genes had more than one general category letter association in the COG database and were 
treated as belonging to both. The majority of genes within COG category K (58 %), were 
upregulated, with half (50 %) of the genes involved in signal transduction also upregulated. The 
majority (57 %) of genes within COG category V, defense mechanisms, were downregulated. 
Functional groups of genes are further displayed at the gene level (Table 6-3, Table 6-4, Table 6-5) 
based on COG function and areas highlighted throughout this thesis. 
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Table 6-2: Summary of the Campylobacter jejuni 787 genes (FDR < 0.01) with increased or 
decreased expression in their associated cluster of orthologous groups (COG; 19 genes belonged to 
two different groups). The total number of genes from C. jejuni NCTC11168 within each COG is 
also listed. 
COG categories 
Number of 
genes up 
regulated 
Number of 
genes down 
regulated 
Total 
number of 
genes 
Information storage and processing    
J: Translation 15 (12)a 37 (28) 130 
K: Transcription 18 (58) 6 (19) 31 
L: Replication, recombination and repair 18 (30) 10 (17) 60 
Cellular processes and signaling    
D: Cell cycle control 3 (21) 4 (29) 14 
V: Defense mechanisms 1 (7) 8 (57) 14 
T: Signal transduction mechanism 17 (50) 10 (29) 34 
M: Cell wall/membrane biogenesis 28 (27) 33 (32) 104 
N: Cell motility 15 (33) 10 (22) 45 
U: Intracellular trafficking and secretion 9 (26) 13 (38) 34 
O: Post-translational modification, protein turnover, 
chaperones 17 (26) 28 (43) 65 
Metabolism    
C: Energy production and conversion 39 (38) 12 (12) 103 
G: Carbohydrate transport and metabolism 6 (17) 13 (36) 36 
E: Amino acid transport and metabolism 31 (23) 47 (36) 132 
F: Nucleotide transport and metabolism 11 (22) 11 (22) 49 
H: Coenzyme transport and metabolism 18 (25) 14 (20) 71 
I: Lipid transport and metabolism 8 (22) 13 (36) 36 
P: Inorganic ion transport and metabolism 36 (40) 26 (29) 91 
Q: Secondary metabolites biosynthesis, transport and 
catabolism 5 (29) 5 (29) 17 
Poorly characterised    
S: function unknown 78 (72) 69 (63) 109 
Unclassified 48 16 13 
aPercentage of the total number of genes within that COG 
 
The highly differentially expressed genes after exposure to NaOCl, hrcA (FC 11.6) and cj1556 (FC 
16.1), are within the transcription COG category, in which 58 % of genes were upregulated (Table 
6-2). HrcA is involved in the heat shock response. The heat shock transcriptional regulator hspR 
was also upregulated with a fold change of 1.5 (Table 6-4). Cj1556 has one of the highest fold 
changes, 16.1, noted across the entire transcriptome and is involved in oxidative and aerobic stress 
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(Gundogdu et al., 2011). Using the STRING database (Szklarczyk et al., 2015) cj1556 has been 
previously linked to the transcription related genes cj0480 and mioB (hypothetical protein) through 
coexpression. The transcriptional repressor of the cmeABC efflux pump, cmeR, was upregulated 2.0 
fold. Other described regulators rpoD and rpoN were also upregulated. Down regulated genes 
involved in transcription (n=6) had generally low FC <2.3, except for nusG, a transcription 
termination and anti-termination protein with a FC of -6.1.  
 
The COG category involved in defense mechanisms (57 %) were mostly downregulated compared 
to other categories. The ABC transporter involved in iron acquisition, cj1661, had the highest fold 
change of -4.1. This gene is also co-expressed with cj1180 and macB, two further ABC transporters. 
Both upk and macB are involved in resistance to antimicrobials, bacitracin and macrolides 
respectively, and are integral components of the membrane along with pglK. A number of the 
downregulated genes in this category are ABC transporters and indicate the involvement of the 
membrane in the response to NaOCl. A single gene was upregulated, hsdM, and is involved in the 
type 1 restriction modification system.  
 
As functional areas such as motility, surface structures such as LOS and CPS, and other 
environmental stresses have been previously suggested to influence survival under various 
conditions, these areas were also assessed at the gene level for differential expression. Flagellar and 
chemotaxis related genes and those with a significant (P<0.01) fold change >1.5 are listed in Table 
6-3. Of most note is flagellar biosynthesis regulator, flgM, with the highest fold change (21.1), 
which regulates the later stages of flagellar production to prevent unlimited elongation of the 
flagellum. The response of known stress response genes is quite variable (Table 6-4) with sodB 
(oxidative stress response) being down regulated compared to hrcA, with hspR (heat shock 
response) genes upregulated. A number of the virulence related genes listed in Table 6-5 were 
downregulated.  
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Table 6-3: Differential expression of some genes related to chemotaxis and motility with a Fold 
Change (FC) > 1.5, P <0.01 and a FDR of < 0.01. 
Locus Gene FC Description 
Chemotaxis 
Cj1564  -2.0 methyl-accepting chemotaxis signal transduction protein 
Cj0924c cheB' 2.0 MCP protein-glutamate methylesterase 
Cj0448c  2.0 MCP-type signal transduction protein 
Cj0285c cheV 2.6 chemotaxis protein 
Cj0283c cheW 2.1 chemotaxis protein 
Cj0019c  -6.2 MCP-domain signal transduction protein 
Cj0599  -3.0 OmpA family membrane protein 
Filament 
Cj1339c flaA 1.8 flagellin A 
Cj1338c flaB 7.2 flagellin B 
Cj0548 fliD 2.2 flagellar capping protein 
Cj0720c flaC 4.8 flagellin C 
Hook-Filament junction 
Cj1466 flgK 3.6 flagellar hook-associated protein 
Cj1462 flgI 1.7 flagellar basal body P-ring protein 
Hook and Rod 
Cj0526c fliE 1.5 flagellar hook-basal body protein 
Cj0320 fliH -2.3 flagellar assembly protein 
Cj0319 fliG -1.6 flagellar motor switch protein 
Cj0318 fliF -1.7 flagellar MS-ring protein 
Cj0527c flgC 1.5 flagellar basal body rod protein 
Cj0043 flgE -2.0 flagellar hook protein 
Cj0882c flhA -1.6 flagellar biosynthesis protein 
Cj0820c fliP 2.1 flagellar biosynthesis protein 
Cj0769c flgA 2.1 flagellar basal body P-ring biosynthesis protein 
Cj0060c fliM -1.6 flagellar motor switch protein 
Regulators 
Cj1464 flgM 21.1 flagellar biosynthesis protein 
Cj0064c flhF -1.5 flagellar biosynthesis regulator 
Cj0547 flaG 5.9 flagellar protein regulates filament length 
 
As the LOS and CPS have been suggested to play a role in potential pathogenicity and as they are 
surface exposed, these were further assessed for changes in regulation after exposure to NaOCl 
(Table 6-5). There was limited differential expression of genes within the capsular polysaccharide 
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(CPS) genes with only eight of the 38 identified CDS genes (chapter 4) demonstrating significant 
(P<0.01) changes in expression. Down regulated genes included kfiD, cj1436c, cj1433, fcl, cj1417c 
and cj1418c while two sugar transferases, cj1421 and cj1422, were upregulated. Key areas 
discussed in previous chapters were selected for further examination of the effect of chlorine 
exposure on gene expression. Motility and chemotaxis are known to be affected by exposure to 
other stresses (Table 6-3), some known stress response genes are highlighted in Table 6-4, and 
LOS/CPS as outer membrane structures, are potentially related to pathogenicity and may therefore 
be affected by exposure to chlorine (Table 6-5). The effect of chlorine stress on the expression of 
virulence genes (Table 6-5) is linked to one of the overarching themes across this thesis, the 
potential for the selection of more pathogenic strains through poultry processing.  
 
Table 6-4: Differential expression of genes related to stress response and regulation, with a Fold 
Change (FC) > 1.5, P <0.01 and a FDR of < 0.01. 
Locus Gene FC Description 
General stress response 
 
Cj0169 sodB -2.9 superoxide dismutase 
Cj1228c htrA -2.7 serine protease 
Cj1107 clpS -1.9 ATP-dependent Clp protease adaptor protein 
Cj1108 clpA -3.8 ATP-dependent Clp protease ATP-binding subunit 
Cj0757 hrcA 11.6 transcription repressor 
Cj1230 hspR 1.5 transcriptional regulator 
Cj1260c dnaJ 2.7 chaperone protein  
Cj1220 groES 4.6 chaperone 
CJ1221 groEL 1.7 chaperone 
Cj1229 cbpA 3.1 DNA binding protein 
Cj0509 clpB 2.0 chaperone 
Cj1256c 
 
1.5 membrane protein 
Cj1257c 
 
1.8 efflux pump protein 
Regulators    
Cj1261 racR 3.1 two-component regulator 
Cj1262 racS 2.8 two-component sensor histidine kinase 
Cj0670 rpoN 1.54  
Cj0355 cosR -2.9 2 component regulator 
Cj1227 cprR -3.4 2 component regulator 
Cj1546/1556 rrpA/ B 3.1,16.1 2 component regulator 
Cj1227 cprR -3.4  
Cj1272 spoT -2.3 transcriptional regulator 
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Table 6-5: Differential expression of genes within the lipooligosaccharide (LOS) and virulence 
related genes, with a Fold Change (FC) > 1.5, P <0.01 and a FDR of < 0.01. 
 
Locus Gene FC Description 
LOS    
cj1133 waaC 2.6 heptosyltransferase I 
cj1134 htrB 2.6 lipid A biosynthesis lauroyl acyltransferase 
cj1136 
 
1.7 glycosyltransferase  
cj1138 
 
2.6 glycosyltransferase  
cj1139c wlaN 3.1 wlaN  
cj1141 neuB1 1.5 sialic acid synthase 
cj1148 waaF 1.9 waaF  
    
Virulence    
Cj0914c ciaB -4.2 invasion antigen 
Cj1478c cadF -1.7 outer membrane fibronectin-binding protein 
Cj0077c cdtC -2.7 cytolethal distending toxin C 
Cj0079c cdtA -2.1 cytolethal distending toxin A 
 
 
 
6.4 Discussion 
 
Since the advent of RNAseq technology that enables the study of the complete transcriptome there 
has been a steadily increasing number of studies that incorporate the technology into understanding 
the response of Campylobacter to various environmental and processing stresses. The data 
presented in this study provide the first report of the molecular basis of C. jejuni response to 
exposure to NaOCl. While only C. jejuni NCTC11168 was incorporated in this study, the 
techniques and analysis pathway can be utilised in future studies to examine the variation across 
strains. While the Ribo-Zero kit has been shown to have the highest rRNA removal efficiency from 
selected subtractive hybridisation kits (Petrova et al., 2017), the results from this study demonstrate 
a level of variation in rRNA removal. A total of four samples had close to or less than 10 % rRNA 
reads which is the manufacturer’s predicted removal efficiency. While the remaining samples 
varied from 25.8 to 41.6 % rRNA reads, the process of filtering out the rRNA reads and 
subsampling both forward and reverse allowed all samples to be successfully mapped to the 
reference. 
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Campylobacter has a very broad transcriptomic response to exposure to sub-lethal levels of NaOCl, 
with over 50 % of genes having a > 1.5 fold change in expression (P <0.01). Confirmation of 
RNAseq data using qRT-PCR has not been undertaken, however the up or down regulation of a 
selected number of genes will be subject to future studies. While qRT-PCR is still considered an 
important component of RNAseq experimental design, the use of biological replicates and technical 
replicates, and the improvements in the techniques and sequencing approaches themselves, may see 
well designed and analysed RNAseq experiments be considered the new gold standard for 
measurement of gene expression (de Sa et al., 2015; Kreuder et al., 2017).  
 
Through the use of sub-lethal levels of NaOCl, this study examined the response of the cell to 
damage at levels that can be repaired, although these may differ to those that occur during the use of 
lethal doses of chlorine. It has been demonstrated that a number of the responses of various 
organisms to oxidative and peroxide stress are also involved in the response to RCS (Gray et al., 
2013). While this study is the first presentation of the response of Campylobacter to NaOCl, 
examination of the response to oxidative and peroxide stress has been extensively studied (Atack 
and Kelly, 2009; Koolman et al., 2016; Oh et al., 2015; Palyada et al., 2009) and recently reviewed 
(Flint et al., 2016; Kim et al., 2015b). Mechanisms that defend Campylobacter against one stress 
have been shown to provide cross-protection to another stress. Acid shock response shares some 
elements with both heat shock response and oxidative stress, while there is a limited overlap of 
acidic and nitrosative stress response (Reid et al., 2008). In the current study, the defense against 
oxidative stress and RCS have some overlap, although there is a greater overlap in the response to 
RCS and heat shock response. It would therefore be an important future study to determine if 
exposure to heat followed by chlorine, as occurs in poultry processing, has a protective impact on 
Campylobacter. Organisms that have switched on their heat shock response pathway may have 
improved ability to survive exposure to chlorine, although use of industry related timeframes and 
exposure levels are also important to examine. 
 
The sole catalase and superoxide dismutase genes in C. jejuni are katA and sodB (Atack and Kelly, 
2009). Regulation of peroxide stress response is largely undertaken by perR in C. jejuni, with at 
least 104 genes directly or indirectly regulated (Palyada et al., 2009). PerR is a negative regulator of 
katA, ahpC, tpx and sodB, which are all involved in oxidative stress response (Kim et al., 2015a; 
Palyada et al., 2009). Sensitivity to HOCl increased when catalase deficient mutants of E. coli and 
the Campylobacter related organism Helicobacter pylori were exposed for 4 h (Dukan et al., 1996; 
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Mahawar et al., 2011). This is further confirmed by the upregulation of catalases in E. coli (Wang et 
al., 2009) and Pseudomonas aeruginosa (Small et al., 2007a) after exposure to sodium hypochlorite 
(NaOCl). In this study, perR had a non-significant fold change of 1.1 (P=0.59). As perR is a 
negative regulator of a number of genes, including katA, the downregulation of katA (cj1385), 
which had a non-significant (P=0.67) fold change of -1.2, is expected. Optimal H2O2 detoxification 
and the presence of hemin within katA involves the chaperone kapA (Flint and Stintzi, 2015). This 
gene (cj1386) had a fold change of -2.2 in the current study and has a role in the transfer of hemin 
to katA. The exposure time in this experiment (1 h) may not have been long enough to produce 
higher changes in expression. The fold change of some genes recorded for C. jejuni 81-176 after 
exposure to hyperosmotic stress varied across the 12 h of sampling (Cameron et al., 2012). The 
amino acid biosynthesis genes, leuB and leuC, genes have previously been demonstrated to be 
upregulated after exposure to hyperosmotic stress for up to 6 h but downregulated 12 h after 
exposure (Cameron et al., 2012). The genes trpD and trpF, involved in tryptophan biosynthesis, 
were also upregulated upon exposure to hyperosmotic stress (Cameron et al., 2012) but 
downregulated when exposed to NaOCl in this study.  
 
C. jejuni has three periredoxins, AhpC, Tpx and Bcp involved in oxidative stress (Flint et al., 2016). 
AhpC has been shown to play a role in oxidative stress caused by cumene hydroperoxide and 
atmospheric oxygen but not that caused by H2O2 (Baillon et al., 1999). Bcp can reduce organic 
peroxides as well as H2O2 whereas Tpx has been shown to be substrate specific and only reduces 
H2O2 (Atack et al., 2008). Both AhpC and Tpx were downregulated in the current study compared to 
Bcp which was upregulated (FC 2.6), which may infer that bcp is not under regulation from perR. 
C. jejuni has a single cytoplasmic superoxide dismutase (sodB) that dismutates superoxide O2— into 
H2O2 and O2 (Parkhill et al., 2000; Pesci et al., 1994). Sensitivity to O2--, H2O2, and organic 
peroxides increased when sodB was deleted (Palyada et al., 2009) indicating a role for this gene in 
the response to reactive oxygen species (ROS). After exposure to NaOCl in this study, sodB had a 
fold change of -2.9, which is in agreement with the upregulation of perR. Superoxide dismutases 
have been shown to be upregulated in E. coli and Pseudomonas in response to RCS (Small et al., 
2007a; Wang et al., 2009), while in Staphylococcus aureus, SODs are impaired in their activity in 
the presence of RCS (Maalej et al., 2006). Flint et al (2016) suggests that the presence of sodB is 
indispensable in the Campylobacter genome while other genes such as ahpC and tpx may 
compensate for the lack of katA in some strains. A single isolate (2704) from chicken in this study 
(chapter 2) contained sodB but was not detected by PCR (chapter 4). It would be of interest to 
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determine if the sodB in isolate 2704 has sequence differences that led to initial lack of detection by 
PCR and if sodB confers the same level of resistance to stress in this isolate compared to others. 
 
Peroxidases are also H2O2 scavengers and are suggested to work at low H2O2 concentrations (Gray 
et al., 2013). C. jejuni has two putative cytochrome c peroxidases, cj0020 and cj0358. Down 
regulation of cj0020 (FC -2.5) occurred, while cj0358 was upregulated with a FC of 2.4. Flint et al., 
(2014) demonstrated that the defense of oxidative stress can be influenced in a strain dependent 
manner with mutations in cj0358. Strain variation in response to NaOCl was not investigated in this 
study, however, as indicated in chapter 4 and 5, the level of variation across strains can be extensive 
and should be assessed. The role of these two peroxidases in oxidative or chlorine stress is clouded 
by the lack of change in resistance to H2O2 by mutant cj0020c or cj0382 strains (Bingham-Ramos 
and Hendrixson, 2008).  
 
The constitutively expressed iron-binding protein, Dps, also has a role in H2O2 stress response 
(Ishikawa et al., 2003). While not induced upon exposure to H2O2, dps sequesters intracellular free 
iron, helping to prevent the formation of oxygen free radicals (Ishikawa et al., 2003) and binds to 
DNA to prevent enzymatic cleavage and damage by hydroxyl radicals (Huergo et al., 2013). 
Huergo et al. (2013) also proposed that Dps-DNA binding is activated by low pH, H2O2 and Fe2+, 
hence it has a role during colonisation. Under the experimental conditions used in this study, dps 
was upregulated (FC 1.5, P=0.002), which suggests that dps may also have a role in the RCS stress 
response. The expression of dps in Campylobacter is also increased by exposure to HCl or acetic 
acid (Birk et al., 2012). The pH of the NaOCl broth used in this study was adjusted by the addition 
of citric acid to ensure the dissociation of NaOCl provided maximum HOCl, and hence 
antimicrobial activity, which also mimics the use of these chemicals in immersion chillers in 
poultry processing plants. The effect of citric acid alone has not been assessed.  
 
Also involved in bacterial defences against ROS, methionine sulfoxide reductases are upregulated 
by E. coli and P. aeruginosa after exposure to chlorine (Small et al., 2007a; Wang et al., 2009) and 
mutations in Campylobacter of msrA and msrB have been shown to be more sensitive to peroxide, 
superoxide and nitrosative stress (Atack and Kelly, 2009). Similarly, H. pylori that lack msr genes 
are also more sensitive to HOCl (Mahawar et al., 2011). However, msrA (cj0637) and msrB 
(cj1112) were both downregulated in the current study. The role of these reductases is to reduce 
oxidised methionine to methionine and hence restore methionine function in protein synthesis. This 
process has been shown in H. pylori to be dependent on the chaperone GroEL (Mahawar et al., 
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2011) which is upregulated in NCTC11168 (FC 1.7) in the current study. This is counter intuitive as 
GroEL can be inactivated by HOCl due to methionine oxidation in E. coli (Wang et al., 2009). 
However, protein unfolding and aggregation occurs upon exposure to RCS as opposed to ROS, 
which has little effect on this process (Gray et al., 2013). Cells may respond by upregulating 
molecular chaperones, such as GroEL, and proteases to combat unfolding and degrade unfolded 
proteins (Small et al., 2007a; Wang et al., 2009).  
 
The heat shock proteins (HSP) are involved in reducing the intracellular level of unfolded and 
aggregated proteins (Holmes et al., 2010). As RCS have been shown to also affect protein unfolding 
and aggregation (Gray et al., 2013) the upregulation of these HSPs is not unexpected. The heat 
shock response includes but is not limited to hrcA, grpE, dnaK, groESL, cbpA, clpB and hspR 
(Holmes et al., 2010). All of these were upregulated with a fold change of 11.6 for hrcA (Table 
6-4). Further studies will be required to confirm the role of HSPs when Campylobacter is exposed 
to RCS and should also incorporate a range of times of exposure. As heat is applied through 
scalding during chicken processing, the finding of upregulated heat shock proteins when exposed to 
NaOCl used in immersion chilling may impact on survival at this later stage of processing.  
 
The response to RCS is not well known in comparison to that of ROS, and the lack of specific 
regulators in response to RCS results in a number of regulators and their downstream genes having 
secondary roles in the RCS response. The Mar-R type transcriptional regulators, rrpA (cj1546) and 
rrpB (Cj1556), with a fold change of 3.1 and 16.1, respectively, in the current study, have been 
shown to have a role in the response to peroxide, oxidative and aerobic stress and act as DNA 
binding proteins (Gundogdu et al., 2015). The Campylobacter oxidative regulator (cosR, cj0355), 
which is essential for Campylobacter survival (Garenaux et al., 2008a), is a two-component 
response regulator, involved in the regulation of 32 proteins (Hwang et al., 2011b). CosR regulates 
ahpC, katA, and negatively regulates sodB, dps, and rrc (Hwang et al., 2011b; Hwang et al., 2012). 
CosR was downregulated in the current study with a fold change of -2.9 which would apply 
downward pressure on the expression of ahpC and katA and upward pressure on the expression of 
those genes negatively regulated. This contrasts with the regulation of some of these genes by perR. 
The cmeABC operon, an efflux pump, had no significant change in expression in the current study, 
although it has been shown to be under negative regulation by cosR (Hwang et al., 2012). The 
global regulator, spoT, is also downregulated, with a -2.3 FC. Specific polymorphisms in spoT have 
been linked to higher prevalence in clinical isolates and correlated with survival of chill stress 
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(Groot et al., 2014). The NCTC11168 strain used in this study was not assessed for the presence of 
this SNP.  
 
Campylobacter has three sigma factors, RpoD, FliA and RpoN (Parkhill et al., 2000). RpoD (σ70) 
regulates the expression of housekeeping genes (Petersen et al., 2003) and was upregulated upon 
exposure to NaOCl for 1 h (3.3) in this study. Heat shock of 55 °C for 3 min or oxidative stress was 
not sufficient to alter expression of rpoD although quantitative real-time PCR demonstrated that 10 
– 20 min of heat shock was required to increase expression of rpoD (Klancnik et al., 2006). FliA 
(σ28) did not largely change expression after NaOCl exposure (FC 1.1) and is associated with 
flagella biosynthesis (Hendrixson et al., 2001). The third sigma factor RpoN (σ54) regulates flagellar 
biosynthesis, with roles in the flagellar secretory apparatus, bacterial motility, colonisation and 
invasion (Fernando et al., 2007; Hendrixson and DiRita, 2003; Konkel et al., 2004). Studies with 
RpoN mutants state that while RpoN has a role in osmotic, acid and oxidative (H2O2) stress it did 
not have a role in resistance to alkaline pH, heat, cold or the antimicrobials erythromycin, 
cefotaxime, gentamicin, polymyxin, rifampicin and ampicillin (Hwang et al., 2011a).  
 
Motility has been suggested as an important component in the pathogenesis of Campylobacter 
(Szymanski et al., 1995; Van Vliet and Ketley, 2001). Bacterial motility also indirectly contributes 
to C. jejuni resistance to superoxide stress, as mutations of genes involved in flagellar biosynthesis 
and modification (e.g., motAB, flgR, flhB, flgD, and pseB) render C. jejuni significantly sensitive to 
menadione, a superoxide generator, and slightly to H2O2 (Flint et al., 2014). Most of the 
differentially expressed flagellar related genes were upregulated (n=12) compared to seven that 
were down regulated in this study. FlaC has been shown to be downregulated when the strain was 
exposed to a heat stress (Holmes et al., 2010). In another study, a total of eight flagellar related 
genes were downregulated upon heat stress and strains had elongated filaments (Andersen et al., 
2005). The length of the filament is controlled by flgM (Wosten et al., 2010) which had a large 
increase in expression when exposed to NaOCl (FC 21.1). Exposure to oxidative stress has been 
shown to produce either up (Garenaux et al., 2008b) or down (Koolman et al., 2016) regulation of 
flaA and flaB compared to a significant upregulation in this study. Other components of the flagellar 
system were also highly significantly upregulated, namely flaC and pseE, as part of the flagellar 
glycosylation locus. Genes of unknown function such as cj1465 with a FC of 16.9 is also collocated 
with the flagellar gene cluster (Chaudhuri et al., 2011). It has been suggested by Koolman et al. 
(2016) and Chaisowong et al. (2012) that motility may not be required for survival under oxidative 
or cold stress. Motility and agglutination, both linked to flagellar presence, were not assessed after 
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exposure to NaOCl and changes in the synthesis may affect these phenotypic traits (Misawa and 
Blaser, 2000; Szymanski et al., 1995).  
 
A number of suggested virulence genes have been shown to have changes in expression when 
subjected to oxidative stress (Koolman et al., 2016). The cdtB gene of NCTC11168 was 
significantly down regulated under oxidative stress (Koolman et al., 2016) and was also 
downregulated, with a fold change -1.1, when exposed to NaOCl in this study, but not significantly 
(P=0.21). In comparison, the cdtA and cdtC genes were both significantly downregulated 
(P<0.0001). While the three toxin genes are located on the same operon, some strains have been 
shown to independently regulate cdtC (Carrillo et al., 2004). As all three toxin genes are 
downregulated, with cdtB to a lesser extent, perhaps transcription of the three toxin genes is not 
equivalent, however this requires further investigation to demonstrate.  
 
The number of genes related to the various aspects of virulence is large and only those with 
significant fold changes > 1.5 are listed in Table 6-4. Other virulence related genes that were not 
significantly (P>0.01) different in their expression include but are not limited to: invasion, iamB, 
pldA; adhesion and colonisation, PEB1, jlpA, dnaJ; and protection against harsh conditions, cbrR. 
The fibronectin binding protein, cadF, and flpA, which is involved in cell adhesion, was 
significantly (P<0.0001) downregulated upon exposure to NaOCl. The ciaB gene that plays a role in 
the secretion of proteins during invasion was also significantly (P<0.0001) downregulated with a 
fold change of -4.2. In contrast, the invasion related ceuE was significantly (P<0.0001) upregulated 
4.2 fold. The binary typing scheme utilised in chapter 4 to describe the potential pathogenicity of 
the 32 isolates/strains determined the presence/absence of 18 genes originally selected for their role 
as epidemicity markers (Cornelius et al., 2010). Of these 18 genes, cj0122, cj0265, and cj0423 were 
significantly (P<0.0001) upregulated with a > 4 fold change. A single gene, gmhA, a conserved part 
of the LOS, was downregulated, although not significantly (P=0.028). These conflicting changes in 
expression across a number of virulence related genes require further investigation to determine if 
exposure to NaOCl increases the potential pathogenicity of Campylobacter through the use of 
adhesion and invasion assays  
 
6.5 Conclusion 
 
This is the first report of the transcriptomic response of C. jejuni to a sub-lethal level of NaOCl. 
While Campylobacter produces a global response to exposure to NaOCl, a number of areas of 
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related genes are differentially expressed. NaOCl, under the conditions used in this study, has a 
global effect on expression with approximately half of all the mapped genes (787/1570) having a 
significant (P<0.01) change in expression levels. Campylobacter has a recognised response to 
oxidative stress pathway and a recognised heat stress response. Most of the genes that have been 
shown to respond to oxidative stress are downregulated upon exposure to NaOCl under the 
experimental conditions used. In comparison, heat stress response genes were largely upregulated 
upon exposure to NaOCl. A variety of stresses occur within the poultry processing line. 
Campylobacter may undergo heat stress during scalding, exposure to oxygen throughout 
processing, and exposure to chlorine during immersion chilling. Understanding the response of 
Campylobacter to each stress is important in understanding what effect the processing parameters 
have on survival and hence the impact on food safety. The response to repeated or cumulative 
stresses that do not kill Campylobacter would be useful in understanding the effects of the poultry 
processing line as a whole, on the survival of this organism. 
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7.1 Summary of thesis objectives 
The purpose of this thesis was to investigate the selection and survival of Campylobacter through 
poultry processing in Australia. The specific aims of this study were to: 
 
1 – Determine the effect of current poultry processing parameters in two Australian abattoirs on 
both the level and prevalence of Campylobacter on whole chickens through the processing line. 
(Chapter 2). 
2 – Map the genotypic diversity of Campylobacter through poultry processing in order to identify 
persistent strains and compare to those genotypes circulating in the human population. (Chapter 3). 
3 – Characterise Campylobacter from poultry and humans for virulence potential as measured by 
attachment and invasion to Caco-2 cell lines and investigate associations between other phenotypic 
and genetic factors. (Chapter 4). 
4 – Explore the survival and macromolecular response of a representative subset of C. jejuni and 
C. coli from poultry and humans when subjected to stresses that commonly occur in the poultry 
processing plant. (Chapter 5). 
5 – Explore the genetic response to immersion chilling stress using RNAseq. (Chapter 6). 
 
7.2 Major findings and contribution of this thesis 
 
A review of the literature of Campylobacter in poultry processing revealed that there was very 
limited data available on Australian poultry processing. An estimate of the burden of acute 
gastroenteritis in Australia in 2010 resulted in 774,003 cases of campylobacteriosis, leading to 102 
cases of GBS and 52 deaths (Gibney et al., 2014). As a major contributor to the level of 
campylobacteriosis, understanding and potentially controlling the poultry contamination pathway is 
a key focus for reducing the burden of disease. The poultry production chain can be divided into 
breeding, on-farm raising of meat chickens, slaughter and dressing, further production of retail 
products, retail, and the consumer. There is a disputed level of evidence for the vertical transmission 
from breeding flocks to the egg (Cox et al., 2012) and it is currently accepted that the meat chickens 
usually become Campylobacter positive on-farm (van Gerwe et al., 2009). Efforts to reduce the 
prevalence and/or the numbers of Campylobacter during farm production are important in the farm 
to fork continuum of food safety assurance and therefore to reducing campylobacteriosis in the 
Chapter 7 General discussion and future directions 
 
 
138 
 
population (FAO/WHO, 2009). While the level of Campylobacter on chickens entering the 
processing plant can impact on the outcomes of processing interventions on the numbers of 
Campylobacter, the on-farm impacts are not assessed within this thesis. The inability of this 
organism to grow under aerobic conditions and at temperatures < 30 °C ensure that the numbers of 
Campylobacter on slaughtered, dressed, whole chickens at the end of production is highly unlikely 
to increase before the product reaches the consumer. Therefore understanding the effects of the 
current poultry processing parameters on the numbers and prevalence of Campylobacter is 
important to analyse the effectiveness of current controls, and is assessed in Chapter 2.  
 
The review of Rosenquist et al. (2006) highlighted the processing stages that can lead to a reduction 
in Campylobacter numbers: scalding and chilling. Other stages of processing such as defeathering 
or evisceration can produce an increase in numbers, or at best produce no significant change in 
numbers of Campylobacter. This international data was used to design the study in chapter 2. 
Overall, the control of the processing technology at the time of slaughter produced decreases of 
between approximately 3 and 5 log10 CFU/mL, which is similar to other published studies. 
However, the decrease was not uniform. Further, more targeted, studies may enhance our 
understanding of the effect of specific processing factors on the resulting prevalence and 
concentration of Campylobacter. Within each broad processing intervention there are numerous 
factors that can affect the survival of Campylobacter and other organisms. Examination of the effect 
of the process (chapter 2) provides the overall impact but does not further our understanding of 
which factors such as pH, temperature or mechanical actions have the greatest influence. Isolating 
these factors and understanding their effect before examining the additive effect may therefore 
provide opportunity for greater impact. Currently, Australia has no regulation around the numbers 
or prevalence of Campylobacter on whole chickens at the point of distribution. In 2016, FSANZ 
provided guidelines through the process hygiene criteria (FSANZ, 2018) which could be applied to 
verify hygiene measures or ensure control of process, and are designed to be applied at specific 
points in the process. While the study completed in Chapter 2 is limited in size, it is likely that 
poultry processors would be able to meet the process hygiene criteria if these were converted to 
regulation at a future date. In the rapidly moving world of intensive food production, the time 
consuming process of Campylobacter detection and enumeration can be assisted by the use of E. 
coli as a surrogate in any process control plans for this key foodborne pathogen. This study 
confirmed the findings of Ghafir et al. (2008) with respect to correlation between the concentration 
of Campylobacter and E. coli. Importantly, this study highlights that when Campylobacter is 
present, processes currently operating in these abattoirs that decrease E. coli concentration will also 
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effect a similar decrease in Campylobacter concentration. Since the publication of Chapter 2 (Duffy 
et al., 2014), this correlation has been supported by studies in slaughterhouses in Germany and The 
Netherlands (Pacholewicz et al., 2015). This first publication of through-chain quantitative data in 
Australian poultry processing enables this data to be entered into future risk assessments to improve 
the data quality, underlying assumptions, and overall output from these exercises. 
 
Chapter 2 highlighted the processes which influence the prevalence and numbers of Campylobacter, 
although survival throughout processing may depend on the genetic diversity of this organism 
(Allen et al., 2007; Alter et al., 2005a; Habib et al., 2010; Newell et al., 2001; Park, 2002). The 
variable survival of some genotypes noted in chapter 3 may be due to the increased survival of 
dominating genotypes and/or the lower level of detection of minor genotypes. The complexity of 
Campylobacter survival through poultry processing is highlighted by the difference noted in the 
changing Simpson’s Index of Diversity (D) for each flock (Chapter 3). While each of these flocks 
were grown on different farms, and each processing facility had measured processing parameters 
that were the same within that facility, the level of diversity can be seen to be flock dependent. This 
variation within flocks impacts on future intervention studies and emphasises the need for an 
adequate diversity of samples to be taken.  
 
Comparison of human isolates collected over the same frame as the chicken samples provides 
further evidence for the relationship between human and chicken Campylobacter, but also 
highlights the diversity found in human isolates (Chapter 3). Studies have previously demonstrated 
the link between human and chicken Campylobacter through source attribution studies (Mullner et 
al., 2009; Stafford et al., 2008). While not designed as a definitive source attribution study, the 
collection of human clinical isolates over the same time frame allowed some comparisons to be 
drawn. The work in Chapter 3 reaffirms the paradigm that poultry is an important source of human 
campylobacteriosis, with the majority of isolates from both clinical (55 %) and chicken (63 %) 
samples belonging to the same top six genotypes. However, there is a greater variety of genotypes 
circulating in the human population and not all of these may have come from a poultry source. Thus 
confirming the findings of Fitch et al., (2005) where there was greater variation in flaA-short 
variable region in clinical compared to human isolates. A number of genotypes were found only in 
the human population (Chapter 3) which suggests that there are other possible sources which should 
not be dismissed from future efforts to identify and control transmission pathways.  
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“Does evading mitigation in processing make a pathogen more virulent?” (Acheson, 2014). While 
this headline refers to Salmonella, it can be considered important to all foodborne pathogens. With 
the lack of an animal model, the investigation of adhesion and invasion to host cells has become 
important in providing a measure of the potential pathogenicity of Campylobacter isolates. It is 
important to account for the genotypic diversity in the wild population of Campylobacter (Habib et 
al., 2010; Koolman et al., 2016) in studies looking at phenotypic and genotypic characterisation. To 
further explore these two key areas, a subset of 30 Campylobacter isolates were selected from the 
2,363 isolates collected in chapter 2. Phenotypic assays, AAG, motility, gene carriage, resistance to 
bile salts, adhesion and invasion of Caco-2 cells, and the use of sequence data to determine the 
MLST and the gene content of the LOS and CPS were used to describe the variation across the 
selected isolates/strains, assess any relationship between the assays, and determine if the groupings 
based on poultry processing survival and isolation from humans demonstrated any potential of 
poultry processing to select for potentially more pathogenic strains (Chapter 4). 
 
No pattern or relationship could be consistently noted for the grouping of isolates across any 
individual assay. Taken together these phenotypic and genetic analyses demonstrate that there is no 
evidence to support the hypothesis of poultry processing selecting for more pathogenic strains. 
Chapter 3 found greater than 34 genotypes across the 1,866 chicken and human sourced 
isolates/strains. Therefore, the decision, made for resource reasons, to incorporate only 32 
isolates/strains from 12 genotypes, or eight MLST CCs, into the studies undertaken in later chapters 
may limit the applicability of those results to the Campylobacter circulating in the Australian 
poultry flock. The importance of strain variation, however, cannot be underestimated. The gene 
network for survival and/or pathogenicity is not fully elucidated for Campylobacter and the 
presence of phase variable genes along with host factors such as acquired immunity further 
complicate this issue. The data collected in chapter 4 suggest that poultry processing does not select 
for more pathogenic strains as determined by host cell adhesion and invasion. This should not 
exclude the increase in risk for causing human disease by the fact that surviving processing 
enhances the potential opportunity for human exposure. The data in Chapter 4 and 5 demonstrate 
the diversity that can occur within genotypes and hence the necessity to incorporate sufficient 
diversity into the selection of isolates for any study that examines processes designed to reduce 
Campylobacter numbers or prevalence. 
 
The level of variation across isolate/strains, in assays that measure aspects of potential 
pathogenicity (Chapter 4), suggests that there may also be a level of variation in their ability to 
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survive the stress encountered in poultry processing. The groupings described in chapter 4 were 
based on the survival through processing and the frequency of isolation from humans. Knowledge 
on the survival of these varied but limited isolate/strain sets may be used to influence the operating 
parameters within poultry processing, thus ensuring maximum reduction of Campylobacter and 
hence a reduction in human exposure. The processing steps that have the most effect on 
Campylobacter numbers, scalding and chlorine based immersion chilling, were replicated in the 
laboratory. As these stages also demonstrated some effect on the diversity of genotypes for some 
flocks (chapter 3), and considering the basis for selection of the subset of isolates/strains, the 
question of survival based on genotype or based on the numbers of each genotype could also be 
examined. The use of GInaFit software, besides providing a convenient user interface, also provides 
a platform to readily model and compare inactivation curves from multiple isolate/strains and 
multiple treatments. Future comparisons can also be made if processing parameters were altered.  
 
At lower scalding temperatures, C. coli was found to be more heat resistant then C. jejuni (Chapter 
5), but not at 57.3 °C. While C. jejuni is more common in human cases of campylobacteriosis, there 
is still potential for human exposure if Campylobacter is inadequately controlled. Differences in the 
survival of CCs in chapter 5 supports the work in chapter 3 where specific genotypes were more 
frequently isolated than others. As the human isolates in this study are in effect a subset of those 
they are exposed to, and considering that the major source of human cases is from the poultry 
sector, it is not unexpected that there is no difference in survival of chicken and human 
isolates/strains. Overall the Campylobacter isolates/strains used in this study demonstrate no 
unusual heat resistance compared to other published data. There are two aspects of the thermal 
inactivation of theses isolates/strains that the poultry industry should be considerate of. The 
development of a heat resistant sub-population with a higher δ for some strains is of concern for 
future thermal processes. The changing shape of the thermal inactivation curve when 
Campylobacter are heated at higher scalding temperatures can provide evidence to operators of 
when, in the scalding cycle, the most kill is being achieved. Not only does this study highlight the 
variation in thermal inactivation and the presence of tailing for some strains at higher scald 
temperatures, but also fills the data gap where there are no previous studies that examine the 
thermal inactivation of Australian Campylobacter. The diversity of the thermal inactivation curves, 
particularly at the lower end of scalding temperatures, may be of concern as the most resistant 
strains may not be adequately reduced. At higher temperatures, tailing and resistant sub-populations 
should be of concern for the poultry industry. 
 
Chapter 7 General discussion and future directions 
 
 
142 
 
The chilling stage is a critical control point for the reduction of Campylobacter numbers, as 
demonstrated in Chapter 3 and in the reviews of other published data by Rosenquist et al. (2003) 
and Guerin et al (2010). Inadequate control at this final processing stage can lead to increased 
prevalence and /or numbers which may lead to increased incidence of disease. In Australia, poultry 
must be chilled to < 7 °C within 6 h of stunning and < 5 °C within 12 h of stunning (FSANZ, 2018). 
Compared to the limited overseas studies, it is likely Australian Campylobacter do not have an 
unusual level of resistance to chlorine. No genotypes or CCs demonstrated greater survival 
compared to others, and neither species survived better, indicating that the poultry process of 
immersion chilling with chlorine is unlikely to be selecting for specific Campylobacter. Altering the 
immersion time, however, may alter potential survival as the shape of the decline differed between 
some CCs. Ensuring the maximum removal of these organisms from the carcase in the immersion 
chiller water, with good control of chlorine and pH, and other processing parameters will ensure 
that cross contamination at this stage of processing is minimized.  
 
The lack of knowledge on how Campylobacter combats the effect of chlorine is apparent from the 
literature (Chapter 1) and from the work undertaken in chapter 5. Campylobacter, with a genome of 
only approximately 1.6 mB, has surprised researchers in its ability to survive the environmental 
stresses to which it is exposed. Reactive chlorine species (RCS) such as HOCl can kill bacteria 
although the process is not entirely understood (Gray et al., 2013). Exposure to NaOCl, with the pH 
modified by citric acid, elicits a global response from C. jejuni NCTC11168 with 787 of 1,570 
genes differentially expressed. The response to NaOCl incorporates a number of heat shock 
response genes. Organisms that have switched on their heat shock response pathway during the 
scald process may have improved ability to survive exposure to chlorine, although use of industry 
related timeframes and exposure levels are also important to consider. In comparison, known 
oxidative stress response genes are less responsive to chlorine stress. This is likely due to the 
response to the unfolding and aggregating of proteins that occurs during heating and upon exposure 
to reactive chlorine species.  
 
Overall, this study provides information and support to the Australian poultry industry through 
addressing the stated aims. Chapter 2 demonstrates that the survival of Campylobacter through 
Australian poultry processing (Aim 1) is not unusual compared to international data and that both 
scalding tanks and immersion chillers can be effective intervention points in reducing 
Campylobacter numbers. The diversity and survival of Campylobacter genotypes through 
processing (Aim 2) is addressed in Chapter 3. Survival through processing is genotype dependent. 
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The circulating genotypes have considerable overlap with human genotypes although other sources 
of human campylobacteriosis should not be dismissed. While the chosen subset of 32 
isolates/strains is limited, the finding of no relationship between potential pathogenicity and source 
as described in chapter 4, addresses aim 3. Exploring the survival of Campylobacter when subjected 
to stresses found in poultry processing (Aim 4) suggests that the higher levels of campylobacteriosis 
in Australia compared to the UK and US are not due to unusual survival characteristics, through the 
poultry processing stages of scalding and immersion chilling (Chapter 5). In addressing aim 4, it 
was noted that adjustments to processing parameters should be considered in the context of not just 
the overall reduction of Campylobacter but also the shape of that reduction to ensure an 
understanding of the risk when processes do not conform to the expected parameters (Chapter 5). In 
addressing aim 5 it was noted that exposure to NaOCl, with the pH modified by citric acid, elicits a 
global response incorporating a number of known heat shock response genes (Chapter 6). The fact 
that Campylobacter produce a response similar to the heat shock response after exposure to 
chlorine, may be an important component to the survival through processing, as the heat shock 
response may already have been initiated after exposure to scalding temperatures. Considering the 
initial selection of the 32 isolates/strains, used in this thesis, based on source, genotype and 
frequency of isolation, and incorporating phenomic (Chapter 4 and 5), genomic (Chapter 4) and 
transcriptomic (Chapter 6) work conducted in this thesis, it is suggested that Australian poultry 
processing parameter, are not selective for more potentially pathogenic Campylobacter.  
 
As noted where appropriate throughout this thesis, there are limitations on the scope of the overall 
study. The first aim to determine the effect of current poultry processing parameters as described in 
chapter 2 would benefit from a larger study that incorporates more flocks from more processing 
plants that may utilise different operating parameters. Repeated sampling from each processing 
plant would also improve the robustness of the study. A well designed source attribution study was 
outside the scope of this study but a greater knowledge in this area may lend further weight to the 
possibility that poultry, while clearly an important source, is not the only source.  
 
Chapters 2 and 3 examined the survival of Campylobacter in general, and for limited number of 
specific genotypes through poultry processing. However the behaviour of other organisms was not 
examined. The application of robust metagenomics tools throughout the poultry processing line 
would enable a deeper understanding not just of Campylobacter but the overall microbial 
population that may alter in number and diversity in response to poultry processing stresses. 
Complex interactions between Campylobacter and the other carcase flora may influence 
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Campylobacter ecology at the end point of processing. Continued development and accessibility of 
whole genome sequencing and metagenomics analysis techniques should soon make such 
approaches more tenable. 
 
Numerous assays were used to assess the potential pathogenicity of the isolates/strains used in this 
study (Chapter 4). Overall there was no strong evidence to suggest that surviving poultry processing 
selects for more pathogenic Campylobacter. This is complicated by the fact that definitive 
pathogenicity genes of Campylobacter are largely undefined. Subjecting isolates/strains to well 
defined stresses within the laboratory before assessing potential pathogenicity may further elucidate 
the effects of poultry processing on Campylobacter. Incorporation of methodological processes that 
account for survival and virulence changes associated with multiple hurdles, as encountered in 
poultry processing, will also improve the applicability of the results to the poultry processing 
industry. Undertaking laboratory scale experiments in defined media provides an understanding that 
is not confounded by the complex biological interactions that occur in the production environment. 
Yang et al. (2001) demonstrated an increase in Campylobacter survival when attached to chicken 
skin, before exposure to scalding or chlorine. The results of the studies undertaken will have a 
greater application to the poultry industry if the survival and response to heat and chlorine are 
conducted on Campylobacter that are attached to chicken skin as noted in chapter 5.  
 
The response to immersion chilling was found to include a number of heat shock response genes 
being upregulated, and this may have implications for the survival of Campylobacter in immersion 
chillers operated with NaOCl and acidified with citric acid. It would therefore be important in future 
studies to determine if exposure to heat followed by chlorine, as occurs in poultry processing, has a 
protective impact on Campylobacter. As noted throughout this study, variation between strains is 
common in Campylobacter and to improve our understanding of the mechanisms of survival, a 
greater number of isolates/strains should be investigated with these transcriptomic tools, including 
confirmation through the use of quantitative RT-PCR.  
 
The high rates of Campylobacter prevalence on Australian chickens at the end of processing 
(Chapter 2) and the focus on reducing both Campylobacter and Salmonella in the recently released 
Foodborne Illness Reduction Strategy 2018-2021 (FRSC, 2018), support the need to reduce 
Campylobacter numbers on processed poultry. Other antimicrobial chemicals are allowed under 
Australian legislation as processing aids to legislated levels. It may prove useful for the Australian 
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poultry industry to have information on the effects of other agents on Campylobacter and the 
overall microbial population through poultry processing. 
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Figure A-2: AAG activity of all isolates at 6 h (black) and 24 h (grey hash). Error bars represent the 
standard deviation. 
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Table A-1: Motility measurements (diameter mm ± standard deviation), for all isolates at each 
temperature/time combination. A diameter of ≤6 mm is considered non-motile. 
Sample Groupb 37 °C/24 h 37 °C/48 h 42 °C/24 h 42°C/48 h 
117 NH – NP 11.00±5.20a 22.67±3.22ab 6.67±0.58c 17.00±2.65ab 
436 H – P 10.00±1.00b 15.33±1.53a 8.00±1.73b 11.00±0.00b 
448 H – P 9.67±0.58c 25.00±2.65b 11.33±1.16c 46.00±3.61a 
462 NH – P 11.67±2.52c 18.67±0.58b 6.33±1.16d 45.33±1.16a 
470 H – P 5.33±1.53c 13.00±1.00b 7.33±0.58c 18.67±1.53a 
697 H - NP 6.33±2.08b 26.33±7.37a 7.33±1.53b 36.00±1.00a 
722 NH - P 18.33±1.53d 50.67±3.06b 25.33±1.16c 64.00±2.00a 
741 NH - P 7.00±0.00c 19.00±6.08b 13.33±0.58bc 53.67±2.08a 
743 H – P 5.00±1.73c 5.67±1.12c 15.00±2.65b 55.00±5.30a 
744 H - P 15.67±0.58d 39.67±2.08b 20.00±0.00c 55.33±0.58a 
1180 H - P 5.67±0.58c 12.67±1.16b 11.67±0.58b 45.00±2.00a 
1377 NH - P 12.67±1.53b 25.00±9.54b 9.33±1.16b 43.33±8.51a 
1431 H – P 6.67±1.53b 27.00±9.54a 7.67±1.16b 40.67±4.04a 
1765 H - NP 13.33±0.58c 42.67±2.31b 16.33±1.16c 50.67±0.58a 
1786 H - P 10.33±0.58c 26.67±2.52b 9.67±0.58c 39.00±0.00a 
1790 NH - P 14.00±1.73d 44.67±1.53b 20.67±0.58c 63.33±0.58a 
1898 H - P 7.00±2.65c 11.33±0.58ab 7.67±0.58bc 13.33±1.53a 
1973 NH - NP 15.00±3.61c 43.00±5.30b 17.67±0.58c 57.68±2.08a 
1998 NH - NP 15.67±1.16c 47.00±2.00b 9.67±0.58d 60.66±3.79a 
2043 H - P 5.33±0.58d 14.00±0.00b 9.67±0.58c 23.33±1.16a 
2046 H - NP 10.00±2.65b 10.33±2.08b 10.67±1.53b 39.33±3.79a 
2189 H - P 18.67±0.58d 43.67±0.58b 26.33±2.31c 69.67±3.79a 
2323 H - P 7.00±2.65a 19.33±11.02a 10.00±5.20a 39.00±27.87a 
2350 H - NP 14.67±0.58d 45.33±2.31b 22.00±2.00c 69.00±0.00a 
2554 H - NP 8.00±3.29d 11.00±0.00b 8.33±0.58c 15.67±0.58a 
2670 H - P 8.67±2.31c 17.67±3.22b 10.67±2.31c 35.00±1.73a 
2672 H - P 10.00±0.00c 14.33±1.16b 13.00±0.00bc 33.67±2.08a 
2674 H - P 5.00+0.00a 5.00+0.00a 5.00+0.00a 5.00+0.00a 
2689 H - P 4.67±0.58c 20.00±0.00b 7.33±0.58c 30.00±2.65a 
2704 H - NP 17.00±1.73bc 19.67±0.58b 9.33±2.08c 41.33±6.35a 
NCTC11168 - 5.33±0.58d 28.33±0.58b 11.33±1.15c 37.00±1.00a 
RM2228 - 8.00±1.73b 23.33±0.58a 9.67±0.58b 24.67±1.12a 
aValues that have the same superscript letter following are not significantly different in rows  
Isolate groups using flaA-RFLP genotypes were generated as follows; H-P, found in humans and 
survive poultry processing; H-NP, found in humans but not found at end of poultry processing 
(found in caecal or before scald samples only); NH-NP, not commonly found in humans (less than 
five isolates) and not found at end of poultry processing; and NH-P, not commonly found in 
humans and survive poultry processing. 
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Table A-2: Primer sequences used for detection of 18 virulence associated genes. 
Primer Sequence 5’ – 3’ Reference 
cbrR-F TAA TAC GAC TCA CTA TAG GGT CAA CTC TAT CCT TGC CAT TAT CTT (Biswas et al., 2011) 
cbrR-R GTA GAT ATT GCT TTT GGT TTT GCT G  
sodB-F ATG ATA CCA ATG CTT TTG GTG ATT T (Hanning et al., 2010) 
sodB-R TAA TAC GAC TCA CTA TAG GGC ATT TGC ATA AAA GCT AAC TGA TCC  
htrA-F AAA ACC ATT GCG ATA TAC CCA AAC T (Biswas et al., 2011) 
htrA-R TAA TAC GAC TCA CTA TAG GGT AAG TTT AGC AAG TGC TTT ATT TGC  
flaC-F TAA TAC GAC TCA CTA TAG GGA TGA TGA TCT CTG ATG CAA CTA TGA (Biswas et al., 2011) 
flaC-R AAA GCA GCA GCA TTT TCT TTT AGA T  
clpA-F AAA TCA CCA TGA ATT TGT TAC CTG T (Hanning et al., 2010) 
clpA-R TAA TAC GAC TCA CTA TAG GGC CAA GTT TGA TTT TAG CTA TAC CAC  
cadF-F TTG AAG GTA ATT TAG ATA TG (Konkel et al., 1999a) 
cadF-R CTA ATA CCT AAA GTT GAA AC  
racR-F GAT GAT CCT GAC TTT G (Datta et al., 2003) 
racR-R TCT CCT ATT TTT ACC C  
flaA-F AAT AAA AAT GCT GAT AAA ACA GGT G (Datta et al., 2003) 
flaA-R TAC CGA ACC AAT GTC TGC TCT GAT T  
ciaB-F TTT CCA AAT TTA GAT GAT GC (Datta et al., 2003) 
ciaB-R GTT CTT TAA ATT TTT CAT AAT GC  
ceuA-F CCT GCT ACG GTG AAA GTT TTG C (Gonzalez et al., 2009) 
ceuA-R GAT CTT TTT GTT TTG TGC TGC  
cdtA-GNW GGA AAT TGG ATT TGG GGC TAT ACT (Bang et al., 2003) 
cdtA-IVH ATC ACA AGG ATA ATG GAC AAT  
cdtB-VAT2 GTT AAA ATC CCT GCT ATC AAC CA (Bang et al., 2003) 
cdtB-WMIR GTT GGC ACT TGG AAT TTG CAA GGC  
cdtC-WMIF TGG ATG ATA GCA GGG GAT TTT AAC (Bang et al., 2003) 
cdtC-LPFX TTG CAC ATA ACC AAA AGG AAG  
Cdt cluster cdtA-GNW and cdtC-LPFX (Bang et al., 2003) 
wlaN-F TTA AGA GCA AGA TAT GAA GGT G (Linton et al., 2000) 
wlaN-R CCA TTT GAA TTG ATA TTT TTG  
pldA-F AAG CTT ATG CGT TTT T (Datta et al., 2003) 
pldA-R TAT AAG GCT TTC TCC A  
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Primer Sequence 5’ – 3’ Reference 
virB11-F TCT TGT GAG TTG CCT TAC CCC TTT T (Datta et al., 2003) 
virB11-R CCT GCG TGT CCT GTG TTA TTT ACC C  
dnaJ-F AAG GCT TTG GCT CAT C (Datta et al., 2003) 
dnaJ-R CTT TTT GTT CAT CGT T  
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Figure A-3: Cell association of all isolates. Error bars represent the standard deviation. C. coli – 
grey columns, C. jejuni - hashed columns.  
 
 
Figure A-4: Invasion efficiency (adherence; IEa) percentage for all isolates. Error bars represent the 
standard deviation. C. coli – grey columns, C. jejuni - hashed columns.  
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Table A-3: Annotation data for lipooligosaccharide locus 
 
Ortholog Prokka ID Product Length 
C. jejuni 117 - Chicken - NH-NP 
   
waaC CDS Prokka:CAMJ117_01128 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ117_01129 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ117_01130 glucosyltransferase 1,551 
wlaN 1 CDS Prokka:CAMJ117_01131 beta-1,3 galactosyltransferase 888 
glycosyltransferase CDS Prokka:CAMJ117_01132 glycosyltransferase 981 
wlaN 2 CDS Prokka:CAMJ117_01133 beta-1,3 galactosyltransferase 630 
wlaN 3 CDS Prokka:CAMJ117_01134 beta-1,3 galactosyltransferase 150 
suagr transferase 
  
1,053 
sugar transferase CDS Prokka:CAMJ117_01135 sugar transferase 1,047 
glf CDS Prokka:CAMJ117_01136 UDP-galactopyranose mutase 1,261 
gne 2 CDS Prokka:CAMJ117_01137 UDP-GlcNAc/Glc 4-epimerase 975 
kfiD CDS Prokka:CAMJ117_01138 UDP-glucose 6-dehydrogenase 1,299 
nucleotide sugar dehydratase CDS Prokka:CAMJ117_01139 nucleotide sugar dehydratase 957 
waaV CDS Prokka:CAMJ117_01140 glucosyltransferase 822 
waaF CDS Prokka:CAMJ117_01141 heptosyltransferase II 951 
    
C. jejuni 448 - Chicken - H-P 
   
waaC CDS Prokka:CAMJ448_01190 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ448_01191 lipid A biosynthesis lauroyl acyltransferase 907 
glucosyltransferase CDS Prokka:CAMJ448_01192 glucosyltransferase 1,551 
wlaN 1 CDS Prokka:CAMJ448_01193 beta-1,3 galactosyltransferase 888 
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Ortholog Prokka ID Product Length 
glycosyltransferase CDS Prokka:CAMJ448_01194 glycosyltransferase 982 
wlaN 2 CDS Prokka:CAMJ448_01195 beta-1,3 galactosyltransferase 630 
wlaN 3 CDS Prokka:CAMJ448_01196 beta-1,3 galactosyltransferase 150 
Unknown 
  
138 
sugar transferase CDS Prokka:CAMJ448_01206 sugar transferase 1,053 
sugar transferase CDS Prokka:CAMJ448_01207 sugar transferase 1,050 
glf CDS Prokka:CAMJ448_01208 UDP-galactopyranose mutase 1,258 
gne 2 CDS Prokka:CAMJ448_01209 UDP-GlcNAc/Glc 4-epimerase 975 
kfiD CDS Prokka:CAMJ448_01210 UDP-glucose 6-dehydrogenase 1,299 
nucleotide sugar dehydratase CDS Prokka:CAMJ448_01211 nucleotide sugar dehydratase 957 
waaV CDS Prokka:CAMJ448_01212 glucosyltransferase 822 
waaF CDS Prokka:CAMJ448_01213 heptosyltransferase II 951 
    
C. jejuni 697 - Human - H-NP 
   
waaC CDS Prokka:CAMJ697_01158 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ697_01159 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ697_01160 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ697_01161 glycosyltransferase 1,194 
neuA1 1 CDS Prokka:CAMJ697_01162 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,059 
wlaN CDS Prokka:CAMJ697_01163 beta-1,3 galactosyltransferase 894 
cstIII CDS Prokka:CAMJ697_01164 alpha-2,3 sialyltransferase 714 
neuB1 CDS Prokka:CAMJ697_01165 sialic acid synthase 1,041 
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Ortholog Prokka ID Product Length 
neuC1 CDS Prokka:CAMJ697_01166 UDP-N-acetylglucosamine 2-epimerase 1,125 
neuA1 2 CDS Prokka:CAMJ697_01167 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
618 
neuA1 3 CDS Prokka:CAMJ697_01168 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
333 
neuA1 4 CDS Prokka:CAMJ697_01169 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
hypothetical protein CDS Prokka:CAMJ697_01170 hypothetical protein 174 
cat CDS Prokka:CAMJ697_01171 Chloramphenicol acetyltransferase 531 
waaV CDS Prokka:CAMJ697_01172 glucosyltransferase 813 
waaF CDS Prokka:CAMJ697_01173 heptosyltransferase II 960 
    
C. jejuni 741 - Human - NH-P 
   
waaC CDS Prokka:CAMJ741_01129 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ741_01130 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ741_01131 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ741_01132 glycosyltransferase 1,173 
Beta-1,4-N-acetylgalactosaminyltransferase (CgtA) 
CDS 
Prokka:CAMJ741_01133 Beta-1,4-N-acetylgalactosaminyltransferase (CgtA) 261 
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Ortholog Prokka ID Product Length 
neuA1 1 CDS Prokka:CAMJ741_01134 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
801 
wlaN CDS Prokka:CAMJ741_01135 beta-1,3 galactosyltransferase 894 
cstIII CDS Prokka:CAMJ741_01136 alpha-2,3 sialyltransferase 876 
neuB1 CDS Prokka:CAMJ741_01137 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ741_01138 UDP-N-acetylglucosamine 2-epimerase 1,125 
neuA1 2 CDS Prokka:CAMJ741_01139 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
948 
neuA1 3 CDS Prokka:CAMJ741_01140 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
vatD CDS Prokka:CAMJ741_01142 Streptogramin A acetyltransferase 831 
waaV CDS Prokka:CAMJ741_01143 glucosyltransferase 813 
waaF CDS Prokka:CAMJ741_01144 heptosyltransferase II 960 
    
C. jejuni 743 -Human - H-P 
   
waaC CDS Prokka:CAMJ743_01112 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ743_01113 lipid A biosynthesis lauroyl acyltransferase 907 
glucosyltransferase CDS Prokka:CAMJ743_01114 glucosyltransferase 1,551 
wlaN 
  
888 
hypothetical protein CDS Prokka:CAMJ743_01116 hypothetical protein 648 
hypothetical protein CDS Prokka:CAMJ743_01117 hypothetical protein 309 
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Ortholog Prokka ID Product Length 
waaV CDS Prokka:CAMJ743_01118 glucosyltransferase 810 
waaF CDS Prokka:CAMJ743_01119 heptosyltransferase II 1,029 
    
C. jejuni 744 - Human - H-P 
   
waaC CDS Prokka:CAMJ744_01087 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ744_01088 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ744_01089 glucosyltransferase 1,551 
wlaN 1 CDS Prokka:CAMJ744_01090 beta-1,3 galactosyltransferase 888 
glycosyltransferase CDS Prokka:CAMJ744_01091 glycosyltransferase 1,209 
wlaN 2 CDS Prokka:CAMJ744_01092 beta-1,3 galactosyltransferase 972 
hypothetical protein CDS Prokka:CAMJ744_01093 hypothetical protein 888 
waaV CDS Prokka:CAMJ744_01094 glucosyltransferase 810 
waaF CDS Prokka:CAMJ744_01095 heptosyltransferase II 951 
    
C. jejuni 1180 - Chicken - H-P 
   
waaC CDS Prokka:CAMJ1180_01085 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ1180_01086 lipid A biosynthesis lauroyl acyltransferase 903 
glucosyltransferase CDS Prokka:CAMJ1180_01087 glucosyltransferase 1,551 
wlaN 1 CDS Prokka:CAMJ1180_01088 beta-1,3 galactosyltransferase 630 
wlaN 2 CDS Prokka:CAMJ1180_01089 beta-1,3 galactosyltransferase 276 
glycosyltransferase CDS Prokka:CAMJ1180_01090 glycosyltransferase 981 
hypothetical protein CDS Prokka:CAMJ1180_01091 hypothetical protein 412 
hypothetical protein CDS Prokka:CAMJ1180_01092 hypothetical protein 888 
waaV CDS Prokka:CAMJ1180_01093 glucosyltransferase 810 
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Ortholog Prokka ID Product Length 
waaF CDS Prokka:CAMJ1180_01094 heptosyltransferase II 1,029 
    
C. jejuni 1377 - Human - NH-P 
   
waaC CDS Prokka:CAMJ1377_01148 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ1377_01149 lipid A biosynthesis lauroyl acyltransferase 879 
glucosyltransferase CDS Prokka:CAMJ1377_01150 glucosyltransferase 702 
hddC 1 CDS Prokka:CAMJ1377_01151 D-glycero-D-manno-heptose 1-phosphate 
guanosyltransferase 
879 
nucleotide sugar dehydratase CDS Prokka:CAMJ1377_01152 nucleotide sugar dehydratase 1,032 
fdtA 1 CDS Prokka:CAMJ1377_01153 TDP-4-oxo-6-deoxy-alpha-D-glucose-3, 4-
oxoisomerase 
450 
fdtA 2 CDS Prokka:CAMJ1377_01154 TDP-4-oxo-6-deoxy-alpha-D-glucose-3, 4-
oxoisomerase 
405 
cysE 2 CDS Prokka:CAMJ1377_01155 serine acetyltransferase 444 
hypothetical protein CDS Prokka:CAMJ1377_01156 hypothetical protein 528 
CDS Prokka:CAMJ1377_01157 glucosyltransferase 1,065 
sugar transferase CDS Prokka:CAMJ1377_01158 sugar transferase 1,053 
DegT family aminotransferase CDS Prokka:CAMJ1377_01159 DegT family aminotransferase 1,083 
sugar transferase CDS Prokka:CAMJ1377_01160 sugar transferase 1,260 
hypothetical protein CDS Prokka:CAMJ1377_01161 hypothetical protein 300 
neuA1 1 CDS Prokka:CAMJ1377_01162 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
336 
Appendix A 
 
 
 
209 
 
Ortholog Prokka ID Product Length 
Beta-1,4-N-acetylgalactosaminyltransferase (CgtA) 
CDS 
Prokka:CAMJ1377_01163 Beta-1,4-N-acetylgalactosaminyltransferase (CgtA) 216 
Glycosyltransferase family 25 (LPS biosynthesis 
protein) CDS 
Prokka:CAMJ1377_01164 Glycosyltransferase family 25 (LPS biosynthesis 
protein) 
774 
glycosyltransferase CDS Prokka:CAMJ1377_01165 glycosyltransferase 957 
hypothetical protein CDS Prokka:CAMJ1377_01166 hypothetical protein 960 
waaV CDS Prokka:CAMJ1377_01167 glucosyltransferase 819 
waaF CDS Prokka:CAMJ1377_01168 heptosyltransferase II 960 
    
C. jejuni 1431 - Human - H-P 
   
waaC CDS Prokka:CAMJ1431_01122 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ1431_01123 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ1431_01124 glucosyltransferase 1,551 
wlaN 1 CDS Prokka:CAMJ1431_01125 beta-1,3 galactosyltransferase 888 
glycosyltransferase CDS Prokka:CAMJ1431_01126 glycosyltransferase 1,209 
wlaN 2 CDS Prokka:CAMJ1431_01127 beta-1,3 galactosyltransferase 630 
wlaN 3 CDS Prokka:CAMJ1431_01128 beta-1,3 galactosyltransferase 150 
sugar transferase CDS Prokka:CAMJ1431_01129 sugar transferase 1,044 
glf CDS Prokka:CAMJ1431_01130 UDP-galactopyranose mutase 1,110 
gne 2 CDS Prokka:CAMJ1431_01131 UDP-GlcNAc/Glc 4-epimerase 975 
kfiD CDS Prokka:CAMJ1431_01132 UDP-glucose 6-dehydrogenase 1,299 
nucleotide sugar dehydratase CDS Prokka:CAMJ1431_01133 nucleotide sugar dehydratase 957 
waaV CDS Prokka:CAMJ1431_01134 glucosyltransferase 822 
waaF CDS Prokka:CAMJ1431_01135 heptosyltransferase II 951 
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Ortholog Prokka ID Product Length 
    
C. jejuni 1898 - Chicken - H-P 
   
waaC CDS Prokka:CAMJ1898_01352 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ1898_01353 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ1898_01354 glucosyltransferase 1,551 
wlaN 2 CDS Prokka:CAMJ1898_01355 beta-1,3 galactosyltransferase 888 
glycosyltransferase CDS Prokka:CAMJ1898_01356 glycosyltransferase 981 
hypothetical protein CDS Prokka:CAMJ1898_01357 hypothetical protein 750 
hypothetical protein CDS Prokka:CAMJ1898_01358 hypothetical protein 837 
hypothetical protein CDS Prokka:CAMJ1898_01359 hypothetical protein 321 
waaV CDS Prokka:CAMJ1898_01360 glucosyltransferase 810 
waaF CDS Prokka:CAMJ1898_01361 heptosyltransferase II 1,029 
    
C. jejuni 2043 - Human - H-P 
   
waaC CDS Prokka:CAMJ2043_01080 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2043_01081 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ2043_01082 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2043_01083 glycosyltransferase 1,173 
glycosyltransferase CDS Prokka:CAMJ2043_01084 glycosyltransferase 723 
glycosyltransferase CDS Prokka:CAMJ2043_01085 glycosyltransferase 1,302 
wlaN 1 CDS Prokka:CAMJ2043_01086 beta-1,3 galactosyltransferase 453 
wlaN 2 CDS Prokka:CAMJ2043_01087 beta-1,3 galactosyltransferase 342 
cstIII CDS Prokka:CAMJ2043_01088 alpha-2,3 sialyltransferase 885 
neuB1 CDS Prokka:CAMJ2043_01089 sialic acid synthase 1,032 
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Ortholog Prokka ID Product Length 
neuC1 CDS Prokka:CAMJ2043_01090 UDP-N-acetylglucosamine 2-epimerase 1,116 
neuA1 CDS Prokka:CAMJ2043_01091 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,611 
hypothetical protein CDS Prokka:CAMJ2043_01092 hypothetical protein 474 
waaV CDS Prokka:CAMJ2043_01093 glucosyltransferase 825 
waaF CDS Prokka:CAMJ2043_01094 heptosyltransferase II 960 
    
C. jejuni 2046 - Human - H-P 
   
waaC CDS Prokka:CAMJ2046_01119 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2046_01120 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ2046_01121 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2046_01122 glycosyltransferase 1,217 
neuA1 1 CDS Prokka:CAMJ2046_01123 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,038 
wlaN CDS Prokka:CAMJ2046_01124 beta-1,3 galactosyltransferase 894 
cstIII CDS Prokka:CAMJ2046_01125 alpha-2,3 sialyltransferase 789 
neuB1 CDS Prokka:CAMJ2046_01126 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ2046_01127 UDP-N-acetylglucosamine 2-epimerase 1,065 
neuA1 2 CDS Prokka:CAMJ2046_01128 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
618 
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neuA1 3 CDS Prokka:CAMJ2046_01129 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
333 
neuA1 4 CDS Prokka:CAMJ2046_01130 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
vatD CDS Prokka:CAMJ2046_01131 Streptogramin A acetyltransferase 831 
waaV CDS Prokka:CAMJ2046_01132 glucosyltransferase 813 
waaF CDS Prokka:CAMJ2046_01133 heptosyltransferase II 1,038 
    
C. jejuni 2189 - Human - H-P 
   
waaC CDS Prokka:CAMJ2189_01174 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2189_01175 lipid A biosynthesis lauroyl acyltransferase 879 
glucosyltransferase CDS Prokka:CAMJ2189_01176 glucosyltransferase 702 
hddC 1 CDS Prokka:CAMJ2189_01177 D-glycero-D-manno-heptose 1-phosphate 
guanosyltransferase 
922 
nucleotide sugar dehydratase CDS Prokka:CAMJ2189_01178 nucleotide sugar dehydratase 1,032 
fdtA 1 CDS Prokka:CAMJ2189_01179 TDP-4-oxo-6-deoxy-alpha-D-glucose-3, 4-
oxoisomerase 
426 
fdtA 2 CDS Prokka:CAMJ2189_01180 TDP-4-oxo-6-deoxy-alpha-D-glucose-3, 4-
oxoisomerase 
405 
cysE 2 CDS Prokka:CAMJ2189_01181 serine acetyltransferase 444 
hypothetical protein CDS Prokka:CAMJ2189_01182 hypothetical protein 528 
CDS Prokka:CAMJ2189_01183 glucosyltransferase 1,065 
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sugar transferase CDS Prokka:CAMJ2189_01184 sugar transferase 1,052 
hypothetical protein CDS Prokka:CAMJ2189_01185 hypothetical protein 960 
waaV CDS Prokka:CAMJ2189_01186 glucosyltransferase 819 
waaF CDS Prokka:CAMJ2189_01187 heptosyltransferase II 1,037 
    
C. jejuni 2323 - Human - H-P 
   
waaC CDS Prokka:CAMJ2323_00758 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2323_00759 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ2323_00760 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2323_00761 glycosyltransferase 1,194 
neuA1 1 CDS Prokka:CAMJ2323_00762 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,059 
wlaN CDS Prokka:CAMJ2323_00763 beta-1,3 galactosyltransferase 894 
cstIII CDS Prokka:CAMJ2323_00764 alpha-2,3 sialyltransferase 876 
neuB1 CDS Prokka:CAMJ2323_00765 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ2323_00766 UDP-N-acetylglucosamine 2-epimerase 1,071 
neuA1 2 CDS Prokka:CAMJ2323_00767 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
948 
neuA1 3 CDS Prokka:CAMJ2323_00768 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
hypothetical protein CDS Prokka:CAMJ2323_00769 hypothetical protein 195 
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vatD CDS Prokka:CAMJ2323_00770 Streptogramin A acetyltransferase 675 
waaV CDS Prokka:CAMJ2323_00771 glucosyltransferase 813 
waaF CDS Prokka:CAMJ2323_00772 heptosyltransferase II 1,040 
    
C. jejuni 2554 - Chicken - H-NP 
   
waaC CDS Prokka:CAMJ2554_01136 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2554_01137 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ2554_01138 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2554_01139 glycosyltransferase 1,194 
neuA1 1 CDS Prokka:CAMJ2554_01140 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,059 
wlaN CDS Prokka:CAMJ2554_01141 beta-1,3 galactosyltransferase 894 
cstIII CDS Prokka:CAMJ2554_01142 alpha-2,3 sialyltransferase 792 
neuB1 CDS Prokka:CAMJ2554_01143 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ2554_01144 UDP-N-acetylglucosamine 2-epimerase 1,068 
neuA1 2 CDS Prokka:CAMJ2554_01145 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
618 
neuA1 3 CDS Prokka:CAMJ2554_01146 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
333 
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neuA1 4 CDS Prokka:CAMJ2554_01147 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
hypothetical protein CDS Prokka:CAMJ2554_01148 hypothetical protein 192 
vatD CDS Prokka:CAMJ2554_01149 Streptogramin A acetyltransferase 530 
waaV CDS Prokka:CAMJ2554_01150 glucosyltransferase 813 
waaF CDS Prokka:CAMJ2554_01151 heptosyltransferase II 1,035 
    
C. jejuni 2670 - Chicken - H-P 
   
waaC CDS Prokka:CAMJ2670_01120 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2670_01121 lipid A biosynthesis lauroyl acyltransferase 906 
glucosyltransferase CDS Prokka:CAMJ2670_01122 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2670_01123 glycosyltransferase 1,194 
neuA1 1 CDS Prokka:CAMJ2670_01124 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,055 
wlaN CDS Prokka:CAMJ2670_01125 beta-1,3 galactosyltransferase 892 
cstIII CDS Prokka:CAMJ2670_01126 alpha-2,3 sialyltransferase 879 
neuB1 CDS Prokka:CAMJ2670_01127 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ2670_01128 UDP-N-acetylglucosamine 2-epimerase 1,065 
neuA1 2 CDS Prokka:CAMJ2670_01129 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
618 
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neuA1 3 CDS Prokka:CAMJ2670_01130 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
333 
neuA1 4 CDS Prokka:CAMJ2670_01131 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
hypothetical protein CDS Prokka:CAMJ2670_01132 hypothetical protein 174 
cat CDS Prokka:CAMJ2670_01133 Chloramphenicol acetyltransferase 531 
waaV CDS Prokka:CAMJ2670_01134 glucosyltransferase 813 
waaF CDS Prokka:CAMJ2670_01135 heptosyltransferase II 1,038 
    
C. jejuni 2672 - Chicken - H-P 
   
waaC CDS Prokka:CAMJ2672_01179 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2672_01180 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ2672_01181 glucosyltransferase 1,551 
wlaN CDS Prokka:CAMJ2672_01182 beta-1,3 galactosyltransferase 888 
gspA 1 CDS Prokka:CAMJ2672_01183 General stress protein A 1,146 
waaV CDS Prokka:CAMJ2672_01184 glucosyltransferase 822 
waaF CDS Prokka:CAMJ2672_01185 heptosyltransferase II 1,029 
    
C. jejuni 2674 - Chicken - H-P 
   
waaC CDS Prokka:CAMJ2674_01111 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2674_01112 lipid A biosynthesis lauroyl acyltransferase 906 
glucosyltransferase CDS Prokka:CAMJ2674_01113 glucosyltransferase 1,548 
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glycosyltransferase CDS Prokka:CAMJ2674_01114 glycosyltransferase 1,194 
Unknown 
  
1,068 
wlaN CDS Prokka:CAMJ2674_01115 beta-1,3 galactosyltransferase 894 
cstIII CDS Prokka:CAMJ2674_01116 alpha-2,3 sialyltransferase 879 
neuB1 CDS Prokka:CAMJ2674_01117 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ2674_01118 UDP-N-acetylglucosamine 2-epimerase 1,065 
neuA1 1 CDS Prokka:CAMJ2674_01119 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
546 
unknown 
  
333 
neuA1 2 CDS Prokka:CAMJ2674_01120 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
vatD CDS Prokka:CAMJ2674_01121 Streptogramin A acetyltransferase 750 
waaV CDS Prokka:CAMJ2674_01122 glucosyltransferase 813 
waaF CDS Prokka:CAMJ2674_01123 heptosyltransferase II 1,038 
    
C. jejuni 2689 - Chicken - H-P 
   
waaC CDS Prokka:CAMJ2689_01116 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2689_01117 lipid A biosynthesis lauroyl acyltransferase 906 
glucosyltransferase CDS Prokka:CAMJ2689_01118 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2689_01119 glycosyltransferase 1,185 
neuA1 1 
  
1,044 
unknown 
  
906 
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cstIII CDS Prokka:CAMJ2689_01122 alpha-2,3 sialyltransferase 915 
neuB1 CDS Prokka:CAMJ2689_01123 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ2689_01124 UDP-N-acetylglucosamine 2-epimerase 1,059 
neuA1 2 CDS Prokka:CAMJ2689_01125 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
vatD CDS Prokka:CAMJ2689_01126 Streptogramin A acetyltransferase 747 
waaV CDS Prokka:CAMJ2689_01127 glucosyltransferase 813 
waaF CDS Prokka:CAMJ2689_01128 heptosyltransferase II 1,038 
    
C. jejuni 2704 - Chicken - H-NP 
   
waaC CDS Prokka:CAMJ2704_01204 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2704_01205 lipid A biosynthesis lauroyl acyltransferase 888 
glucosyltransferase CDS Prokka:CAMJ2704_01206 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2704_01207 glycosyltransferase 1,194 
neuA1 1 CDS Prokka:CAMJ2704_01208 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,059 
wlaN CDS Prokka:CAMJ2704_01209 beta-1,3 galactosyltransferase 894 
cstIII CDS Prokka:CAMJ2704_01210 alpha-2,3 sialyltransferase 735 
neuB1 CDS Prokka:CAMJ2704_01211 sialic acid synthase 1,041 
neuC1 CDS Prokka:CAMJ2704_01212 UDP-N-acetylglucosamine 2-epimerase 1,125 
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neuA1 2 CDS Prokka:CAMJ2704_01213 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
618 
neuA1 3 CDS Prokka:CAMJ2704_01214 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
333 
neuA1 4 CDS Prokka:CAMJ2704_01215 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
666 
hypothetical protein CDS Prokka:CAMJ2704_01216 hypothetical protein 174 
cat CDS Prokka:CAMJ2704_01217 Chloramphenicol acetyltransferase 531 
waaV CDS Prokka:CAMJ2704_01218 glucosyltransferase 813 
waaF CDS Prokka:CAMJ2704_01219 heptosyltransferase II 1,038 
    
C. jejuni NCTC11168 - Human 
   
waaC CDS Prokka:CAMJ2898_01143 heptosyltransferase I 1,029 
htrB CDS Prokka:CAMJ2898_01144 lipid A biosynthesis lauroyl acyltransferase 906 
glucosyltransferase CDS Prokka:CAMJ2898_01145 glucosyltransferase 1,548 
glycosyltransferase CDS Prokka:CAMJ2898_01146 glycosyltransferase 1,173 
glycosyltransferase CDS Prokka:CAMJ2898_01147 glycosyltransferase 996 
glycosyltransferase CDS Prokka:CAMJ2898_01149 glycosyltransferase 1,170 
wlaN CDS Prokka:CAMJ2898_01150 beta-1,3 galactosyltransferase 912 
cstIII CDS Prokka:CAMJ2898_01151 alpha-2,3 sialyltransferase 885 
neuB1 CDS Prokka:CAMJ2898_01152 sialic acid synthase 1,032 
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neuC1 CDS Prokka:CAMJ2898_01153 UDP-N-acetylglucosamine 2-epimerase 1,116 
neuA1 CDS Prokka:CAMJ2898_01154 bifunctional beta-1,4-N-
acetylgalactosaminyltransferase/CMP-Neu5Ac 
synthase 
1,611 
hypothetical protein CDS Prokka:CAMJ2898_01155 hypothetical protein 528 
hypothetical protein CDS Prokka:CAMJ2898_01156 hypothetical protein 333 
waaV CDS Prokka:CAMJ2898_01157 glucosyltransferase 825 
waaF CDS Prokka:CAMJ2898_01158 heptosyltransferase II 1,062 
    
C. coli 436 - Human - H-P 
   
Lipopolysaccharide heptosyltransferase I CDS Prokka:CAMC436_00736 Lipopolysaccharide heptosyltransferase I 1,029 
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC436_00737 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC436_00738 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC436_00739 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,177 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC436_00740 Capsular polysaccharide synthesis protein 981 
hypothetical protein CDS Prokka:CAMC436_00741 hypothetical protein 942 
Alpha-2,3-sialyltransferase (CST-I) CDS Prokka:CAMC436_00742 Alpha-2,3-sialyltransferase (CST-I) 891 
hypothetical protein CDS Prokka:CAMC436_00743 hypothetical protein 186 
hypothetical protein CDS Prokka:CAMC436_00744 hypothetical protein 874 
hypothetical protein CDS Prokka:CAMC436_00745 hypothetical protein 189 
hypothetical protein CDS Prokka:CAMC436_00746 hypothetical protein 345 
Polysaccharide pyruvyl transferase CDS Prokka:CAMC436_00747 Polysaccharide pyruvyl transferase 1,128 
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Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC436_00748 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC436_00749 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
    
C. coli 462 - Chicken - NH-P 
   
Lipopolysaccharide heptosyltransferase I CDS Prokka:CAMC462_00490 Lipopolysaccharide heptosyltransferase I 1,029 
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC462_00491 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC462_00492 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC462_00493 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,176 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC462_00494 Capsular polysaccharide synthesis protein 981 
hypothetical protein CDS Prokka:CAMC462_00495 hypothetical protein 942 
Alpha-2,3-sialyltransferase (CST-I) CDS Prokka:CAMC462_00496 Alpha-2,3-sialyltransferase (CST-I) 891 
hypothetical protein CDS Prokka:CAMC462_00497 hypothetical protein 186 
hypothetical protein CDS Prokka:CAMC462_00498 hypothetical protein 825 
hypothetical protein CDS Prokka:CAMC462_00499 hypothetical protein 189 
hypothetical protein CDS Prokka:CAMC462_00500 hypothetical protein 345 
Polysaccharide pyruvyl transferase CDS Prokka:CAMC462_00501 Polysaccharide pyruvyl transferase 1,128 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC462_00502 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC462_00503 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
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C. coli 470 - Chicken - H-P 
   
waaC Lipopolysaccharide heptosyltransferase I CDS Prokka:CAMC470_01218 Lipopolysaccharide heptosyltransferase I 1,029 
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC470_01219 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC470_01220 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC470_01221 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,176 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC470_01222 Capsular polysaccharide synthesis protein 981 
Hypothetical protein CDS 
  
942 
alpha-2, 3-sialyltransferase CDS 
  
891 
Hypothetical protein CDS 
  
873 
Hypothetical protein CDS 
  
345 
Polysaccharide pyruvyl transferase CDS 
  
1,128 
waaV Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC470_01225 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
waaF ADP-heptose--lipooligosaccharide 
heptosyltransferase II CDS 
Prokka:CAMC470_01226 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
    
C. coli 722 - Human - NH-P 
   
Lipopolysaccharide heptosyltransferase I CDS Prokka:CAMC722_01087 Lipopolysaccharide heptosyltransferase I 1,029 
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC722_01088 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC722_01089 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC722_01090 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,179 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC722_01091 Capsular polysaccharide synthesis protein 981 
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HtrL YibB CDS 
  
942 
cstI CDS 
  
891 
arylsulfatase CDS 
  
873 
Hypothetical protein CDS 
  
345 
Polysaccharide pyruvyl transferase CDS Prokka:CAMC722_01093 Polysaccharide pyruvyl transferase 1,128 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC722_01094 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC722_01095 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
    
C. coli 1765 - Chicken - H-NP 
   
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC1765_01035 Lipid A biosynthesis lauroyl acyltransferase 907 
Putative two-domain glycosyltransferase CDS Prokka:CAMC1765_01036 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1765_01037 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,175 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC1765_01038 Capsular polysaccharide synthesis protein 981 
hypothetical protein CDS Prokka:CAMC1765_01039 hypothetical protein 942 
Alpha-2,3-sialyltransferase (CST-I) CDS Prokka:CAMC1765_01040 Alpha-2,3-sialyltransferase (CST-I) 891 
hypothetical protein CDS Prokka:CAMC1765_01041 hypothetical protein 184 
hypothetical protein CDS Prokka:CAMC1765_01042 hypothetical protein 872 
hypothetical protein CDS Prokka:CAMC1765_01043 hypothetical protein 189 
hypothetical protein CDS Prokka:CAMC1765_01044 hypothetical protein 345 
Polysaccharide pyruvyl transferase CDS Prokka:CAMC1765_01045 Polysaccharide pyruvyl transferase 1,128 
Appendix A 
 
 
 
224 
 
Ortholog Prokka ID Product Length 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1765_01046 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC1765_01047 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
    
C. coli 1786 - Chicken - H-P 
   
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC1786_01203 Lipid A biosynthesis lauroyl acyltransferase 888 
Putative two-domain glycosyltransferase CDS Prokka:CAMC1786_01204 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1786_01205 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,158 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC1786_01206 Capsular polysaccharide synthesis protein 981 
hypothetical protein CDS Prokka:CAMC1786_01207 hypothetical protein 942 
Hypothetical protein CDS 
  
858 
hypothetical protein CDS Prokka:CAMC1786_01210 hypothetical protein 201 
lexA 2 CDS Prokka:CAMC1786_01211 LexA repressor 738 
hypothetical protein CDS Prokka:CAMC1786_01212 hypothetical protein 702 
Polysaccharide pyruvyl transferase CDS Prokka:CAMC1786_01213 Polysaccharide pyruvyl transferase 1,119 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1786_01214 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC1786_01215 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
960 
    
C. coli 1790 - Chicken - NH-P 
   
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC1790_01095 Lipid A biosynthesis lauroyl acyltransferase 909 
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Putative two-domain glycosyltransferase CDS Prokka:CAMC1790_01096 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1790_01097 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,176 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC1790_01098 Capsular polysaccharide synthesis protein 981 
hypothetical protein CDS Prokka:CAMC1790_01099 hypothetical protein 942 
Alpha-2,3-sialyltransferase (CST-I) CDS Prokka:CAMC1790_01100 Alpha-2,3-sialyltransferase (CST-I) 891 
hypothetical protein CDS Prokka:CAMC1790_01101 hypothetical protein 186 
hypothetical protein CDS Prokka:CAMC1790_01102 hypothetical protein 873 
hypothetical protein CDS Prokka:CAMC1790_01103 hypothetical protein 189 
hypothetical protein CDS Prokka:CAMC1790_01104 hypothetical protein 345 
unknown 
  
222 
Polysaccharide pyruvyl transferase CDS Prokka:CAMC1790_01105 Polysaccharide pyruvyl transferase 1,128 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1790_01106 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC1790_01107 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
    
C. coli 1973 - Chicken - NH-NP 
   
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC1973_01258 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC1973_01259 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1973_01260 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,176 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC1973_01261 Capsular polysaccharide synthesis protein 981 
hypothetical protein CDS Prokka:CAMC1973_01262 hypothetical protein 942 
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Alpha-2,3-sialyltransferase (CST-I) CDS Prokka:CAMC1973_01263 Alpha-2,3-sialyltransferase (CST-I) 891 
hypothetical protein CDS Prokka:CAMC1973_01264 hypothetical protein 189 
hypothetical protein CDS Prokka:CAMC1973_01265 hypothetical protein 873 
hypothetical protein CDS Prokka:CAMC1973_01266 hypothetical protein 189 
hypothetical protein CDS Prokka:CAMC1973_01267 hypothetical protein 345 
unknown 
  
189 
unknown 
  
222 
unknown 
  
1,128 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1973_01268 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC1973_01269 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
    
C. coli 1998 - Chicken - NH-NP 
   
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC1998_01205 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC1998_01206 Putative two-domain glycosyltransferase 1,551 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1998_01207 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,176 
Glycosyly transferase CDS 
  
981 
Hypothetical protein (yibB sprfam) CDS 
  
942 
Alpha-2,3-sialyltransferase (CST-I) CDS Prokka:CAMC1998_01208 Alpha-2,3-sialyltransferase (CST-I) 891 
hypothetical protein CDS Prokka:CAMC1998_01209 hypothetical protein 186 
hypothetical protein CDS Prokka:CAMC1998_01210 hypothetical protein 874 
hypothetical protein CDS Prokka:CAMC1998_01211 hypothetical protein 189 
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hypothetical protein CDS Prokka:CAMC1998_01212 hypothetical protein 345 
Polysaccharide pyruvyl transferase CDS Prokka:CAMC1998_01213 Polysaccharide pyruvyl transferase 1,128 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC1998_01214 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
819 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC1998_01215 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,038 
    
C. coli 2350 - Human - H-NP 
   
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC2350_00937 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC2350_00938 Putative two-domain glycosyltransferase 1,548 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC2350_00939 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,158 
Capsular polysaccharide synthesis protein CDS Prokka:CAMC2350_00940 Capsular polysaccharide synthesis protein 981 
hypothetical protein CDS Prokka:CAMC2350_00941 hypothetical protein 489 
ATP/GTP phosphatase CDS Prokka:CAMC2350_00942 ATP/GTP phosphatase 1,038 
hypothetical protein CDS Prokka:CAMC2350_00943 hypothetical protein 936 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC2350_00944 DegT/DnrJ/EryC1/StrS aminotransferase 1,095 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC2350_00945 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,068 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC2350_00946 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
1,005 
hypothetical protein CDS Prokka:CAMC2350_00947 hypothetical protein 525 
Hypothetical protein CDS Prokka:CAMC2350_00948 Hypothetical protein 1,008 
hypothetical protein CDS Prokka:CAMC2350_00949 hypothetical protein 915 
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transferase, putative CDS Prokka:CAMC2350_00950 transferase, putative 672 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC2350_00951 Unknown, Putative lipopolysaccharide biosynthesis 
protein 
336 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC2350_00952 dTDP-glucose 4,6-dehydratase 1,032 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC2350_00953 Glucose-1-phosphate thymidylyltransferase 879 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC2350_00954 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
837 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC2350_00955 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
966 
    
C. coli RM2228 - Chicken 
   
Lipid A biosynthesis lauroyl acyltransferase CDS Prokka:CAMC2899_01169 Lipid A biosynthesis lauroyl acyltransferase 909 
Putative two-domain glycosyltransferase CDS Prokka:CAMC2899_01170 Putative two-domain glycosyltransferase 1,548 
Alpha-1,4-N-acetylgalactosamine transferase PglH 
CDS 
Prokka:CAMC2899_01172 Alpha-1,4-N-acetylgalactosamine transferase PglH 1,061 
Glycosyl transferase family 8 family protein CDS Prokka:CAMC2899_01173 Glycosyl transferase family 8 family protein 1,212 
Glycosyl transferase family A CDS 
  
936 
Hypothetical protein (methyl transferase) CDS 
  
828 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC2899_01174 Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase 
923 
ADP-heptose--lipooligosaccharide heptosyltransferase 
II CDS 
Prokka:CAMC2899_01175 ADP-heptose--lipooligosaccharide heptosyltransferase 
II 
1,023 
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Table A-4: Annotation data for the capsular polysaccharide locus 
 
 
Ortholog Prokka ID Product Length 
C. jejuni 117 - Chicken - NH-NP 
   
kpsC CDS Prokka:CAMJ117_01467 capsule polysaccharide modification protein 2,073 
sugar transferase CDS Prokka:CAMJ117_01468 sugar transferase 1,884 
hddC 1 CDS Prokka:CAMJ117_01469 capsular polysaccharide heptosyltransferase 1,896 
glmU CDS Prokka:CAMJ117_01470 Bifunctional protein GlmU 1,482 
mtnB CDS Prokka:CAMJ117_01471 Methylthioribulose-1-phosphate dehydratase 726 
prk CDS Prokka:CAMJ117_01472 Phosphoribulokinase 1,302 
hypothetical protein CDS Prokka:CAMJ117_01473 hypothetical protein 594 
hddC 2 CDS Prokka:CAMJ117_01474 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 681 
gmhA2 CDS Prokka:CAMJ117_01475 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ117_01476 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ117_01477 nucleotide sugar dehydratase 1,032 
fcl CDS Prokka:CAMJ117_01478 GDP-L-fucose synthetase 1,050 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ117_01479 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
1,611 
hypothetical protein CDS Prokka:CAMJ117_01480 hypothetical protein 1,437 
Glycosyl transferases group 1 CDS Prokka:CAMJ117_01481 Glycosyl transferases group 1 1,344 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ117_01482 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
1,602 
kpsF CDS Prokka:CAMJ117_01483 D-arabinose 5-phosphate isomerase 948 
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Ortholog Prokka ID Product Length 
C. jejuni 448 - Chicken - H-P 
   
kpsC CDS Prokka:CAMJ448_01532 capsule polysaccharide modification protein 2,073 
sugar transferase CDS Prokka:CAMJ448_01533 sugar transferase 1,872 
hddC 1 CDS Prokka:CAMJ448_01534 capsular polysaccharide heptosyltransferase 1,992 
glmU CDS Prokka:CAMJ448_01535 Bifunctional protein GlmU 1,482 
mtnB CDS Prokka:CAMJ448_01536 Methylthioribulose-1-phosphate dehydratase 726 
prk CDS Prokka:CAMJ448_01537 Phosphoribulokinase 1,302 
hypothetical protein CDS Prokka:CAMJ448_01538 hypothetical protein 594 
hddC 2 CDS Prokka:CAMJ448_01539 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 681 
gmhA2 CDS Prokka:CAMJ448_01540 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ448_01541 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ448_01542 nucleotide sugar dehydratase 1,032 
fcl CDS Prokka:CAMJ448_01543 GDP-L-fucose synthetase 1,050 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ448_01544 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
1,611 
hypothetical protein CDS Prokka:CAMJ448_01545 hypothetical protein 1,437 
Glycosyl transferases group 1 CDS Prokka:CAMJ448_01546 Glycosyl transferases group 1 1,344 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ448_01547 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
1,602 
kpsF CDS Prokka:CAMJ448_01548 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 697 - Human - H-NP 
   
kpsC CDS Prokka:CAMJ697_01442 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ697_01443 adenylylsulfate kinase 513 
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sugar nucleotidyltransferase CDS Prokka:CAMJ697_01444 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ697_01445 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ697_01446 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ697_01447 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ697_01448 methyltransferase 195 
methyltransferase CDS Prokka:CAMJ697_01449 methyltransferase 438 
sugar transferase CDS Prokka:CAMJ697_01450 sugar transferase 1,131 
hddC 2 CDS Prokka:CAMJ697_01451 capsular polysaccharide heptosyltransferase 1,296 
sugar-phosphate nucleotide transferase CDS Prokka:CAMJ697_01452 sugar-phosphate nucleotide transferase 1,482 
L-fuculose phosphate aldolase CDS Prokka:CAMJ697_01453 L-fuculose phosphate aldolase 723 
prk CDS Prokka:CAMJ697_01454 Phosphoribulokinase 1,275 
hypothetical protein CDS Prokka:CAMJ697_01455 hypothetical protein 276 
hddC 3 CDS Prokka:CAMJ697_01456 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 696 
gmhA2 CDS Prokka:CAMJ697_01457 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ697_01458 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ697_01459 nucleotide sugar dehydratase 1,032 
fcl CDS Prokka:CAMJ697_01460 GDP-L-fucose synthetase 1,041 
rfbC CDS Prokka:CAMJ697_01461 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
sugar transferase CDS Prokka:CAMJ697_01462 sugar transferase 3,726 
sugar transferase CDS Prokka:CAMJ697_01463 sugar transferase 1,791 
glycosyltransferase CDS Prokka:CAMJ697_01464 glycosyltransferase 2,517 
sugar transferase CDS Prokka:CAMJ697_01465 sugar transferase 1,626 
kpsF CDS Prokka:CAMJ697_01466 D-arabinose 5-phosphate isomerase 948 
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Ortholog Prokka ID Product Length 
C. jejuni 741 - Human - NH-P 
   
kpsC CDS Prokka:CAMJ741_01409 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ741_01410 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ741_01411 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ741_01412 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ741_01413 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ741_01414 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ741_01415 methyltransferase 195 
methyltransferase CDS Prokka:CAMJ741_01416 methyltransferase 456 
sugar transferase CDS Prokka:CAMJ741_01417 sugar transferase 1,107 
sugar transferase CDS Prokka:CAMJ741_01418 sugar transferase 1,617 
sugar transferase CDS Prokka:CAMJ741_01419 sugar transferase 171 
hddC 1 CDS Prokka:CAMJ741_01420 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 666 
gmhA2 CDS Prokka:CAMJ741_01421 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ741_01422 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
methyltransferase family protein CDS Prokka:CAMJ741_01423 methyltransferase family protein 852 
sugar-nucleotide epimerase/dehydratease CDS Prokka:CAMJ741_01424 sugar-nucleotide epimerase/dehydratease 942 
fcl CDS Prokka:CAMJ741_01425 GDP-L-fucose synthetase 1,041 
hypothetical protein CDS Prokka:CAMJ741_01426 hypothetical protein 927 
rfbC CDS Prokka:CAMJ741_01427 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
hddC 2 CDS Prokka:CAMJ741_01428 capsular polysaccharide heptosyltransferase 1,749 
sugar transferase CDS Prokka:CAMJ741_01429 sugar transferase 3,096 
hypothetical protein CDS Prokka:CAMJ741_01430 hypothetical protein 1,002 
sugar transferase CDS Prokka:CAMJ741_01431 sugar transferase 1,557 
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phosphatase CDS Prokka:CAMJ741_01432 phosphatase 636 
aminotransferase CDS Prokka:CAMJ741_01433 aminotransferase 1,230 
aminotransferase CDS Prokka:CAMJ741_01434 aminotransferase 897 
sugar transferase CDS Prokka:CAMJ741_01435 sugar transferase 702 
glf CDS Prokka:CAMJ741_01436 UDP-galactopyranose mutase 1,107 
sugar transferase CDS Prokka:CAMJ741_01437 sugar transferase 1,224 
kfiD CDS Prokka:CAMJ741_01438 UDP-glucose 6-dehydrogenase 1,182 
sugar transferase CDS Prokka:CAMJ741_01439 sugar transferase 1,635 
kpsF CDS Prokka:CAMJ741_01440 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 743 -Human - H-P 
   
kpsC CDS Prokka:CAMJ743_01395 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ743_01396 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ743_01397 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ743_01398 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ743_01399 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ743_01400 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ743_01401 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ743_01402 sugar transferase 411 
sugar transferase CDS Prokka:CAMJ743_01403 sugar transferase 1,173 
hypothetical protein CDS Prokka:CAMJ743_01404 hypothetical protein 1,938 
hypothetical protein CDS Prokka:CAMJ743_01405 hypothetical protein 102 
glmU CDS Prokka:CAMJ743_01406 Bifunctional protein GlmU 1,473 
hypothetical protein CDS Prokka:CAMJ743_01407 hypothetical protein 714 
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prk CDS Prokka:CAMJ743_01408 Phosphoribulokinase 639 
yjjG CDS Prokka:CAMJ743_01409 Pyrimidine 5'-nucleotidase YjjG 585 
hypothetical protein CDS Prokka:CAMJ743_01410 hypothetical protein 594 
hddC 1 CDS Prokka:CAMJ743_01411 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 681 
gmhA2 CDS Prokka:CAMJ743_01412 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ743_01413 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ743_01414 nucleotide sugar dehydratase 1,032 
fcl 1 CDS Prokka:CAMJ743_01415 GDP-L-fucose synthetase 1,059 
fcl 2 CDS Prokka:CAMJ743_01416 GDP-L-fucose synthetase 1,131 
hypothetical protein CDS Prokka:CAMJ743_01417 hypothetical protein 912 
rfbC CDS Prokka:CAMJ743_01418 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
hypothetical protein CDS Prokka:CAMJ743_01419 hypothetical protein 1,029 
hddC 2 CDS Prokka:CAMJ743_01420 capsular polysaccharide heptosyltransferase 1,650 
tagF CDS Prokka:CAMJ743_01421 CDP-glycerol:poly(glycerophosphate) glycerophosphotransferase 3,273 
nucleotide sugar dehydratase CDS Prokka:CAMJ743_01422 nucleotide sugar dehydratase 1,008 
ispDF 1 CDS Prokka:CAMJ743_01423 bifunctional 2-C-methyl-D-erythritol 4-
phosphatecytidylyltransferase/2-C-methyl-D-erythritol2,4-
cyclodiphosphate synthase 
714 
tagB CDS Prokka:CAMJ743_01424 Putative CDP-glycerol:glycerophosphate 
glycerophosphotransferase 
1,050 
kpsF CDS Prokka:CAMJ743_01425 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 744 - Human - H-P 
   
kpsC CDS Prokka:CAMJ744_01361 capsule polysaccharide modification protein 2,070 
Appendix A 
 
 
 
235 
 
Ortholog Prokka ID Product Length 
cysC CDS Prokka:CAMJ744_01362 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ744_01363 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ744_01364 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ744_01365 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ744_01366 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ744_01367 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ744_01368 sugar transferase 1,833 
hddC 1 CDS Prokka:CAMJ744_01369 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 675 
gmhA2 CDS Prokka:CAMJ744_01370 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ744_01371 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ744_01372 nucleotide sugar dehydratase 1,032 
pseC 2 CDS Prokka:CAMJ744_01373 C4 aminotransferase 1,164 
fcl CDS Prokka:CAMJ744_01374 GDP-L-fucose synthetase 1,047 
rfbC CDS Prokka:CAMJ744_01375 dTDP-4-dehydrorhamnose 3,5-epimerase 561 
hddC 2 CDS Prokka:CAMJ744_01376 capsular polysaccharide heptosyltransferase 1,488 
hddC 3 CDS Prokka:CAMJ744_01377 capsular polysaccharide heptosyltransferase 1,647 
tagF CDS Prokka:CAMJ744_01378 CDP-glycerol:poly(glycerophosphate) glycerophosphotransferase 3,273 
nucleotide sugar dehydratase CDS Prokka:CAMJ744_01379 nucleotide sugar dehydratase 1,008 
ispDF 1 CDS Prokka:CAMJ744_01380 bifunctional 2-C-methyl-D-erythritol 4-
phosphatecytidylyltransferase/2-C-methyl-D-erythritol2,4-
cyclodiphosphate synthase 
714 
tagB CDS Prokka:CAMJ744_01381 Putative CDP-glycerol:glycerophosphate 
glycerophosphotransferase 
1,050 
kpsF CDS Prokka:CAMJ744_01382 D-arabinose 5-phosphate isomerase 948 
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Ortholog Prokka ID Product Length 
    
C. jejuni 1180 - Chicken - H-P 
   
kpsS CDS Prokka:CAMJ1180_01409 capsule polysaccharide modification protein 1,185 
kpsC CDS Prokka:CAMJ1180_01410 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ1180_01411 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ1180_01412 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ1180_01413 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ1180_01414 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ1180_01415 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ1180_01416 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ1180_01417 sugar transferase 1,833 
hddC 1 CDS Prokka:CAMJ1180_01418 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 675 
gmhA2 CDS Prokka:CAMJ1180_01419 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ1180_01420 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ1180_01421 nucleotide sugar dehydratase 1,032 
pseC 2 CDS Prokka:CAMJ1180_01422 C4 aminotransferase 1,164 
fcl CDS Prokka:CAMJ1180_01423 GDP-L-fucose synthetase 1,047 
rfbC CDS Prokka:CAMJ1180_01424 dTDP-4-dehydrorhamnose 3,5-epimerase 561 
hddC 2 CDS Prokka:CAMJ1180_01425 capsular polysaccharide heptosyltransferase 2,196 
hddC 3 CDS Prokka:CAMJ1180_01426 capsular polysaccharide heptosyltransferase 1,338 
tagF CDS Prokka:CAMJ1180_01427 CDP-glycerol:poly(glycerophosphate) glycerophosphotransferase 3,273 
nucleotide sugar dehydratase CDS Prokka:CAMJ1180_01428 nucleotide sugar dehydratase 1,008 
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ispDF 1 CDS Prokka:CAMJ1180_01429 bifunctional 2-C-methyl-D-erythritol 4-
phosphatecytidylyltransferase/2-C-methyl-D-erythritol2,4-
cyclodiphosphate synthase 
714 
tagB CDS Prokka:CAMJ1180_01430 Putative CDP-glycerol:glycerophosphate 
glycerophosphotransferase 
1,050 
kpsF CDS Prokka:CAMJ1180_01431 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 1377 - Human - NH-P 
   
kpsC CDS Prokka:CAMJ1377_01436 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ1377_01437 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ1377_01438 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ1377_01439 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ1377_01440 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ1377_01441 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ1377_01442 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ1377_01443 sugar transferase 885 
sugar transferase CDS Prokka:CAMJ1377_01444 sugar transferase 444 
hddC 2 CDS Prokka:CAMJ1377_01445 capsular polysaccharide heptosyltransferase 342 
hypothetical protein CDS Prokka:CAMJ1377_01446 hypothetical protein 273 
hypothetical protein CDS Prokka:CAMJ1377_01447 hypothetical protein 552 
hypothetical protein CDS Prokka:CAMJ1377_01448 hypothetical protein 240 
hypothetical protein CDS Prokka:CAMJ1377_01449 hypothetical protein 126 
hypothetical protein CDS Prokka:CAMJ1377_01450 hypothetical protein 93 
glmU CDS Prokka:CAMJ1377_01451 Bifunctional protein GlmU 1,473 
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hypothetical protein CDS Prokka:CAMJ1377_01452 hypothetical protein 726 
prk CDS Prokka:CAMJ1377_01453 Phosphoribulokinase 642 
yjjG CDS Prokka:CAMJ1377_01454 Pyrimidine 5'-nucleotidase YjjG 588 
hypothetical protein CDS Prokka:CAMJ1377_01455 hypothetical protein 594 
hddC 3 CDS Prokka:CAMJ1377_01456 capsular polysaccharide heptosyltransferase 1,692 
hddC 4 CDS Prokka:CAMJ1377_01457 capsular polysaccharide heptosyltransferase 1,998 
sugar transferase CDS Prokka:CAMJ1377_01458 sugar transferase 3,267 
cysQ 1 CDS Prokka:CAMJ1377_01459 CysQ protein 750 
hypothetical protein CDS Prokka:CAMJ1377_01460 hypothetical protein 495 
serA 2 CDS Prokka:CAMJ1377_01461 D-3-phosphoglycerate dehydrogenase 933 
neuA1 2 CDS Prokka:CAMJ1377_01462 bifunctional beta-1,4-N-acetylgalactosaminyltransferase/CMP-
Neu5Ac synthase 
711 
oxidoreductase CDS Prokka:CAMJ1377_01463 oxidoreductase 1,008 
gmhA 2 CDS Prokka:CAMJ1377_01464 phosphoheptose isomerase 573 
kynB CDS Prokka:CAMJ1377_01465 Kynurenine formamidase 708 
sugar transferase CDS Prokka:CAMJ1377_01466 sugar transferase 2,877 
wlaN CDS Prokka:CAMJ1377_01467 beta-1,3 galactosyltransferase 2,001 
sugar transferase CDS Prokka:CAMJ1377_01468 sugar transferase 1,395 
sugar transferase CDS Prokka:CAMJ1377_01469 sugar transferase 1,653 
kpsF CDS Prokka:CAMJ1377_01470 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 1431 - Human - H-P 
   
kpsS CDS Prokka:CAMJ1431_01460 capsule polysaccharide modification protein 1,185 
kpsC CDS Prokka:CAMJ1431_01461 capsule polysaccharide modification protein 2,073 
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sugar transferase CDS Prokka:CAMJ1431_01462 sugar transferase 1,920 
hddC 1 CDS Prokka:CAMJ1431_01463 capsular polysaccharide heptosyltransferase 1,953 
glmU CDS Prokka:CAMJ1431_01464 Bifunctional protein GlmU 1,482 
mtnB CDS Prokka:CAMJ1431_01465 Methylthioribulose-1-phosphate dehydratase 726 
prk CDS Prokka:CAMJ1431_01466 Phosphoribulokinase 1,302 
hypothetical protein CDS Prokka:CAMJ1431_01467 hypothetical protein 594 
hddC 2 CDS Prokka:CAMJ1431_01468 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 681 
gmhA2 CDS Prokka:CAMJ1431_01469 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ1431_01470 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ1431_01471 nucleotide sugar dehydratase 1,032 
fcl CDS Prokka:CAMJ1431_01472 GDP-L-fucose synthetase 1,050 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ1431_01473 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
1,611 
hypothetical protein CDS Prokka:CAMJ1431_01474 hypothetical protein 1,437 
Glycosyl transferases group 1 CDS Prokka:CAMJ1431_01475 Glycosyl transferases group 1 1,344 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ1431_01476 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
1,554 
kpsF CDS Prokka:CAMJ1431_01477 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 1898 - Chicken - H-P 
   
kpsC CDS Prokka:CAMJ1898_01636 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ1898_01637 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ1898_01638 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ1898_01639 amidotransferase 603 
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hypothetical protein CDS Prokka:CAMJ1898_01640 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ1898_01641 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ1898_01642 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ1898_01643 sugar transferase 1,641 
hypothetical protein CDS Prokka:CAMJ1898_01644 hypothetical protein 1,938 
hypothetical protein CDS Prokka:CAMJ1898_01645 hypothetical protein 102 
glmU CDS Prokka:CAMJ1898_01646 Bifunctional protein GlmU 1,473 
hypothetical protein CDS Prokka:CAMJ1898_01647 hypothetical protein 714 
prk CDS Prokka:CAMJ1898_01648 Phosphoribulokinase 1,299 
hypothetical protein CDS Prokka:CAMJ1898_01649 hypothetical protein 594 
hddC 1 CDS Prokka:CAMJ1898_01650 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 681 
gmhA2 CDS Prokka:CAMJ1898_01651 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ1898_01652 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ1898_01653 nucleotide sugar dehydratase 1,032 
fcl 1 CDS Prokka:CAMJ1898_01654 GDP-L-fucose synthetase 1,059 
fcl 2 CDS Prokka:CAMJ1898_01655 GDP-L-fucose synthetase 1,131 
hypothetical protein CDS Prokka:CAMJ1898_01656 hypothetical protein 912 
rfbC CDS Prokka:CAMJ1898_01657 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
hypothetical protein CDS Prokka:CAMJ1898_01658 hypothetical protein 612 
hypothetical protein CDS Prokka:CAMJ1898_01659 hypothetical protein 420 
hddC 2 CDS Prokka:CAMJ1898_01660 capsular polysaccharide heptosyltransferase 1,650 
tagF CDS Prokka:CAMJ1898_01661 CDP-glycerol:poly(glycerophosphate) glycerophosphotransferase 3,273 
nucleotide sugar dehydratase CDS Prokka:CAMJ1898_01662 nucleotide sugar dehydratase 1,008 
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ispDF 1 CDS Prokka:CAMJ1898_01663 bifunctional 2-C-methyl-D-erythritol 4-
phosphatecytidylyltransferase/2-C-methyl-D-erythritol2,4-
cyclodiphosphate synthase 
714 
tagB CDS Prokka:CAMJ1898_01664 Putative CDP-glycerol:glycerophosphate 
glycerophosphotransferase 
1,050 
kpsF CDS Prokka:CAMJ1898_01665 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2043 - Human - H-P 
   
kpsC CDS Prokka:CAMJ2043_01368 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2043_01369 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2043_01370 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2043_01371 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2043_01372 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2043_01373 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2043_01374 methyltransferase 195 
methyltransferase CDS Prokka:CAMJ2043_01375 methyltransferase 414 
sugar transferase CDS Prokka:CAMJ2043_01376 sugar transferase 1,914 
hypothetical protein CDS Prokka:CAMJ2043_01377 hypothetical protein 723 
hypothetical protein CDS Prokka:CAMJ2043_01378 hypothetical protein 1,524 
hypothetical protein CDS Prokka:CAMJ2043_01379 hypothetical protein 399 
hddC 1 CDS Prokka:CAMJ2043_01380 capsular polysaccharide heptosyltransferase 1,920 
glmU CDS Prokka:CAMJ2043_01381 Bifunctional protein GlmU 1,860 
hypothetical protein CDS Prokka:CAMJ2043_01382 hypothetical protein 330 
SnoaL-like domain protein CDS Prokka:CAMJ2043_01383 SnoaL-like domain protein 336 
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MobA-like NTP transferase domain protein CDS Prokka:CAMJ2043_01384 MobA-like NTP transferase domain protein 726 
Phosphorylated carbohydrates phosphatase CDS Prokka:CAMJ2043_01385 Phosphorylated carbohydrates phosphatase 639 
hypothetical protein CDS Prokka:CAMJ2043_01386 hypothetical protein 639 
pglJ 2 CDS Prokka:CAMJ2043_01387 GalNAc transferase 3,288 
LicD family protein CDS Prokka:CAMJ2043_01388 LicD family protein 1,209 
hldE 2 CDS Prokka:CAMJ2043_01389 D-beta-D-heptose 7-phosphate kinase/D-beta-D-heptose 1-
phosphate adenylyltransferase 
390 
kpsF CDS Prokka:CAMJ2043_01390 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2046 - Human - H-P 
   
kpsC CDS Prokka:CAMJ2046_01406 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2046_01407 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2046_01408 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2046_01409 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2046_01410 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2046_01411 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2046_01412 methyltransferase 195 
methyltransferase CDS Prokka:CAMJ2046_01413 methyltransferase 438 
sugar transferase CDS Prokka:CAMJ2046_01414 sugar transferase 1,137 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ2046_01415 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
990 
sugar transferase CDS Prokka:CAMJ2046_01416 sugar transferase 1,086 
hypothetical protein CDS Prokka:CAMJ2046_01417 hypothetical protein 246 
hddC 2 CDS Prokka:CAMJ2046_01418 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 696 
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gmhA2 CDS Prokka:CAMJ2046_01419 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ2046_01420 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ2046_01421 nucleotide sugar dehydratase 1,032 
fcl CDS Prokka:CAMJ2046_01422 GDP-L-fucose synthetase 1,041 
rfbC CDS Prokka:CAMJ2046_01423 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
sugar transferase CDS Prokka:CAMJ2046_01424 sugar transferase 3,726 
sugar transferase CDS Prokka:CAMJ2046_01425 sugar transferase 120 
sugar transferase CDS Prokka:CAMJ2046_01426 sugar transferase 705 
glycosyltransferase CDS Prokka:CAMJ2046_01427 glycosyltransferase 780 
sugar transferase CDS Prokka:CAMJ2046_01428 sugar transferase 1,626 
kpsF CDS Prokka:CAMJ2046_01429 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2189 - Human - H-P 
   
kpsC CDS Prokka:CAMJ2189_01437 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2189_01438 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2189_01439 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2189_01440 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2189_01441 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2189_01442 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2189_01443 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ2189_01444 sugar transferase 885 
sugar transferase CDS Prokka:CAMJ2189_01445 sugar transferase 444 
hddC 2 CDS Prokka:CAMJ2189_01446 capsular polysaccharide heptosyltransferase 342 
hypothetical protein CDS Prokka:CAMJ2189_01447 hypothetical protein 273 
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hypothetical protein CDS Prokka:CAMJ2189_01448 hypothetical protein 552 
hypothetical protein CDS Prokka:CAMJ2189_01449 hypothetical protein 240 
hypothetical protein CDS Prokka:CAMJ2189_01450 hypothetical protein 126 
hypothetical protein CDS Prokka:CAMJ2189_01451 hypothetical protein 93 
glmU CDS Prokka:CAMJ2189_01452 Bifunctional protein GlmU 1,473 
hypothetical protein CDS Prokka:CAMJ2189_01453 hypothetical protein 726 
prk CDS Prokka:CAMJ2189_01454 Phosphoribulokinase 642 
yjjG CDS Prokka:CAMJ2189_01455 Pyrimidine 5'-nucleotidase YjjG 588 
hypothetical protein CDS Prokka:CAMJ2189_01456 hypothetical protein 594 
hddC 3 CDS Prokka:CAMJ2189_01457 capsular polysaccharide heptosyltransferase 1,692 
hddC 4 CDS Prokka:CAMJ2189_01458 capsular polysaccharide heptosyltransferase 1,998 
sugar transferase CDS Prokka:CAMJ2189_01459 sugar transferase 3,267 
cysQ 1 CDS Prokka:CAMJ2189_01460 CysQ protein 750 
tabA CDS Prokka:CAMJ2189_01461 Toxin-antitoxin biofilm protein TabA 495 
serA 2 CDS Prokka:CAMJ2189_01462 D-3-phosphoglycerate dehydrogenase 933 
neuA1 1 CDS Prokka:CAMJ2189_01463 bifunctional beta-1,4-N-acetylgalactosaminyltransferase/CMP-
Neu5Ac synthase 
711 
oxidoreductase CDS Prokka:CAMJ2189_01464 oxidoreductase 1,008 
gmhA 2 CDS Prokka:CAMJ2189_01465 phosphoheptose isomerase 573 
kynB CDS Prokka:CAMJ2189_01466 Kynurenine formamidase 708 
sugar transferase CDS Prokka:CAMJ2189_01467 sugar transferase 2,739 
maf4 2 CDS Prokka:CAMJ2189_01468 motility accessory factor 723 
maf4 3 CDS Prokka:CAMJ2189_01469 motility accessory factor 261 
pseD 2 CDS Prokka:CAMJ2189_01470 PseD protein 270 
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maf3 CDS Prokka:CAMJ2189_01471 motility accessory factor 1,878 
nucleotide sugar dehydratase CDS Prokka:CAMJ2189_01472 nucleotide sugar dehydratase 993 
DegT family aminotransferase CDS Prokka:CAMJ2189_01473 DegT family aminotransferase 1,155 
transferase CDS Prokka:CAMJ2189_01474 transferase 597 
hypothetical protein CDS Prokka:CAMJ2189_01475 hypothetical protein 318 
hypothetical protein CDS Prokka:CAMJ2189_01476 hypothetical protein 387 
hypothetical protein CDS Prokka:CAMJ2189_01477 hypothetical protein 1,122 
neuB2 CDS Prokka:CAMJ2189_01478 N-acetylneuraminic acid synthetase 1,005 
neuC2 CDS Prokka:CAMJ2189_01479 UDP-N-acetylglucosamine 2-epimerase 1,155 
sugar-phosphate nucleotide transferase CDS Prokka:CAMJ2189_01480 sugar-phosphate nucleotide transferase 1,026 
hypothetical protein CDS Prokka:CAMJ2189_01481 hypothetical protein 906 
ptmB CDS Prokka:CAMJ2189_01482 acylneuraminate cytidylyltransferase 708 
ptmA CDS Prokka:CAMJ2189_01483 flagellin modification protein A 771 
flaB 1 CDS Prokka:CAMJ2189_01484 flagellin 207 
flaB 2 CDS Prokka:CAMJ2189_01485 flagellin 1,590 
hypothetical protein CDS Prokka:CAMJ2189_01486 hypothetical protein 279 
wlaN CDS Prokka:CAMJ2189_01487 beta-1,3 galactosyltransferase 2,001 
sugar transferase CDS Prokka:CAMJ2189_01488 sugar transferase 1,395 
sugar transferase CDS Prokka:CAMJ2189_01489 sugar transferase 1,653 
kpsF CDS Prokka:CAMJ2189_01490 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2323 - Human - H-P 
   
kpsC CDS Prokka:CAMJ2323_01383 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2323_01384 adenylylsulfate kinase 513 
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sugar nucleotidyltransferase CDS Prokka:CAMJ2323_01385 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2323_01386 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2323_01387 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2323_01388 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2323_01389 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ2323_01390 sugar transferase 1,137 
sugar transferase CDS Prokka:CAMJ2323_01391 sugar transferase 3,726 
rfbC CDS Prokka:CAMJ2323_01392 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
fcl CDS Prokka:CAMJ2323_01393 GDP-L-fucose synthetase 1,041 
nucleotide sugar dehydratase CDS Prokka:CAMJ2323_01394 nucleotide sugar dehydratase 1,032 
hddA CDS Prokka:CAMJ2323_01395 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
gmhA2 CDS Prokka:CAMJ2323_01396 phosphoheptose isomerase 606 
hddC 2 CDS Prokka:CAMJ2323_01397 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 696 
hypothetical protein CDS Prokka:CAMJ2323_01398 hypothetical protein 264 
prk CDS Prokka:CAMJ2323_01399 Phosphoribulokinase 1,275 
L-fuculose phosphate aldolase CDS Prokka:CAMJ2323_01400 L-fuculose phosphate aldolase 723 
sugar-phosphate nucleotide transferase CDS Prokka:CAMJ2323_01401 sugar-phosphate nucleotide transferase 1,482 
hddC 3 CDS Prokka:CAMJ2323_01402 capsular polysaccharide heptosyltransferase 1,296 
sugar transferase CDS Prokka:CAMJ2323_01403 sugar transferase 1,797 
glycosyltransferase CDS Prokka:CAMJ2323_01404 glycosyltransferase 2,517 
sugar transferase CDS Prokka:CAMJ2323_01405 sugar transferase 1,626 
kpsF CDS Prokka:CAMJ2323_01406 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2554 - Chicken - H-NP 
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kpsC CDS Prokka:CAMJ2554_01424 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2554_01425 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2554_01426 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2554_01427 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2554_01428 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2554_01429 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2554_01430 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ2554_01431 sugar transferase 1,575 
sugar transferase CDS Prokka:CAMJ2554_01432 sugar transferase 108 
hddC 2 CDS Prokka:CAMJ2554_01433 capsular polysaccharide heptosyltransferase 1,296 
sugar-phosphate nucleotide transferase CDS Prokka:CAMJ2554_01434 sugar-phosphate nucleotide transferase 1,482 
L-fuculose phosphate aldolase CDS Prokka:CAMJ2554_01435 L-fuculose phosphate aldolase 723 
prk CDS Prokka:CAMJ2554_01436 Phosphoribulokinase 1,275 
hypothetical protein CDS Prokka:CAMJ2554_01437 hypothetical protein 621 
hddC 3 CDS Prokka:CAMJ2554_01438 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 696 
gmhA2 CDS Prokka:CAMJ2554_01439 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ2554_01440 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
sugar-nucleotide epimerase/dehydratease CDS Prokka:CAMJ2554_01441 sugar-nucleotide epimerase/dehydratease 939 
nucleotide sugar dehydratase CDS Prokka:CAMJ2554_01442 nucleotide sugar dehydratase 858 
fcl CDS Prokka:CAMJ2554_01443 GDP-L-fucose synthetase 1,056 
rfbC CDS Prokka:CAMJ2554_01444 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
sugar transferase CDS Prokka:CAMJ2554_01445 sugar transferase 3,726 
sugar transferase CDS Prokka:CAMJ2554_01446 sugar transferase 324 
glycosyltransferase CDS Prokka:CAMJ2554_01447 glycosyltransferase 426 
Appendix A 
 
 
 
248 
 
Ortholog Prokka ID Product Length 
sugar transferase CDS Prokka:CAMJ2554_01448 sugar transferase 1,626 
kpsF CDS Prokka:CAMJ2554_01449 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2670 - Chicken - H-P 
   
kpsC CDS Prokka:CAMJ2670_01465 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2670_01466 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2670_01467 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2670_01468 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2670_01469 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2670_01470 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2670_01471 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ2670_01472 sugar transferase 1,773 
sugar transferase CDS Prokka:CAMJ2670_01473 sugar transferase 120 
sugar transferase CDS Prokka:CAMJ2670_01474 sugar transferase 3,726 
rfbC CDS Prokka:CAMJ2670_01475 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
fcl CDS Prokka:CAMJ2670_01476 GDP-L-fucose synthetase 1,056 
nucleotide sugar dehydratase CDS Prokka:CAMJ2670_01477 nucleotide sugar dehydratase 1,035 
sugar-nucleotide epimerase/dehydratease CDS Prokka:CAMJ2670_01478 sugar-nucleotide epimerase/dehydratease 939 
hddA CDS Prokka:CAMJ2670_01479 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
gmhA2 CDS Prokka:CAMJ2670_01480 phosphoheptose isomerase 606 
hddC 2 CDS Prokka:CAMJ2670_01481 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 696 
hypothetical protein CDS Prokka:CAMJ2670_01482 hypothetical protein 339 
glycosyltransferase CDS Prokka:CAMJ2670_01483 glycosyltransferase 618 
sugar transferase CDS Prokka:CAMJ2670_01484 sugar transferase 1,626 
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kpsF CDS Prokka:CAMJ2670_01485 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2672 - Chicken - H-P 
   
kpsC CDS Prokka:CAMJ2672_01459 capsule polysaccharide modification protein 1,116 
mdh CDS Prokka:CAMJ2672_01460 NAD-dependent methanol dehydrogenase 1,056 
hypothetical protein CDS Prokka:CAMJ2672_01461 hypothetical protein 1,197 
pphA CDS Prokka:CAMJ2672_01462 Phosphonopyruvate hydrolase 1,323 
neuA1 CDS Prokka:CAMJ2672_01463 bifunctional beta-1,4-N-acetylgalactosaminyltransferase/CMP-
Neu5Ac synthase 
1,185 
novP CDS Prokka:CAMJ2672_01464 Demethyldecarbamoylnovobiocin O-methyltransferase 663 
pgdA CDS Prokka:CAMJ2672_01465 Peptidoglycan-N-acetylglucosamine deacetylase 948 
sugar transferase CDS Prokka:CAMJ2672_01466 sugar transferase 1,392 
bifunctional 3-demethylubiquinone-9 3-
methyltransferase/ 2-octaprenyl-6-hydroxy phenol 
methylase CDS 
Prokka:CAMJ2672_01467 bifunctional 3-demethylubiquinone-9 3-methyltransferase/ 2-
octaprenyl-6-hydroxy phenol methylase 
867 
neuC1 CDS Prokka:CAMJ2672_01468 UDP-N-acetylglucosamine 2-epimerase 1,122 
neuB1 CDS Prokka:CAMJ2672_01469 sialic acid synthase 1,041 
hddC CDS Prokka:CAMJ2672_01470 capsular polysaccharide heptosyltransferase 1,998 
sugar transferase CDS Prokka:CAMJ2672_01471 sugar transferase 1,230 
glf CDS Prokka:CAMJ2672_01472 UDP-galactopyranose mutase 1,116 
gne 2 CDS Prokka:CAMJ2672_01473 UDP-GlcNAc/Glc 4-epimerase 975 
kfiD CDS Prokka:CAMJ2672_01474 UDP-glucose 6-dehydrogenase 1,299 
nucleotide sugar dehydratase CDS Prokka:CAMJ2672_01475 nucleotide sugar dehydratase 1,044 
glycosyltransferase CDS Prokka:CAMJ2672_01476 glycosyltransferase 1,398 
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sugar transferase CDS Prokka:CAMJ2672_01477 sugar transferase 858 
sugar transferase CDS Prokka:CAMJ2672_01478 sugar transferase 978 
kpsF CDS Prokka:CAMJ2672_01479 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2674 - Chicken - H-P 
   
kpsC CDS Prokka:CAMJ2674_01400 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2674_01401 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2674_01402 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2674_01403 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2674_01404 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2674_01405 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2674_01406 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ2674_01407 sugar transferase 1,686 
sugar transferase CDS Prokka:CAMJ2674_01408 sugar transferase 1,110 
sugar transferase CDS Prokka:CAMJ2674_01409 sugar transferase 102 
hddC 1 CDS Prokka:CAMJ2674_01410 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 666 
gmhA2 CDS Prokka:CAMJ2674_01411 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ2674_01412 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
methyltransferase family protein CDS Prokka:CAMJ2674_01413 methyltransferase family protein 345 
methyltransferase family protein CDS Prokka:CAMJ2674_01414 methyltransferase family protein 351 
sugar-nucleotide epimerase/dehydratease CDS Prokka:CAMJ2674_01415 sugar-nucleotide epimerase/dehydratease 942 
fcl CDS Prokka:CAMJ2674_01416 GDP-L-fucose synthetase 1,041 
hypothetical protein CDS Prokka:CAMJ2674_01417 hypothetical protein 624 
hypothetical protein CDS Prokka:CAMJ2674_01418 hypothetical protein 312 
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rfbC CDS Prokka:CAMJ2674_01419 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
hddC 2 CDS Prokka:CAMJ2674_01420 capsular polysaccharide heptosyltransferase 1,749 
sugar transferase CDS Prokka:CAMJ2674_01421 sugar transferase 3,096 
hypothetical protein CDS Prokka:CAMJ2674_01422 hypothetical protein 657 
hypothetical protein CDS Prokka:CAMJ2674_01423 hypothetical protein 174 
sugar transferase CDS Prokka:CAMJ2674_01424 sugar transferase 414 
sugar transferase CDS Prokka:CAMJ2674_01425 sugar transferase 576 
phosphatase CDS Prokka:CAMJ2674_01426 phosphatase 636 
aminotransferase CDS Prokka:CAMJ2674_01427 aminotransferase 1,230 
aminotransferase CDS Prokka:CAMJ2674_01428 aminotransferase 906 
sugar transferase CDS Prokka:CAMJ2674_01429 sugar transferase 1,827 
glf CDS Prokka:CAMJ2674_01430 UDP-galactopyranose mutase 1,080 
sugar transferase CDS Prokka:CAMJ2674_01431 sugar transferase 1,224 
kfiD CDS Prokka:CAMJ2674_01432 UDP-glucose 6-dehydrogenase 1,182 
sugar transferase CDS Prokka:CAMJ2674_01433 sugar transferase 1,635 
kpsF CDS Prokka:CAMJ2674_01434 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2689 - Chicken - H-P 
   
kpsC CDS Prokka:CAMJ2689_01398 capsule polysaccharide modification protein 2,070 
mdh CDS Prokka:CAMJ2689_01399 NAD-dependent methanol dehydrogenase 1,053 
hypothetical protein CDS Prokka:CAMJ2689_01400 hypothetical protein 1,197 
pphA CDS Prokka:CAMJ2689_01401 Phosphonopyruvate hydrolase 1,323 
cysC 1 CDS Prokka:CAMJ2689_01402 adenylylsulfate kinase 528 
methyltransferase CDS Prokka:CAMJ2689_01403 methyltransferase 771 
Appendix A 
 
 
 
252 
 
Ortholog Prokka ID Product Length 
sugar transferase CDS Prokka:CAMJ2689_01404 sugar transferase 1,860 
hddC CDS Prokka:CAMJ2689_01405 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 675 
gmhA2 CDS Prokka:CAMJ2689_01406 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ2689_01407 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
nucleotide sugar dehydratase CDS Prokka:CAMJ2689_01408 nucleotide sugar dehydratase 1,032 
fcl CDS Prokka:CAMJ2689_01409 GDP-L-fucose synthetase 1,059 
rfbC CDS Prokka:CAMJ2689_01410 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMJ2689_01411 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
2,061 
sugar transferase CDS Prokka:CAMJ2689_01412 sugar transferase 1,083 
sugar transferase CDS Prokka:CAMJ2689_01413 sugar transferase 1,287 
sugar transferase CDS Prokka:CAMJ2689_01414 sugar transferase 1,428 
glycosyltransferase CDS Prokka:CAMJ2689_01415 glycosyltransferase 306 
sugar transferase CDS Prokka:CAMJ2689_01416 sugar transferase 1,629 
kpsF CDS Prokka:CAMJ2689_01417 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni 2704 - Chicken - H-NP 
   
kpsC CDS Prokka:CAMJ2704_01489 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2704_01490 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2704_01491 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2704_01492 amidotransferase 603 
hypothetical protein CDS Prokka:CAMJ2704_01493 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2704_01494 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2704_01495 methyltransferase 774 
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sugar transferase CDS Prokka:CAMJ2704_01496 sugar transferase 1,842 
hddC 2 CDS Prokka:CAMJ2704_01497 capsular polysaccharide heptosyltransferase 1,296 
sugar-phosphate nucleotide transferase CDS Prokka:CAMJ2704_01498 sugar-phosphate nucleotide transferase 1,482 
L-fuculose phosphate aldolase CDS Prokka:CAMJ2704_01499 L-fuculose phosphate aldolase 723 
prk CDS Prokka:CAMJ2704_01500 Phosphoribulokinase 1,275 
hypothetical protein CDS Prokka:CAMJ2704_01501 hypothetical protein 300 
hddC 3 CDS Prokka:CAMJ2704_01502 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 696 
gmhA2 CDS Prokka:CAMJ2704_01503 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ2704_01504 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
sugar-nucleotide epimerase/dehydratease CDS Prokka:CAMJ2704_01505 sugar-nucleotide epimerase/dehydratease 939 
hypothetical protein CDS Prokka:CAMJ2704_01506 hypothetical protein 204 
nucleotide sugar dehydratase CDS Prokka:CAMJ2704_01507 nucleotide sugar dehydratase 855 
fcl CDS Prokka:CAMJ2704_01508 GDP-L-fucose synthetase 1,056 
rfbC CDS Prokka:CAMJ2704_01509 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
sugar transferase CDS Prokka:CAMJ2704_01510 sugar transferase 3,726 
glycosyltransferase CDS Prokka:CAMJ2704_01511 glycosyltransferase 777 
sugar transferase CDS Prokka:CAMJ2704_01512 sugar transferase 1,626 
kpsF CDS Prokka:CAMJ2704_01513 D-arabinose 5-phosphate isomerase 948 
    
C. jejuni NCTC11168 - Human 
   
kpsC CDS Prokka:CAMJ2898_01438 capsule polysaccharide modification protein 2,070 
cysC CDS Prokka:CAMJ2898_01439 adenylylsulfate kinase 513 
sugar nucleotidyltransferase CDS Prokka:CAMJ2898_01440 sugar nucleotidyltransferase 762 
amidotransferase CDS Prokka:CAMJ2898_01441 amidotransferase 603 
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hypothetical protein CDS Prokka:CAMJ2898_01442 hypothetical protein 2,340 
methyltransferase CDS Prokka:CAMJ2898_01443 methyltransferase 762 
methyltransferase CDS Prokka:CAMJ2898_01444 methyltransferase 774 
sugar transferase CDS Prokka:CAMJ2898_01445 sugar transferase 315 
sugar transferase CDS Prokka:CAMJ2898_01446 sugar transferase 1,443 
sugar transferase CDS Prokka:CAMJ2898_01447 sugar transferase 399 
sugar transferase CDS Prokka:CAMJ2898_01448 sugar transferase 663 
hddC 1 CDS Prokka:CAMJ2898_01449 D-glycero-D-manno-heptose 1-phosphate guanosyltransferase 666 
gmhA2 CDS Prokka:CAMJ2898_01450 phosphoheptose isomerase 606 
hddA CDS Prokka:CAMJ2898_01451 D-glycero-D-manno-heptose 7-phosphate kinase 1,020 
methyltransferase family protein CDS Prokka:CAMJ2898_01452 methyltransferase family protein 561 
methyltransferase family protein CDS Prokka:CAMJ2898_01453 methyltransferase family protein 330 
sugar-nucleotide epimerase/dehydratease CDS Prokka:CAMJ2898_01454 sugar-nucleotide epimerase/dehydratease 942 
fcl CDS Prokka:CAMJ2898_01455 GDP-L-fucose synthetase 1,041 
hypothetical protein CDS Prokka:CAMJ2898_01456 hypothetical protein 624 
hypothetical protein CDS Prokka:CAMJ2898_01457 hypothetical protein 312 
rfbC CDS Prokka:CAMJ2898_01458 dTDP-4-dehydrorhamnose 3,5-epimerase 546 
hddC 2 CDS Prokka:CAMJ2898_01459 capsular polysaccharide heptosyltransferase 1,749 
sugar transferase CDS Prokka:CAMJ2898_01460 sugar transferase 2,538 
hypothetical protein CDS Prokka:CAMJ2898_01461 hypothetical protein 657 
hypothetical protein CDS Prokka:CAMJ2898_01462 hypothetical protein 174 
sugar transferase CDS Prokka:CAMJ2898_01463 sugar transferase 1,659 
hypothetical protein CDS Prokka:CAMJ2898_01464 hypothetical protein 90 
phosphatase CDS Prokka:CAMJ2898_01465 phosphatase 636 
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aminotransferase CDS Prokka:CAMJ2898_01466 aminotransferase 1,230 
aminotransferase CDS Prokka:CAMJ2898_01467 aminotransferase 297 
aminotransferase CDS Prokka:CAMJ2898_01468 aminotransferase 903 
sugar transferase CDS Prokka:CAMJ2898_01469 sugar transferase 1,416 
sugar transferase CDS Prokka:CAMJ2898_01470 sugar transferase 378 
glf CDS Prokka:CAMJ2898_01471 UDP-galactopyranose mutase 1,107 
sugar transferase CDS Prokka:CAMJ2898_01472 sugar transferase 558 
kfiD CDS Prokka:CAMJ2898_01473 UDP-glucose 6-dehydrogenase 1,182 
sugar transferase CDS Prokka:CAMJ2898_01474 sugar transferase 1,635 
kpsF CDS Prokka:CAMJ2898_01475 D-arabinose 5-phosphate isomerase 948 
    
C. coli 436 - Human - H-P 
   
kpsC CDS Prokka:CAMC436_01259 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC436_01260 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,782 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC436_01261 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS Prokka:CAMC436_01262 Hypothetical protein 933 
transferase, putative CDS Prokka:CAMC436_01263 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC436_01264 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC436_01265 3-oxoacyl-[acyl-carrier protein] reductase 756 
Hypothetical protein CDS Prokka:CAMC436_01266 Hypothetical protein 300 
Hypothetical protein CDS Prokka:CAMC436_01267 Hypothetical protein 2,736 
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2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC436_01268 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC436_01269 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC436_01270 Hypothetical protein 1,470 
glycosyl transferase CDS Prokka:CAMC436_01271 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC436_01272 dTDP-glucose 4,6-dehydratase 1,008 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC436_01273 dTDP-4-dehydrorhamnose reductase 882 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC436_01274 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC436_01275 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC436_01276 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 462 - Chicken - NH-P 
   
kpsC Prokka:CAMC462_00906 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC462_00907 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,782 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC462_00908 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS Prokka:CAMC462_00909 Hypothetical protein 933 
transferase, putative CDS Prokka:CAMC462_00910 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC462_00911 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC462_00912 3-oxoacyl-[acyl-carrier protein] reductase 756 
Hypothetical protein CDS Prokka:CAMC462_00913 Hypothetical protein 300 
Hypothetical protein CDS Prokka:CAMC462_00914 Hypothetical protein 2,736 
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2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC462_00915 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC462_00916 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC462_00917 Hypothetical protein 1,470 
glycosyl transferase CDS Prokka:CAMC462_00918 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC462_00919 dTDP-glucose 4,6-dehydratase 1,008 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC462_00920 dTDP-4-dehydrorhamnose reductase 882 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC462_00921 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC462_00922 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC462_00923 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 470 - Chicken - H-P 
   
kpsC Prokka:CAMC470_01655 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC470_01656 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,782 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC470_01657 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS Prokka:CAMC470_01658 Hypothetical protein 933 
transferase, putative CDS Prokka:CAMC470_01659 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC470_01660 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC470_01661 3-oxoacyl-[acyl-carrier protein] reductase 756 
Hypothetical protein CDS Prokka:CAMC470_01662 Hypothetical protein 300 
Hypothetical protein CDS Prokka:CAMC470_01663 Hypothetical protein 2,736 
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2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC470_01664 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC470_01665 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC470_01666 Hypothetical protein 1,470 
glycosyl transferase CDS Prokka:CAMC470_01667 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC470_01668 dTDP-glucose 4,6-dehydratase 1,008 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC470_01669 dTDP-4-dehydrorhamnose reductase 882 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC470_01670 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC470_01671 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC470_01672 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 722 - Human - NH-P 
   
kpsC Prokka:CAMC722_01444 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC722_01445 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,782 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC722_01446 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS 
  
936 
Hypothetical protein CDS Prokka:CAMC722_01447 Hypothetical protein 954 
transferase, putative CDS Prokka:CAMC722_01448 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC722_01449 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC722_01450 3-oxoacyl-[acyl-carrier protein] reductase 756 
Hypothetical protein CDS Prokka:CAMC722_01451 Hypothetical protein 300 
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Hypothetical protein CDS Prokka:CAMC722_01452 Hypothetical protein 2,736 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC722_01453 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC722_01454 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC722_01455 Hypothetical protein 1,481 
glycosyl transferase CDS Prokka:CAMC722_01456 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC722_01457 dTDP-glucose 4,6-dehydratase 1,040 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC722_01458 dTDP-4-dehydrorhamnose reductase 951 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC722_01459 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC722_01460 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC722_01461 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 1765 - Chicken - H-NP 
   
kpsC Prokka:CAMC1765_01449 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC1765_01450 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,782 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC1765_01451 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS Prokka:CAMC1765_01452 Hypothetical protein 933 
transferase, putative CDS Prokka:CAMC1765_01453 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC1765_01454 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC1765_01455 3-oxoacyl-[acyl-carrier protein] reductase 756 
Hypothetical protein CDS Prokka:CAMC1765_01456 Hypothetical protein 300 
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Hypothetical protein CDS Prokka:CAMC1765_01457 Hypothetical protein 2,736 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC1765_01458 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC1765_01459 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC1765_01460 Hypothetical protein 1,470 
glycosyl transferase CDS Prokka:CAMC1765_01461 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC1765_01462 dTDP-glucose 4,6-dehydratase 1,008 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC1765_01463 dTDP-4-dehydrorhamnose reductase 882 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC1765_01464 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC1765_01465 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC1765_01466 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 1786 - Chicken - H-P 
   
kpsC Prokka:CAMC1786_01535 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC1786_01536 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,818 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC1786_01537 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS Prokka:CAMC1786_01538 Hypothetical protein 936 
Hypothetical protein CDS Prokka:CAMC1786_01539 Hypothetical protein 1,014 
transferase, putative CDS Prokka:CAMC1786_01540 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC1786_01541 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC1786_01542 3-oxoacyl-[acyl-carrier protein] reductase 756 
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Hypothetical protein CDS Prokka:CAMC1786_01543 Hypothetical protein 300 
Hypothetical protein CDS Prokka:CAMC1786_01544 Hypothetical protein 2,736 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC1786_01545 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC1786_01546 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC1786_01547 Hypothetical protein 1,470 
glycosyl transferase CDS Prokka:CAMC1786_01548 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC1786_01549 dTDP-glucose 4,6-dehydratase 1,008 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC1786_01550 dTDP-4-dehydrorhamnose reductase 948 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC1786_01551 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC1786_01552 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC1786_01553 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 1790 - Chicken - NH-P 
   
kpsC Prokka:CAMC1790_01373 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC1790_01374 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,818 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC1790_01375 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS Prokka:CAMC1790_01376 Hypothetical protein 933 
transferase, putative CDS Prokka:CAMC1790_01377 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC1790_01378 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC1790_01379 3-oxoacyl-[acyl-carrier protein] reductase 756 
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Hypothetical protein CDS Prokka:CAMC1790_01380 Hypothetical protein 300 
Hypothetical protein CDS Prokka:CAMC1790_01381 Hypothetical protein 2,736 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC1790_01382 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC1790_01383 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC1790_01384 Hypothetical protein 1,470 
glycosyl transferase CDS Prokka:CAMC1790_01385 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC1790_01386 dTDP-glucose 4,6-dehydratase 1,008 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC1790_01387 dTDP-4-dehydrorhamnose reductase 882 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC1790_01388 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC1790_01389 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC1790_01390 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 1973 - Chicken - NH-NP 
   
kpsC Prokka:CAMC1973_01610 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC1973_01611 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,782 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC1973_01612 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS 
  
936 
Hypothetical protein CDS Prokka:CAMC1973_01613 Hypothetical protein 954 
transferase, putative CDS Prokka:CAMC1973_01614 transferase, putative 687 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC1973_01615 Long-chain-fatty-acid--CoA ligase 1,359 
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3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC1973_01616 3-oxoacyl-[acyl-carrier protein] reductase 756 
Hypothetical protein CDS Prokka:CAMC1973_01617 Hypothetical protein 300 
Hypothetical protein CDS 
  
2,736 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC1973_01622 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC1973_01623 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC1973_01624 Hypothetical protein 1,470 
glycosyl transferase CDS Prokka:CAMC1973_01625 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC1973_01626 dTDP-glucose 4,6-dehydratase 1,037 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC1973_01627 dTDP-4-dehydrorhamnose reductase 953 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC1973_01628 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC1973_01629 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC1973_01630 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 1998 - Chicken - NH-NP 
   
kpsC Prokka:CAMC1998_01508 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC1998_01509 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,794 
Unknown, Putative lipopolysaccharide biosynthesis 
protein CDS 
Prokka:CAMC1998_01510 Unknown, Putative lipopolysaccharide biosynthesis protein 402 
Hypothetical protein CDS Prokka:CAMC1998_01511 Hypothetical protein 936 
Hypothetical protein CDS Prokka:CAMC1998_01512 Hypothetical protein 1,002 
transferase, putative CDS Prokka:CAMC1998_01513 transferase, putative 687 
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Ortholog Prokka ID Product Length 
Long-chain-fatty-acid--CoA ligase CDS Prokka:CAMC1998_01514 Long-chain-fatty-acid--CoA ligase 1,359 
3-oxoacyl-[acyl-carrier protein] reductase CDS Prokka:CAMC1998_01515 3-oxoacyl-[acyl-carrier protein] reductase 756 
Hypothetical protein CDS Prokka:CAMC1998_01516 Hypothetical protein 300 
Hypothetical protein CDS Prokka:CAMC1998_01517 Hypothetical protein 2,736 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC1998_01518 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,347 
DegT/DnrJ/EryC1/StrS aminotransferase CDS Prokka:CAMC1998_01519 DegT/DnrJ/EryC1/StrS aminotransferase 1,092 
Hypothetical protein CDS Prokka:CAMC1998_01520 Hypothetical protein 1,482 
glycosyl transferase CDS Prokka:CAMC1998_01522 glycosyl transferase 939 
dTDP-glucose 4,6-dehydratase CDS Prokka:CAMC1998_01523 dTDP-glucose 4,6-dehydratase 1,041 
dTDP-4-dehydrorhamnose reductase CDS Prokka:CAMC1998_01524 dTDP-4-dehydrorhamnose reductase 951 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC1998_01525 dTDP-4-dehydrorhamnose 3,5-epimerase 576 
Glucose-1-phosphate thymidylyltransferase CDS Prokka:CAMC1998_01526 Glucose-1-phosphate thymidylyltransferase 888 
kpsF CDS Prokka:CAMC1998_01527 Capsular polysaccharide export system protein KpsF 948 
    
C. coli 2350 - Human - H-NP 
   
kpsC Prokka:CAMC2350_01396 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC2350_01397 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,971 
CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase CDS Prokka:CAMC2350_01398 CDP-4-dehydro-6-deoxy-D-glucose 3-dehydratase 1,161 
NAD-dependent epimerase/dehydratase family protein 
CDS 
Prokka:CAMC2350_01399 NAD-dependent epimerase/dehydratase family protein 1,029 
dTDP-4-dehydrorhamnose 3,5-epimerase CDS Prokka:CAMC2350_01400 dTDP-4-dehydrorhamnose 3,5-epimerase 558 
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Ortholog Prokka ID Product Length 
GDP-mannose 4,6-dehydratase CDS Prokka:CAMC2350_01401 GDP-mannose 4,6-dehydratase 1,140 
Mannose-1-phosphate guanylyltransferase (GDP) CDS Prokka:CAMC2350_01402 Mannose-1-phosphate guanylyltransferase (GDP) 1,368 
fcf2 CDS Prokka:CAMC2350_01403 dTDP-fucopyranose mutase 1,257 
F5/8 type C domain protein CDS Prokka:CAMC2350_01404 F5/8 type C domain protein 1,872 
Beta-1,3-galactosyltransferase / Beta-1,4-
galactosyltransferase CDS 
Prokka:CAMC2350_01405 Beta-1,3-galactosyltransferase / Beta-1,4-galactosyltransferase 1,320 
hypothetical protein CDS Prokka:CAMC2350_01406 hypothetical protein 1,110 
hypothetical protein CDS Prokka:CAMC2350_01407 hypothetical protein 1,029 
CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase CDS 
Prokka:CAMC2350_01408 CDP-Glycerol:Poly(glycerophosphate) 
glycerophosphotransferase 
1,191 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 
CDS 
Prokka:CAMC2350_01409 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 1,377 
kpsF CDS Prokka:CAMC2350_01410 Capsular polysaccharide export system protein KpsF 954 
    
C. coli RM2228 - Chicken 
   
kpsC Prokka:CAMC2899_01461 Capsular polysaccharide biosynthesis/export periplasmic protein 
WcbA; Capsular polysaccharide export system protein KpsC 
2,028 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC2899_01462 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,188 
cysC CDS Prokka:CAMC2899_01463 Adenylyl-sulfate kinase 582 
yidE CDS Prokka:CAMC2899_01464 Putative transport protein YidE 1,716 
tuf 2 CDS Prokka:CAMC2899_01465 Translation elongation factor Tu 1,425 
cysD CDS Prokka:CAMC2899_01466 Sulfate adenylyltransferase subunit 2 894 
3'(2'),5'-bisphosphate nucleotidase CDS Prokka:CAMC2899_01467 3'(2'),5'-bisphosphate nucleotidase 744 
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Ortholog Prokka ID Product Length 
CMP-N-acetylneuraminate-beta-galactosamide- alpha-
2,3-sialyltransferase CDS 
Prokka:CAMC2899_01468 CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-
sialyltransferase 
1,080 
gph CDS Prokka:CAMC2899_01469 Phosphoglycolate phosphatase 594 
tabA CDS Prokka:CAMC2899_01470 Toxin-antitoxin biofilm protein TabA 489 
kynB CDS Prokka:CAMC2899_01471 Kynurenine formamidase 672 
UDP-GlcNAc-specific C4,6 dehydratase/C5 epimerase 
(PseB, first step of pseudaminic acid biosynthesis) CDS 
Prokka:CAMC2899_01472 UDP-GlcNAc-specific C4,6 dehydratase/C5 epimerase (PseB, 
first step of pseudaminic acid biosynthesis) 
876 
serA 2 CDS Prokka:CAMC2899_01473 D-3-phosphoglycerate dehydrogenase 954 
rhmA CDS Prokka:CAMC2899_01474 2-keto-3-deoxy-L-rhamnonate aldolase 765 
Pseudaminic acid cytidylyltransferase CDS Prokka:CAMC2899_01475 Pseudaminic acid cytidylyltransferase 675 
hypothetical protein CDS Prokka:CAMC2899_01476 hypothetical protein 261 
putative glycosyltransferase involved in 
capsulebiosynthesis CDS 
Prokka:CAMC2899_01477 putative glycosyltransferase involved in capsulebiosynthesis 978 
kpsF CDS Prokka:CAMC2899_01478 Capsular polysaccharide export system protein KpsF 954 
 
 
 
 
Appendix B 
 
 
 
267 
 
Appendix B - Supplementary data chapter 5 
 
Table A-1: Motility measurements (diameter mm ± standard deviation), for all isolates at each 
temperature/time combination. A diameter of ≤6 mm is considered non-motile. ........................... 199 
Table A-2: Primer sequences used for detection of 18 virulence associated genes. ........................ 200 
Table A-3: Annotation data for lipooligosaccharide locus .............................................................. 203 
Table A-4: Annotation data for the capsular polysaccharide locus ................................................. 229 
Table B-1: Model parameters and AICc for all isolates/strains at 53 °C. ........................................ 268 
Table B-2: Model parameters and AICc for all isolates/strains at 57 °C. ........................................ 272 
Table B-3: Model parameters for all isolates/strains after exposure to chlorine at 1.10 ppm, pH 6.50. 
Unlikely is stated if given by the model, Standard Error is stated if the standard error of any model 
parameter is larger than the parameter. ............................................................................................ 276 
 
 
Appendix B 
 
 
 
268 
 
117 436 448 462 470 697 722 741
W53δ 117.5433 188.7274 87.55903 202.9385 154.4426 19.8904 131.0455 110.6132
W53 β 1.381546 1.07696 1.122067 1.631193 1.097516 0.514872 1.454254 1.398169
W53log10(N0) 6.751833 7.59909 7.068205 6.90376 7.037645 6.049627 6.986191 6.69132
LSSE 9.08 0.3 3.81 4.05 1.58 9.72 2.2 10.91
MSSE 0.302552 0.016049 0.126959 0.135035 0.083057 0.323959 0.116007 0.574173
RMSE 0.550047 0.126686 0.356313 0.367472 0.288197 0.569174 0.340599 0.757742
R2 0.836745 0.952145 0.933673 0.757991 0.859317 0.830682 0.92199 0.776831
R2adj 0.825861 0.947107 0.929251 0.741857 0.844508 0.819394 0.913778 0.753339
logN180 4.950105 6.648802 4.823419 6.081465 5.854628 2.941192 5.399582 4.715876
dec180 1.801728 0.950288 2.244786 0.822296 1.183016 3.108435 1.586608 1.975444
AICc -30.3621 -80.7403 -59.0208 -57.0049 -44.1896 -28.1144 -36.9069 -1.67998
WTlog10(Nres) -65.8409 -95.5139 3.354479 4.815409 -154.305 2.52039 3.57506 -59.9449
WT53δ 117.5433 188.7274 105.4227 201.0334 154.4426 13.94207 139.5343 110.6132
WT53 β 1.381546 1.07696 1.493861 1.942174 1.097516 0.555306 1.688395 1.398169
WT53log10(N0) 6.751833 7.59909 6.947175 6.871906 7.037645 6.560782 6.931531 6.69132
LSSE 9.08 0.3 3.14 4.02 1.58 7.25 2.12 10.91
MSSE 0.312985 0.016941 0.108247 0.138701 0.087672 0.250172 0.117526 0.606072
RMSE 0.55945 0.130157 0.329009 0.372425 0.296094 0.500172 0.34282 0.778506
R2 0.836745 0.952145 0.945334 0.759708 0.859317 0.873605 0.925128 0.776831
R2adj 0.819856 0.944169 0.939679 0.73485 0.83587 0.86053 0.91265 0.739636
AICc -27.3535 -76.8903 -62.3946 -54.2417 -40.3396 -34.7809 -33.8718 2.170022
comment No No No No
DW53α 4.51 1.67 3.018353 1.72 2.6 3.274991 2.54 2.783446
DW53δ 1 117.5433 188.7274 106.8199 199.15 154.4426 16.3691 138.7741 123.325
DW53β 1.381546 1.07696 1.552893 1.967713 1.097516 0.630421 1.700459 1.749433
DW53log10(N0) 6.751833 7.59909 6.934926 6.870211 7.037645 6.554691 6.931008 6.603612
DW53δ 2 117.5433 188.7274 428.2169 570.5401 154.4426 442.5758 342.0874 296.1441
LSSE 9.08 0.3 3.13 4.03 1.58 7.15 2.14 10.71
MSSE 0.312985 0.016941 0.108014 0.138858 0.087672 0.24667 0.118641 0.594748
RMSE 0.55945 0.130157 0.328655 0.372637 0.296094 0.496659 0.344443 0.771199
R2 0.836745 0.952145 0.945451 0.759435 0.859317 0.875374 0.924418 0.781001
R2adj 0.819856 0.944169 0.939808 0.734549 0.83587 0.862482 0.911821 0.744501
AICc -24.1043 -72.4903 -59.2507 -50.9105 -35.9396 -31.99 -29.2652 6.162979
∆AIC-min -30.3621 -80.7403 -62.3946 -57.0049 -44.1896 -34.7809 -36.9069 -1.67998
∆AIC W 0 0 3.373864 0 0 6.66653 0 0
∆AIC WT 3.008547 3.85 0 2.763193 3.85 0 3.035092 3.85
∆AIC DW 6.257778 8.25 3.143968 6.094411 8.25 2.79089 7.641666 7.842958
wi - sum exp 1.265945 1.162039 1.392719 1.298669 1.162039 1.283399 1.241159 1.165688
wi - W 0.789924 0.860556 0.132896 0.770019 0.860556 0.027798 0.805699 0.857863
wi - WT 0.175504 0.125534 0.71802 0.193411 0.125534 0.779181 0.176649 0.125141
wi - DW 0.034572 0.01391 0.149085 0.036569 0.01391 0.193021 0.017652 0.016996
Table B-1: Model parameters and AICc for all isolates/strains at 53 °C.  
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743 744 1180 1377 1431 1765 1786 1790
W53δ 77.06743 141.2555 80.77984 95.0673 105.5592 103.0767 185.8399 149.215
W53 β 1.163643 1.134393 0.970033 1.092658 1.142087 0.972263 1.474157 1.355488
W53log10(N0) 6.63041 6.202886 6.549089 7.072863 7.069552 7.191684 6.452618 6.694927
LSSE 3.85 1.18 4.65 2.82 0.45 1.48 3.02 3.2
MSSE 0.128209 0.061945 0.24478 0.093841 0.02346 0.049458 0.159138 0.168257
RMSE 0.358063 0.248887 0.494753 0.306335 0.153167 0.222392 0.398922 0.410191
R2 0.954392 0.913791 0.856905 0.936393 0.98219 0.946353 0.76095 0.828396
R2adj 0.951351 0.904717 0.841843 0.932153 0.980315 0.942776 0.735787 0.810332
logN180 3.946995 4.886407 4.373674 5.064094 5.230014 5.472206 5.498595 5.405436
dec180 2.683415 1.316479 2.175414 2.008769 1.839538 1.719478 0.954023 1.289491
AICc -58.6761 -50.6116 -20.4419 -68.9502 -71.8201 -90.2251 -29.9373 -28.6636
WTlog10(Nres) -7.97272 -158.844 -20.1434 -5.61557 3.774956 4.45206 -86.706 -130.148
WT53δ 77.06742 141.2555 80.77984 95.06727 113.9677 113.1396 185.8399 149.215
WT53 β 1.163642 1.134393 0.970033 1.092658 1.338055 1.242529 1.474157 1.355488
WT53log10(N0) 6.63041 6.202886 6.549089 7.072863 7.01677 7.12602 6.452618 6.694927
LSSE 3.85 1.18 4.65 2.82 0.35 1.27 3.02 3.2
MSSE 0.13263 0.065386 0.258379 0.097077 0.0194 0.043765 0.167979 0.177604
RMSE 0.364185 0.255707 0.50831 0.311572 0.139285 0.209201 0.409853 0.421431
R2 0.954392 0.913791 0.856905 0.936393 0.986047 0.95411 0.76095 0.828396
R2adj 0.949673 0.899423 0.833056 0.929813 0.983721 0.949363 0.721108 0.799795
AICc -55.6676 -46.7616 -16.5919 -65.9417 -73.499 -92.2664 -26.0873 -24.8136
comment No No No No No No No
DW53α 0.531512 2.76 2.154465 0.951991 1.443854 1.488515 0.8836 2.089256
DW53δ 1 48.54649 141.2555 80.91033 87.3748 111.8771 110.15 169.4365 148.4862
DW53β 1.492851 1.134393 1.00092 1.847166 1.504209 1.426212 2.13388 1.406276
DW53log10(N0) 6.691485 6.202886 6.549585 7.001488 6.997912 7.105147 6.397049 6.68693
DW53δ 2 111.8442 141.2555 160.4151 183.9317 212.3238 276.9262 302.0673 298.2609
LSSE 3.73 1.18 4.64 2.69 0.34 1.25 2.99 3.19
MSSE 0.128457 0.065386 0.257995 0.092807 0.018813 0.04317 0.166163 0.177457
RMSE 0.358409 0.255707 0.507932 0.304643 0.137161 0.207774 0.40763 0.421256
R2 0.955827 0.913791 0.857118 0.939191 0.986469 0.954734 0.763536 0.828538
R2adj 0.951257 0.899423 0.833304 0.9329 0.984214 0.950052 0.724125 0.799962
AICc -53.4633 -42.3616 -12.2392 -64.2499 -69.7367 -89.541 -21.9069 -20.4825
∆AIC-min -58.6761 -50.6116 -20.4419 -68.9502 -73.499 -92.2664 -29.9373 -28.6636
∆AIC W 0 0 0 0 1.678917 2.041284 0 0
∆AIC WT 3.008547 3.85 3.85 3.008547 0 0 3.85 3.85
∆AIC DW 5.212836 8.25 8.202637 4.70032 3.762274 2.72541 8.030364 8.181142
wi - sum exp 1.295977 1.162039 1.162427 1.317533 1.584361 1.616331 1.163915 1.162605
wi - W 0.771619 0.860556 0.860269 0.758995 0.27263 0.222952 0.859169 0.860137
wi - WT 0.171437 0.125534 0.125492 0.168632 0.631169 0.618685 0.125332 0.125473
wi - DW 0.056944 0.01391 0.014238 0.072373 0.096201 0.158363 0.015499 0.01439
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1898 1973 1998 2043 2046 2189 2323 2350
W53δ 98.45259 157.6155 131.95 75.69265 19.434 82.19015 28.92471 262.7484
W53 β 1.197175 2.016453 1.316089 0.786872 0.51077 0.97802 0.753647 1.196265
W53log10(N0) 6.984856 6.612747 7.239697 6.913701 6.413152 6.900516 7.287628 6.850389
LSSE 1.41 0.74 3.59 0.77 6.29 2.99 2.98 1.61
MSSE 0.073966 0.039051 0.18913 0.040345 0.209803 0.072854 0.157025 0.084493
RMSE 0.271967 0.197613 0.434891 0.200861 0.458042 0.269915 0.396264 0.290677
R2 0.958993 0.977191 0.848399 0.95931 0.888096 0.948572 0.958818 0.661132
R2adj 0.954676 0.97479 0.832441 0.955026 0.880636 0.946063 0.954483 0.625462
logN180 4.925582 5.305686 5.734852 4.936566 3.295938 4.747885 3.321214 6.214337
dec180 2.059275 1.307061 1.504845 1.977134 3.117214 2.152631 3.966414 0.636052
AICc -46.694 -60.8772 -26.1336 -60.003 -13.7958 -106.733 -30.2306 -43.7758
WTlog10(Nres) -24.3059 -75.6151 -60.2559 3.44025 2.490272 2.69743 -12.9546 -1871.16
WT53δ 98.45259 157.6155 131.95 78.10332 19.49795 84.56199 28.92471 262.7484
WT53 β 1.197175 2.016453 1.316089 0.827558 0.57628 1.01083 0.753647 1.196265
WT53log10(N0) 6.984856 6.612747 7.239697 6.900101 6.591493 6.884854 7.287628 6.850389
LSSE 1.41 0.74 3.59 0.76 4.59 2.99 2.98 1.61
MSSE 0.078075 0.041221 0.199637 0.042173 0.158337 0.074709 0.165749 0.089187
RMSE 0.27942 0.203029 0.446808 0.20536 0.397915 0.27333 0.407122 0.298643
R2 0.958993 0.977191 0.848399 0.959705 0.918362 0.948548 0.958818 0.661132
R2adj 0.952158 0.973389 0.823132 0.952989 0.909917 0.944689 0.951954 0.604654
AICc -42.844 -57.0272 -22.2836 -56.4405 -16.8776 -104.042 -26.3806 -39.9258
comment No No No No No No No
DW53α 0.508541 2.745638 3.045071 0.906359 3.721727 1.020055 2.128108 0.65
DW53δ 1 92.91852 162.0427 139.0267 72.21046 14.37141 83.90634 42.08637 262.7484
DW53β 1.333859 2.230399 1.515013 0.927755 0.596022 1.541595 1.544465 1.196264
DW53log10(N0) 6.959453 6.581487 7.193073 6.887636 7.00659 6.805871 7.210746 6.850389
DW53δ 2 126.6906 294.7469 53156103 142.6453 1307.954 171.247 128.542 262.7484
LSSE 1.4 0.71 3.54 0.76 3.18 2.87 2.22 1.61
MSSE 0.077792 0.03944 0.196696 0.042033 0.109737 0.071875 0.123537 0.089187
RMSE 0.278913 0.198596 0.443504 0.20502 0.331266 0.268094 0.351479 0.298643
R2 0.959141 0.978176 0.850633 0.959838 0.94342 0.950501 0.969306 0.661132
R2adj 0.952331 0.974538 0.825739 0.953144 0.937567 0.946788 0.96419 0.604654
AICc -38.6005 -53.5377 -18.1921 -52.0405 -20.5515 -103.004 -28.4578 -35.5258
∆AIC-min -46.694 -60.8772 -26.1336 -60.003 -20.5515 -106.733 -30.2306 -43.7758
∆AIC W 0 0 0 0 6.755757 0 0 0
∆AIC WT 3.85 3.85 3.85 3.562414 3.673974 2.691323 3.85 3.85
∆AIC DW 8.093416 7.339525 7.94144 7.962414 0 3.729864 1.772846 8.25
wi - sum exp 1.163356 1.171358 1.164736 1.187098 1.193416 1.415274 1.558003 1.162039
wi - W 0.859582 0.85371 0.858564 0.842391 0.02859 0.706577 0.641847 0.860556
wi - WT 0.125392 0.124536 0.125244 0.141888 0.13348 0.18397 0.09363 0.125534
wi - DW 0.015025 0.021755 0.016192 0.015722 0.83793 0.109454 0.264523 0.01391
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2554 2670 2672 2674 2689 2704 2898 2899
W53δ 42.02869 26.1324 92.37411 108.2657 104.8964 38.48352 115.2055 161.4678
W53 β 0.775531 0.556009 1.021355 0.983233 1.013758 0.755878 1.135294 2.00715
W53log10(N0) 5.796042 6.341022 6.334934 6.568194 6.865891 6.337093 6.724772 6.247448
LSSE 7.49 1.05 3.92 1.98 2 7.15 0.43 6.06
MSSE 0.39412 0.055353 0.206567 0.104353 0.066563 0.37632 0.022491 0.319052
RMSE 0.62779 0.235271 0.454497 0.323038 0.257997 0.613449 0.149971 0.564847
R2 0.875519 0.964149 0.86201 0.891321 0.933141 0.8634 0.978924 0.824656
R2adj 0.862415 0.960375 0.847485 0.879881 0.928683 0.849021 0.976706 0.806199
logN180 2.706291 3.416958 4.358377 4.919729 5.137116 3.127602 5.065113 5.003763
dec180 3.089752 2.924064 1.976557 1.648465 1.728775 3.209491 1.659659 1.243686
AICc -9.95442 -53.1796 -24.1989 -39.2248 -80.2887 -10.9765 -72.8203 -14.6153
WTlog10(Nres) 1.357048 -0.64305 3.163701 3.688207 -7.07115 0.191636 -12.285 -85.274
WT53δ 32.75471 33.12073 102.7754 112.7623 104.8964 11.53 115.2055 161.4678
WT53 β 0.788064 0.632126 1.270734 1.112076 1.013758 0.499118 1.135294 2.00715
WT53log10(N0) 6.284022 6.326429 6.272142 6.537659 6.865891 7.049691 6.724772 6.247448
LSSE 6.09 1.24 3.75 1.95 2 5.33 0.43 6.06
MSSE 0.338476 0.06877 0.208594 0.108226 0.068858 0.296335 0.023741 0.336778
RMSE 0.581787 0.26224 0.456721 0.328978 0.262408 0.544367 0.15408 0.580325
R2 0.89872 0.957803 0.86799 0.89322 0.933141 0.898095 0.978924 0.824656
R2adj 0.88184 0.95077 0.845989 0.875423 0.926224 0.881111 0.975411 0.795433
AICc -10.6567 -45.6705 -21.3243 -35.7107 -77.2801 -13.5892 -68.9703 -10.7653
comment No No No No No
DW53α 3.58 1.513703 1.263285 0.851534 2.85 2.572893 2.71 2.729978
DW53δ 1 33.20965 34.91735 91.30096 97.71891 104.8964 28.46014 115.2055 161.4597
DW53β 0.800707 1.055654 1.5816 1.515442 1.013758 1.347185 1.135294 2.007182
DW53log10(N0) 6.270908 6.291748 6.319184 6.505815 6.865891 7.000363 6.724772 6.247446
DW53δ 2 201.0345 136.181 196.376 210.4606 104.8964 152.5941 115.2055 165.885
LSSE 6.21 0.89 3.68 1.92 2 4.46 0.43 6.06
MSSE 0.345175 0.049455 0.204349 0.106435 0.068858 0.247808 0.023741 0.336778
RMSE 0.587516 0.222384 0.45205 0.326244 0.262408 0.497803 0.15408 0.580325
R2 0.896716 0.969654 0.870677 0.894987 0.933141 0.914783 0.978924 0.824656
R2adj 0.879502 0.964597 0.849123 0.877485 0.926224 0.90058 0.975411 0.795433
AICc -5.82739 -48.5667 -17.3389 -31.6518 -74.0309 -13.1097 -64.5703 -6.36532
∆AIC-min -10.6567 -53.1796 -24.1989 -39.2248 -80.2887 -13.5892 -72.8203 -14.6153
∆AIC W 0.702256 0 0 0 0 2.612745 0 0
∆AIC WT 0 7.509067 2.874612 3.514116 3.008547 0 3.85 3.85
∆AIC DW 4.829282 4.612872 6.860064 7.573024 6.257778 0.479546 8.25 8.25
wi - sum exp 1.793293 1.123027 1.269953 1.195226 1.265945 2.057607 1.162039 1.162039
wi - W 0.392515 0.890451 0.787431 0.836662 0.789924 0.131609 0.860556 0.860556
wi - WT 0.557633 0.020847 0.187067 0.144367 0.175504 0.486001 0.125534 0.125534
wi - DW 0.049852 0.088703 0.025502 0.018971 0.034572 0.382389 0.01391 0.01391
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117 436 448 462 470 697 722 741
W53δ 1.687619 2.701126 0.77224 0.257145 1.599448 0.847162 6.498921 2.754173
W53 β 0.385563 0.330278 0.31553 0.284888 0.3216 0.224255 0.514872 0.40537
W53log10(N0) 7.27318 7.129342 7.075317 7.272724 6.332765 4.654582 5.894657 7.095332
LSSE 11.09 6.38 10.13 12.07 9.55 34.43 8.35 7.6
MSSE 0.791983 0.303862 0.562982 0.861928 0.391559 1.639437 0.695725 0.399827
RMSE 0.889935 0.551237 0.750322 0.928401 0.454669 1.280405 0.834101 0.632319
R2 0.89299 0.905205 0.898091 0.889066 0.674291 0.636748 0.882062 0.927531
R2adj 0.877703 0.896177 0.886768 0.873218 0.884168 0.602153 0.862405 0.919902
logN180 1.220868 3.126789 1.490295 0.808249 0.873136 0.873136 0.873136 0.873136
dec180 6.052312 4.002552 5.585022 6.464475 5.45963 3.781446 5.021521 6.222196
AICc 8.192663 -18.4639 -1.30944 9.63221 -8.78297 21.99432 7.879837 -9.63367
WTlog10(Nres) 1.098901 2.904849 1.524275 0.880533 1.48627 -3.2551 -2.76691 0.690946
WT53δ 8.102616 3.806327 25.78479 10.33129 3.319914 1.45E-06 0.475818 3.701789
WT53 β 0.66167 0.459757 1.439372 0.856713 0.398576 0.087301 0.292414 0.44181
WT53log10(N0) 7.100609 7.28415 6.265177 6.831071 6.386125 6.291343 6.462784 7.057052
LSSE 9.62 4.69 15.47 6.99 11.7 14.74 5.14 7.58
MSSE 0.740362 0.234569 0.909818 0.53751 0.585049 0.736873 0.467004 0.420956
RMSE 0.860443 0.484323 0.953844 0.733151 0.764885 0.858413 0.683377 0.648811
R2 0.90711 0.930307 0.844458 0.935761 0.858049 0.844505 0.927431 0.927717
R2adj 0.885674 0.919853 0.817009 0.920937 0.836757 0.821181 0.90764 0.915669
AICc 10.72073 -22.2417 11.58198 5.291543 -0.30198 5.241442 6.435043 -5.84164
comment unlikely unlikely
DW53α 4.229457 2.852029 3.808871 5.899997 7.03 2 2.298512 3.019331
DW53δ 1 11.25379 0.778177 1.403319 1.486358 0.001017 2.05E-06 0.037082 8.760536
DW53β 0.810511 0.318368 0.353896 0.374185 0.144909 0.088367 0.211535 0.622865
DW53log10(N0) 7.065391 7.600212 6.912653 6.712537 7.605412 6.281256 6.984064 6.935311
DW53δ 2 101.6075 24.60307 21.84447 20.20849 0.001017 2.05E-06 0.037082 44.829
LSSE 8.87 3.79 10.23 13.28 5.07 14.87 4.55 7.2
MSSE 0.68261 0.189641 0.601699 1.02131 0.253538 0.743606 0.413303 0.400021
RMSE 0.826202 0.435478 0.775692 1.010599 0.503526 0.862326 0.642886 0.632472
R2 0.914356 0.943655 0.897134 0.877942 0.938484 0.843084 0.935776 0.931311
R2adj 0.894592 0.935204 0.878981 0.849775 0.929256 0.819547 0.91826 0.919863
AICc 15.38529 -23.2965 7.51223 22.24622 -16.3131 9.511006 12.10616 -2.57315
∆AIC-min 8.192663 -23.2965 -1.30944 5.291543 -16.3131 5.241442 6.435043 -9.63367
∆AIC W 0 4.832583 0 4.340668 7.530141 16.75288 1.444794 0
∆AIC WT 2.528062 1.054774 12.89143 0 16.01113 0 0 3.792029
∆AIC DW 7.192626 0 8.821673 16.95468 0 4.269564 5.671112 7.060521
wi - sum exp 1.309938 1.679397 1.013732 1.114348 1.0235 1.118501 1.544273 1.179463
wi - W 0.763395 0.053145 0.986454 0.102427 0.022634 0.000206 0.314444 0.847843
wi - WT 0.215669 0.351403 0.001566 0.897386 0.000326 0.894054 0.647554 0.127317
wi - DW 0.020936 0.595452 0.01198 0.000187 0.97704 0.10574 0.038002 0.02484
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Table B-2 continued 
 
743 744 1180 1377 1431 1765 1786 1790
W53δ 0.641495 5.44802 29.86199 11.65531 4.782514 0.54385 16.23971 11.63601
W53 β 0.286456 0.433976 0.711797 0.565929 0.45689 0.284727 0.612192 0.45336
W53log10(N0) 5.961581 5.721938 4.630239 6.381541 6.866854 7.426009 6.639141 5.414527
LSSE 19.5 16.24 25.59 11.52 7.87 7.73 19.56 21.16
MSSE 1.083393 1.082623 1.505198 0.639771 0.43724 0.368297 0.652081 1.007559
RMSE 1.040862 1.040492 1.226865 0.799857 0.661241 0.606875 0.807515 1.003773
R2 0.800094 0.84246 0.684444 0.868622 0.921246 0.916432 0.868229 0.705521
R2adj 0.777882 0.821455 0.64732 0.854025 0.912495 0.908473 0.859444 0.677476
logN180 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136
dec180 5.088445 4.848802 3.757103 5.508405 5.993718 6.552873 5.766005 4.541391
AICc 12.44373 13.1479 19.2151 1.390807 -6.61075 -13.8573 -5.03747 10.31074
WTlog10(Nres) -2.9023 0.829218 -0.87691 -5.206 1.556909 -9.41269 1.648648 -4.67995
WT53δ 6.88E-06 3.194279 5.474271 5.799408 25.166 6.393856 16.56768 22.31922
WT53 β 0.104701 0.458217 0.391363 0.437254 1.238913 0.452845 0.736323 0.556825
WT53log10(N0) 7.02555 6.949224 5.14045 6.228409 6.658718 6.746129 7.073591 5.225687
LSSE 8.32 11.44 18.9 9.36 9.31 9.85 12.17 23.03
MSSE 0.489618 0.817308 1.181348 0.550502 0.547838 0.492406 0.419513 1.151521
RMSE 0.699727 0.904051 1.086898 0.741958 0.740161 0.701717 0.647698 1.073089
R2 0.914676 0.888997 0.766906 0.893234 0.906807 0.893592 0.918052 0.679472
R2adj 0.899618 0.86521 0.723201 0.874393 0.890361 0.87763 0.909574 0.631393
AICc -1.44306 11.47776 17.33013 1.03038 0.9179 -4.4328 -17.6878 15.95103
comment unlikely unlikely unlikely unlikely unlikely
DW53α 2 6.113829 5.91 2.58847 3.825635 3.591027 5.424944 5.756964
DW53δ 1 5.47E-06 1.020308 0.119368 0.313945 28.19821 0.199124 16.56768 0.110786
DW53β 0.104701 0.347972 0.226611 0.654399 1.426826 1.366568 0.736323 0.201591
DW53log10(N0) 7.15 6.861099 6.443734 7.22398 6.618364 7.525 7.07359 6.377101
DW53δ 2 1.16E-05 6.390726 4.327343 37.01407 162.9931 135.1591 1.35E+13 0.110786
LSSE 8.35 9.53 13.48 6.19 5.17 7.19 12.17 16.82
MSSE 0.491464 0.680849 0.842317 0.364232 0.304084 0.359431 0.419513 0.840953
RMSE 0.701045 0.825136 0.917778 0.603517 0.551438 0.599526 0.647698 0.917035
R2 0.914354 0.90753 0.833801 0.92936 0.948272 0.922328 0.918052 0.765919
R2adj 0.89924 0.887715 0.802638 0.916894 0.939144 0.910677 0.909574 0.730807
AICc 3.247906 13.75331 15.44283 -3.03795 -6.81926 -7.9287 -14.4386 12.46836
∆AIC-min -1.44306 11.47776 15.44283 -3.03795 -6.81926 -13.8573 -17.6878 10.31074
∆AIC W 13.8868 1.670141 3.772272 4.428756 0.208508 0 12.65037 0
∆AIC WT 0 0 1.887301 4.06833 7.73716 9.424545 0 5.640286
∆AIC DW 4.69097 2.275554 0 0 0 5.928642 3.249231 2.157612
wi - sum exp 1.096766 1.754375 1.540861 1.240011 1.921884 1.06058 1.198778 1.399599
wi - W 0.00088 0.247293 0.098423 0.088081 0.468809 0.94288 0.001494 0.714491
wi - WT 0.911772 0.570004 0.252589 0.105475 0.010869 0.008471 0.834183 0.042582
wi - DW 0.087348 0.182704 0.648988 0.806444 0.520323 0.048648 0.164324 0.242928
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1898 1973 1998 2043 2046 2189 2323 2350
W53δ 18.1684 13.44105 2.666253 5.727457 7.40518 0.60192 5.725274 10.72204
W53 β 0.649326 0.657537 0.377399 0.482 0.486515 0.322395 0.463913 0.480023
W53log10(N0) 5.850493 6.256077 6.288007 6.042897 5.251514 7.634091 6.631512 6.9684
LSSE 18.44 27.58 8.45 14.55 40.51 6.1 9.78 8.22
MSSE 1.0244 1.723775 0.563387 0.632698 1.396896 0.304889 0.514927 0.391352
RMSE 1.012127 1.312926 0.750591 0.795423 1.181903 0.552168 0.717584 0.625581
R2 0.779822 0.77801 0.874941 0.893868 0.745083 0.953287 0.901487 0.909065
R2adj 0.755357 0.750261 0.858267 0.884639 0.727503 0.948616 0.891117 0.900404
logN180 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136
dec180 4.977357 5.382941 5.414871 5.169761 4.378378 6.760955 5.758376 6.095264
AICc 11.27 21.69577 1.388304 -2.09314 19.85371 -16.9963 -4.08547 -12.3823
WTlog10(Nres) -1.7037 0.792432 1.483018 1.032669 1.414147 1.367302 0.41455 2.42222
WT53δ 19.72635 14.54242 0.338088 25.04434 15.98801 12.81933 4.426597 17.43493
WT53 β 0.644351 0.797367 0.272567 1.306237 1.787315 0.94526 0.408723 0.692312
WT53log10(N0) 5.597451 6.558468 6.676541 6.074755 5.941483 7.368367 6.375509 7.190477
LSSE 17.84 24.93 8.23 15.22 41.93 11.24 10.22 6.42
MSSE 1.049692 1.661925 0.587679 0.69191 1.497667 0.591317 0.567597 0.320764
RMSE 1.024545 1.289157 0.766602 0.831811 1.223792 0.768971 0.75339 0.566361
R2 0.78692 0.799352 0.878246 0.888982 0.736118 0.913932 0.897126 0.929016
R2adj 0.749317 0.759222 0.852156 0.873843 0.707845 0.900343 0.87998 0.918368
AICc 14.57533 24.16103 5.54982 2.498412 24.0085 0.781646 0.732691 -14.7061
comment unlikely
DW53α 7.17 3.598515 5.433724 5.514336 6.62 6.79 6.99 5.508111
DW53δ 1 0.008195 13.59347 0.172288 0.718028 0.00051 1.936437 0.372299 5.18481
DW53β 0.175499 0.865512 0.23885 0.320973 0.142347 0.39332 0.28134 0.460153
DW53log10(N0) 7.29979 6.718147 6.693038 6.800801 7.238263 7.266851 7.385019 7.653853
DW53δ 2 0.008195 72.33011 0.172288 21.28231 0.00051 25.23534 0.372299 77398.16
LSSE 7.82 23.97 6.88 9.67 22.96 6.84 7.22 4.83
MSSE 0.460274 1.598177 0.49151 0.439761 0.820082 0.360131 0.401151 0.241682
RMSE 0.678435 1.26419 0.701077 0.663145 0.905584 0.600109 0.633365 0.491611
R2 0.906568 0.807048 0.89817 0.92944 0.855505 0.947582 0.927293 0.946517
R2adj 0.890079 0.768458 0.876349 0.919818 0.840024 0.939305 0.915176 0.938494
AICc 1.870789 28.59674 7.888444 -5.49355 8.043232 -6.42558 -2.51213 -17.477
∆AIC-min 1.870789 21.69577 1.388304 -5.49355 8.043232 -16.9963 -4.08547 -17.477
∆AIC W 9.399206 0 0 3.400408 11.81047 0 0 5.094703
∆AIC WT 12.70455 2.465255 4.161516 7.991964 15.96527 17.77796 4.818156 2.770896
∆AIC DW 0 6.900965 6.50014 0 0 10.57073 1.57334 0
wi - sum exp 1.010842 1.323256 1.163607 1.201036 1.003066 1.005203 1.545257 1.3285
wi - W 0.009001 0.755712 0.859397 0.152074 0.002717 0.994824 0.647142 0.05893
wi - WT 0.001724 0.220309 0.107283 0.015311 0.00034 0.000137 0.058177 0.188341
wi - DW 0.989275 0.023979 0.03332 0.832615 0.996943 0.005039 0.294681 0.752728
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2554 2670 2672 2674 2689 2704 2898 2899
W53δ 0.017945 8.701349 0.218887 0.445207 11.32715 16.97738 8.691454 8.272191
W53 β 0.184493 0.436469 0.238222 0.2828 0.490945 0.580455 0.537067 0.443945
W53log10(N0) 5.834935 4.845385 6.465643 7.000935 6.425766 4.44892 6.705802 5.721725
LSSE 7.19 20.93 8.44 12.29 25.25 26 11.49 21.65
MSSE 1.197613 0.91006 0.496376 0.455298 1.202146 1.733306 0.425679 0.773357
RMSE 1.094355 0.953971 0.70454 0.674758 1.096424 1.316551 0.652441 0.879407
R2 0.820207 0.781196 0.874663 0.903013 0.756213 0.667766 0.924976 0.83118
R2adj 0.760276 0.76217 0.859917 0.895829 0.732996 0.623468 0.919418 0.819121
logN180 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136 0.873136
dec180 4.961799 3.972249 5.592507 6.127799 5.55263 3.575784 5.832666 4.848589
AICc 27.9792 7.360262 -2.96929 -14.2723 13.40665 21.61905 -16.2916 1.271566
WTlog10(Nres) 0.854286 -0.03714 -6.30305 -3.55699 -1.81615 -2.07414 -8.30764 0.682838
WT53δ 19.73698 0.1738 0.218887 2.239677 13.58045 0.772747 3.996035 1.281038
WT53 β 6.802192 0.230842 0.238222 0.372403 0.50877 0.295014 0.454389 0.316139
WT53log10(N0) 5.095 5.988012 6.465643 6.595691 6.693182 5.666606 7.216243 6.374499
LSSE 11.99 10.69 8.44 13.15 28.42 15.27 10.15 15.87
MSSE 2.398364 0.485846 0.5274 0.505614 1.421123 1.090944 0.390404 0.587945
RMSE 1.548665 0.697027 0.726223 0.711065 1.192109 1.044483 0.624823 0.766776
R2 0.699952 0.888268 0.874663 0.896284 0.72553 0.804832 0.933741 0.876238
R2adj 0.519924 0.873031 0.851162 0.884317 0.68436 0.763011 0.926096 0.862486
AICc 56.58164 -6.68743 1.206539 -9.09109 20.99812 16.67569 -16.8595 -5.25626
comment unlikely unlikely unlikely unlikely unlikely unlikely
DW53α 4.295 6.025104 2.07571 0.830628 7.36 6.96 1.510887 6.95
DW53δ 1 2.404695 0.043527 0.218887 1E-10 0.377563 0.020683 4.572327 0.052867
DW53β 4 0.197875 0.238222 0.371511 0.268885 0.187541 0.488896 0.212243
DW53log10(N0) 7.5 6.274484 6.465643 7.16 7.719424 6.225599 7.202767 7.295324
DW53δ 2 24.04695 0.347675 0.218887 2.70659 0.377563 0.775338 8.99961 0.052867
LSSE err 9.13 8.44 11.79 19.99 9.75 10.07 12.96
MSSE err 0.414991 0.5274 0.453497 0.999687 0.696152 0.3872 0.479827
RMSE err 0.644198 0.726223 0.673422 0.999843 0.834357 0.622254 0.692695
R2 err 0.904563 0.874663 0.906975 0.806925 0.87546 0.934285 0.898997
R2adj err 0.891549 0.851162 0.896241 0.777963 0.848772 0.926703 0.887774
AICc err -6.98758 6.078334 -8.92746 16.61228 14.16412 -13.6582 -8.16614
∆AIC-min err -6.98758 -2.96929 -14.2723 13.40665 14.16412 -16.8595 -8.16614
∆AIC W err 14.34784 0 0 0 7.454927 0.567928 9.437705
∆AIC WT err 0.300149 4.175824 5.181249 7.591466 2.511575 0 2.909883
∆AIC DW err 0 9.047619 5.344883 3.205627 0 3.201345 0
wi - sum exp err 1.86141 1.134793 1.144057 1.223796 1.308905 1.954555 1.242339
wi - W err 0.000412 0.881218 0.874083 0.81713 0.018377 0.385149 0.007184
wi - WT err 0.462361 0.109223 0.065533 0.018358 0.217626 0.511626 0.187883
wi - DW err 0.537227 0.009559 0.060385 0.164512 0.763997 0.103226 0.804933
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Table B-3: Model parameters for all isolates/strains after exposure to chlorine at 1.10 ppm, pH 6.50. 
Unlikely is stated if given by the model, Standard Error is stated if the standard error of any model 
parameter is larger than the parameter. 
 
 
 
 
 
 
 
 
 
 
 
 
117 436 448 462 470 697 722 741
W δa 0.750000 1.534210 2.887414 3.203440 1.431361 0.466544 0.318009 1.746659
W β 0.510000 0.338624 0.698268 0.402415 0.725015 0.545398 0.416975 1.098926
W log10(N) 7.260000 7.503968 7.327668 7.465280 7.099727 7.047583 7.746248 6.627481
MSSE 1.414146 0.047000 0.323361 0.026686 0.818460 0.276352 2.173835 1.029395
RMSSE 1.189179 0.216794 0.568649 0.163359 0.904688 0.525692 1.474393 1.014591
R2 0.705260 0.936628 0.863222 0.953990 0.872891 0.956960 0.637824 0.883557
R2adj 0.659915 0.928178 0.844985 0.947855 0.853335 0.949787 0.586085 0.860269
4D ±11.6 ±9.8 ±6 ±9 ±6.24
Comment
WT log10(Nres) 2.727543 -4.792510 -5.780989 5.407988 1.613691 -1.225079 2.743380 0.400054
WT δ 2.009831 1.534211 2.887414 3.634765 0.972422 0.468024 1.096499 1.745717
WT β 0.899126 0.338624 0.698268 0.582804 0.696252 0.546065 0.687100 1.101074
WT log10(N0) 6.974438 7.503968 7.327668 7.387740 7.487080 7.046768 7.439830 6.627455
MSSE 1.369106 0.050357 0.346459 0.022781 0.631421 0.301471 2.142488 0.608219
RMSSE 1.170088 0.224403 0.588607 0.150935 0.794620 0.549063 1.463724 0.779884
r2 0.736597 0.936628 0.863222 0.963341 0.909482 0.956961 0.668543 0.938080
r2adj 0.670747 0.923048 0.833913 0.955485 0.886852 0.945222 0.592054 0.917440
4D ±10.4 ±7.2 ±6 ±8.6 ±6.24
Comment Unlikely Unlikely Unlikely Standard error Standard error Standard error
DW α 4.019498 2.770000 2.331163 1.251095 5.453508 1.005456 3.770000 4.564736
DW δ1 2.197887 1.534210 2.887414 3.105267 0.992085 0.441138 1.193488 1.723550
DW β 0.686975 0.338624 0.698268 0.411851 0.704036 0.708569 0.716986 1.637527
DW LOG10(N0) 0.685262 7.503968 7.327668 7.455341 7.480356 7.030714 7.358192 6.978877
DW delta2 6.76E+10 1.534210 2.887414 7.504407 59.383005 1.310091 21.543557 7.850019
MSSE 1.369106 0.050357 0.346459 0.028386 0.630882 0.297787 2.178554 0.228008
RMSSE 1.170088 0.224403 0.588607 0.168482 0.794281 0.545698 1.475993 0.477502
R2 0.736597 0.936628 0.863222 0.954321 0.909559 0.957487 0.662964 0.976787
R2adj 0.670747 0.923048 0.833913 0.944533 0.886949 0.945892 0.585186 0.969050
4D ±10.4 ±7.2 ±6.15 ±9.2 ±4.08
Comment Standard error Standard error Standard error Standard error Standard error Standard error Standard error
Biphasic f 0.999930 0.893313 0.915513 0.975643 0.999968 0.985680 0.999954 0.999975
kmax1 0.988232 3.114109 0.696268 0.458652 1.212819 3.926173 1.105029 2.124748
kmax2 0.000000 0.163431 0.306557 0.009556 0.137496 0.754875 0.000000 0.396588
LOG10(N0) 6.905181 7.390464 7.221187 7.226006 7.176394 6.961697 7.153339 7.197900
MSSE 1.372095 0.060357 0.348996 0.029796 0.676490 0.310812 2.176292 0.263576
RMSSE 1.171365 0.245676 0.590759 0.172614 0.822490 0.557505 1.475226 0.513396
R2 0.736022 0.924043 0.862220 0.952053 0.903021 0.955627 0.663314 0.973166
R2adj 0.670028 0.907767 0.832696 0.941779 0.878776 0.943525 0.585617 0.964222
Comment ±10.6 ±7.8 ±6.6 ±9 ±4.44
Unlikely
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743 744 1180 1377 1431 1765 1786 1790
W δa 3.137392 1.287024 6.152193 0.648945 2.318346 2.078170 7.704551 2.774714
W β 1.098926 0.387804 1.203204 0.585141 0.724117 1.098926 0.800032 0.665507
W log10(N) 6.378786 6.451658 6.536444 7.476849 6.973291 7.028937 6.929442 6.683894
MSSE 1.211694 2.920497 0.210600 0.678126 0.097686 0.598772 0.056457 1.151787
RMSSE 1.100770 1.708946 0.458911 0.823484 0.312547 0.773803 0.237607 1.073213
R2 0.839630 0.266264 0.915773 0.907742 0.969497 0.927871 0.917964 0.621353
R2adj 0.816719 0.161444 0.904542 0.892366 0.965430 0.915850 0.907026 0.570867
4D ±11.2 ±19.6 ±7 ±15.8 ±7.35
Comment
WT log10(Nres) 0.601015 -10.140801 1.375200 0.807372 2.133382 0.399983 4.609903 -6.714898
WT δ 4.235036 1.743531 6.193408 1.014235 2.723668 2.077220 8.035355 2.774723
WT β 1.612706 0.407639 1.216451 0.717056 0.810487 1.101074 0.986810 0.665508
WT log10(N0) 6.663104 6.281217 6.533525 7.343325 6.917978 7.028482 6.885915 6.683892
MSSE 0.463454 3.152191 0.225603 0.700117 0.098717 0.204411 0.059238 1.234057
RMSSE 0.680775 1.775441 0.474977 0.836730 0.314193 0.452119 0.243389 1.110881
r2 0.943042 0.264621 0.915787 0.912688 0.971230 0.977428 0.919661 0.621353
r2adj 0.929898 0.094918 0.897742 0.888875 0.965065 0.971272 0.902446 0.540215
4D ±10.2 ±19.6 ±7.2 ±15.6 ±7.35
Comment Unlikely Unlikely Unlikely Unlikely Unlikely
DW α 6.062088 0.950000 1.312635 3.683533 4.784583 6.970000 1.462776 2.580000
DW δ1 4.235035 1.551134 6.660807 0.654780 2.723666 1.203361 7.592705 2.774714
DW β 1.612707 0.553982 1.927149 0.587289 0.810487 0.835927 0.832612 0.665507
DW LOG10(N0) 6.663104 6.327669 6.458277 7.466046 6.917980 7.267794 6.921333 6.683894
DW delta2 3.39E+06 7.159675 12.016743 2.009255 2.72E+09 7.39E+04 14.851623 2.774714
MSSE 0.463454 3.115935 0.220226 0.727966 0.098717 0.127037 0.060388 1.234057
RMSSE 0.680775 1.765201 0.469283 0.853209 0.314193 0.356422 0.245739 1.110881
R2 0.943042 0.273079 0.917795 0.909215 0.971230 0.985972 0.918102 0.621353
R2adj 0.929898 0.105328 0.900179 0.884455 0.965065 0.982146 0.900553 0.540215
4D ±10.2 ±20 ±7 ±15.6 ±6.45
Comment Standard error Standard error Standard error Standard error Standard error Standard error Standard error
Biphasic f 0.999996 0.996955 0.796600 0.999857 0.980785 0.998745 0.994469 0.950331
kmax1 1.012017 0.617073 0.470285 1.353781 0.723068 1.542632 0.285236 0.547308
kmax2 0.124960 0.000000 0.470285 0.311788 0.325347 0.646423 0.000000 0.263425
LOG10(N0) 7.021873 6.186644 6.662316 7.154841 6.838410 7.184859 6.882620 6.477492
MSSE 0.600135 2.939523 0.241018 0.615167 0.102282 0.148973 0.059243 1.252843
RMSSE 0.774684 1.714504 0.490936 0.784326 0.319815 0.385971 0.243398 1.119305
R2 0.926244 0.314235 0.910033 0.923282 0.970191 0.983550 0.919655 0.615589
R2adj 0.909224 0.155981 0.890755 0.902359 0.963803 0.979064 0.902438 0.533216
Comment ±9.2 ±19.6 ±7 ±16.4 ±6.15
Unlikely Standard error
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1898 1973 1998 2043 2046 2189 2323 2350
W δa 7.724856 1.773255 1.903543 2.961060 1.865626 4.314780 2.858347 1.409219
W β 1.314277 0.658225 0.769441 0.853585 0.716625 0.774965 0.705939 0.730313
W log10(N) 6.865774 7.315711 6.659433 6.456131 7.145929 6.951786 7.183248 7.313115
MSSE 0.131394 1.895989 1.083812 1.478015 0.225693 2.241504 0.229226 0.300383
RMSSE 0.362484 1.376949 1.041063 1.215736 0.475071 1.497165 0.478776 0.548072
R2 0.924929 0.635699 0.816689 0.678643 0.947856 0.397478 0.902990 0.956470
R2adj 0.914920 0.587125 0.788487 0.632735 0.940903 0.317141 0.890056 0.950666
4D ±14.6 ±11.6 ±15.2 ±13 ±9.6
Comment
WT log10(Nres) 3.220566 1.747856 1.797526 1.579850 2.086359 3.691615 -6.447967 0.435913
WT δ 8.233524 2.346217 1.546334 3.913088 2.737806 5.207649 2.858350 1.755411
WT β 1.518230 0.748955 0.855303 1.068471 0.939127 0.988847 0.705939 0.817207
WT log10(N0) 6.830376 7.135266 7.021889 6.341089 7.017800 6.876189 7.183247 7.229328
MSSE 0.138489 2.045953 0.764087 1.568917 0.198751 2.392678 0.245600 0.307558
RMSSE 0.372141 1.430368 0.874120 1.252564 0.445816 1.546828 0.495580 0.554579
r2 0.926151 0.633092 0.880707 0.683245 0.957142 0.399719 0.902990 0.958401
r2adj 0.910326 0.554468 0.850883 0.610148 0.947958 0.271087 0.882203 0.949487
4D ±15.2 ±8 ±14.6 ±12.2 ±9.6
Comment Standard error Standard error Unlikely Standard error
DW α 3.609703 3.440000 5.080000 4.761232 3.035358 0.820000 2.008054 6.790000
DW δ1 8.233525 1.773255 1.580122 3.913088 3.343696 4.194942 2.858347 0.939357
DW β 1.518230 0.658225 0.865332 1.068471 1.175736 0.902750 0.705939 0.618281
DW LOG10(N0) 6.830376 7.315711 7.003233 6.341089 6.937437 6.915837 7.183248 7.504893
DW delta2 1.68E+06 1.773255 207.528 4.09E+08 11.560771 7.605881 2.858347 3.515963
MSSE 0.138489 2.031416 0.765284 1.568917 0.178676 2.399818 0.245600 0.380665
RMSSE 0.372141 1.425278 0.874805 1.252564 0.422701 1.549135 0.495580 0.616981
R2 0.926151 0.635699 0.880520 0.683245 0.961471 0.397928 0.902990 0.948513
R2adj 0.910326 0.557634 0.850650 0.610148 0.953214 0.268912 0.882203 0.937480
4D ±14.6 ±8 ±14.6 ±12.4 ±9
Comment Standard error Standard errorStandard error Standard error Standard error Standard error Standard error
Biphasic f 0.906759 0.893907 0.999991 0.999985 0.999260 0.999328 0.810623 0.999785
kmax1 0.394302 1.452880 1.145154 0.642337 0.821575 0.437721 3.594259 0.931879
kmax2 0.394302 0.457906 0.000000 0.000000 0.217612 0.000000 0.395493 0.326171
LOG10(N0) 7.017365 7.235368 6.891060 6.385500 7.021018 6.871440 7.303202 7.060931
MSSE 0.161496 2.033465 0.775834 1.570044 0.183461 2.392691 0.226195 0.321111
RMSSE 0.401866 1.425996 0.880814 1.253014 0.428324 1.546832 0.475600 0.566667
R2 0.913882 0.635331 0.878873 0.683017 0.960439 0.399716 0.910655 0.956568
R2adj 0.895428 0.557188 0.848591 0.609867 0.951961 0.271083 0.891510 0.947261
Comment ±15.4 ±8.2 ±14.6 ±12.2 ±19.2 ±10
Unlikely Standard error Standard error Standard error Standard error Standard error
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2554 2670 2672 2674 2689 2704 2898 2899
W δa 0.052123 2.330674 6.450516 7.731098 2.782863 0.724800 2.890507 5.525967
W β 0.368217 0.535709 0.867368 0.840874 0.775931 0.405315 0.920338 1.251374
W log10(N) 6.891524 6.138411 7.135882 7.086444 6.929616 6.638845 6.913708 7.297497
MSSE 0.219374 0.117757 0.333895 0.328172 0.395277 0.684311 0.113020 0.534619
RMSSE 0.468374 0.343157 0.577836 0.572863 0.628710 0.827231 0.336184 0.731176
R2 0.968164 0.918864 0.743536 0.674131 0.877570 0.733152 0.977623 0.862061
R2adj 0.960205 0.908046 0.696907 0.630682 0.857165 0.697573 0.974181 0.843669
4D ±2.25 ±16.8 ±13.2 ±16.8
Comment Standard error
WT log10(Nres) -0.138788 -7.676268 4.509760 -5.353889 2.758826 -7.128698 0.852716 2.714832
WT δ 0.058219 2.330678 7.906287 7.731098 4.873682 0.099183 3.176128 8.071458
WT β 0.379175 0.535709 1.334261 0.840874 1.315936 0.264837 0.996088 2.414997
WT log10(N0) 6.877461 6.138410 7.017535 7.086444 6.722657 7.130541 6.877333 7.112620
MSSE 0.248178 0.126168 0.352724 0.351613 0.296043 0.689305 0.117824 0.402093
RMSSE 0.498174 0.355201 0.593906 0.592969 0.544099 0.830244 0.343255 0.634108
r2 0.968486 0.918864 0.753703 0.674131 0.915947 0.749125 0.978466 0.903171
r2adj 0.954980 0.901477 0.679814 0.604302 0.893023 0.695366 0.973083 0.882422
4D ±2.34 ±18.8 ±12.8 ±14.8
Comment Unlikely Unlikely Unlikely Unlikely
DW α 6.370000 3.818118 2.506424 1.660000 3.720000 2.015633 1.630992 4.397772
DW δ1 0.079429 2.330674 7.906283 7.731098 5.034319 0.099183 3.588743 8.071455
DW β 0.398772 0.535709 1.334260 0.840874 1.357317 0.264837 1.241645 2.414994
DW LOG10(N0) 6.753360 6.138411 7.017535 7.086444 6.680273 7.130543 6.815346 7.112621
DW delta2 0.168905 2.330674 3.67E+08 7.731098 82.678433 0.099183 6.392375 94530.230
MSSE 0.260338 0.126168 0.352724 0.351613 0.302308 0.689305 0.113051 0.402093
RMSSE 0.510233 0.355201 0.593906 0.592969 0.549825 0.830244 0.336230 0.634108
R2 0.966942 0.918864 0.753703 0.674131 0.914168 0.749125 0.979339 0.903171
R2adj 0.952774 0.901477 0.679814 0.604302 0.890760 0.695366 0.974173 0.882422
4D ±2.61 ±18.8 ±13 ±14.8
Comment Standard error Standard error Standard error Standard error Standard error Standard error Standard error
Biphasic f 0.999918 0.872791 0.998311 0.595751 0.999928 0.989643 0.996179 0.904662
kmax1 2.559092 10.134287 0.347868 119.988148 0.645377 22.982927 0.741185 0.567011
kmax2 0.361088 0.303377 0.000000 0.240109 0.000000 0.305669 0.407277 0.567011
LOG10(N0) 5.850882 6.309836 7.127478 7.310001 6.878320 7.260000 6.890603 7.477971
MSSE 0.854592 0.109348 0.357965 0.337645 0.317070 0.587957 0.116501 0.608667
RMSSE 0.924442 0.330677 0.598302 0.581072 0.563090 0.766784 0.341322 0.780171
R2 0.891483 0.929681 0.750044 0.687076 0.909977 0.786011 0.978708 0.853425
R2adj 0.844976 0.914612 0.675057 0.620021 0.885425 0.740156 0.973385 0.822016
Comment ±3.78 ±16.4 ±15.2 ±12.8 ±16.4
Standard error Standard error Standard error Unlikely
Table B-3 continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix C 
 
 
 
280 
 
 
 
 
 
 
 
 
 
Appendix C – Supplementary data chapter 6 
 
 
 
 
 
 
Table C-1: List of 787 annotated genes (locus tag, gene name and product) with log base 2 fold 
change (log2FC) generated from edgeR, calculated fold change (FC) > 1.5, P value <0.01 and false 
discovery rate (FDR) <0.01 (from edgeR) and COG category determined using EggNOG (category 
a: not assigned to a category). Genes are listed in order of FC from most negative to most positive
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Table C-1: List of 787 annotated genes (locus tag, gene name and product) with log base 2 fold change (log2FC) generated from edgeR, calculated fold 
change (FC) > 1.5, P value <0.01 and false discovery rate (FDR) <0.01 (from edgeR) and COG category determined using EggNOG (category a: not 
assigned to a category). Genes are listed in order of FC from most negative to most positive 
 
Locus 
Tag 
Gene Product log2FC FC logCPM F PValue FDR COG 
Cat. 
Cj0378c 
 
ferric reductase-like transmembrane protein -3.2421041 -9.4617307 4.0905747 46.241786 1.66E-05 6.98E-05 P 
Cj1659 p19 hypothetical protein -3.200837 -9.1949199 8.1315372 94.80506 3.84E-07 3.61E-06 P 
Cj0347 trpF N-(5'-phosphoribosyl)anthranilate isomerase -3.0539738 -8.3049635 6.9626079 225.28478 2.76E-09 1.50E-07 E 
Cj1226c 
 
two-component sensor histidine kinase -3.0347308 -8.194925 8.4876327 115.94425 1.26E-07 1.55E-06 T 
Cj1717c leuC 3-isopropylmalate dehydratase large subunit -2.9749976 -7.8625519 8.3890605 223.94637 2.86E-09 1.50E-07 E 
Cj0361 lspA lipoprotein signal peptidase -2.959332 -7.7776374 7.3316371 84.815188 7.06E-07 5.63E-06 M, U 
Cj0710 rpsP 30S ribosomal protein S16 -2.9332659 -7.6383755 7.3240357 265.46391 1.05E-09 9.70E-08 J 
Cj0173c cfbpC iron-uptake ABC transporter ATP-binding protein -2.9085055 -7.5083998 4.6809438 96.88873 3.41E-07 3.33E-06 P 
Cj0472 secE protein translocase subunit SecE -2.8851838 -7.3879997 8.7160022 245.02712 1.68E-09 1.10E-07 U 
Cj0711 
 
hypothetical protein -2.7918127 -6.9249933 7.1237464 154.20458 2.49E-08 5.73E-07 S 
Cj1718c leuB 3-isopropylmalate dehydrogenase -2.7893494 -6.9131795 8.2842281 247.78375 1.58E-09 1.10E-07 E 
Cj0019c 
 
MCP-domain signal transduction protein -2.6305965 -6.1928199 9.5769098 200.57697 5.44E-09 2.13E-07 N, T 
Cj0473 nusG transcription termination/antitermination protein NusG -2.6105453 -6.107345 10.55725 200.85702 5.39E-09 2.13E-07 K 
Cj0712 rimM ribosome maturation factor RimM -2.6054805 -6.0859416 6.389642 145.2169 3.51E-08 6.79E-07 J 
Cj1092c secF protein translocase subunit SecF -2.5906229 -6.0235872 8.4674842 276.4559 8.26E-10 8.82E-08 U 
Cj0258 
 
ArsR family transcriptional regulator -2.5175593 -5.7261253 2.3668904 18.7671 0.0009184 0.0021319 S 
Cj0116 fabD malonyl CoA-acyl carrier protein transacylase -2.5091903 -5.6930046 8.0510375 160.41325 1.98E-08 4.87E-07 I 
Cj0613 pstS phosphate ABC transporter substrate-binding protein -2.4605922 -5.5044261 8.9299419 95.289337 3.74E-07 3.55E-06 P 
Cj0182 
 
transmembrane transport protein -2.4115264 -5.3203693 7.9853784 204.66782 4.83E-09 2.00E-07 P 
Cj0597 fba fructose-bisphosphate aldolase -2.3621544 -5.1413757 11.675965 150.39105 2.87E-08 6.18E-07 G 
Cj0133 
 
glycoprotease family protein -2.3598302 -5.1330994 5.4444824 73.786676 1.50E-06 1.01E-05 O 
Cj0520 
 
membrane protein -2.3556547 -5.1182646 5.3716753 62.888682 3.48E-06 2.01E-05 S 
Cj0778 peb2 major antigenic peptide PEB2 -2.3412123 -5.0672826 11.499402 209.06919 4.27E-09 1.91E-07 S 
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Locus 
Tag 
Gene Product log2FC FC logCPM F PValue FDR COG 
Cat. 
Cj0477 rplL 50S ribosomal protein L7/L12 -2.3404612 -5.064645 9.3203726 151.31138 2.77E-08 6.13E-07 J 
Cj0823 
 
hypothetical protein -2.3223732 -5.0015427 5.6299933 85.700544 6.67E-07 5.40E-06 a 
Cj0471 rpmG 50S ribosomal protein L33 -2.2616604 -4.7954307 7.0067445 178.1015 1.08E-08 3.21E-07 J 
Cj0141c 
 
ABC transporter permease -2.20638 -4.6151579 7.146305 84.920837 7.01E-07 5.62E-06 P 
Cj0142c 
 
ABC transporter ATP-binding protein -2.2035759 -4.6061964 8.4939289 273.06689 8.88E-10 8.82E-08 P 
Cj0415 
 
GMC oxidoreductase subunit -2.1627852 -4.4777848 10.951229 37.331267 4.69E-05 0.0001678 E 
Cj1093c secD protein translocase subunit SecD -2.1536894 -4.4496425 8.9858974 272.54821 8.99E-10 8.82E-08 U 
Cj0346 trpD anthranilate synthase subunit II -2.1401862 -4.4081893 8.9780051 245.82976 1.65E-09 1.10E-07 E 
Cj1111c 
 
MarC family integral membrane protein -2.1086278 -4.312809 4.7874059 36.535022 5.20E-05 0.0001821 U 
Cj0824 uppS UDP diphosphate synthase -2.0921042 -4.2636948 6.0856841 72.930316 1.59E-06 1.05E-05 I 
Cj1716c leuD 3-isopropylmalate dehydratase small subunit -2.088252 -4.2523253 5.9033446 41.659155 2.77E-05 0.0001075 E 
Cj0348 trpB tryptophan synthase subunit beta -2.0849714 -4.2426668 7.8039008 45.870166 1.73E-05 7.21E-05 E 
Cj0914c ciaB invasion antigen CiaB -2.0822589 -4.2346975 9.1632948 143.28624 3.79E-08 7.08E-07 S 
Cj0115 slyD FKBP-type peptidyl-prolyl cis-trans isomerase -2.07362 -4.2094156 7.9662154 120.81679 9.96E-08 1.37E-06 O 
Cj0256 
 
sulfatase family protein -2.0625255 -4.1771688 8.406586 164.22174 1.73E-08 4.32E-07 S 
Cj0379c 
 
sulfoxide reductase catalytic subunit -2.0613191 -4.1736776 10.601982 37.047842 4.86E-05 0.0001728 S 
Cj0396c 
 
lipoprotein -2.0592087 -4.1675765 8.3582134 174.35616 1.23E-08 3.50E-07 a 
Cj1115c 
 
phosphatidylserine decarboxylase-like protein -2.0540931 -4.1528251 8.8029476 185.31814 8.62E-09 2.60E-07 I 
Cj1661 
 
ABC transporter permease -2.0497223 -4.1402627 5.7067659 41.814196 2.72E-05 0.0001059 V 
Cj0596 peb4cbf2 peptidyl-prolyl cis-trans isomerase -2.0495106 -4.1396551 12.63491 144.96238 3.54E-08 6.79E-07 O 
Cj1205c radA DNA repair protein RadA -2.0170161 -4.0474581 7.4773316 50.852475 1.03E-05 4.67E-05 O 
Cj0068 pspA protease -2.0165849 -4.0462485 6.9148622 155.76445 2.35E-08 5.50E-07 O, U 
Cj0498 trpC Indole-3-glycerol phosphate synthase -2.0126622 -4.0352617 6.8973112 134.72272 5.38E-08 9.38E-07 E 
Cj0880c 
 
hypothetical protein -1.9950994 -3.9864357 3.5029215 16.125333 0.0016277 0.0034911 a 
Cj1365c 
 
serine protease -1.9670554 -3.9096933 10.316027 207.21859 4.50E-09 1.91E-07 O 
Cj0420 
 
periplasmic protein -1.9459419 -3.8528924 11.774677 134.3225 5.47E-08 9.44E-07 S 
Cj0507 maf Maf-like protein -1.9338332 -3.8206901 3.9532258 27.766687 0.0001814 0.0005149 D 
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Cj1245c 
 
membrane protein -1.9336878 -3.8203051 6.0770724 82.684343 8.11E-07 6.24E-06 a 
Cj1108 clpA ATP-dependent Clp protease ATP-binding subunit -1.9318015 -3.8153133 9.305521 208.26396 4.37E-09 1.91E-07 O 
Cj0405 aroE shikimate 5-dehydrogenase -1.9208958 -3.7865812 7.2341365 94.395066 3.93E-07 3.63E-06 E 
Cj0275 clpX ATP-dependent protease ATP-binding subunit ClpX -1.9189963 -3.7815988 8.3181798 59.577181 4.61E-06 2.50E-05 O 
Cj0175c cfbpA iron-uptake ABC transporter substrate-binding protein -1.904188 -3.7429818 10.522434 37.489403 4.60E-05 0.000166 P 
Cj1366c glmS glucosamine--fructose-6-phosphate aminotransferase -1.8926308 -3.713117 10.778758 235.8185 2.11E-09 1.27E-07 M 
Cj0649 
 
OstA family protein -1.8914994 -3.7102063 7.1603772 59.247804 4.74E-06 2.52E-05 S 
Cj1072 rpsR 30S ribosomal protein S18 -1.8845497 -3.6923766 8.7563068 88.916138 5.46E-07 4.71E-06 J 
Cj1278c trmB tRNA (guanine-N(7)-)-methyltransferase -1.8824063 -3.686895 8.4520494 198.56757 5.77E-09 2.18E-07 S 
Cj1599 hisB bifunctional imidazole glycerol-phosphate 
dehydratase/histidinol phosphatase 
-1.8734066 -3.6639672 8.9359607 129.03121 6.87E-08 1.09E-06 E 
Cj1397 feoA ferrous iron transport protein -1.8707263 -3.6571664 5.1261301 24.836359 0.0002938 0.0007924 P 
Cj1279c 
 
fibronectin domain-containing lipoprotein -1.8604515 -3.631213 10.427317 221.21181 3.07E-09 1.55E-07 S 
Cj1367c 
 
nucleotidyltransferase -1.8560904 -3.6202527 7.9944442 69.181582 2.11E-06 1.33E-05 O 
Cj1380 
 
periplasmic protein -1.8508826 -3.6072079 10.440562 177.51013 1.11E-08 3.22E-07 S 
Cj0250c 
 
MFS transport protein -1.8405958 -3.5815792 7.629446 166.76028 1.59E-08 4.08E-07 G 
Cj0614 pstC phosphate ABC transporter permease -1.8358983 -3.5699362 5.156329 37.56084 4.56E-05 0.0001653 P 
Cj1304 acpP3 acyl carrier protein -1.8356378 -3.5692916 5.3171327 45.281245 1.85E-05 7.60E-05 I, Q 
Cj0497 
 
lipoprotein -1.8254102 -3.5440777 7.1538202 104.54902 2.24E-07 2.46E-06 S 
Cj1418c 
 
hypothetical protein -1.8139362 -3.5160027 9.0394134 223.83848 2.86E-09 1.50E-07 G 
Cj1602 
 
hypothetical protein -1.8084067 -3.5025527 6.6809968 29.336603 0.0001422 0.0004196 S 
Cj0985c hipO hippurate hydrolase -1.8048874 -3.4940188 8.0241577 28.322455 0.0001662 0.0004815 E 
Cj0277 mreC rod shape-determining protein MreC -1.7957337 -3.47192 6.4397644 81.45822 8.79E-07 6.70E-06 M 
Cj0110 exbD3 ExbD/TolR family transport protein -1.7941874 -3.4682006 5.8533138 48.534319 1.31E-05 5.61E-05 P 
Cj0900c 
 
hypothetical protein -1.791385 -3.4614704 5.5017967 33.384252 7.91E-05 0.000254 a 
Cj0349 trpA tryptophan synthase subunit alpha -1.7760058 -3.4247669 6.919625 47.750319 1.42E-05 6.03E-05 E 
Cj0499 
 
histidine triad (HIT) family protein -1.7702576 -3.4111485 6.2205385 33.106609 8.22E-05 0.0002618 F, G 
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Cj1227c 
 
two-component regulator -1.7692105 -3.4086737 9.7456852 80.867973 9.14E-07 6.90E-06 T 
Cj0362 
 
integral membrane protein -1.7667952 -3.4029718 6.4991188 102.97189 2.43E-07 2.56E-06 S 
Cj1319 
 
NAD-dependent 4,6-dehydratase -1.7643634 -3.3972406 8.1892237 193.4718 6.71E-09 2.27E-07 G, M 
Cj1600 hisH imidazole glycerol phosphate synthase subunit HisH -1.7555592 -3.3765716 7.3961779 69.970035 1.98E-06 1.27E-05 E 
Cj0496 
 
hypothetical protein -1.747785 -3.3584254 6.2664147 56.055111 6.30E-06 3.16E-05 S 
Cj1168c 
 
integral membrane protein -1.7443794 -3.350507 7.980139 71.704512 1.74E-06 1.13E-05 S 
Cj1637c 
 
periplasmic protein -1.741865 -3.3446726 5.8755426 33.569551 7.71E-05 0.0002491 S 
Cj0807 
 
oxidoreductase -1.7343658 -3.327332 9.9217817 70.464934 1.91E-06 1.22E-05 I, Q 
Cj0847 psd phosphatidylserine decarboxylase -1.7303885 -3.3181717 6.8892102 128.50172 7.03E-08 1.09E-06 I 
Cj0912c cysM cysteine synthase -1.7257339 -3.3074835 9.3513656 66.97554 2.50E-06 1.53E-05 E 
Cj0257 dgkA diacylglycerol kinase -1.725693 -3.3073897 5.043103 42.024077 2.66E-05 0.0001041 M 
Cj0168c 
 
periplasmic protein -1.7188003 -3.2916257 11.263527 51.897736 9.33E-06 4.30E-05 a 
Cj0274 lpxA acyl-carrier-protein-UDP-N-acetylglucosamine O-
acyltransferase 
-1.705621 -3.2616929 8.6030434 73.737638 1.50E-06 1.01E-05 M 
Cj0633 
 
periplasmic protein -1.6975503 -3.2434974 5.5054203 41.205576 2.93E-05 0.0001119 S 
Cj0936 atpE ATP synthase subunit C -1.6956164 -3.2391525 9.0947813 126.15907 7.80E-08 1.16E-06 C 
Cj0134 thrB homoserine kinase -1.6873455 -3.2206356 6.6463157 72.492731 1.64E-06 1.08E-05 E 
Cj0998c 
 
periplasmic protein -1.6699105 -3.1819485 10.33274 164.92874 1.69E-08 4.28E-07 S 
Cj0806 dapA 4-hydroxy-tetrahydrodipicolinate synthase -1.6619668 -3.1644764 10.679951 145.12551 3.52E-08 6.79E-07 E 
Cj0469 
 
amino acid ABC transporter ATP-binding protein -1.6548551 -3.1489156 5.8250494 79.647074 9.92E-07 7.35E-06 E 
Cj1417c 
 
amidotransferase -1.649989 -3.1383125 6.138665 53.656018 7.88E-06 3.77E-05 S 
Cj0779 tpx 2-Cys peroxiredoxin -1.6490391 -3.1362468 12.659648 94.621392 3.88E-07 3.63E-06 O 
Cj1116c ftsH ATP-dependent zinc metalloprotease FtsH -1.647282 -3.1324293 11.228124 133.5121 5.66E-08 9.52E-07 O 
Cj0598 
 
membrane protein -1.6461979 -3.1300764 8.621659 97.150279 3.36E-07 3.32E-06 S 
Cj0589 ribF bifunctional riboflavin kinase/FMN adenylyltransferase -1.6456586 -3.1289066 5.3688731 43.987252 2.13E-05 8.61E-05 H 
Cj1206c ftsY signal recognition particle protein -1.6453855 -3.1283145 8.7544415 104.39897 2.25E-07 2.46E-06 U 
Cj0289c peb3 major antigenic peptide PEB3 -1.6438171 -3.1249154 9.5879855 118.70461 1.10E-07 1.43E-06 S 
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Cj1128c pglI GalNAc(5)-diNAcBac-PP-undecaprenol beta-1,3-
glucosyltransferase 
-1.6400015 -3.1166616 6.8347506 62.706634 3.53E-06 2.02E-05 M 
Cj1666c 
 
periplasmic protein -1.6353955 -3.106727 8.2172921 28.986414 0.00015 0.0004393 S 
Cj0844c 
 
integral membrane protein -1.6353951 -3.1067263 6.411221 58.474422 5.07E-06 2.66E-05 S 
Cj1719c leuA 2-isopropylmalate synthase -1.6200861 -3.0739338 9.8043464 54.081997 7.57E-06 3.66E-05 E 
Cj0404 
 
transmembrane protein -1.6067098 -3.0455647 10.076619 149.13587 3.01E-08 6.23E-07 S 
Cj1007c 
 
mechanosensitive ion channel family protein -1.6058692 -3.0437908 8.1701699 84.659956 7.13E-07 5.65E-06 M 
Cj1016c livM branched-chain amino acid ABC transporter permease -1.6027414 -3.0371989 6.1073314 64.656099 3.01E-06 1.78E-05 E 
Cj1201 metE 5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase 
-1.6008561 -3.0332325 8.0550753 82.952018 7.96E-07 6.16E-06 E 
Cj0239c 
 
nitrogen fixation protein NifU -1.5982196 -3.0276945 9.7747441 121.54989 9.63E-08 1.34E-06 O 
Cj1407c 
 
phospho-sugar mutase -1.5894665 -3.0093804 8.6161083 92.397236 4.42E-07 3.98E-06 G 
Cj0960c rnpA ribonuclease P protein component -1.5845749 -2.999194 6.7415403 42.28712 2.58E-05 0.0001012 J 
Cj0599 
 
OmpA family membrane protein -1.5840197 -2.9980401 6.8571986 53.671811 7.87E-06 3.77E-05 N 
Cj0067 
 
amidohydrolase family protein -1.5810152 -2.991803 7.7446946 124.25748 8.50E-08 1.21E-06 F 
Cj1013c 
 
cytochrome C biogenesis protein -1.5714185 -2.9719678 8.3808009 84.269794 7.31E-07 5.74E-06 O 
Cj1303 fabH2 3-oxoacyl-ACP synthase -1.5671353 -2.9631574 6.8420957 59.257725 4.74E-06 2.52E-05 I 
Cj1091c leuS leucine--tRNA ligase -1.5511274 -2.9304606 9.1393433 144.5462 3.60E-08 6.82E-07 J 
Cj0114 
 
periplasmic protein -1.5406008 -2.9091562 9.2461724 86.050428 6.53E-07 5.31E-06 S 
Cj0169 sodB superoxide dismutase -1.5352744 -2.8984355 11.62463 69.270666 2.09E-06 1.32E-05 P 
Cj1601 hisA 1-(5-phosphoribosyl)-5- -1.5273546 -2.8825679 7.2341684 30.802964 0.0001142 0.0003475 E 
Cj0722c 
 
DNA methylase -1.5146953 -2.8573847 5.0014433 41.30569 2.89E-05 0.0001112 J 
Cj0355c 
 
two-component regulator -1.5144508 -2.8569005 11.023838 43.255845 2.31E-05 9.25E-05 T 
Cj1398 feoB ferrous iron transport protein -1.5136852 -2.8553849 8.2842679 104.95993 2.19E-07 2.42E-06 P 
Cj0403 
 
hypothetical protein -1.5064786 -2.8411571 9.0895721 133.36668 5.70E-08 9.52E-07 S 
Cj0813 kdsB 3-deoxy-manno-octulosonate cytidylyltransferase -1.5038176 -2.8359215 7.6805627 117.99972 1.14E-07 1.46E-06 M 
Cj1302 
 
HAD-superfamily hydrolase -1.5000128 -2.8284521 7.2649204 84.461759 7.22E-07 5.70E-06 Q 
Cj0958c 
 
membrane protein insertase YidC -1.4992275 -2.826913 6.5865663 52.908333 8.47E-06 3.98E-05 U 
Appendix C 
 
 
 
286 
 
Locus 
Tag 
Gene Product log2FC FC logCPM F PValue FDR COG 
Cat. 
Cj0843c 
 
transglycosylase -1.4931633 -2.8150554 8.383473 126.17976 7.80E-08 1.16E-06 M 
Cj1130c pglK protein glycosylation K/ ATP dependent translocation -1.4914137 -2.8116436 6.5806939 31.097666 0.0001094 0.000336 V 
Cj1131c gne UDP-GlcNAc/Glc 4-epimerase -1.4898919 -2.8086793 9.5010503 135.19095 5.27E-08 9.30E-07 M 
Cj1598 hisD histidinol dehydrogenase -1.4867011 -2.8024741 9.9122254 100.76827 2.74E-07 2.83E-06 E 
Cj0109 exbB3 MotA/TolQ/ExbB proton channel family protein -1.4857715 -2.800669 7.0720769 58.763777 4.95E-06 2.61E-05 U 
Cj1337 pseE protein PseE -1.4844769 -2.7981569 8.6051622 96.064944 3.57E-07 3.46E-06 S 
Cj1298 
 
N-acetyltransferase -1.483555 -2.7963696 5.0153486 14.102636 0.002626 0.0052386 V 
Cj1066 rdxA nitroreductase -1.4826663 -2.7946475 5.0551515 30.774371 0.0001147 0.0003483 C 
Cj1059c gatA aspartyl/glutamyl-tRNA amidotransferase subunit A -1.4757065 -2.781198 8.5949462 58.389335 5.11E-06 2.67E-05 J 
Cj0276 mreB rod shape-determining protein MreB -1.4689574 -2.7682177 8.8532812 109.65879 1.71E-07 1.95E-06 D 
Cj1589 
 
hypothetical protein -1.4580605 -2.7473877 7.3153195 59.321035 4.71E-06 2.52E-05 S 
Cj1375 
 
multidrug efflux transporter -1.4561808 -2.7438104 7.0496651 87.229203 6.06E-07 5.09E-06 G 
Cj0707 kdtA 3-deoxy-D-manno-octulosonic acid transferase -1.4556976 -2.7428917 5.5868572 37.455309 4.62E-05 0.0001663 M 
Cj1120c pglF UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase -1.4534156 -2.7385563 8.0356505 49.22206 1.22E-05 5.33E-05 M 
Cj0899c thiJ 4-methyl-5(beta-hydroxyethyl)-thiazole monophosphate 
synthesis protein 
-1.4521006 -2.7360613 9.6359723 123.60666 8.76E-08 1.24E-06 S 
Cj0311 
 
50S ribosomal protein L25/general stress protein Ctc -1.4513902 -2.7347144 10.386818 56.034807 6.32E-06 3.16E-05 J 
Cj0407 lgt prolipoprotein diacylglyceryl transferase -1.4507891 -2.7335752 6.7195913 39.328085 3.66E-05 0.0001353 M 
Cj1280c 
 
pseudouridine synthase -1.4474017 -2.7271645 8.4676033 113.98788 1.38E-07 1.62E-06 J 
Cj1228c htrA serine protease -1.4408253 -2.7147611 10.566944 59.391195 4.68E-06 2.52E-05 O 
Cj1244 
 
radical SAM domain-containing protein -1.4378539 -2.7091756 7.7742027 78.641975 1.06E-06 7.79E-06 C 
Cj0077c cdtC cytolethal distending toxin C -1.4366875 -2.7069862 6.9739562 45.621766 1.78E-05 7.37E-05 S 
Cj1626c 
 
membrane protein -1.4349449 -2.7037184 10.562363 132.22337 5.98E-08 9.89E-07 S 
Cj1067 pgsA CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase 
-1.4310949 -2.6965128 6.1783091 39.298417 3.67E-05 0.0001354 I 
Cj0249 
 
hypothetical protein -1.4221425 -2.6798318 5.4699401 44.260874 2.06E-05 8.40E-05 a 
Cj0186c 
 
TerC family integral membrane protein -1.421396 -2.6784456 6.5387043 67.245715 2.45E-06 1.51E-05 P 
Cj0312 pth peptidyl-tRNA hydrolase -1.4148575 -2.6663341 7.2711505 33.368207 7.93E-05 0.000254 J 
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Cj0822 dfp bifunctional phosphopantothenoylcysteine 
decarboxylase/phosphopantothenate synthase 
-1.4087673 -2.655102 8.1166316 98.88078 3.05E-07 3.05E-06 H 
Cj1081c thiE thiamin-phosphate pyrophosphorylase -1.4012133 -2.6412361 7.7510836 37.533403 4.57E-05 0.0001655 H 
Cj1080c hemD uroporphyrinogen-III synthase -1.3937655 -2.6276361 5.2296448 14.8218 0.0022055 0.0045442 H 
Cj1207c 
 
lipoprotein thiredoxin -1.3882589 -2.6176258 8.7427455 74.337062 1.44E-06 9.77E-06 O 
Cj1119c pglG integral membrane protein -1.3851475 -2.6119866 7.0072261 63.013152 3.44E-06 2.00E-05 S 
Cj0705 
 
hypothetical protein -1.3849707 -2.6116665 6.4818701 42.390059 2.55E-05 0.0001003 S 
Cj0961c rpmH 50S ribosomal protein L34 -1.3818135 -2.6059574 6.0287196 14.880986 0.0021746 0.0044982 J 
Cj0991c 
 
oxidoreductase ferredoxin-type electron transport protein -1.3778078 -2.598732 7.9954115 43.295889 2.30E-05 9.23E-05 C 
Cj0399 
 
colicin V production protein -1.3740903 -2.5920442 8.7666359 51.954119 9.28E-06 4.29E-05 S 
Cj0856 lepP signal peptidase I -1.3728653 -2.5898441 7.3051166 50.147855 1.11E-05 4.94E-05 U 
Cj1627c 
 
hypothetical protein -1.3686233 -2.5822403 7.2912427 92.355723 4.44E-07 3.98E-06 a 
Cj0321 dxs 1-deoxy-D-xylulose-5-phosphate synthase -1.3604594 -2.5676693 8.2553085 34.537701 6.76E-05 0.0002239 H 
Cj0131 
 
peptidase M23 family protein -1.3565235 -2.5606738 9.7647745 119.00746 1.08E-07 1.42E-06 M 
Cj0132 lpxC 3-hydroxymyristoyl N-acetylglucosamine deacetylase -1.3544093 -2.5569241 9.1869659 125.89538 7.90E-08 1.16E-06 M 
Cj1364c fumC fumarate hydratase -1.3521496 -2.5529222 11.881262 81.979429 8.49E-07 6.50E-06 C 
Cj1180c 
 
ABC transporter ATP-binding protein -1.3411146 -2.5334698 5.7876324 33.05388 8.28E-05 0.0002632 V 
Cj1651c map methionine aminopeptidase -1.3405851 -2.53254 7.7401772 54.162532 7.51E-06 3.65E-05 J 
Cj0845c gltX glutamate--tRNA ligase -1.3374408 -2.5270265 9.519533 77.031244 1.19E-06 8.32E-06 J 
Cj1085c mfd transcription-repair coupling factor -1.3370351 -2.526316 9.4675836 48.974307 1.25E-05 5.43E-05 L 
Cj0476 rplJ 50S ribosomal protein L10 -1.3362501 -2.5249417 11.007945 29.472724 0.0001393 0.0004141 J 
Cj0406c 
 
lipoprotein -1.3339539 -2.5209263 9.3349475 62.72578 3.52E-06 2.02E-05 S 
Cj0120 
 
recombination protein RecO -1.3325546 -2.5184824 4.3094101 23.731372 0.000356 0.00093 S 
Cj1129c pglH GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-
PP-undecaprenol alpha-1,4-N-acetyl-D-
galactosaminyltransferase 
-1.329679 -2.5134674 7.4157026 94.409336 3.93E-07 3.63E-06 M 
Cj1071 ssb single-stranded DNA-binding protein -1.3279289 -2.5104203 10.859935 53.183149 8.25E-06 3.89E-05 L 
Cj0993c 
 
hypothetical protein -1.3219932 -2.5001128 8.946991 119.2639 1.07E-07 1.42E-06 S 
Cj0334 ahpC alkyl hydroperoxide reductase -1.3215537 -2.4993513 12.520584 61.827474 3.80E-06 2.15E-05 O 
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Cj0273 fabZ 3-hydroxyacyl-ACP dehydratase -1.3193469 -2.4955312 8.1200676 27.937258 0.0001766 0.0005031 I 
Cj0664c rplI 50S ribosomal protein L9 -1.3100962 -2.4795808 9.7032339 53.668281 7.87E-06 3.77E-05 J 
Cj1295 
 
hypothetical protein -1.3045343 -2.4700399 7.8970992 32.176825 9.37E-05 0.0002947 S 
Cj0519 
 
rhodanese-like domain-containing protein -1.3037149 -2.4686374 6.8135053 66.653505 2.56E-06 1.56E-05 P 
Cj0159c 
 
6-pyruvoyl-tetrahydropterin synthase -1.2987647 -2.4601814 8.115376 62.076727 3.72E-06 2.12E-05 H 
Cj1215 
 
peptidase M23 family protein -1.2977955 -2.4585293 7.8145037 108.62362 1.81E-07 2.02E-06 M 
Cj0020c 
 
cytochrome C551 peroxidase -1.2976742 -2.4583226 9.80919 55.183665 6.83E-06 3.39E-05 P 
Cj0345 trpE anthranilate synthase subunit I -1.2954115 -2.4544699 8.4523173 91.755887 4.60E-07 4.10E-06 E 
Cj0950c 
 
lipoprotein -1.2944076 -2.4527626 9.8660686 60.682569 4.19E-06 2.33E-05 O 
Cj0474 rplK 50S ribosomal protein L11 -1.2892129 -2.4439468 9.7852339 28.970172 0.0001504 0.0004396 J 
Cj0920c 
 
amino acid ABC transporter permease -1.2750564 -2.4200827 8.261374 49.839441 1.14E-05 5.08E-05 E 
Cj1047c thiS thiamine biosynthesis protein -1.2479632 -2.3750588 5.565614 26.592867 0.000219 0.0006054 H 
Cj1200 
 
NLPA family lipoprotein -1.2377581 -2.3583178 7.0965957 28.101129 0.0001721 0.0004939 P 
Cj1105 smpB SsrA-binding protein -1.2325391 -2.3498018 8.2472989 56.664537 5.96E-06 3.02E-05 O 
Cj1481c 
 
helicase -1.2296652 -2.3451257 6.148713 39.487912 3.59E-05 0.000133 L 
Cj1320 
 
PLP-dependent aminotransferase -1.2285744 -2.3433531 7.3841296 53.456414 8.03E-06 3.83E-05 E 
Cj0381c pyrF orotidine 5'-phosphate decarboxylase -1.2280717 -2.3425368 7.7157003 41.195153 2.93E-05 0.0001119 F 
Cj0500 
 
rhodanese-like domain-containing protein -1.2260426 -2.3392444 5.5050329 35.456788 5.98E-05 0.0002032 S 
Cj1060c 
 
membrane protein -1.2243467 -2.3364962 4.6524285 15.713833 0.0017886 0.0038049 a 
Cj0653c 
 
aminopeptidase -1.2213606 -2.3316652 8.4744106 62.324313 3.64E-06 2.08E-05 E 
Cj0650 engB GTP-binding protein EngB -1.2209178 -2.3309495 5.7779212 36.105463 5.49E-05 0.00019 S 
Cj0855 folD bifunctional 5,10-methylene-tetrahydrofolate 
dehydrogenase/ 5,10-methylene-tetrahydrofolate 
cyclohydrolase 
-1.2157938 -2.3226854 7.8369192 55.206391 6.82E-06 3.39E-05 H 
Cj0708 
 
pseudouridine synthase -1.2156139 -2.3223959 7.1455102 59.454337 4.66E-06 2.51E-05 J 
Cj1272c spoT guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase -1.2112513 -2.3153838 9.8637198 80.473345 9.39E-07 7.02E-06 K, T 
Cj0774c 
 
methionine ABC transporter ATP-binding protei -1.2112433 -2.3153709 8.1612977 61.730888 3.83E-06 2.16E-05 P 
Cj1710c 
 
metallo-beta-lactamase family protein -1.2000423 -2.2974641 9.7703633 33.950524 7.32E-05 0.0002389 S 
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Cj0663c hslV ATP-dependent protease peptidase subunit -1.1991388 -2.2960256 9.9428294 63.533334 3.30E-06 1.92E-05 O 
Cj1688c secY protein translocase subunit SecY -1.1987565 -2.2954173 9.1409634 18.440455 0.0009829 0.0022627 U 
Cj1017c livH branched-chain amino acid ABC transporter permease -1.1929558 -2.2862067 7.02298 48.952106 1.25E-05 5.43E-05 E 
Cj0331c 
 
hypothetical protein -1.1924346 -2.2853809 9.5526803 69.430697 2.07E-06 1.31E-05 a 
Cj0320 fliH flagellar assembly protein FliH -1.1873701 -2.2773722 7.4779254 26.665547 0.0002164 0.0006004 N 
Cj0412 
 
ATP/GTP binding protein -1.1849484 -2.2735527 5.9244197 25.681487 0.0002546 0.000694 S 
Cj1401c tpiA triosephosphate isomerase -1.1838055 -2.2717522 8.2231804 26.945327 0.0002068 0.0005778 G 
Cj0585 folP dihydropteroate synthase -1.1818446 -2.2686666 6.2920071 19.326584 0.000819 0.001925 H 
Cj0723c 
 
integral membrane zinc-metalloprotease -1.1803615 -2.2663356 6.890401 21.378043 0.0005478 0.0013564 O 
Cj1191c 
 
PAS domain-containing signal-transduction sensor protein -1.1761069 -2.2596619 6.084179 24.005948 0.0003392 0.0008951 T 
Cj1008c aroB 3-dehydroquinate synthase -1.1727223 -2.2543668 8.5737576 66.209825 2.66E-06 1.59E-05 E 
Cj0576 lpxD UDP-3-O-acylglucosamine N-acyltransferase -1.1608282 -2.2358575 8.8345026 23.686157 0.0003589 0.0009344 M 
Cj0846 
 
metallophosphoesterase -1.1477978 -2.2157542 7.2777067 57.763363 5.40E-06 2.82E-05 S 
Cj0174c cfbpB iron-uptake ABC transporter permease -1.1437354 -2.2095236 5.3343009 19.751064 0.0007519 0.0017779 P 
Cj1646 iamB ABC transporter permease -1.1428621 -2.2081866 5.8217949 21.91497 0.0004951 0.0012398 Q 
Cj0992c hemN coproporphyrinogen III oxidase -1.1402701 -2.2042228 8.9302688 103.64316 2.35E-07 2.52E-06 H 
Cj1198 
 
S-ribosylhomocysteine lyase -1.1345967 -2.1955718 10.597398 40.093395 3.34E-05 0.0001251 T 
Cj1189c cetB bipartate energy taxis response protein CetB -1.1338377 -2.1944169 7.821107 29.220244 0.0001447 0.0004255 T 
Cj0440c 
 
transcriptional regulator -1.1336886 -2.1941902 8.8105459 54.325191 7.40E-06 3.61E-05 K 
Cj1269c amiA N-acetylmuramoyl-L-alanine amidase -1.1254443 -2.1816873 7.7117432 41.980972 2.67E-05 0.0001044 M 
Cj0245 rplT 50S ribosomal protein L20 -1.1118119 -2.1611691 7.6780742 51.714602 9.50E-06 4.36E-05 J 
Cj0959c 
 
membrane protein insertion efficiency factor -1.0955192 -2.1368997 4.4709232 13.240389 0.0032596 0.0063651 S 
Cj1243 hemE uroporphyrinogen decarboxylase -1.0950055 -2.1361389 9.4702969 51.328072 9.87E-06 4.50E-05 H 
Cj0812 thrC threonine synthase -1.0936879 -2.1341889 9.0541603 67.868089 2.33E-06 1.44E-05 E 
Cj0372 
 
glutathionylspermidine synthase -1.0921757 -2.1319531 9.6970476 78.741373 1.06E-06 7.78E-06 E 
Cj0401 lysS lysine--tRNA ligase -1.0868861 -2.1241506 9.8966876 77.674604 1.14E-06 8.07E-06 J 
Cj0248 
 
hypothetical protein -1.0862156 -2.1231637 8.6303728 76.445491 1.24E-06 8.63E-06 T 
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Cj1014c livF ABC transporter ATP-binding protein -1.083713 -2.1194839 6.5952178 38.469619 4.07E-05 0.0001485 E 
Cj1084c 
 
ATP/GTP-binding protein -1.0835984 -2.1193155 5.9094508 32.218686 9.31E-05 0.0002936 S 
Cj0392c pyk pyruvate kinase -1.0771687 -2.1098914 11.629709 35.359799 6.06E-05 0.0002052 G 
Cj1213c glcD glycolate oxidase subunit D -1.0701409 -2.0996384 8.0958059 24.502722 0.0003111 0.0008265 C 
Cj1507c 
 
regulatory protein -1.0650168 -2.0921943 9.1473178 37.406951 4.65E-05 0.000167 K 
Cj1711c ksgA rRNA small subunit methyltransferase A -1.0545567 -2.0770799 7.7254056 20.606872 0.0006352 0.0015437 J 
Cj1592 rpsM 30S ribosomal protein S13 -1.0530733 -2.0749453 8.7926697 36.545933 5.19E-05 0.0001821 J 
Cj1056c 
 
carbon-nitrogen hydrolase family protein -1.0515891 -2.0728117 7.9517223 46.460639 1.62E-05 6.84E-05 S 
Cj1594 rpsD 30S ribosomal protein S4 -1.0489564 -2.0690327 10.319921 18.718263 0.0009277 0.002142 J 
Cj1328 neuC2 GDP/UDP-N,N'-diacetylbacillosamine 2-epimerase -1.0460246 -2.0648322 6.6452984 42.595983 2.49E-05 9.82E-05 M 
Cj0079c cdtA cytolethal distending toxin A -1.0445299 -2.0626941 8.7082093 83.299519 7.79E-07 6.05E-06 M 
Cj1652c murI glutamate racemase -1.0436058 -2.0613734 5.6635256 30.954228 0.0001117 0.0003419 M 
Cj0106 atpG ATP synthase subunit gamma -1.0381325 -2.0535678 8.5622778 62.763211 3.51E-06 2.02E-05 C 
Cj0637c mrsA methionine sulfoxide reductase A -1.03492 -2.049 5.732133 15.190361 0.0020208 0.0042246 O 
Cj0994c argF ornithine carbamoyltransferase -1.0344379 -2.0483154 10.469898 56.129039 6.26E-06 3.15E-05 E 
Cj1233 
 
HAD-superfamily hydrolase -1.0334113 -2.0468584 6.3343304 25.821036 0.0002487 0.0006816 S 
Cj1301 
 
hypothetical protein -1.0331469 -2.0464833 7.6773199 56.309617 6.16E-06 3.11E-05 E 
Cj1591 rpmJ 50S ribosomal protein L36 -1.0277802 -2.0388847 7.2059975 49.549188 1.18E-05 5.20E-05 J 
Cj0929 pepA cytosol aminopeptidase -1.0225057 -2.0314441 7.9838033 30.736735 0.0001153 0.0003496 E 
Cj0586 ligA DNA ligase -1.0193523 -2.0270087 7.4797231 31.125561 0.000109 0.0003354 L 
Cj1477c 
 
hydrolase -1.0175323 -2.0244531 6.9984438 45.080391 1.89E-05 7.73E-05 S 
Cj0400 fur ferric uptake regulator -1.0167513 -2.0233576 8.9246902 61.257128 3.99E-06 2.24E-05 P 
Cj1433c 
 
hypothetical protein -1.015071 -2.0210023 9.4623634 40.008814 3.37E-05 0.0001257 S 
Cj0928 
 
integral membrane protein -1.0145777 -2.0203114 5.8545094 24.528302 0.0003097 0.0008265 S 
Cj0508 pbpA penicillin-binding protein -1.0111593 -2.0155301 8.5072764 50.190257 1.11E-05 4.94E-05 M 
Cj0607 macB macrolide export ATP-binding protein/permease -1.0043919 -2.0060978 8.9568803 42.621857 2.48E-05 9.82E-05 V 
Cj1275c 
 
peptidase M23 family protein -0.9993078 -1.9990406 5.9042035 31.312493 0.000106 0.0003277 M 
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Cj0158c 
 
heme-binding lipoprotein -0.9940509 -1.9917698 6.4623554 27.351128 0.0001938 0.0005452 a 
Cj1664 
 
thiredoxin -0.9916256 -1.9884242 5.0251683 17.946814 0.0010907 0.0024569 O 
Cj1636c rnhA ribonuclease H -0.9915774 -1.9883578 6.3838645 18.728266 0.0009258 0.0021412 L 
Cj0717 
 
ArsC family protein -0.9811692 -1.9740646 7.0994493 29.75802 0.0001334 0.0003982 P 
Cj0043 flgE flagellar hook protein -0.9801733 -1.9727023 9.7002553 27.805602 0.0001803 0.0005127 N 
Cj0463 
 
zinc protease-like protein -0.9790236 -1.9711309 8.4847077 70.707039 1.88E-06 1.21E-05 O 
Cj0881c 
 
hypothetical protein -0.9702995 -1.9592473 4.7570626 13.322418 0.0031922 0.0062568 S 
Cj1564 
 
methyl-accepting chemotaxis signal transduction protein -0.9690663 -1.9575733 9.9957199 44.118677 2.10E-05 8.51E-05 N, T 
Cj0143c 
 
ABC transporter substrate-binding protein -0.9655055 -1.9527477 10.061993 36.192348 5.43E-05 0.0001882 P 
Cj1181c tsf elongation factor Ts -0.9613441 -1.9471231 10.562799 28.20644 0.0001692 0.0004869 J 
Cj0821 glmU bifunctional N-acetylglucosamine-1-phosphate 
uridyltransferase/glucosamine-1-phosphate 
acetyltransferase 
-0.9598212 -1.9450689 9.7710422 52.774419 8.58E-06 4.02E-05 M 
Cj1482c 
 
hypothetical protein -0.9596665 -1.9448603 6.2242317 17.578353 0.0011802 0.002632 L 
Cj0191c def peptide deformylase -0.9587765 -1.9436608 7.5842943 22.318554 0.0004594 0.001154 J 
Cj0188c 
 
kinase -0.955727 -1.9395567 5.7861575 22.483245 0.0004457 0.0011232 G 
Cj0117 pfs aminodeoxyfutalosine nucleosidase -0.9554124 -1.9391338 8.1380532 45.453987 1.81E-05 7.48E-05 F 
Cj1107 clpS ATP-dependent Clp protease adaptor protein -0.9524323 -1.9351324 7.5915809 40.656429 3.12E-05 0.0001178 O 
Cj1094c yajC protein translocase subunit YajC -0.9501627 -1.9320905 7.2635209 20.478741 0.0006513 0.0015779 U 
Cj1015c livG ABC transporter ATP-binding protein -0.9475794 -1.928634 5.844053 26.499826 0.0002224 0.0006136 E 
Cj0603c dsbD thiol:disulfide interchange protein -0.94474 -1.924842 6.7587594 29.412225 0.0001406 0.0004165 O 
Cj1597 hisG ATP phosphoribosyltransferase -0.9384256 -1.9164357 9.5837011 50.1322 1.11E-05 4.94E-05 E 
Cj1274c pyrH uridylate kinase -0.9372286 -1.9148463 9.5031416 17.968218 0.0010858 0.0024492 F 
Cj0146c trxB thioredoxin reductase -0.9361799 -1.9134548 11.551962 18.294155 0.0010135 0.0023162 O 
Cj1593 rpsK 30S ribosomal protein S11 -0.9323842 -1.9084273 9.3612632 22.798105 0.0004208 0.0010656 J 
Cj0544 
 
integral membrane protein -0.9302586 -1.9056176 4.4913667 14.401678 0.0024407 0.0049636 S 
Cj1219c 
 
periplasmic protein -0.9285346 -1.9033417 9.1615765 41.925828 2.69E-05 0.0001048 a 
Cj1164c 
 
hypothetical protein -0.9283601 -1.9031115 6.7024925 17.158053 0.001293 0.002847 a 
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Cj0642 recN DNA repair protein -0.9246728 -1.8982537 8.1106844 48.909326 1.26E-05 5.44E-05 L 
Cj0610c 
 
periplasmic protein -0.91757 -1.888931 5.4902012 15.717449 0.0017871 0.0038049 S 
Cj0721c 
 
integral membrane protein -0.9135656 -1.8836953 7.1800318 18.912156 0.0008914 0.0020815 S 
Cj0773c 
 
binding-protein dependent transport system permease -0.912436 -1.882221 6.7462647 21.44613 0.0005407 0.0013411 P 
Cj0926 
 
membrane protein -0.9116706 -1.8812226 6.4662929 26.288449 0.0002302 0.0006341 S 
Cj1057c 
 
hypothetical protein -0.9092453 -1.8780627 7.3037284 27.656387 0.0001846 0.0005231 L 
Cj1070 rpsF 30S ribosomal protein S6 -0.905357 -1.8730079 11.135429 20.054532 0.0007079 0.0016839 J 
Cj1132c 
 
hypothetical protein -0.9044848 -1.871876 5.6565239 23.910428 0.000345 0.0009067 L 
Cj0801 
 
integral membrane protein -0.893686 -1.8579169 6.0147371 18.113477 0.0010529 0.0023852 S 
Cj0995c hemB delta-aminolevulinic acid dehydratase -0.8932534 -1.8573599 11.001825 33.372712 7.92E-05 0.000254 H 
Cj0330c rpmF 50S ribosomal protein L32 -0.8921177 -1.8558984 8.3838631 38.497057 4.05E-05 0.0001484 J 
Cj0591c 
 
lipoprotein -0.878719 -1.838742 5.9623217 14.872372 0.0021791 0.0045015 S 
Cj0200c 
 
periplasmic protein -0.8782509 -1.8381455 10.29634 39.967085 3.39E-05 0.0001261 a 
Cj1061c ileS isoleucine--tRNA ligase -0.8777534 -1.8375117 10.551766 52.22782 9.04E-06 4.20E-05 J 
Cj0545 hemC porphobilinogen deaminase -0.8767653 -1.8362536 7.326647 30.917987 0.0001123 0.0003431 H 
Cj0931c argH argininosuccinate lyase -0.8732354 -1.8317662 9.5482877 27.263592 0.0001965 0.0005509 E 
Cj1277c 
 
ABC transporter ATP-binding protein -0.870722 -1.8285777 6.993485 28.039468 0.0001737 0.0004966 D 
Cj0093 
 
periplasmic protein -0.8705042 -1.8283017 8.4576301 15.592782 0.0018394 0.0038879 S 
Cj0475 rplA 50S ribosomal protein L1 -0.8670888 -1.8239786 10.84661 12.065355 0.0044347 0.0084291 J 
Cj0608 
 
outer membrane efflux protein -0.8657901 -1.8223374 6.4463473 20.341001 0.000669 0.001611 M 
Cj0661c era GTPase Era -0.8645976 -1.8208317 7.5844058 35.135002 6.24E-05 0.0002093 S 
Cj0251c 
 
highly acidic protein -0.8630099 -1.818829 7.0280982 36.418226 5.27E-05 0.000184 a 
Cj1121c pglE UDP-N-acetylbacillosamine transaminase -0.8571909 -1.8115077 8.722568 41.00186 3.00E-05 0.0001139 E 
Cj1273c rpoZ DNA-directed RNA polymerase subunit omega -0.8571288 -1.8114297 7.6841878 16.503903 0.0014944 0.0032448 K 
Cj0329c plsX phosphate acyltransferase -0.8473204 -1.7991562 9.5342304 33.214776 8.10E-05 0.0002584 I 
Cj0041 fliK flagellar hook-length control protein -0.8438522 -1.7948362 9.0484689 15.235378 0.0019995 0.0041856 S 
Cj0948c 
 
cation efflux family protein -0.841279 -1.7916378 5.476917 11.788166 0.0047802 0.0090312 P 
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Cj0259 pyrC dihydroorotase -0.8406151 -1.7908134 6.9859809 35.168737 6.21E-05 0.0002089 F 
Cj0515 
 
periplasmic protein -0.8364156 -1.7856082 6.643979 14.702867 0.0022693 0.0046452 S 
Cj1444c kpsD capsule polysaccharide ABC transporter substrate-binding 
protein 
-0.8362808 -1.7854414 9.6803862 25.425384 0.0002658 0.000722 M 
Cj1090c 
 
lipoprotein -0.8345609 -1.7833142 6.6327668 22.766493 0.0004232 0.00107 S 
Cj0360 glmM phosphoglucosamine mutase -0.8340924 -1.7827352 8.9552198 13.051394 0.0034214 0.0066316 G 
Cj1402c pgk phosphoglycerate kinase -0.8295456 -1.7771255 9.8843798 34.779268 6.54E-05 0.0002172 G 
Cj0328c fabH 3-oxoacyl-ACP synthase III -0.8241638 -1.7705086 9.4108021 36.041838 5.54E-05 0.0001907 I 
Cj0206 thrS threonine--tRNA ligase -0.821091 -1.7667415 8.8117623 35.033312 6.33E-05 0.0002113 J 
Cj1441c kfiD UDP-glucose 6-dehydrogenase -0.8081987 -1.7510238 6.054972 13.16559 0.0033225 0.0064559 M 
Cj0107 atpD ATP synthase subunit beta -0.8060204 -1.7483819 10.522983 41.286708 2.90E-05 0.0001112 C 
Cj1436c 
 
aminotransferase -0.8057813 -1.7480922 8.1308355 16.482418 0.0015016 0.0032518 E 
Cj0776c 
 
periplasmic protein -0.7994726 -1.7404648 8.2308833 22.321315 0.0004592 0.001154 S 
Cj0803 msbA lipid ABC transporter ATP-binding protein/permease -0.7972415 -1.7377753 5.9067474 15.671834 0.001806 0.0038368 V 
Cj1252 
 
hypothetical protein -0.7825212 -1.7201342 8.9371575 39.072974 3.78E-05 0.0001389 M 
Cj0105 atpA ATP synthase subunit alpha -0.7804932 -1.717718 10.273243 31.706483 0.0001002 0.0003115 C 
Cj1494c carA carbamoyl phosphate synthase small subunit -0.7784651 -1.715305 8.9790461 34.152366 7.12E-05 0.0002339 F 
Cj1568c nuoL NADH-quinone oxidoreductase subunit L -0.771181 -1.7066663 8.3039465 15.017641 0.002105 0.0043716 C 
Cj0318 fliF flagellar MS-ring protein -0.7693873 -1.7045457 8.7903965 35.932233 5.62E-05 0.0001924 N 
Cj1400c fabI enoyl-ACP reductase -0.7679942 -1.7029005 9.1598405 23.894032 0.0003459 0.0009067 I 
Cj0108 atpC ATP synthase subunit epsilon -0.7679555 -1.7028549 7.7092116 20.824022 0.000609 0.001487 C 
Cj1478c cadF outer membrane fibronectin-binding protein -0.7669272 -1.7016416 9.8223423 18.410164 0.0009892 0.0022705 M 
Cj0543 proS proline--tRNA ligase -0.7623414 -1.6962413 8.234622 24.378033 0.0003179 0.0008417 J 
Cj1083c 
 
endonuclease III -0.7595763 -1.6929934 5.8895115 14.102882 0.0026258 0.0052386 L 
Cj0715 
 
5-hydroxyisourate hydrolase -0.7463707 -1.6775674 12.476007 28.233328 0.0001685 0.0004864 F 
Cj0244 rpmI 50S ribosomal protein L35 -0.7458758 -1.676992 7.646028 35.701367 5.79E-05 0.0001976 J 
Cj0326 serC 3-phosphoserine/phosphohydroxythreonine 
aminotransferase 
-0.7375767 -1.6673728 9.5849 25.879719 0.0002463 0.0006761 E 
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Cj0709 ffh signal recognition particle protein -0.7363945 -1.666007 8.2774388 14.745537 0.0022462 0.0046038 U 
Cj0118 
 
hypothetical protein -0.7356226 -1.6651159 7.9980869 23.400301 0.0003776 0.0009782 D 
Cj0512 purC phosphoribosylaminoimidazolesuccinocarboxamide 
synthase 
-0.7321414 -1.6611028 8.0160573 20.041876 0.0007097 0.0016856 F 
Cj0139 
 
endonuclease -0.730424 -1.6591266 7.3039718 17.301697 0.0012531 0.0027709 V 
Cj0938c aas 2-acylglycerophosphoethanolamine acyltransferase -0.7251731 -1.653099 7.3499329 29.296545 0.000143 0.0004214 I 
Cj0716 
 
phospho-2-dehydro-3-deoxyheptonate aldolase -0.7221859 -1.6496796 12.50415 23.011561 0.0004049 0.0010352 E 
Cj0882c flhA flagellar biosynthesis protein FlhA -0.7209094 -1.6482207 7.1177565 14.262613 0.0025249 0.0051149 N 
Cj1684c 
 
transmembrane transport protein -0.7111482 -1.6371066 6.7065404 15.105811 0.0020615 0.004304 P 
Cj0386 engA GTPase -0.7071965 -1.6326285 8.6772287 27.452555 0.0001907 0.0005374 S 
Cj0514 purQ phosphoribosylformylglycinamidine synthase I -0.7047408 -1.6298518 7.8956283 12.383323 0.0040737 0.0078092 F 
Cj0145 
 
TAT pathway signal sequence domain-containing protein -0.7040421 -1.6290627 8.4648352 25.516643 0.0002617 0.0007122 S 
Cj0932c pckA phosphoenolpyruvate carboxykinase -0.702031 -1.6267934 10.691607 17.109475 0.0013068 0.0028723 C 
Cj0622 hypF carbamoyltransferase -0.7007697 -1.6253718 6.3009276 17.542198 0.0011894 0.0026488 K 
Cj1018c livK branched-chain amino acid ABC transporter substrate-
binding protein 
-0.6940718 -1.6178433 8.6371393 13.880112 0.0027745 0.0054793 E 
Cj1182c rpsB 30S ribosomal protein S2 -0.6933195 -1.6169998 10.202918 24.196394 0.0003281 0.0008672 J 
Cj1082c thiD phosphomethylpyrimidine kinase -0.6900531 -1.6133429 7.9757788 15.568939 0.0018496 0.0038979 H 
Cj1604 hisI bifunctional phosphoribosyl-AMP 
cyclohydrolase/phosphoribosyl-ATP pyrophosphatase 
-0.6895299 -1.6127579 6.7749792 16.726201 0.0014221 0.0031139 E 
Cj0402 glyA serine hydroxymethyltransferase -0.6893047 -1.6125062 11.217951 26.594739 0.000219 0.0006054 E 
Cj1126c pglB undecaprenyl-diphosphooligosaccharide--protein 
glycotransferase 
-0.6887072 -1.6118385 7.8887342 16.383768 0.0015353 0.0033085 S 
Cj0130 tyrA prephenate dehydrogenase -0.6885565 -1.6116701 7.621457 20.457707 0.0006539 0.0015819 E 
Cj0319 fliG flagellar motor switch protein -0.6847475 -1.6074206 7.9150851 15.568833 0.0018496 0.0038979 N 
Cj0518 htpG chaperone protein HtpG -0.6690222 -1.5899949 9.2630132 15.263377 0.0019864 0.0041693 O 
Cj1660 
 
integral membrane protein -0.6549486 -1.5745599 5.8672255 13.000253 0.0034668 0.0066948 S 
Cj1309c 
 
hypothetical protein -0.6477912 -1.5667676 8.9859865 13.906232 0.0027566 0.0054611 a 
Cj0060c fliM flagellar motor switch protein FliM -0.6437798 -1.5624173 8.916651 29.981903 0.000129 0.0003872 N 
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Cj0205 upk undecaprenyl-diphosphatase -0.6425266 -1.5610607 8.2213671 15.306519 0.0019664 0.0041328 V 
Cj0615 pstA phosphate ABC transporter permease -0.6254786 -1.5427225 7.5597654 18.1524 0.0010442 0.0023736 P 
Cj1235 
 
peptidase M23 family protein -0.6206627 -1.5375813 7.0089785 15.914501 0.0017079 0.0036432 M 
Cj1588c 
 
MFS transport protein -0.6186499 -1.5354376 5.9378778 13.786513 0.00284 0.0055944 G 
Cj0064c flhF flagellar biosynthesis regulator FlhF -0.6122022 -1.5285907 8.5502283 20.095085 0.0007022 0.001673 N 
Cj0231c nrdF ribonucleotide-diphosphate reductase subunit beta -0.6028643 -1.5187288 8.6220088 16.439949 0.001516 0.0032755 F 
Cj1428c fcl GDP-L-fucose synthetase -0.6017117 -1.517516 8.7084471 17.718639 0.0011452 0.0025672 M 
Cj0947c 
 
carbon-nitrogen hydrolase -0.6014788 -1.517271 6.53911 12.217629 0.0042573 0.0081117 E 
Cj0234c frr ribosome recycling factor -0.6010673 -1.5168383 8.600471 24.729948 0.0002992 0.0008056 J 
Cj0662c hslU ATP-dependent protease ATP-binding subunit HslU -0.6002802 -1.516011 10.854523 21.349799 0.0005507 0.001359 O 
Cj1300 
 
SAM domain-containing methyltransferase -0.5924122 -1.5077657 8.4239279 13.955552 0.0027231 0.0054117 Q 
Cj0665c argG argininosuccinate synthase -0.5855002 -1.5005592 11.112674 14.580458 0.0023372 0.0047717 E 
Cj0036 
 
hypothetical protein 0.5858708 1.5009447 8.5151926 14.998771 0.0021145 0.0043854 S 
Cj0540 
 
exporting protein 0.5898434 1.5050834 6.5446493 13.769472 0.0028521 0.0056112 a 
Cj0527c flgC flagellar basal body rod protein FlgC 0.5907117 1.5059895 9.9122799 18.166726 0.0010411 0.0023723 N 
Cj0339 
 
MFS transport protein 0.5962531 1.5117851 9.3319062 17.246434 0.0012682 0.0027965 G 
Cj1513c 
 
hypothetical protein 0.5993158 1.5149979 7.80724 17.507401 0.0011984 0.002665 S 
Cj0526c fliE flagellar hook-basal body protein FliE 0.6049657 1.5209426 8.6061867 14.200367 0.0025637 0.0051518 N 
Cj0686 ispG 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase 
(flavodoxin) 
0.6101003 1.5263653 8.6831889 24.505802 0.0003109 0.0008265 I 
Cj0789 cca poly(A) polymerase family protein 0.6101497 1.5264176 6.911549 12.749858 0.0036994 0.0071004 J 
Cj1230 hspR heat shock transcriptional regulator 0.6182229 1.5349832 9.0231791 16.437791 0.0015167 0.0032755 K 
Cj0809c 
 
hydrolase 0.6198076 1.5366703 6.9867378 14.233881 0.0025427 0.0051333 S 
Cj1256c 
 
membrane protein 0.6212641 1.5382224 7.1929715 18.342225 0.0010033 0.0022963 a 
Cj1141 neuB1 sialic acid synthase 0.6244788 1.5416538 9.5822098 21.893843 0.0004971 0.0012419 M 
Cj0726c corA magnesium and cobalt transport protein 0.6248356 1.5420351 9.7217861 17.710178 0.0011472 0.0025672 P 
Cj0670 rpoN RNA polymerase factor sigma-54 0.6283289 1.5457735 7.4329811 18.995925 0.0008762 0.0020531 K 
Cj0460 nusA transcription elongation factor NusA 0.6367984 1.5548748 8.9733576 24.962478 0.0002875 0.0007769 K 
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Cj1624c sdaA L-serine dehydratase 0.6426715 1.5612175 10.551231 16.797829 0.0013997 0.0030691 E 
Cj1540 
 
periplasmic protein 0.6465301 1.5653986 10.118988 29.839056 0.0001318 0.0003941 P 
Cj1368 
 
hypothetical protein 0.6498045 1.5689556 8.57877 20.442504 0.0006559 0.0015842 H 
Cj0196c purF amidophosphoribosyltransferase 0.6506913 1.5699203 9.2704725 20.758885 0.0006167 0.0015012 F 
Cj0536 oorA 2-oxoglutarate-acceptor oxidoreductase subunit OorA 0.6544968 1.5740669 11.44157 12.93822 0.0035228 0.0067946 C 
Cj1250 purD phosphoribosylamine--glycine ligase 0.6586758 1.578633 11.872165 25.709528 0.0002534 0.0006919 F 
Cj0147c trxA thioredoxin 0.6603292 1.5804433 10.717668 28.844507 0.0001533 0.0004474 O 
Cj1242 
 
hypothetical protein 0.6681138 1.5889942 10.490131 28.031095 0.000174 0.0004966 a 
Cj1612 prfA peptide chain release factor 1 0.6812593 1.6035388 8.3858464 20.36121 0.0006664 0.0016071 J 
Cj1640 
 
hypothetical protein 0.6828132 1.6052669 5.8416953 16.104115 0.0016356 0.0034991 a 
Cj0253 
 
hypothetical protein 0.6838763 1.6064502 5.9272372 14.756031 0.0022406 0.0045983 S 
Cj1118c cheY chemotaxis protein CheY 0.6906332 1.6139918 10.029425 20.241821 0.0006822 0.0016348 T 
Cj0863c xerD DNA recombinase 0.6913595 1.6148045 5.6324294 14.356123 0.0024679 0.0050124 L 
Cj1668c 
 
periplasmic protein 0.6949465 1.6188244 6.4855126 19.964064 0.0007207 0.0017092 a 
Cj1031 cmeD multidrug efflux system outer membrane protein 0.6962633 1.6203026 8.6268055 19.88891 0.0007315 0.0017323 M 
Cj0363c 
 
coproporphyrinogen III oxidase 0.6964493 1.6205116 6.8069144 16.569067 0.0014728 0.003207 H 
Cj1239 pdxA 4-hydroxythreonine-4-phosphate dehydrogenase 0.7041747 1.6292124 7.014279 20.811992 0.0006104 0.0014882 H 
Cj0612c cft ferritin 0.7107488 1.6366533 8.7444077 31.908198 9.73E-05 0.0003044 P 
Cj0374 
 
nucleotide-binding protein 0.7114657 1.6374668 8.9896985 27.642073 0.000185 0.0005233 S 
Cj1643 
 
periplasmic protein 0.7160333 1.6426594 8.36465 33.976866 7.29E-05 0.0002385 S 
Cj0771c 
 
NLPA family lipoprotein 0.7245296 1.6523618 9.741732 25.807952 0.0002493 0.0006818 P 
Cj0574 ilvI acetolactate synthase 3 catalytic subunit 0.7254693 1.6534384 10.003973 17.267221 0.0012625 0.0027878 E 
Cj1221 groEL chaperone GroEL 0.7370741 1.666792 14.892893 14.130565 0.002608 0.005216 O 
Cj1136 
 
glycosyltransferase 0.7390684 1.6690977 5.7276234 13.322459 0.0031921 0.0062568 M 
Cj0088 dcuA anaerobic C4-dicarboxylate transporter 0.7436477 1.6744041 13.355939 16.630121 0.0014528 0.0031724 S 
Cj1541 
 
LamB/YcsF family protein 0.7453727 1.6764073 7.9353356 31.087335 0.0001096 0.000336 S 
Cj0369c 
 
ferredoxin domain-containing integral membrane protein 0.7464975 1.6777148 7.2939224 18.125804 0.0010501 0.0023825 C 
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Cj1575c 
 
hypothetical protein 0.7528326 1.6850981 7.0956851 13.044539 0.0034274 0.0066351 C 
Cj1462 flgI flagellar basal body P-ring protein 0.7595975 1.6930182 9.2806487 24.443438 0.0003143 0.0008336 N 
Cj1265c hydC Ni/Fe-hydrogenase B-type cytochrome subunit 0.7617667 1.6955657 10.428677 19.275081 0.0008276 0.0019423 C 
Cj1639 
 
NifU protein 0.7637183 1.6978609 6.8650104 22.546808 0.0004405 0.001112 O 
Cj1199 
 
oxidoreductase 0.7667261 1.7014044 9.0472017 13.234397 0.0032646 0.006367 S 
Cj0097 proB glutamate 5-kinase 0.7713359 1.7068496 6.7468675 22.975385 0.0004075 0.0010403 E 
Cj1487c ccoP cbb3-type cytochrome C oxidase subunit III 0.7734228 1.7093204 9.0143997 18.878194 0.0008976 0.0020878 C 
Cj0616 pstB phosphate ABC transporter ATP-binding protein 0.7787695 1.715667 7.1921761 14.015418 0.0026831 0.0053389 P 
Cj0039c typA GTP-binding protein TypA 0.7812143 1.7185768 9.2486114 14.22542 0.002548 0.0051352 T 
Cj0325 xseA exodeoxyribonuclease VII large subunit 0.7831307 1.7208612 7.715631 18.150362 0.0010447 0.0023736 L 
Cj1026c 
 
lipoprotein 0.7834866 1.7212857 11.791851 28.563239 0.0001601 0.0004646 S 
Cj1579c nuoA NADH-quinone oxidoreductase subunit A 0.7839153 1.7217972 7.3013134 21.762432 0.0005094 0.0012696 C 
Cj0023 purB adenylosuccinate lyase 0.7894158 1.7283745 7.8887805 14.567769 0.0023444 0.0047801 F 
Cj1178c 
 
highly acidic protein 0.7920623 1.7315479 9.7309943 18.727062 0.0009261 0.0021412 a 
Cj1522c 
 
CRISPR-associated endonuclease Cas1 0.7957852 1.7360219 6.8169945 17.839193 0.001116 0.0025102 L 
Cj1501 
 
hypothetical protein 0.7958857 1.7361429 5.5447808 13.84548 0.0027985 0.0055197 O 
Cj1451 dut dUTPase 0.8003841 1.7415647 11.076301 26.953346 0.0002066 0.0005778 S 
Cj1037c pycA acetyl-CoA carboxylase subunit A 0.8030347 1.7447674 10.230313 35.351834 6.06E-05 0.0002052 I 
Cj0027 pyrG CTP synthetase 0.8084484 1.7513269 9.8408107 14.763611 0.0022365 0.0045959 F 
Cj1467 
 
hypothetical protein 0.8102915 1.7535657 6.3062637 24.566069 0.0003077 0.0008259 S 
Cj0578c tatC Sec-independent protein translocase TatC 0.8194159 1.7646914 7.3254274 25.905238 0.0002453 0.0006744 U 
Cj0058 
 
peptidase C39 family protein 0.8322106 1.7804113 5.6722084 14.196586 0.002566 0.0051518 O 
Cj0353c 
 
phosphatase 0.8341622 1.7828214 6.3822573 21.312927 0.0005546 0.0013647 F, P 
Cj0430 
 
integral membrane protein 0.8349755 1.7838267 6.3162179 23.896264 0.0003458 0.0009067 S 
Cj1550c rloH ATP/GTP-binding protein 0.8492874 1.8016108 8.0152867 32.012959 9.59E-05 0.0003005 S 
Cj1257c 
 
efflux pump protein 0.8572786 1.8116178 7.8556169 18.479314 0.000975 0.0022478 P 
Cj1563c 
 
transcriptional regulator 0.8585484 1.813213 6.1938715 21.072281 0.0005806 0.0014244 K 
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Cj1374c 
 
Non-canonical purine NTP pyrophosphatase 0.8619634 1.8175102 4.7934611 11.566903 0.0050787 0.0095721 F 
Cj1506c 
 
MCP-type signal transduction protein 0.8751951 1.8342561 11.124734 47.525433 1.45E-05 6.14E-05 T 
Cj1339c flaA flagellin A 0.886421 1.8485845 15.378591 20.326343 0.000671 0.0016132 N 
Cj1476c 
 
pyruvate-flavodoxin oxidoreductase 0.886926 1.8492316 12.884086 26.877109 0.0002091 0.0005821 C 
Cj0297c panC pantothenate synthetase 0.8902531 1.8535012 7.8397867 21.198979 0.0005667 0.0013924 H 
Cj1194 
 
phosphate permease 0.8930026 1.857037 9.8672895 59.888326 4.48E-06 2.45E-05 P 
Cj1266c hydB Ni/Fe-hydrogenase large subunit 0.8960749 1.8609959 12.708148 22.91149 0.0004123 0.0010507 C 
Cj1054c murC UDP-N-acetylmuramate--L-alanine ligase 0.8980491 1.8635442 8.9882502 28.079582 0.0001726 0.0004946 M 
Cj1268c mnmC bifunctional tRNA (mnm(5)s(2)U34)-
methyltransferase/FAD-dependent cmnm(5)s(2)U34 
oxidoreductase 
0.9049449 1.872473 6.305372 23.943674 0.0003429 0.0009034 E 
Cj0459c 
 
hypothetical protein 0.914134 1.8844375 7.0079542 23.608294 0.0003639 0.0009458 a 
Cj0510c 
 
hypothetical protein 0.9199253 1.8920173 5.2404957 16.103161 0.0016359 0.0034991 S 
Cj1259 porA major outer membrane protein 0.9209246 1.8933284 15.652792 22.809737 0.0004199 0.0010651 M 
Cj0129c 
 
outer membrane protein assembly factor 0.9292749 1.9043187 11.133674 31.865447 9.79E-05 0.0003051 M 
Cj0393c mqo malate:quinone oxidoreductase 0.9431062 1.9226634 9.8137884 51.044534 1.01E-05 4.61E-05 C 
Cj0535 oorD 2-oxoglutarate-acceptor oxidoreductase subunit OorD 0.9460929 1.9266478 9.6933159 34.859588 6.47E-05 0.0002158 C 
Cj1148 waaF heptosyltransferase II 0.9549574 1.9385224 7.5362035 40.975177 3.01E-05 0.000114 M 
Cj0282c serB phosphoserine phosphatase 0.9618354 1.9477862 7.7734791 34.457328 6.83E-05 0.0002254 E 
Cj0487 
 
amidohydrolase 0.9635177 1.9500589 4.9454081 12.850621 0.0036037 0.0069251 S 
Cj0261c 
 
SAM-dependent methyltransferase 0.9682202 1.9564255 6.1411807 20.972141 0.0005919 0.0014497 Q 
Cj1288c gltX glutamate--tRNA ligase 0.9702353 1.9591601 9.6885325 47.562628 1.45E-05 6.14E-05 J 
Cj0408 frdC fumarate reductase cytochrome B subunit 0.9710128 1.9602162 11.179597 26.679133 0.000216 0.0006001 C 
Cj1010 tgt queuine tRNA-ribosyltransferase 0.9741646 1.9645033 6.931742 18.907218 0.0008923 0.0020815 J 
Cj0448c 
 
MCP-type signal transduction protein 0.9756947 1.966588 11.158226 52.747513 8.60E-06 4.02E-05 N, T 
Cj1576c nuoD NADH-quinone oxidoreductase subunit D 0.9762469 1.9673408 9.6628969 29.373281 0.0001414 0.000418 C 
Cj1373 
 
integral membrane protein 0.9779633 1.9696827 6.2555546 14.197308 0.0025656 0.0051518 S 
Cj1543 
 
allophanate hydrolase subunit 2 0.9783438 1.9702023 8.4914932 33.011234 8.33E-05 0.0002642 E 
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Cj0729 
 
type I phosphodiesterase/nucleotide pyrophosphatase 0.9786962 1.9706836 4.5821361 15.591408 0.00184 0.0038879 S 
Cj0732 
 
ABC transporter ATP-binding protein 0.9807989 1.9735579 3.8646617 12.342426 0.0041182 0.0078848 E 
Cj1027c gyrA DNA gyrase subunit A 0.9828283 1.9763361 11.691672 38.385332 4.11E-05 0.0001498 L 
Cj0368c cmeR transcriptional regulator CmeR 0.9838367 1.9777179 5.7863451 24.504025 0.000311 0.0008265 K 
Cj0833c 
 
oxidoreductase 0.9840111 1.977957 7.6547151 23.135033 0.000396 0.0010158 S 
Cj0012c rrc non-heme iron protein 0.9868436 1.9818442 11.975729 18.947102 0.000885 0.0020707 C 
Cj1377c 
 
ferredoxin 0.9886122 1.9842753 8.1421458 54.609838 7.21E-06 3.56E-05 C 
Cj0924c cheB' MCP protein-glutamate methylesterase 0.9965141 1.9951733 8.6481591 75.292361 1.34E-06 9.24E-06 N, T 
Cj0224 argC N-acetyl-gamma-glutamyl-phosphate reductase 0.9965208 1.9951826 7.3377008 40.679386 3.11E-05 0.0001177 E 
Cj0001 dnaA chromosomal replication initiation protein 0.997433 1.9964446 7.9079052 22.885776 0.0004142 0.0010539 L 
Cj0935c 
 
sodium:amino-acid symporter family protein 1.0013465 2.0018675 5.4276946 12.323374 0.0041391 0.0079151 P 
Cj0016 
 
7-cyano-7-deazaguanine synthase 1.0015997 2.0022189 5.8110164 11.972418 0.0045472 0.008622 S 
Cj1267c hydA Ni/Fe-hydrogenase small subunit 1.0050313 2.0069871 11.622711 30.195289 0.000125 0.0003758 C 
Cj0561c 
 
periplasmic protein 1.0100814 2.0140248 8.8267091 59.856543 4.50E-06 2.45E-05 S 
Cj1361c 
 
hypothetical protein 1.0130277 2.018142 6.7929212 17.705595 0.0011484 0.0025672 S 
Cj1537c acs acetyl-CoA synthetase 1.0130697 2.0182008 9.6168559 15.644707 0.0018174 0.0038558 I 
Cj0022c 
 
pseudouridine synthase 1.0138388 2.019277 6.5025065 21.713141 0.0005142 0.0012793 J 
Cj1156 rho transcription termination factor Rho 1.0251569 2.0351808 9.0514763 40.524087 3.17E-05 0.0001194 K 
Cj1312 pseG UDP-2,4-diacetamido-2,4,6-trideoxy-beta-L-altropyranose 
hydrolase 
1.0271278 2.0379629 7.5001533 49.002142 1.25E-05 5.43E-05 M 
Cj0797c 
 
hypothetical protein 1.0282812 2.0395929 5.1265016 15.521782 0.00187 0.0039354 S 
Cj1097 
 
serine/threonine transporter SstT 1.0285899 2.0400293 6.9757538 36.565757 5.18E-05 0.0001821 E 
Cj0298c panB 3-methyl-2-oxobutanoate hydroxymethyltransferase 1.0304421 2.0426501 7.8209235 25.161002 0.0002779 0.0007524 H 
Cj0009 gltD glutamate synthase subunit beta 1.0348089 2.0488423 9.8558058 21.343286 0.0005514 0.001359 E 
Cj0198c 
 
recombination factor protein RarA 1.0355338 2.049872 5.2181092 14.159372 0.0025896 0.0051858 L 
Cj1040c 
 
MFS transport protein 1.0361431 2.0507378 6.5534116 32.86958 8.50E-05 0.000269 P 
Cj0033 
 
integral membrane protein 1.0397441 2.0558629 5.9829993 33.735338 7.54E-05 0.0002445 S 
Cj0767c coaD phosphopantetheine adenylyltransferase 1.0552326 2.0780532 6.537227 33.256153 8.05E-05 0.0002575 H 
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Cj0410 frdB fumarate reductase iron-sulfur subunit 1.0556394 2.0786392 11.275098 58.595066 5.02E-06 2.64E-05 C 
Cj0820c fliP flagellar biosynthesis protein FliP 1.0568277 2.080352 6.4070653 23.71139 0.0003573 0.0009318 N 
Cj1635c rnc ribonuclease III 1.0618017 2.0875369 8.057332 31.230558 0.0001073 0.000331 K 
Cj1002c 
 
phosphoglycerate/bisphosphoglycerate mutase 1.0624527 2.0884791 5.8998004 30.578156 0.0001181 0.0003571 T 
Cj0194 folE GTP cyclohydrolase I 1.0655504 2.0929683 6.868428 28.576218 0.0001598 0.0004645 H 
Cj0100 
 
ParA family protein 1.0688083 2.0976998 8.8476361 60.783782 4.15E-06 2.32E-05 D 
Cj0769c flgA flagellar basal body P-ring biosynthesis protein FlgA 1.0709704 2.100846 6.2038745 36.197957 5.43E-05 0.0001882 N 
Cj1197c gatB aspartyl/glutamyl-tRNA amidotransferase subunit B 1.075256 2.1070959 9.7031397 73.909811 1.48E-06 1.00E-05 J 
Cj1357c nrfA cytochrome c nitrite reductase cytochrome c552 subunit 1.0766055 2.1090679 9.5218709 16.498149 0.0014963 0.0032448 P 
Cj0854c 
 
periplasmic protein 1.0766875 2.1091877 6.5167837 37.805131 4.42E-05 0.0001606 a 
Cj0782 napH quinol dehydrogenase membrane subunit 1.0771087 2.1098036 8.6176609 43.798011 2.17E-05 8.77E-05 C 
Cj0758 grpE heat shock protein GrpE 1.0846744 2.1208967 10.771787 16.583196 0.0014681 0.0032014 O 
Cj0955c purL phosphoribosylformylglycinamidine synthase II 1.0914277 2.130848 8.7825526 71.534573 1.76E-06 1.14E-05 F 
Cj0324 ubiE ubiquinone/menaquinone biosynthesis methyltransferase 1.0938556 2.1344371 7.9383204 49.42283 1.19E-05 5.24E-05 H 
Cj1347c cdsA phosphatidate cytidylyltransferase 1.0992647 2.1424547 7.892094 56.979967 5.80E-06 2.95E-05 I 
Cj1167 ldh L-lactate dehydrogenase 1.0998943 2.1433899 7.5072949 54.42633 7.33E-06 3.59E-05 C 
Cj0283c cheW chemotaxis protein 1.099932 2.1434459 10.25273 64.856113 2.96E-06 1.76E-05 N, T 
Cj1050c npdA NAD-dependent protein deacetylase 1.100613 2.1444579 6.8064798 37.144645 4.81E-05 0.0001711 K 
Cj1222c dccS two-component sensor histidine kinase 1.1012727 2.1454387 7.1952044 42.731727 2.45E-05 9.72E-05 T 
Cj1166c 
 
integral membrane protein 1.1032523 2.1483847 6.6717844 35.977649 5.59E-05 0.0001919 S 
Cj0581 
 
RNA pyrophosphohydrolase 1.106949 2.1538967 8.7284862 77.423163 1.16E-06 8.14E-06 L 
Cj1623 
 
membrane protein 1.1186583 2.1714493 5.6747399 20.172154 0.0006916 0.0016528 S 
Cj0172c 
 
saccharopine dehydrogenase 1.1246244 2.1804477 9.1802699 48.65341 1.29E-05 5.56E-05 E 
Cj0548 fliD flagellar hook-associated protein 2 1.1273533 2.184576 12.807243 43.684489 2.20E-05 8.86E-05 N 
Cj1503c putA proline dehydrogenase/delta-1-pyrroline-5-carboxylate 
dehydrogenase 
1.1275175 2.1848246 9.9264828 35.041966 6.32E-05 0.0002113 E 
Cj0099 birA acetyl-CoA-carboxylase synthetase 1.1287945 2.1867595 7.5454773 57.521084 5.52E-06 2.84E-05 H 
Cj1349c 
 
fibronectin/fibrinogen-binding protein 1.1294211 2.1877094 6.1463751 26.887758 0.0002088 0.0005821 K 
Appendix C 
 
 
 
301 
 
Locus 
Tag 
Gene Product log2FC FC logCPM F PValue FDR COG 
Cat. 
Cj0284c cheA chemotaxis histidine kinase 1.1306785 2.189617 12.599303 47.394286 1.47E-05 6.21E-05 T 
Cj0906c 
 
periplasmic protein 1.1357138 2.1972726 7.8116994 30.410058 0.000121 0.0003647 S 
Cj0793 flgS signal transduction histidine kinase 1.1397609 2.2034451 7.0364973 36.708662 5.08E-05 0.0001797 T 
Cj0354c fdxB ferredoxin 1.1452455 2.2118376 6.1751819 23.146783 0.0003951 0.0010153 C 
Cj1378 selA L-seryl-tRNA(Sec) selenium transferase 1.1500406 2.2192014 7.623729 59.4464 4.66E-06 2.51E-05 E 
Cj0076c lctP L-lactate permease 1.1573492 2.2304723 11.397082 51.029307 1.02E-05 4.61E-05 C 
Cj0794 
 
hypothetical protein 1.1585891 2.23239 7.0297695 33.865108 7.41E-05 0.0002412 a 
Cj1237c 
 
phosphatase 1.1604354 2.2352487 6.6720184 36.059877 5.53E-05 0.0001907 T 
Cj0409 frdA fumarate reductase flavoprotein subunit 1.1668604 2.2452256 12.510336 16.539917 0.0014824 0.0032235 C 
Cj1258 
 
phosphotyrosine protein phosphatase 1.1696708 2.2496036 5.6425362 33.663735 7.61E-05 0.0002464 T 
Cj0909 
 
periplasmic protein 1.1697991 2.2498036 7.1467372 42.734384 2.45E-05 9.72E-05 S 
Cj1715 
 
acetyltransferase 1.1700634 2.2502159 7.8908004 83.888333 7.49E-07 5.85E-06 K 
Cj1634c aroC chorismate synthase 1.1703312 2.2506336 8.6623506 36.758431 5.05E-05 0.0001789 E 
Cj0902 glnQ glutamine transporter ATP-binding protein 1.1796037 2.2651454 6.4266841 46.119334 1.69E-05 7.04E-05 E 
Cj0831c trmA tRNA/tmRNA (uracil-C(5))-methyltransferase 1.1883134 2.2788617 6.299772 36.343488 5.33E-05 0.0001854 J 
Cj1238 pdxJ pyridoxine 5'-phosphate synthase 1.1900945 2.2816768 7.9891477 66.536876 2.59E-06 1.57E-05 H 
Cj0718 dnaE DNA polymerase III subunit alpha 1.192376 2.2852879 9.3850641 54.464735 7.30E-06 3.59E-05 L 
Cj0488 
 
hypothetical protein 1.202548 2.3014578 5.0475391 15.084 0.0020722 0.0043205 S 
Cj0623 hypB hydrogenase isoenzymes formation protein 1.2041057 2.3039441 9.4204869 102.88239 2.45E-07 2.56E-06 O 
Cj0486 
 
sugar transporter 1.2050778 2.3054971 5.9432193 29.409798 0.0001406 0.0004165 G 
Cj1677 
 
lipoprotein 1.2094224 2.3124504 6.7875915 41.616756 2.79E-05 0.0001078 S 
Cj1468 
 
integral membrane protein 1.2123899 2.3172118 6.6002947 44.820857 1.94E-05 7.93E-05 S 
Cj0014c 
 
integral membrane protein 1.2217718 2.3323298 7.540944 73.029245 1.58E-06 1.05E-05 S 
Cj0787 
 
hypothetical protein 1.224052 2.336019 6.4043134 45.747551 1.75E-05 7.29E-05 a 
Cj0539 
 
hypothetical protein 1.2305533 2.3465696 5.9892258 34.313067 6.97E-05 0.0002293 S 
Cj0301c modB molybdenum ABC transporter permease 1.2306938 2.3467982 4.4738608 15.613748 0.0018305 0.0038783 P 
Cj0358 
 
cytochrome C551 peroxidase 1.2368598 2.3568497 11.046744 75.343959 1.34E-06 9.24E-06 P 
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Cj0967 
 
periplasmic protein 1.2380218 2.3587488 8.2665162 49.740974 1.16E-05 5.11E-05 a 
Cj1208 
 
5-formyltetrahydrofolate cyclo-ligase 1.2450461 2.3702613 6.0126979 40.065402 3.35E-05 0.0001252 H 
Cj1412c 
 
integral membrane protein 1.2553879 2.3873132 7.5326025 73.614638 1.51E-06 1.01E-05 S 
Cj0128c 
 
inositol monophosphatase family protein 1.2615122 2.397469 7.1006901 45.142545 1.87E-05 7.70E-05 G 
Cj1490c ccoN cbb3-type cytochrome c oxidase subunit I 1.2626256 2.3993201 10.489806 60.37691 4.30E-06 2.38E-05 C 
Cj1388 
 
endoribonuclease L-PSP 1.2645472 2.402518 9.9245992 36.506489 5.21E-05 0.0001823 J 
Cj1713 
 
23S rRNA (adenine(2503)-C(2))-methyltransferase RlmN 1.2651348 2.4034967 6.0006705 33.805293 7.47E-05 0.0002427 J 
Cj0431 
 
ATP/GTP-binding protein 1.2653658 2.4038815 4.7885572 20.577619 0.0006388 0.0015502 a 
Cj1170c omp50 outer membrane protein 1.2677836 2.4079135 9.5689525 35.611781 5.86E-05 0.0001995 M 
Cj0579c tatB Sec-independent translocase TatB 1.27765 2.4244374 8.2061269 66.365412 2.62E-06 1.58E-05 U 
Cj0783 napB nitrate reductase small subunit 1.2809206 2.4299399 8.1289178 67.975806 2.31E-06 1.43E-05 C 
Cj0858c murA UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1.2812586 2.4305092 8.7750463 69.056392 2.13E-06 1.33E-05 M 
Cj0228c pcm protein-L-isoaspartate O-methyltransferase 1.2878672 2.4416683 7.7396375 80.596391 9.31E-07 6.99E-06 O 
Cj1359 ppk polyphosphate kinase 1.292263 2.4491192 9.9021039 80.986759 9.07E-07 6.88E-06 P 
Cj1151c hldD ADP-glyceromanno-heptose 6-epimerase 1.2983555 2.4594837 8.6713684 117.35698 1.17E-07 1.50E-06 M 
Cj1332 ptmA flagellin modification protein A 1.3008185 2.4636862 8.3510653 77.642435 1.14E-06 8.07E-06 I, Q 
Cj0013 ilvD dihydroxy-acid dehydratase 1.3018377 2.4654274 9.0103843 94.14374 3.99E-07 3.67E-06 E 
Cj0341c 
 
integral membrane protein 1.3025494 2.4666437 4.8002693 17.481854 0.001205 0.002676 S 
Cj1585c 
 
oxidoreductase 1.3075449 2.4751996 9.0706282 88.588237 5.57E-07 4.78E-06 C 
Cj0124c 
 
membrane protein 1.3088581 2.4774536 5.9635324 31.549381 0.0001025 0.000318 a 
Cj1539c 
 
anion-uptake ABC transporter permease 1.311514 2.4820187 6.299307 49.476639 1.19E-05 5.22E-05 P 
Cj1263 recR recombination protein RecR 1.3354568 2.5235536 7.5674333 78.047936 1.11E-06 8.04E-06 L 
Cj0978c 
 
lipoprotein 1.3356049 2.5238128 6.318367 35.220765 6.17E-05 0.0002079 a 
Cj1622 ribD riboflavin-specific deaminase/reductase 1.3413357 2.5338581 6.3759133 52.179733 9.08E-06 4.21E-05 H 
Cj1404 nadD nicotinate-nucleotide adenylyltransferase 1.3429448 2.5366857 5.0125712 23.08384 0.0003996 0.0010235 H 
Cj0573 
 
GatB/Yqey family protein 1.3446438 2.5396749 8.7284598 50.591936 1.06E-05 4.78E-05 S 
Cj0781 napG quinol dehydrogenase periplasmic subunit 1.3451299 2.5405306 10.274015 78.408664 1.08E-06 7.88E-06 C 
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Cj1138 
 
glycosyltransferase 1.3518895 2.552462 4.7406736 31.512903 0.000103 0.000319 M 
Cj1354 ceuD enterochelin uptake ATP-binding protein 1.3587878 2.564696 3.3639712 14.492085 0.0023877 0.0048621 P 
Cj1358c nrfH cytochrome c nitrite reductase small subunit 1.3662691 2.5780301 6.4027477 24.506297 0.0003109 0.0008265 C 
Cj0086c ung uracil-DNA glycosylase 1.370681 2.5859261 5.1202363 15.063064 0.0020825 0.0043305 L 
Cj1134 htrB lipid A biosynthesis lauroyl acyltransferase 1.3722051 2.5886593 6.2795514 48.194726 1.35E-05 5.79E-05 M 
Cj1133 waaC heptosyltransferase I 1.3741092 2.5920781 6.6494968 28.240976 0.0001683 0.0004864 M 
Cj1173 
 
multidrug resistance protein 1.3788418 2.6005951 4.0611692 24.677529 0.0003019 0.0008115 P 
Cj1350 mobA molybdopterin-guanine dinucleotide biosynthesis protein 1.3831642 2.6083984 5.1988145 32.05168 9.54E-05 0.0002994 H 
Cj0338c polA DNA polymerase I 1.3842525 2.6103667 8.3546796 114.12214 1.37E-07 1.62E-06 L 
Cj0788 
 
hypothetical protein 1.3849514 2.6116315 7.2616784 76.285479 1.25E-06 8.69E-06 a 
Cj1649 
 
lipoprotein 1.3862818 2.6140411 5.9460183 33.554003 7.73E-05 0.0002491 S 
Cj0285c cheV chemotaxis protein 1.3873145 2.615913 10.686624 60.017861 4.43E-06 2.43E-05 N, T 
Cj1488c ccoQ cbb3-type cytochrome C oxidase subunit IV 1.3977927 2.6349813 7.0879748 39.908661 3.41E-05 0.0001267 C 
Cj0150c 
 
aminotransferase 1.4022647 2.6431617 9.6065987 71.18908 1.81E-06 1.17E-05 E 
Cj0667 
 
S4 domain-containing protein 1.4037965 2.6459695 5.0454251 28.203555 0.0001693 0.0004869 J 
Cj0271 
 
bacterioferritin comigratory protein 1.4046389 2.6475151 6.8116412 61.813085 3.80E-06 2.15E-05 O 
Cj0853c hemL glutamate-1-semialdehyde aminotransferase 1.4062182 2.6504148 10.023332 66.325062 2.63E-06 1.58E-05 H 
Cj1240c 
 
periplasmic protein 1.4083223 2.6542831 5.4034902 36.58471 5.16E-05 0.0001821 a 
Cj1552c mloB hypothetical protein 1.409026 2.6555781 7.371429 90.644885 4.91E-07 4.31E-06 K 
Cj1260c dnaJ chaperone protein DnaJ 1.4142809 2.6652686 6.6635569 57.722218 5.42E-06 2.82E-05 O 
Cj0005c 
 
molydopterin containing oxidoreductase 1.4320019 2.6982086 8.7497303 80.350776 9.46E-07 7.04E-06 S 
Cj0424 
 
acidic periplasmic protein 1.4356048 2.7049554 6.7500163 17.301698 0.0012531 0.0027709 S 
Cj0630c 
 
DNA polymerase III subunit delta 1.4427588 2.718402 6.5542851 69.053911 2.13E-06 1.33E-05 L 
Cj0199c 
 
periplasmic protein 1.4487189 2.7296555 3.4294119 13.903661 0.0027584 0.0054611 S 
Cj0766c tmk thymidylate kinase 1.4509134 2.7338108 5.8458718 38.935775 3.84E-05 0.0001409 F 
Cj0015c 
 
hypothetical protein 1.462416 2.7556946 7.9109708 95.80675 3.63E-07 3.49E-06 U 
Cj1203c 
 
integral membrane protein 1.4651303 2.760884 3.310534 15.99065 0.0016784 0.0035852 a 
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Cj1004 
 
periplasmic protein 1.4669445 2.7643582 5.8597034 27.279929 0.000196 0.0005505 S 
Cj1609 
 
sulfate adenylyltransferase 1.4760531 2.7818663 8.5607308 90.566387 4.94E-07 4.31E-06 P 
Cj0425 
 
periplasmic protein 1.4835216 2.7963047 6.3776295 35.921689 5.63E-05 0.0001924 a 
Cj0179 exbB1 biopolymer transport protein 1.4885483 2.8060647 5.6033423 63.560802 3.29E-06 1.92E-05 U 
Cj1247c 
 
hypothetical protein 1.4988046 2.8260845 4.945012 21.347654 0.0005509 0.001359 a 
Cj1262 racS two-component sensor histidine kinase 1.5030058 2.8343262 8.4671648 129.35679 6.77E-08 1.09E-06 T 
Cj0004c 
 
monoheme cytochrome C 1.5071384 2.8424567 6.8512568 60.105824 4.40E-06 2.42E-05 P 
Cj0631c 
 
ribonuclease 1.5136679 2.8553505 7.57224 57.48458 5.54E-06 2.84E-05 K 
Cj1531 dapF diaminopimelate epimerase 1.5170127 2.8619783 8.7247931 68.303554 2.25E-06 1.40E-05 E 
Cj0485 
 
short chain dehydrogenase 1.5414762 2.9109221 5.9656805 30.878018 0.000113 0.0003444 I 
Cj0525c pbpB penicillin-binding protein 1.5437972 2.9156089 8.1346755 65.591831 2.79E-06 1.67E-05 M 
Cj0390 
 
transmembrane protein 1.5556032 2.9395661 9.9914273 96.840388 3.42E-07 3.33E-06 S 
Cj1102 truB tRNA pseudouridine synthase B 1.5603304 2.9492138 5.3800977 57.503923 5.53E-06 2.84E-05 J 
Cj1152c gmhB D-glycero-alpha-D-manno-heptose-1,7-bisphosphate 7-
phosphatase 
1.5648375 2.9584419 6.4048229 60.578928 4.22E-06 2.34E-05 E 
Cj0057 
 
periplasmic protein 1.5650739 2.9589266 5.7070718 57.032358 5.77E-06 2.94E-05 S 
Cj0713 trmD tRNA (guanine-N(1)-)-methyltransferase 1.568056 2.9650492 8.7796559 37.304125 4.71E-05 0.000168 J 
Cj0151c 
 
periplasmic protein 1.5802309 2.990177 6.4116743 41.472224 2.84E-05 0.0001094 S 
Cj1363 amaA acid membrane antigen A 1.5919662 3.0145993 8.3458164 77.848125 1.12E-06 8.07E-06 S 
Cj0447 
 
NUDIX hydrolase family protein 1.6037572 3.0393382 7.484543 50.403183 1.08E-05 4.85E-05 L 
Cj0818 
 
lipoprotein 1.6111512 3.0549552 5.2278022 34.478197 6.81E-05 0.0002252 a 
Cj0293 surE 5'-nucleotidase SurE 1.6166448 3.0666103 7.1406475 48.008912 1.38E-05 5.89E-05 F 
Cj1211 
 
competence family protein 1.6181315 3.069772 3.4016734 13.127479 0.0033552 0.0065112 S 
Cj1001 rpoD RNA polymerase sigma factor RpoD 1.618726 3.0710373 11.522969 100.61827 2.77E-07 2.84E-06 K 
Cj1546 
 
transcriptional regulator 1.6204038 3.0746109 6.3925991 46.159801 1.68E-05 7.03E-05 K 
Cj0127c accD acetyl-CoA carboxylase carboxyl transferase subunit beta 1.6208922 3.0756518 8.0896836 54.45519 7.31E-06 3.59E-05 I 
Cj1682c gltA citrate synthase 1.6238559 3.0819766 11.153363 86.892043 6.19E-07 5.11E-06 C 
Cj1154c 
 
cbb3-type cytochrome oxidase maturation protein 1.6300358 3.0952068 4.1634323 23.795947 0.000352 0.000921 P 
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Cj0270 
 
tautomerase family protein 1.6324552 3.1004018 5.7969632 51.64011 9.57E-06 4.38E-05 S 
Cj1139c wlaN beta-1,3 galactosyltransferase 1.6414216 3.119731 4.8885716 18.898384 0.0008939 0.0020822 M 
Cj0719c 
 
hypothetical protein 1.644086 3.1254978 8.1574875 74.686508 1.40E-06 9.61E-06 E 
Cj1547 
 
lipocalin family protein 1.6449109 3.1272854 5.8696536 48.888884 1.26E-05 5.44E-05 M 
Cj1261 racR two-component regulator 1.6472363 3.1323301 9.6721341 121.65983 9.58E-08 1.34E-06 T 
Cj0370 rpsU 30S ribosomal protein S21 1.647384 3.1326509 9.1239399 109.29487 1.75E-07 1.97E-06 J 
Cj0772c 
 
NLPA family lipoprotein 1.6479699 3.1339234 12.461652 113.22403 1.43E-07 1.66E-06 M 
Cj1229 cbpA curved-DNA binding protein 1.6506048 3.1396523 10.447462 24.554977 0.0003083 0.000826 O 
Cj0238 
 
mechanosensitive ion channel family protein 1.651468 3.1415315 8.5367729 87.413515 5.99E-07 5.06E-06 M 
Cj1387c 
 
hypothetical protein 1.6521713 3.1430633 6.0142006 57.528559 5.52E-06 2.84E-05 S 
Cj1613c 
 
pyridoxamine 5'-phosphate oxidase 1.652514 3.1438098 9.3747104 103.09739 2.42E-07 2.56E-06 P 
Cj0429c 
 
hypothetical protein 1.6693177 3.1806413 6.4206388 90.996724 4.81E-07 4.24E-06 S 
Cj0034c 
 
periplasmic protein 1.688472 3.2231515 9.7799707 133.63039 5.63E-08 9.52E-07 S 
Cj0418c 
 
hypothetical protein 1.6909027 3.2285864 8.9778045 100.93553 2.72E-07 2.83E-06 S 
Cj1489c ccoO cbb3-type cytochrome c oxidase subunit II 1.6963448 3.2407884 9.624128 74.475949 1.42E-06 9.71E-06 C 
Cj1581c 
 
peptide ABC transporter ATP-binding protein 1.7165767 3.2865563 3.6708545 29.499068 0.0001387 0.0004133 E, P 
Cj0571 
 
transcriptional regulator 1.7305803 3.3186128 4.4342422 40.156676 3.31E-05 0.0001244 K 
Cj1655c nhaA1 Na(+)/H(+) antiporter 1.7363976 3.3320213 9.7365709 87.09393 6.11E-07 5.09E-06 P 
Cj0021c 
 
fumarylacetoacetate (FAA) hydrolase family protein 1.7368446 3.3330537 9.2901004 127.11505 7.48E-08 1.14E-06 Q 
Cj0073c 
 
hypothetical protein 1.737404 3.3343464 8.7629397 77.613155 1.14E-06 8.07E-06 S 
Cj1724c 
 
7-cyano-7-deazaguanine reductase 1.7415797 3.3440111 5.9114148 37.377351 4.67E-05 0.0001672 S 
Cj0572 ribA 3,4-dihydroxy-2-butanone-4-phosphate synthase 1.7506163 3.3650228 9.6333937 120.40612 1.02E-07 1.39E-06 H 
Cj0517 crcB fluoride ion transporter CrcB 1.7574212 3.3809325 2.9953691 15.072722 0.0020777 0.0043263 D 
Cj1422c 
 
sugar transferase 1.7687116 3.4074951 7.696019 57.19954 5.68E-06 2.91E-05 M 
Cj0830 
 
integral membrane protein 1.7710794 3.4130922 6.2774752 42.858847 2.42E-05 9.63E-05 S 
Cj0835c acnB aconitate hydratase B 1.7798652 3.433941 12.021123 93.126757 4.24E-07 3.85E-06 C 
Cj1532 
 
periplasmic protein 1.7861896 3.4490274 7.5768255 146.65271 3.32E-08 6.62E-07 S 
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Cj0123c 
 
tRNA-dihydrouridine synthase 1.7876321 3.4524778 6.1757625 50.917604 1.03E-05 4.65E-05 J 
Cj1721c 
 
outer membrane protein 1.7999863 3.4821691 8.118973 171.73555 1.34E-08 3.69E-07 a 
Cj0731 
 
ABC transporter permease 1.8003947 3.4831551 3.6599119 16.361841 0.0015429 0.0033182 E 
Cj0035c 
 
efflux protein 1.8041021 3.4921174 4.3943445 34.013342 7.26E-05 0.0002379 P 
Cj0007 gltB glutamate synthase large subunit 1.8147397 3.5179616 12.160114 58.845574 4.91E-06 2.60E-05 E 
Cj0038c 
 
poly(A) polymerase family protein 1.8276744 3.5496441 4.2968615 22.840062 0.0004176 0.001061 a 
Cj1095 
 
apolipoprotein N-acyltransferase 1.8392026 3.5781222 3.549055 23.526543 0.0003692 0.000958 M 
Cj1687 
 
efflux protein 1.8427562 3.5869464 8.0606855 131.15559 6.26E-08 1.02E-06 G 
Cj1466 flgK flagellar hook-associated protein FlgK 1.8513028 3.6082588 12.038444 103.77415 2.33E-07 2.52E-06 N 
Cj1500 
 
inner membrane protein 1.8521485 3.6103744 5.4636179 93.703633 4.10E-07 3.74E-06 S 
Cj0688 pta phosphate acetyltransferase 1.8577528 3.6244267 10.753283 169.39892 1.45E-08 3.86E-07 C 
Cj1720 
 
hypothetical protein 1.8583102 3.6258272 8.2364904 77.644763 1.14E-06 8.07E-06 a 
Cj0971 
 
hypothetical protein 1.8608352 3.6321787 3.1468501 18.192474 0.0010354 0.0023629 U 
Cj0075c 
 
oxidoreductase iron-sulfur subunit 1.8716171 3.6594253 9.8216071 86.401746 6.38E-07 5.23E-06 C 
Cj0437 sdhA succinate dehydrogenase flavoprotein subunit 1.8733896 3.6639241 10.611875 18.76246 0.0009193 0.0021319 C 
Cj0825 
 
processing peptidase 1.8902522 3.7070003 4.3343856 23.385549 0.0003786 0.0009792 U 
Cj0552 
 
membrane protein 1.8907322 3.7082338 8.0591056 129.73917 6.66E-08 1.08E-06 S 
Cj0780 napA nitrate reductase catalytic subunit 1.9087831 3.7549224 13.398612 156.6817 2.27E-08 5.40E-07 C 
Cj0055c 
 
hypothetical protein 1.9096025 3.7570556 10.133671 142.06228 3.98E-08 7.26E-07 a 
Cj0903c 
 
amino acid transport protein 1.9129892 3.7658855 9.0016621 209.08576 4.27E-09 1.91E-07 E 
Cj1542 
 
allophanate hydrolase subunit 1 1.9248368 3.796939 8.8427782 98.667613 3.08E-07 3.06E-06 E 
Cj0680c uvrB excinuclease ABC subunit B 1.9639602 3.9013142 8.1924415 186.83245 8.22E-09 2.58E-07 L 
Cj0850c 
 
MFS transport protein 1.9692773 3.9157192 7.2229398 113.94915 1.38E-07 1.62E-06 G 
Cj1029c mapA outer membrane lipoprotein MapA 1.9704222 3.9188278 9.6058749 149.91237 2.93E-08 6.18E-07 M 
Cj0449c 
 
hypothetical protein 2.0058703 4.0163092 10.658767 168.83838 1.48E-08 3.86E-07 S 
Cj1220 groES co-chaperonin GroES 2.0112094 4.0312001 12.59286 156.99095 2.25E-08 5.40E-07 O 
Cj0422c 
 
H-T-H containing protein 2.0247062 4.0690899 5.8291993 94.900425 3.82E-07 3.61E-06 a 
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Cj0037c 
 
cytochrome C 2.0385454 4.1083111 10.49322 118.95973 1.09E-07 1.42E-06 C 
Cj0263 
 
zinc transporter ZupT 2.054988 4.1554019 7.1178976 63.801382 3.22E-06 1.90E-05 P 
Cj1628 exbB2 ExbB/TolQ family transport protein 2.070583 4.200564 4.3781889 29.87121 0.0001312 0.000393 U 
Cj0554 
 
hypothetical protein 2.0711726 4.2022808 7.6072666 153.87651 2.52E-08 5.73E-07 S 
Cj1311 pseF pseudaminic acid cytidylyltransferase 2.0787719 4.2244746 8.3992697 195.22926 6.37E-09 2.27E-07 M 
Cj1355 ceuE enterochelin uptake substrate-binding protein 2.0845641 4.2414692 6.7834475 103.55184 2.36E-07 2.52E-06 P 
Cj0553 
 
integral membrane protein 2.0863547 4.2467367 7.4390613 193.97632 6.61E-09 2.27E-07 S 
Cj1615 chuB hemin uptake ABC transporter permease 2.0864253 4.2469445 6.2587421 87.053846 6.13E-07 5.09E-06 P 
Cj1648 
 
ABC transporter substrate-binding protein 2.0980259 4.2812317 8.4158169 114.51242 1.35E-07 1.62E-06 Q 
Cj1725 
 
periplasmic protein 2.0983626 4.2822309 10.924859 116.7551 1.21E-07 1.51E-06 O 
Cj0201c 
 
integral membrane protein 2.0987189 4.2832887 3.6710009 31.884833 9.77E-05 0.0003048 S 
Cj1582c 
 
peptide ABC transporter permease 2.1136608 4.3278809 2.3829486 11.472329 0.0052129 0.0097782 E, P 
Cj1158c 
 
hypothetical protein 2.1299102 4.3769025 4.2034546 52.246641 9.02E-06 4.20E-05 S 
Cj0125c 
 
hypothetical protein 2.1554232 4.454993 6.0248258 87.558004 5.94E-07 5.04E-06 T 
Cj1316c pseA pseudaminic acid biosynthesis protein PseA 2.1569502 4.4597109 10.83144 53.443559 8.04E-06 3.83E-05 D 
Cj0439 sdhC succinate dehydrogenase subunit C 2.1623658 4.4764834 10.358318 72.225294 1.68E-06 1.10E-05 C 
Cj1421c 
 
sugar transferase 2.1677639 4.4932644 8.3072578 100.14911 2.84E-07 2.88E-06 M 
Cj0699c glnA glutamine synthetase 2.1725326 4.5081407 11.524649 126.20863 7.79E-08 1.16E-06 E 
Cj0879c 
 
periplasmic protein 2.1784211 4.5265788 8.0980144 187.04271 8.17E-09 2.58E-07 S 
Cj1348c 
 
hypothetical protein 2.1871337 4.553998 8.8500941 193.05904 6.79E-09 2.27E-07 a 
Cj0901 
 
amino acid ABC transporter permease 2.2037947 4.6068949 5.780477 73.594364 1.52E-06 1.01E-05 E 
Cj0580c 
 
coproporphyrinogen III oxidase 2.205066 4.6109562 4.1827112 34.778271 6.54E-05 0.0002172 H 
Cj0827 truA tRNA pseudouridine synthase A 2.2273183 4.6826275 5.8865394 127.53278 7.34E-08 1.13E-06 J 
Cj0878 
 
hypothetical protein 2.2392601 4.7215486 3.3658419 32.686874 8.72E-05 0.0002754 a 
Cj1362 ruvB Holliday junction DNA helicase RuvB 2.2452435 4.7411713 8.2293989 146.72399 3.31E-08 6.62E-07 L 
Cj1608 
 
two-component regulator 2.246432 4.7450785 6.3050884 77.835242 1.12E-06 8.07E-06 T 
Cj0720c flaC flagellin C 2.2495201 4.7552464 12.665838 251.81211 1.43E-09 1.07E-07 N 
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Cj0264c 
 
molybdopterin containing oxidoreductase 2.2510265 4.7602143 12.606335 119.65603 1.05E-07 1.42E-06 C 
Cj0026c thyX thymidylate synthase 2.2582477 4.7841006 7.4364625 198.13334 5.84E-09 2.18E-07 F 
Cj0480c 
 
transcriptional regulator 2.2753648 4.8412005 6.7467106 119.27401 1.07E-07 1.42E-06 K 
Cj0970 
 
hypothetical protein 2.3091418 4.955882 3.334834 25.199668 0.0002761 0.0007487 a 
Cj0122 
 
hypothetical protein 2.3102017 4.9595242 8.189695 99.990555 2.86E-07 2.88E-06 a 
Cj1353 ceuC enterochelin uptake permease 2.3135791 4.971148 4.9589697 30.532451 0.0001189 0.0003589 P 
Cj1553c hsdM type I restriction enzyme M protein 2.3149155 4.9757553 9.1816087 142.59946 3.89E-08 7.19E-07 V 
Cj0570 
 
ATP/GTP binding protein 2.325868 5.0136733 5.8225557 89.260695 5.35E-07 4.64E-06 S 
Cj1731c ruvC Holliday junction resolvase 2.3277864 5.0203446 6.0943292 95.468599 3.70E-07 3.54E-06 L 
Cj1255 
 
isomerase 2.3286217 5.0232523 6.1439756 113.43041 1.42E-07 1.65E-06 S 
Cj0792 
 
hypothetical protein 2.3397517 5.0621552 4.7311694 18.372344 0.000997 0.0022852 S 
Cj1352 ceuB enterochelin uptake permease 2.364979 5.1514514 4.7387878 44.25706 2.06E-05 8.40E-05 P 
Cj0045c 
 
iron-binding protein 2.3821147 5.2130032 8.4232851 85.319673 6.84E-07 5.50E-06 P 
Cj0438 sdhB succinate dehydrogenase iron-sulfur protein 2.3880397 5.2344562 10.21986 67.072751 2.48E-06 1.52E-05 C 
Cj0595c nth endonuclease III 2.4315328 5.3946628 6.509474 139.00827 4.50E-08 8.03E-07 L 
Cj0851c 
 
integral membrane protein 2.4465377 5.4510635 2.9570394 35.273681 6.13E-05 0.0002069 a 
Cj0997 
 
rRNA small subunit methyltransferase G 2.4692248 5.5374618 6.6076772 117.04344 1.19E-07 1.51E-06 M 
Cj0074c 
 
iron-sulfur protein 2.5289557 5.7715373 10.998016 256.91674 1.27E-09 1.02E-07 C 
Cj0423 
 
integral membrane protein 2.5307363 5.7786652 4.4361661 54.918963 7.00E-06 3.47E-05 a 
Cj0178 
 
TonB-denpendent outer membrane receptor 2.5369639 5.8036636 9.3404692 91.117629 4.78E-07 4.24E-06 P 
Cj0547 flaG flagellar protein FlaG 2.5557018 5.8795339 11.840391 124.80382 8.29E-08 1.19E-06 N 
Cj0391c 
 
hypothetical protein 2.5798097 5.9786083 14.136245 124.9864 8.23E-08 1.19E-06 S 
Cj1160c 
 
membrane protein 2.5841537 5.9966373 3.477779 21.888732 0.0004975 0.0012419 S 
Cj1583c 
 
peptide ABC transporter permease 2.5932801 6.0346917 5.1743807 87.605541 5.92E-07 5.04E-06 E, P 
Cj0564 
 
integral membrane protein 2.604465 6.0816593 2.67734 27.523075 0.0001885 0.0005323 a 
Cj1656c 
 
hypothetical protein 2.6057713 6.0871687 12.558106 273.34062 8.83E-10 8.82E-08 a 
Cj0419 
 
histidine triad (HIT) family protein 2.6060641 6.0884038 4.2444379 54.118325 7.55E-06 3.66E-05 F, G 
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Cj1631c 
 
hypothetical protein 2.6141485 6.1226173 8.5869024 256.02084 1.30E-09 1.02E-07 a 
Cj1224 
 
iron-binding protein 2.626435 6.1749821 7.4911256 108.57836 1.81E-07 2.02E-06 P 
Cj0975 
 
outer-membrane protein 2.630846 6.1938911 4.7187989 41.110098 2.96E-05 0.0001127 U 
Cj0755 cfrA ferric enterobactin uptake receptor 2.6333611 6.2046983 6.3342035 114.16095 1.37E-07 1.62E-06 P 
Cj1028c 
 
purine/pyrimidine phosphoribosyltransferase 2.6584129 6.3133813 6.0072507 100.51333 2.78E-07 2.84E-06 S 
Cj0611c 
 
acyltransferase family protein 2.6695914 6.3624895 7.5854272 116.64133 1.21E-07 1.51E-06 M 
Cj0481 dapA dihydrodipicolinate synthase 2.6803403 6.410071 8.3372396 53.239438 8.20E-06 3.89E-05 E 
Cj0972 
 
hypothetical protein 2.7094326 6.5406437 3.0221543 29.12664 0.0001468 0.0004308 U 
Cj1225 
 
hypothetical protein 2.7772863 6.8556159 6.2060427 115.53226 1.28E-07 1.57E-06 S 
Cj1614 chuA hemin uptake system outer membrane receptor 2.807523 7.0008154 7.7522276 86.368596 6.40E-07 5.23E-06 P 
Cj1714 
 
hypothetical protein 2.8320506 7.1208557 3.8005853 43.174516 2.33E-05 9.31E-05 a 
Cj0456c 
 
hypothetical protein 2.8366964 7.1438232 9.2128348 274.16606 8.68E-10 8.82E-08 a 
Cj1338c flaB flagellin B 2.84761 7.1980695 15.070605 208.00508 4.40E-09 1.91E-07 N 
Cj0795c murF UDP-N-acetylmuramoyl-tripeptide D-alanyl-D-alanine 
ligase 
2.8579006 7.2495959 8.9720013 152.53049 2.65E-08 5.94E-07 M 
Cj1607 ispDF bifunctional 2-C-methyl-D-erythritol 4-phosphate 
cytidylyltransferase/2-C-methyl-D-erythritol 2,4-
cyclodiphosphate synthase 
2.8594905 7.25759 9.8138058 299.54746 5.14E-10 8.07E-08 I 
Cj1530 coaE dephospho-CoA kinase 2.8597959 7.2591261 4.0781577 64.167476 3.13E-06 1.85E-05 H 
Cj1330 
 
isomerase 2.867363 7.297301 9.2333246 185.63565 8.53E-09 2.60E-07 S 
Cj0989 
 
membrane protein 2.9038095 7.4839997 3.1544882 21.576527 0.0005276 0.0013106 a 
Cj0265c 
 
cytochrome C-type heme-binding protein 2.9677422 7.8231096 10.080681 327.3804 3.03E-10 8.07E-08 O 
Cj0724 
 
hypothetical protein 2.97718 7.8744549 7.3233782 150.56996 2.85E-08 6.18E-07 a 
Cj0999c 
 
membrane protein 2.9836901 7.9100681 5.9281187 213.03676 3.83E-09 1.88E-07 S 
Cj1331 ptmB CMP-N,N'-diacetyllegionaminic acid synthase 2.9912963 7.9518815 9.7537207 149.66255 2.95E-08 6.18E-07 M 
Cj0736 
 
hypothetical protein 3.0043986 8.0244284 5.0126239 114.57208 1.34E-07 1.62E-06 a 
Cj0672 
 
periplasmic protein 3.0561556 8.3175326 2.6861153 28.678866 0.0001573 0.0004581 a 
Cj0864 
 
periplasmic protein 3.2117391 9.2646667 6.8897582 146.52807 3.33E-08 6.62E-07 O 
Cj0865 dsbB protein-disulfide oxidoreductase 3.2151459 9.2865707 7.1465486 140.42177 4.25E-08 7.67E-07 O 
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Cj1584c 
 
peptide ABC transporter substrate-binding protein 3.2154689 9.2886496 8.1281752 326.3521 3.09E-10 8.07E-08 E 
Cj1034c 
 
adenylosuccinate lyase 3.2508835 9.5194846 8.9784621 328.93717 2.94E-10 8.07E-08 O 
Cj0417 
 
hypothetical protein 3.257615 9.564006 9.5650741 190.64113 7.31E-09 2.39E-07 a 
Cj0977 
 
hypothetical protein 3.2793352 9.7090841 12.102288 241.61977 1.83E-09 1.15E-07 Q 
Cj1521c 
 
CRISPR-associated endoribonuclease Cas2 3.35103 10.203767 7.0292815 230.96767 2.38E-09 1.39E-07 L 
Cj0126c 
 
hypothetical protein 3.3748442 10.373596 6.684481 128.46847 7.04E-08 1.09E-06 S 
Cj1450 
 
ATP/GTP-binding protein 3.4475805 10.91001 12.285413 308.41846 4.32E-10 8.07E-08 S 
Cj0735 
 
periplasmic protein 3.4547444 10.964319 6.3560306 110.34877 1.66E-07 1.90E-06 a 
Cj0757 hrcA heat-inducible transcription repressor 3.5412571 11.64192 11.840582 299.49544 5.14E-10 8.07E-08 K 
Cj0416 
 
hypothetical protein 3.6126875 12.23284 8.818166 305.00815 4.61E-10 8.07E-08 a 
Cj1159c 
 
hypothetical protein 3.6170519 12.269902 2.1287489 23.247801 0.000388 0.0010019 a 
Cj0748 
 
hypothetical protein 3.8040965 13.968415 6.4285927 169.76794 1.43E-08 3.86E-07 a 
Cj0177 
 
iron transport protein 3.8098376 14.024113 6.1761213 172.10553 1.32E-08 3.69E-07 S 
Cj0457c 
 
lipoprotein 3.8323203 14.244373 9.5038201 379.76193 1.25E-10 8.07E-08 S 
Cj1632c 
 
periplasmic protein 3.8566352 14.48648 6.3787269 193.54938 6.69E-09 2.27E-07 a 
Cj0859c 
 
hypothetical protein 3.9132991 15.066779 12.432066 299.4914 5.14E-10 8.07E-08 a 
Cj1556 
 
transcriptional regulator 4.0111259 16.123867 7.140672 281.5581 7.41E-10 8.82E-08 K 
Cj1465 
 
hypothetical protein 4.0799742 16.911986 13.255333 420.89841 6.75E-11 8.07E-08 S 
Cj1464 flgM flagellar biosynthesis protein FlgM 4.3978993 21.081407 13.98308 259.7942 1.19E-09 1.02E-07 a 
Cj1384c 
 
hypothetical protein 5.2264311 37.437991 3.9290009 53.169795 8.26E-06 3.89E-05 S 
 
 
 
 
 
